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Abstract 
2-Pyrones, and related heterocycles such as 2-pyridones, 2-coumarins and 2-
quinolones, are useful model substrates to test a novel methodology due to their 
varied chemical properties. In addition, these moieties possess broad spectrum 
biological activity. Chapter 1 provides a review of C–H activation methodology as it 
has been applied to 2-pyrones and related heterocycles.  
Direct arylation via C–H activation of 2-pyrone, 2-pyridone and 2-coumarin 
compounds is described in Chapter 2. Protocols for the palladium-catalysed direct 
arylation of these molecules were developed and applied to a library of substrates. 
C–H activation at both the C–3 and C–5 positions of the 2-pyrone scaffold was 
achieved. The C–5 direct arylation methodology proceeded with retention of a C–Cl 
bond to give a cyclised 3-chloro-2-pyrone.  
In Chapter 3, the development of cross-coupling conditions for the cyclised 
3-chloro-2-pyrone is discussed. Following on from this, more generally applicable, 
environmentally friendly cross-coupling conditions evolved to allow the application 
of green chemistry principles to the Suzuki-Miyaura cross-coupling of 2-coumarins, 
2-pyrones, 2-pyridones and 2-quinolones, with yields of up to 99%. 
In parallel to the synthetic aspects of this project, investigations were also performed 
to understand the mechanisms through which 2-coumarins and related heterocycles 
undergo C–H activation and direct arylation reactions. In Chapter 4 the experiments 
which were performed as part of these investigations are described, and the results 
are presented. Based upon these results from three different sets of reaction 
conditions, it was proposed that C–H activation of these substrates occurs via 
concerted metallation-deprotonation.  
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H. Jackson Brown Jr. 
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Chapt er 1  Introducti on 
 Preface 
This chapter will consist of a manuscript entitled “Transition Metal-Catalysed C–H 
Activation of 2-Pyrones, 2-Pyridones, 2-Coumarins and 2-Quinolones” which will be 
submitted as a Microreview to the European Journal of Organic Chemistry in 2018. 
Consequently, sections of the chapter such as the abstract and introduction may 
contain repeating concepts and paragraphs. 
 Abstract 
C–H activation has emerged as a viable alternative to traditional C–C bond forming 
reactions such as the Suzuki-Miyaura, Stille, Negishi and others. However, C–H 
activation is rarely employed in total synthesis or fine chemical manufacture, 
particularly as an end-game strategy. This may be due to the harsh conditions 
typically required. For C–H activation to become a truly useful and versatile 
methodology, conditions must emerge which are applicable to compounds with 
multiple functionalities. In this review, we hope to inspire the chemistry community 
to focus their efforts on milder conditions for C–H activation and cross-
dehydrogenative coupling. To this end, we have focused on describing C–H activation 
as it has been applied to several classes of biologically interesting, but chemically 
sensitive motifs: the 2-pyrones, 2-pyridones, 2-coumarins and 2-quinolones. 
 Introduction 
The formation of aryl–heteroaryl bonds is a very important transformation in organic 
synthesis1 due to the abundance of this moiety in natural products and 
pharmaceuticals.2 The most widely used methods for the construction of this 
structural unit involve Suzuki-Miyaura,3-5 Stille,6-8 and Negishi9-10 couplings, and 
similar reactions (Scheme 1.1 (i)).11 More recently, direct arylation protocols which 
involve at least one C–H activation12-15 event, and offer a number of advantages over 
traditional cross-coupling, have emerged.16-20 For example, the installation of 
activating groups is bypassed, and the production of waste (e.g. B, Sn or Zn based) is 
eliminated. In an idealised scenario (Scheme 1.1 (ii)),21 both coupling partners are 
unactivated, with the only by-products being hydrogen gas (H2) or water (H2O). One 
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impediment to the widespread application of C–H activation methodology is the 
development of regioselective methods, as in the majority of cases a number of C–H 
bonds are available for activation. Thus it can be troublesome to control and predict 
regioselectivity, and directing groups are often needed to guide the transition metal 
into position and facilitate smooth reactivity.22 A chemical compromise is sometimes 
required (Scheme 1.1 (iii)), whereby one of the preactivated coupling partners is 
replaced with a simple arene.  
 
Scheme 1.1. Approaches to C–C bond formation. 
Alongside the development of oxidative cross-couplings catalysed by second- and 
third-row transition metals (Pd, Rh, Ru, etc.), first-row transition metal species have 
been discovered where single-electron transfer (SET) processes usually dominate. 
The regioselectivity in these radical-mediated reactions depends on the electronic 
nature of the potential reaction sites. The promising area of radical-mediated C–H 
activation and cross-coupling has recently been reviewed.23 
This review will focus on C−H activation reactions which have been reported to 
proceed via an organometallic mode of action, as distinct from direct 
functionalisation reactions which occur via mechanisms involving oxidation and SET. 
Several general mechanistic modes for transition metal-mediated C−H activation 
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processes have been proposed, such as electrophilic aromatic substitution (SEAr),24-
25 concerted metallation-deprotonation (CMD),26-35 and σ-bond metathesis.36-37 
For C–H activation to become a truly usable and versatile methodology, it must 
become a protocol applicable to compounds with multiple functionalities. C–H 
activation is a seldom-used methodology in total synthesis, especially in late-stage 
functionalisation,38 which reflects the harsh conditions typically required. 
As emphasised by Glorius,39 a major hurdle to the application of a new chemical 
methodology to real synthetic problems is a lack of information regarding its 
application beyond the idealised conditions of the seminal reports. By highlighting 
the strategies and conditions employed in the C–H activation of several chemically 
sensitive but biologically important motifs: 2-pyrone,40-43 2-pyridone,44 2-coumarin45-
47 and 2-quinolone48-50 (Figure 1.1), we hope to inspire other chemists to target their 
research towards milder reaction conditions for C–H activation so that it can become 
a truly useful synthetic tool. Due to the varied reactivity which can be displayed by 
these moieties (vide infra), they are excellent model compounds for the application 
of C–H activation in total synthesis.  
 
Figure 1.1. Biologically important substrates. 
In this review, reactions involving the organometallic C–H activation of 2-pyrones, 2-
pyridones, 2-coumarins and 2-quinolones will be discussed with relevant examples. 
It will be further subdivided based on the metal employed, and organised 
chronologically within each subsection. 
 C–H activation of 2-pyrones 
2-Pyrones are good model systems with which to test new methodologies, as they 
can possess aromatic,51 diene52-53 and enone54-55 properties and they have been 
shown to ring-open under some cross-coupling conditions (Figure 1.2).56 
Chapter 1  Introduction 
4 
 
 
Figure 1.2. Multiple functionality of 2-pyrones. 
Additionally, 2-pyrones are a privileged biological scaffold43 which have been shown 
to possess broad spectrum bioactivity, including antifungal, antibiotic and cytotoxic 
effects.40-42 For example, bufadienolides such as bufalin (Figure 1.3) are an important 
group of compounds characterised by a 2-pyrone connected to a steroid nucleus. The 
bufadienolides can have diverse biological effects, including cardiac poisoning in 
animals and inhibitory activity towards leukaemia cell lines.42 
 
Figure 1.3. Bufalin. 
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1.4.1. Palladium-catalysed C–H activation 
Moreno-Mañas reported the palladium-catalysed alkylation of 2-pyrones with allylic 
systems in 1988,57 which was proposed to occur via an initial reversible O-alkylation 
at C–4, followed by C–alkylation at C–3 (Scheme 1.2). 
 
Scheme 1.2. Palladium-catalysed alkylation of 2-pyrones. 
Majumdar described the intramolecular direct arylation of 2-pyrones and 2-
pyridones using palladium catalysis (Scheme 1.3).58 The reported conditions offered 
advantages over an existing methodology utilising tin hydrides via a proposed radical 
mechanism.59 
 
Scheme 1.3. Palladium-catalysed intramolecular arylation of 2-pyrones. 
Fairlamb reported a similar intramolecular regioselective C–H functionalisation of 2-
pyrones (Scheme 1.4).60 This reaction was also successful with a bromide on the aryl 
ring, and a variety of substitutions on the aryl ring were tolerated, except for 
electron-withdrawing groups which led to a reduction in yield. Substitution of the 
6-Me group by H, Ph and CH2CH2Ph did not hinder the reaction. A Heck-type 
mechanism involving carbopalladation of the 2-pyrone framework was proposed. 
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Scheme 1.4. Intramolecular direct arylation of 2-pyrones. 
C–H activation of 2-pyrone substrates to give six-membered heterocycles has been 
reported by Fairlamb and McGlacken (Scheme 1.5).61 Reaction at C–3 was completely 
regioselective when the substituent at C–6 was more sterically demanding than a 
methyl group. When a methyl group was present at C–6, up to 21% of the C–5 
cyclised product could be isolated. The authors proposed that catalysis occurred via 
a 16-electron [Pd(0)L2X] intermediate (where L is most likely solvent) derived from 
Pd(0) colloidal clusters stabilised by the tetrabutylammonium bromide (TBAB) salt. 
DFT calculations modelling a CMD C–H activation were utilised to examine the 
experimentally observed regioselectivity. It was shown that C–3–H activation was 
favoured over C–5–H activation, but that C–5–H activation remained accessible. 
 
Scheme 1.5. Intramolecular direct arylation to give six-membered rings at C–3 under 
modified Jeffery’s conditions. 
They also found that reaction at C–5 could be forced to occur if the C–3 position was 
blocked with a methyl group or a bromine (Scheme 1.6). The methyl blocking group 
gave an excellent yield of the C–5 coupled product, but this blocking group cannot 
be easily removed or further functionalised. Surprisingly, when a bromine was used 
as the blocking group, hydrodebromination of the C–5 cyclised product occurred. 
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Scheme 1.6. Intramolecular direct arylation to give six-membered rings at C–5 under 
modified Jeffery’s conditions. 
McGlacken reported a second set of conditions for C–H activation of 2-pyrone 
substrates to give six-membered rings (Scheme 1.7).62 These conditions were 
proposed to involve a homogeneous Pd species using PivOH as a necessary 
co-catalyst.61 A CMD mechanism was proposed. A variety of substituents at C–6 were 
well tolerated, and the reaction was regioselective for the C–3 position. The 
exception to this involved an electron-withdrawing group para to the site of oxidative 
addition, which led to reduced regioselectivity and the C–5 cyclised product was 
isolated. 
 
Scheme 1.7. Intramolecular direct arylation to give six-membered rings under CMD 
conditions. 
Palladium-catalysed direct dehydrogenative C–3 alkenylation of 2-pyrones was 
described by Lah in 2015 (Scheme 1.8).63 The reported methodology was 
regioselective for alkenylation at C–3 over C–5 in keeping with the trend of 2-pyrone 
C–H activation processes. The yields were remarkably consistent across the reported 
substrate scope. 
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Scheme 1.8. Dehydrogenative alkenylation of 4-hydroxy-2-pyrones. 
McGlacken reported the Pd-catalysed intramolecular direct arylation of 3-bromo-
2-pyrones (Scheme 1.9).64 These conditions were successfully applied to twelve 
2-pyrone substrates in moderate to excellent yields, including electron-poor aryl 
rings. A kinetic isotope effect of 3.3 for the cleavage of the aryl C–H bond was 
reported for the C–H activation reaction in the same paper, and a CMD mechanism 
was proposed. 
 
Scheme 1.9. Intramolecular direct arylation of 3-bromo-2-pyrones. 
This report also utilised 3-chloro-2-pyrones as substrates. A change in phosphine 
ligand and an increased loading of base were required (Scheme 1.10).64 The 
conditions were applied to three 2-pyrone substrates in good to excellent yields. By 
installing the halide on the 2-pyrone framework rather than on the aryl ring, a 
broader substrate scope was accessible through substituted phenols, which are more 
cost-effective than the corresponding halogenated phenols. 
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Scheme 1.10. Intramolecular direct arylation of 3-chloro-2-pyrones. 
McGlacken reported the double C–H activation, or cross-dehydrogenative coupling 
(CDC), of eight 2-pyrone substrates (Scheme 1.11).65 Despite the presence of two 
available sites for C–H activation on the 2-pyrone at C–3 and C–5, exclusive C–3–H 
activation was observed in all cases. 
 
Scheme 1.11. Double C–H activation/cross-dehydrogenative coupling of 4-phenoxy-
2-pyrones. 
Chen and Xu reported the synthesis of indolo[3,2-c]pyrones from 4-aniline 
substituted 2-pyrones by CDC (Scheme 1.12).66 The catalytic system is mild and base-
free, tolerating a range of phenyl-subsituted substrates to give N-unprotected 
products in good to excellent yields. 
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Scheme 1.12. Cross-dehydrogenative coupling of 4-anilino-2-pyrones. 
To our knowledge, with the exception of McGlacken’s 2014 report,61 all Pd-catalysed 
C–H activations of 2-pyrones have shown preferential reactivity towards C–3 
functionalisation. Recently, McGlacken and co-workers disclosed a direct arylation 
protocol which allowed access to C–5 cyclised products (Scheme 1.13).67 A C–Cl bond 
was retained at C–3 during the direct arylation process which allowed for further 
derivatisation at C–3. This was demonstrated with a Suzuki-Miyaura cross-coupling 
reaction. 
 
Scheme 1.13. Intramolecular direct arylation to give six-membered rings at C–5 with 
retention of C–Cl bond. 
1.4.2. Manganese-mediated C–H activation 
Lynam and Fairlamb have reported the first Mn(I)-catalysed C–H activation of 
2-pyrones.68 A highly reactive manganacycle was detected and characterised. The 
intermediate product is effective for hydride transfer to alkenylated products, or 
reductive elimination to pyridinium products. An excess of phenylacetylene was 
required to favour hydride transfer over reductive elimination (Scheme 1.14). These 
observations provided the first evidence of manganacycles as key intermediates in 
Mn(I)-catalysed C–H activation processes involving substrates containing directing 
groups. 
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Scheme 1.14. Manganese(I)-mediated C–H activation of 2-pyrones. 
 C–H activation of 2-pyridones 
2-Pyridones are isosteres of 2-pyrones, but could potentially ligate to metal catalysts 
via the nitrogen atom. The 2-pyridone moiety is an attractive target for synthetic 
chemists as a number of biologically active molecules contain this structural unit.44 
The 2-pyridone skeleton is present in many natural compounds which possess 
antibacterial and antifungal activity.44 2-Pyridone derivatives are key intermediates 
in the synthesis of pyridine, piperidine, quinolizidine and indolizidine alkaloids.69 
1.5.1. Palladium-catalysed C–H activation 
Li has described the mono-olefination of 2-pyridones at the C–5 position via 
Pd-catalysis with Cu(OAc)2 as the oxidant (Scheme 1.15).70 
 
Scheme 1.15. C–5 olefination of 2-pyridones via C–H activation. 
In the same report, the olefination of 2-pyridones at C–3 was achieved when C–5 was 
blocked with a bromo, alkyl or aryl group (Scheme 1.16).70 It was necessary for there 
to be an electron-withdrawing group on the olefin coupling partner. Sequential 
diolefination was also achieved under similar conditions.70 
Chapter 1  Introduction 
12 
 
 
Scheme 1.16. C–3 olefination of 2-pyridones via C–H activation. 
The CDC of 2-pyridones was also reported by Li in this paper (Scheme 1.17).70 The 
observed reactivity was similar for the olefinations and for the CDC of 2-pyridones 
and polyfluorinated arenes. Sequential diolefination was observed, but diarylation 
could not be achieved. The authors comment that the aryl-aryl cross-coupling 
appears to be both more sterically and electronically demanding than the 
corresponding olefination, and that the initial arylation should significantly 
deactivate the pyridone ring such that no further electrophilic C–H activation can be 
achieved.  
 
Scheme 1.17. The arylation of 2-pyridones via cross-dehydrogenative coupling. 
Fairlamb and McGlacken reported the intramolecular direct arylation of 2-pyridones 
under modified Jeffery’s conditions (Scheme 1.18).61 Interestingly, the conditions 
which were optimised for a 2-pyrone substrate (Scheme 1.5) were directly applicable 
to the corresponding 2-pyridone. Exclusive reaction at C–3 was observed. 
Chapter 1  Introduction 
13 
 
 
Scheme 1.18. Intramolecular direct arylation of 2-pyridones to give six-membered 
rings under modified Jeffery’s conditions. 
The first example of palladium-catalysed direct arylation of 2-pyridones with aryl 
boronic acids at C–3 was reported by Zografos (Scheme 1.19).71 This is a powerful 
and efficient method for the rapid construction of 3-aryl-4-hydroxy-2-pyridones. 
Informative kinetic experiments utilising NMR spectroscopy were used to study the 
undesired homocoupling of the 2-pyridone. It was shown that the formation of the 
C–3–Pd complex was reversible in the absence of K2CO3, and that there was a 
synergistic effect of the base on the formation of the dipyridone side-product. These 
experiments informed the suppression of this undesired side-product through the 
exclusion of K2CO3 from the reaction. 
 
Scheme 1.19. Direct arylation of 2-pyridones via C–H activation. 
McGlacken reported the intramolecular direct arylation of 2-pyridones (Scheme 
1.20).62 Again, exclusive reaction at C–3 was observed. The reaction is reported to 
proceed via a CMD mechanism. Notably, the conditions which were optimised for a 
2-pyrone substrate (Scheme 1.7) gave good yields for related 2-pyridone substrates. 
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Scheme 1.20. Intramolecular direct arylation of 2-pyridones to give six-membered 
rings under CMD conditions. 
Regioselective C–3 alkenylation was observed by Lah for 4-hydroxy-2-pyridones 
(Scheme 1.21).63 This represents the first direct 3-alkenylation of 4-hydroxy-
2-pyridones. The conditions required a catalytic quantity of Cu(OTf)2, which 
presumably acts as a co-oxidant with air.  
 
Scheme 1.21. Dehydrogenative alkenylation of 2-pyridones. 
The direct alkenylation of 2-pyridones was independently reported by Zografos 
(Scheme 1.22).72 In this case, under similar conditions, 3-alkenyl-4-hydroxy-
2-pyridones are also formed when using higher substituted alkenes. However, when 
terminal alkenes are used, intermediate Pd–O formation leads to a further reaction, 
and the efficient production of furo[3,2-c]-pyridinones. The authors suggest that the 
catalytic cycle starts with the direct activation of 4-hydroxy-2-pyridone by Pd(II), in 
line with their previous observations.71 Migratory insertion of the 
pyridone-palladium species to the alkene, followed by reductive elimination gives the 
Pd(0) and the product. Depending on the substrate, the product can undergo further 
oxidation, as is the case in Scheme 1.22. Pd(0) is proposed to undergo oxidation by 
Cu(OAc)2 back to Pd(II) to reenter the catalytic cycle. 
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Scheme 1.22. Sequential direct alkenylation and oxidation of 2-pyridones via C–H 
activation. 
Recently, McGlacken and co-workers disclosed a direct arylation protocol which 
allowed access to C–5 cyclised 2-pyrones with retention of a C–Cl bond (Scheme 
1.13).67 In contrast to a previous study by the same group,61 the methodology was 
successfully extended to 2-pyridone substrates (Scheme 1.23).67 
 
Scheme 1.23. Intramolecular direct arylation to give six-membered rings at C–5 with 
retention of C–Cl bond. 
1.5.2. Rhodium-catalysed C–H activation 
Liu described the 2-pyridine-directed, rhodium-catalysed C–H alkylation of 
2-pyridones with a wide variety of alkyl and cycloalkyl trifluoroborate reagents 
(Scheme 1.24).73 The reaction proceeded with excellent regioselectivity and 
functional group tolerance. Importantly, a protocol for subsequent removal of the 
N-pyridyl directing group was reported. 
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Scheme 1.24. Direct alkylation of 2-pyridones via C–H activation. 
Direct arylation at C–6 could also be achieved using Liu’s conditions, although higher 
temperatures were required (Scheme 1.25).73  
 
Scheme 1.25. Direct arylation of 2-pyridones via C–H activation. 
Direct arylation at C–6 of 2-pyridones was achieved by Samanta with quinone 
diazides under Rh(III) catalysis (Scheme 1.26).74 The authors proposed that a cationic 
Rh(III) species coordinates to the 2-pyridyl directing group on the nitrogen of the 
2-pyridone, then undergoes pivalate-assisted CMD to furnish a rhodacycle 
intermediate. The rhodacycle could then react with the quinonediazide to generate 
a metal-carbenoid intermediate with extrusion of N2. Migratory insertion of Rh, 
followed by protonation and rearomatisation would give the product and regenerate 
the active Rh(III) catalyst. 
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Scheme 1.26. Direct arylation of 2-pyridones via C–H activation. 
1.5.3. Nickel-catalysed C–H activation 
Nakao and Hiyama described the alkenylation of 2-pyridones by nickel catalysis 
(Scheme 1.27).75 Unusually, the transformations allow functionalisation at the 
6-position of 2-pyridones in the absence of a directing group. 
 
Scheme 1.27. Nakao and Hiyama’s direct alkenylation of 2-pyridones via C–H 
activation. 
Intermolecular alkylation using terminal alkenes could not be achieved under Nakao 
and Hiyama’s conditions. However, intramolecular addition across tethered terminal 
alkenes proceeded mainly in an exo-trig fashion to give bicyclic products (Scheme 
1.28).75 
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Scheme 1.28. Intramolecular alkylation of 2-pyridones via C–H activation. 
An exquisitive nickel-catalysed C–H functionalisation of 2-pyridones and subsequent 
cyclisation to 1,6-annulated 2-pyridones by selective intramolecular olefin 
hydroarylation was reported by Cramer.76 The switch between the exo- and 
endocyclisation modes was controlled by two complementary sets of ligands. 
Irrespective of ring size, the regioselectivity of the cyclisation fell under full catalyst 
control (Scheme 1.29). 
 
Scheme 1.29. Intramolecular olefin hydroarylation of 2-pyridones via C–H activation. 
 C–H activation of 2-coumarins 
2-Coumarins are structurally related to 2-pyrones, but the presence of an aromatic 
ring can confer additional stability compared to the 2-pyrone framework. The low 
toxicity of naturally-occurring 2-coumarins and their broad pharmacological 
properties are attractive to medicinal chemists as a source of novel therapeutic 
agents. The pharmaceutical industry, in particular, is deeply aware of this important 
moiety in the search for new drug candidates, as discussed by Proença and 
co-workers in a review of the biological importance of structurally diversified 
2-coumarins in 2016.77 
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1.6.1. Palladium-catalysed C–H activation 
Kapdi reported the microwave-assisted intramolecular direct arylation of 
4-(2-bromophen)oxy-2-coumarins (Scheme 1.30) using a phospha palladacycle.78 
The palladacyclic complex shown was found to be the most active of those screened 
for promoting the transformation. 
 
Scheme 1.30. Intramolecular direct arylation of 2-coumarins. 
McGlacken reported the intramolecular direct arylation of 4-(2-iodobenzyl)oxy-
2-coumarins (Scheme 1.31) after optimising the reaction conditions on the related 
2-pyrone scaffold (Scheme 1.7).62 The reaction was proposed to proceed via a CMD 
mechanism. Mechanistic experiments, including the isolation of an oxidative addition 
intermediate, were performed with the 2-coumarin substrate which demonstrated 
the requirement for PivOH in the success of the reaction. 
 
Scheme 1.31. Intramolecular direct arylation of 2-coumarins. 
The same group described the intramolecular direct arylation of 3-chloro-
2-coumarins to gain access to the coumestan family of compounds (Scheme 1.32), 
using conditions which had been optimised for the 2-pyrone substrate (Scheme 
1.10).64  
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Scheme 1.32. Intramolecular direct arylation of 3-chloro-2-coumarins. 
McGlacken reported the double C–H activation, or CDC, of fourteen 2-coumarin 
substrates (Scheme 1.33). The natural product flemichapparin C was synthesised as 
the major regioisomer in a synthetic route involving just three steps from 
commercially available starting materials (Scheme 1.34).65 The kinetic isotope effect 
for the C–H activation at the C–3 position of the 2-coumarin was determined to be 
1.08, showing that this was not the rate-determining step of the reaction. 
 
Scheme 1.33. Double C–H activation/cross-dehydrogenative coupling of 4-phenoxy-
2-coumarins. 
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Scheme 1.34. Total synthesis of flemichapparin C in 3 steps utilising 
cross-dehydrogenative coupling. 
Cheng et al. independently arrived at similar conditions for the double C–H activation 
of 2-coumarins (Scheme 1.35).79 Synthetic routes to the natural products coumestrol 
and flemichapparin C using this CDC methodology were also described. 
 
Scheme 1.35. Double C–H activation of 4-phenoxy-2-coumarins. 
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Gogoi and co-workers reported the direct synthesis of coumestans via a Pd-catalysed 
C–H activation/C–C and C–O bond formation cascade invoking aryne chemistry 
(Scheme 1.36).80 Flemichapparin C was also synthesised using this methodology. 
 
Scheme 1.36. Direct synthesis of coumestans via aryne chemistry. 
Cheng et al.’s report included an expanded substrate scope involving the synthesis 
of indole[3,2-c]coumarins (Scheme 1.37).79 
 
Scheme 1.37. Double C–H activation of 4-anilino-2-coumarins. 
The same group subsequently reported the synthesis of indolo[3,2-c]coumarins from 
4-aniline substituted 2-coumarins by CDC (Scheme 1.38) using improved conditions 
which did not require additional base or oxidant.66 
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Scheme 1.38. Base-free cross-dehydrogenative coupling of 4-anilino-2-coumarins 
without additional oxidant. 
Hajra also developed conditions for the synthesis of indolo[3,2-c]coumarins by CDC.81 
The synthesis of indolo[3,2-c]coumarins was achieved in one-pot from 4-hydroxy-
2-coumarins and anilines via 4-anilino-2-coumarins (Scheme 1.39). 
 
Scheme 1.39. Cross-dehydrogenative coupling of 4-anilino-2-coumarins. 
Litinas published the microwave-assisted CDC of 4-anilino-2-coumarins via 
Pd-catalysis in the presence of stoichiometric Cu(OAc)2 oxidant in acetic acid 
(Scheme 1.40).82 
 
Scheme 1.40. Cross-dehydrogenative coupling of 4-anilino-2-coumarins. 
An efficient protocol for the direct synthesis of 4-arylcoumarins via Pd-catalysed 
reaction of 2-coumarins and arylboronic acids was developed by Li and Duan 
(Scheme 1.41).83 The authors describe the reaction as an oxidative Heck coupling, 
but no catalytic cycle was proposed. 
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Scheme 1.41. Direct arylation of 2-coumarins. 
Jafarpour and Sharfiee described a very similar regioselective intermolecular 
arylation of 2-coumarins via palladium-catalysed arylation with arylboronic acids 
using an unsubstituted phenanthroline ligand (Scheme 1.42).84 
 
Scheme 1.42. Palladium-catalysed C–H activation of 2-coumarins. 
Hong disclosed a method for the C–4 regioselective CDC of 2-coumarins with 
unactivated arenes, allowing the construction of 4-arylcoumarins (neoflavones) 
(Scheme 1.43).85  
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Scheme 1.43. C–4 selective cross-dehydrogenative coupling of 2-coumarins with 
simple arenes. 
In the same report, Hong documented a preliminary direct alkenylation at C–3 of a 
2-coumarin (Scheme 1.44).85 This was followed by a further paper with improved 
conditions which did not require the radical inhibitor TEMPO (Scheme 1.45).86 
 
Scheme 1.44. Preliminary direct alkenylation of 2-coumarins. 
 
Scheme 1.45. Direct alkenylation of 2-coumarins. 
Jafarpour effected a switch in regioselectivity (Scheme 1.46)87 by altering the 
previously reported reaction conditions shown in Scheme 1.42.84 Trifluoroacetic acid 
anhydride (TFAA) proved an effective alternative to the sacrificial oxidant and 
solvent. The authors propose that Pd(TFA)2 is formed from Pd(OAc)2 in the presence 
of TFAA, and undergoes a subsequent conversion to electrophilic Pd(OCOCF3)+. 
Nucleophilic attack of 2-coumarin is suggested to generate a C–3 palladated 
intermediate, due to the more nucleophilic character of the C–3 position compared 
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to the C–4 position. Successive coordination with arenes, C–H bond metallation and 
reductive elimination releases the 3-arylcoumarin products. The authors state that 
the exact role of TFAA is obscured, but that it proved crucial for catalyst turnover. 
 
Scheme 1.46. C–3 selective CDC of 2-coumarins with simple arenes. 
A palladium-catalysed, regioselective, direct 3-arylation of coumarins with 
arenesulfonyl chlorides and sodium arenesulfinates was described by Jafarpour 
(Scheme 1.47).88 The authors propose that the first step of the mechanism is 
oxidative addition of Pd into the S–Cl bond of the arenesulfonyl chloride, followed by 
extrusion of SO2 to generate an arylpalladium intermediate (similar to the 
intermediate generated from traditional oxidative addition into an arylhalide). C–H 
activation of the 2-coumarin, followed by successive transmetallation with the 
arylpalladium intermediate and reductive elimination affords the 3-arylated 
2-coumarin product. The copper salt is suggested to act as an oxidant for Pd and to 
contribute to the desulfonation process. 
 
Scheme 1.47. Direct arylation of 2-coumarins. 
Jafarpour subsequently described the regioselective 4-arylation of 2-coumarin-
3-carboxylic acids using palladium catalysis (Scheme 1.48).89 The authors propose 
that a palladium-catalysed protodecarboxylation at C–3 is followed by a 
regioselective oxidative Heck reaction at C–4. When 2-coumarin-3-carboxylic acid 
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was submitted to the reaction conditions in the absence of arylboronic acid, the 
protodecarboxylated 2-coumarin was isolated in 46% yield. 
 
Scheme 1.48. Palladium-catalysed C–H activation of coumarin-3-carboxylic acids. 
The presence of a 4-alkoxy group on the 2-coumarin framework has a dramatic effect 
on the relative ease of C–3–H activation and functionalisation compared to the 
unsubstituted 2-coumarin motif. Attempts to facilitate the intermolecular coupling 
of a 4-alkoxy-2-coumarin substrate by McGlacken and co-workers provided <10% 
yield of the desired product in all cases.62 However, when a precatalyst (designed to 
produce Pd(0) quickly29) was utilised, the first intermolecular 3-arylation of 4-alkoxy-
2-coumarins was achieved, albeit in a poor yield of 33% (Scheme 1.49).62 
 
Scheme 1.49. Intermolecular direct arylation of 2-coumarins. 
Shafiee described a protocol for the domino C–C and C–H activation of 
2-coumarins.90 A sequence of arylation-decarbonylation-arylation reactions renders 
2-coumarins as convenient surrogates for the synthesis of diarylbenzo[b]furans 
(Scheme 1.50). The authors propose a mechanism whereby initial 3-arylation of the 
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2-coumarin via C–H activation is followed by decarbonylation of the coumarin ring 
with loss of CO to give a 2-arylated benzo[b]furan. Subsequent arylation via C–H 
activation at the 3-position of the 2-arylbenzo[b]furan results in the formation of the 
2,3-diarylated benzo[b]furan. 
 
Scheme 1.50. One-pot synthesis of benzo[b]furans from 2-coumarins. 
Alami and Messaoudi reported the synthesis of 3-(benzofuran-2-yl)-2-coumarins 
from a single starting material in one pot. This methodology involved a C–C bond 
formation via C–H activation, and C–O bond formation via ring contraction of 
2-coumarin to 2-benzofuran under palladium catalysis (Scheme 1.51).91  
 
Scheme 1.51. One-pot synthesis of 3-(benzofuran-2-yl)-2-coumarins. 
1.6.2. Copper-mediated C–H activation 
The C–O cyclisation via C–H functionalisation of 2-coumarins was reported by Hong 
(Scheme 1.52).92 The C–O cyclisation of 4-arylcoumarins was possible due to the 
favourable metallation of the nucleophilic C–3 position. 
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Scheme 1.52. C–O cyclisation of 4-aryl-2-coumarins. 
 C–H activation of 2-quinolones 
2-Quinolones are structurally related to 2-pyridones, but the additional aromaticity 
and stability conferred by the phenyl ring on the backbone could alter the chemical 
reactions that this moiety participates in. As an important class of compounds, 
2-quinolones are isomeric to 4-quinolones and isosteric to 2-coumarins. Compounds 
bearing the 2-quinolone moiety are associated with antibacterial, anticancer and 
antiviral properties, amongst other biological traits.48 The 2-quinolone could 
potentially be more difficult to functionalise than the corresponding 2-coumarin due 
to the potential of the nitrogen to ligate to metal catalysts. 
1.7.1. Palladium-catalysed C–H activation 
Li described the intermolecular direct arylation of a 2-quinolone substrate (Scheme 
1.53).70 Pentafluorobenzene was used as a coupling partner, rendering the 
electron-poor aryl C–H bond more amenable to activation. Ag2CO3 is proposed to act 
as an oxidant for Pd, while iPr2S was used as an additive. The use of DMSO instead of 
iPr2S was reported to give a slightly lower yield. Sulfides and sulfoxides have been 
proposed to act as ligands to Pd which prevents the formation of palladium black.93  
 
Scheme 1.53. Intermolecular cross-dehydrogenative coupling of 2-quinolones. 
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McGlacken reported the intramolecular direct arylation of 4-(2-iodobenzyl)oxy-
2-quinolone (Scheme 1.54).62 The reaction is proposed to proceed via a CMD 
mechanism.  
 
Scheme 1.54. Intramolecular direct arylation of 2-quinolones. 
McGlacken described the CDC of a 4-phenoxy-2-quinolone, albeit in low yield 
(Scheme 1.55).65  
 
Scheme 1.55. Cross-dehydrogenative coupling of a 2-quinolone. 
Chen and Xu reported the synthesis of indolo[3,2-c]quinolones from 4-aniline 
substituted 2-quinolones by CDC (Scheme 1.56), expanding the scope of the 
base-free conditions which had been optimised for indolo[3,2-c]coumarins.66 
 
Scheme 1.56. Base-free cross-dehydrogenative coupling of 4-anilino-2-quinolones. 
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 Mechanistic considerations 
Two general mechanistic proposals dominate in these substrate classes: CMD and 
oxidative Heck.94-95 
The CMD mechanism is characterised by a non-directed process whereby metallation 
and proton abstraction by an intramolecular carboxylate base occurs in a concerted 
manner (Scheme 1.57).35 The first step could be oxidative addition by Pd(0) into an 
carbon-halide bond, or a CMD-type C–H activation of a C–H bond. A κ2-κ1 
displacement of acetate (or other carboxylate) by the C–H bond leads to the 
formation of an agostic intermediate. The agostic intermediate features a polarised 
C–H bond that can engage in hydrogen bonding with the κ1-OAc ligand. Cleavage of 
the C–H bond proceeds via a six-membered transition state to give a palladated 
intermediate. Reductive elimination of Pd(0), followed by oxidation if required, 
regenerates the active catalyst. Carboxylate bases possess a privileged status in this 
mechanism due to their chelating ability, which allows them to remain bound to the 
metal centre using one oxygen group, while the other effects a deprotonation. 
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Scheme 1.57. Generic mechanism for CMD. 
On the other hand, the oxidative Heck mechanism (Scheme 1.58) is widely proposed 
to operate via generation of a reactive palladium species, addition of palladium to a 
transferable group (R1H), coordination and insertion of the alkene 
(carbopalladation), Pd–H dissociation to give the product and regeneration of the 
active catalytic species.95 Isomerisation of the alkene double bond may occur via 
reversible Pd–H elimination prior to release of the product.95 
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Scheme 1.58. Generic mechanistic proposal for the oxidative Heck reaction. 
 Conclusions and outlook 
In this review, C–H activation reactions as they have been applied to 2-pyrones, 
2-pyridones, 2-coumarins and 2-quinolones have been described.  
Many of the C–H activation reactions reviewed here involve the 4-hydro derivatives 
as substrates, although 4-hydroxy and 4-alkoxy derivatives of these substrates are 
widely encountered in natural products. Reactions involving the 4-hydroxy moiety 
are particularly underdeveloped, which is remarkable considering the known 
potency of such compounds. The difference in reactivity observed when 
substitutions are made to the core 2-pyrone and 2-pyridone ring highlights that the 
success of reaction conditions for 4-hydro derivatives does not predicate success 
with the corresponding 4-hydroxy and 4-alkoxy derivatives. 
The field of C–H activation in general requires more development, such that C–H 
bonds can be activated as required in any molecule. Although great strides have been 
made, a high loading of the metal catalyst (compared to traditional cross-coupling) is 
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often required, and necessary additives are often corrosive and/or expensive. Recent 
research has begun to focus on moving away from platinum group metals, towards 
cheaper, Earth-abundant metals96 such as iron,97 manganese98 and cobalt.99 It is also 
important to consider the environmental impact of new reactions. There is an 
increasing focus on reactions which are sustainable, particularly those executed in 
benign solvents.100-101 
However, all such developments must take into consideration the eventual use of C–
H activation in complex molecules with multiple functional groups. By highlighting 
the techniques and reaction conditions which have been used in the C–H activation 
of 2-pyrones and related heterocycles, it is hoped that the community will be inspired 
to direct their research towards milder reactions conditions. This would allow C–H 
activation to become a truly usable and versatile methodology which could be 
applied as an end-game strategy in total synthesis and the fine chemicals industry. 
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Aims and Objectives 
The overall aim of the research described in this thesis is the development of novel 
methodologies for the synthesis of arylated derivatives of the 2-pyrone framework, 
as well as the extension of any such methodology to the related 2-coumarin, 
2-pyridone and 2-quinolone heterocycles. 
In Chapter 2, the direct arylation of 2-pyrones, 2-pyridones and 2-coumarins via C–H 
activation will be investigated. As part of this research a number of objectives will be 
followed, namely: 
 Develop the use of palladium to effect an intramolecular cyclisation via 
activation of the C–3–H of the 2-pyrone framework. 
 Demonstrate the substrate scope through extending the optimised 
methodology to a range of substrates. 
 Develop the use of palladium and blocking groups to effect an intramolecular 
cyclisation at the C–5 position of the 2-pyrone framework. 
 Extend optimised synthetic methodology to a range of substrates. 
 Investigate the effect of changing the nature of the intramolecular linker. 
 Assess the feasibility of intermolecular direct arylation. 
In Chapter 3, the Suzuki-Miyaura cross-coupling of 3-chloro-2-pyrones, 2-pyridones, 
2-coumarins and 2-quinolones will be investigated. As part of this research a number 
of objectives will be followed, namely: 
 Optimise conditions to effect the Suzuki-Miyaura cross-coupling of the 
3-chloro-C–5-cyclised product of direct arylation. 
 Identify a more environmentally-friendly reagent than N-chlorosuccinimide 
for chlorination of 2-pyrones and 2-coumarins. 
 41 
 
 Develop Suzuki-Miyaura conditions for the 3-arylation of 4-alkoxy-
2-coumarins in an environmentally-benign solvent. 
 Identify a method to access 3-aryl-4-hydroxy-2-coumarins using protecting 
group chemistry. 
In Chapter 4, mechanistic investigations will be performed to develop our 
understanding of the mechanisms through which 2-coumarins and related 
heterocycles undergo C–H activation and direct arylation reactions. Several 
objectives will be followed, namely: 
 Develop protocols to introduce deuterium into target substrates. 
 Conduct H–D exchange and kinetic isotope effect (KIE) experiments. 
 Propose likely mechanisms for CH activation of these substrates. 
 Engage with key collaborators for Density Functional Theory (DFT) 
calculations as required. 
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…a person that started in to carry a cat home by the tail was getting knowledge that 
was always going to be useful to him, and warn’t ever going to grow dim or doubtful. 
Mark Twain 
Tom Sawyer Abroad; 1894 
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Chapt er 2  Direct arylation of 2-pyrones a nd relat ed heterocycle s  
 Introduction 
In this chapter the synthesis of a library of 2-pyrone, 2-pyridone and 2-coumarin 
compounds by direct arylation is described. It was necessary to prepare the target 
direct arylation substrates as they are not commercially available and several are 
novel. 
 Direct arylation at C–3  
The 2-pyrone moiety represents a challenging synthon, due to its varied chemical 
reactivity, as described in Chapter 1. 2-Pyrone and its structurally related 
heterocycles 2-pyridone, 2-coumarin and 2-quinolone are classes of privileged 
biological scaffolds which display a variety of biological activity, as detailed in Chapter 
1. Additionally, most of the direct arylation methodologies published to date have 
been performed on robust aryls and heterocycles, such as indoles. Consequently, the 
development of direct arylation methodology on the delicate 2-pyrone framework 
was chosen as the objective for this research because this moiety is more similar to 
the type of varied functionality which would be found in an active pharmaceutical 
ingredient or natural product. 
Tricyclic 2-pyrone systems have been prepared using a catalytic C–H activation 
process by others.1-3 Catalytic systems involving Pd(0) precatalysts, phosphine 
ligands and Cs2CO3 as base were employed in the formation of new five-membered 
rings from 4-phenoxy-2-pyrone substrates. Regioselective cyclisation at C–3 
occurred. It was expected that similar methodology could be used in the formation 
of new six-membered rings from 4-benzyloxy-2-pyrone substrates. 
2.2.1. Synthesis of substrates  
2-Pyrones 
Initially, research was focused on the direct arylation of 4-benzyloxy-2-pyrones to 
give isochromenone-type structures via C–H activation (Scheme 2.1). 
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Scheme 2.1. General scheme for direct arylation of benzyloxy substrates. 
For the synthesis of the target substrates, 2-iodobenzyl bromide (2) was required. 
Dihalide 2 is commercially available, but it proved more cost-effective to synthesise 
it in-house from 2-iodobenzyl alcohol (1) using standard bromination procedures. 
Using a procedure reported by Kato et al.4 with tetrabutylammonium bromide 
(TBAB) as the bromide source, 2-iodobenzylbromide (2) was synthesised in 81% 
isolated yield and did not require further purification (Scheme 2.2). 
   
1  2, 81% 
Scheme 2.2. Bromination of 2-iodobenzyl alcohol 1.  
The dihalide 2 was also synthesised using PBr3 in distilled THF for 40 min, giving 75% 
isolated yield after recrystallisation from EtOH.5 
4-((2-Iodobenzyl)oxy)-6-methyl-2-pyrone (4) was prepared from 
2-iodobenzylbromide (2) and commercially available 4-hydroxy-6-methyl-2-pyrone 
(3) via a classical benzylation procedure, with 2 as the electrophile and 3 as the 
nucleophile (Scheme 2.3).2 
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3 2  4, 37% 5, yield N. D. 
   crude ratio ca. 4:1 
Scheme 2.3. Benzylation of 4-hydroxy-2-pyrone 3. 
The crude product of this reaction was purified by recrystallisation from EtOH to give 
4 in 37% isolated yield. Purification of 4 by column chromatography on silica gel was 
found to be very low-yielding, due to the co-elution of the side product 5, which is 
the product of a second benzylation at the C–3 position. A sample of 5 was isolated 
and the structure was determined using NMR spectroscopy and high resolution mass 
spectrometry.  
As the purification of our desired starting material from the benzylation reaction was 
proving problematic, several alternative syntheses were attempted. The first 
involved the use of Ag2CO3 instead of K2CO3 as the base, which has been shown to 
promote selective O-alkylation in certain substrates.6 In our case, a complex mixture 
of products was obtained and this method was not pursued further. Deprotonation 
of 2-iodobenzyl alcohol (1) with NaH and subsequent reaction with 4-bromo-
2-pyrone 6 (prepared in 45% yield from 4-hydroxy 2-pyrone 3) was also attempted 
as a regioselective route to 4. However, even at elevated temperatures overnight, 
only starting materials were identified by 1H NMR (Scheme 2.4). 
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1 
 
 
 
3  6, 45%  4 
Scheme 2.4. Attempt to promote selective O-benzylation to 2-pyrone 4. 
Since these alternative syntheses proved less successful than the original synthesis, 
it was determined that future preparation of 4 would use the conditions described in 
Scheme 2.3. The purification is most successful when performed on a multi-gram 
scale. The ratio of 4:5 in the crude reaction mixture was >4:1 and the desired product 
was isolated in 37% yield (Scheme 2.3). During the development of this route it was 
shown that bulk acetone can be used with no effect on yield, which offers an 
improvement over previously reported conditions.7 
A range of C–6 substituted 2-pyrones are found in natural products.8 Therefore, 
6-phenyl-substituted 2-pyrone substrate 9 was synthesised in two steps (Scheme 
2.5). Dioxinone 7 was heated at 110 °C in toluene for 30 min, yielding 4-hydroxy-
2-pyrone 8 in 65% yield after chromatography on silica gel. The 4-hydroxy-2-pyrone 
8 was then benzylated with 2-iodobenzylbromide (2) to yield substrate 9 in 64% yield 
after chromatography on silica gel. While a dibenzylation side product similar to 
compound 5 was observed in the 1H NMR spectrum of the crude reaction mixture, it 
did not cause the same problems for the purification of 9. 
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2 
 
 
 
 
7  8, 65%  9, 64% 
Scheme 2.5. Synthesis of 4-hydroxy-6-phenyl-2-pyrone substrate 9.  
To ultimately probe the effect of electronics on the direct arylation reaction, 
fluorinated substrate 12 was synthesised. First, the appropriately substituted benzyl 
alcohol 10 was brominated to give 11 in 36% yield after column chromatography on 
silica gel (Scheme 2.6). 
   
10  11, 36% 
Scheme 2.6. Synthesis of 5-fluoro-2-iodobenzylbromide (11).  
Compound 11 was then reacted with 2-pyrone 3 in the presence of K2CO3 to give 12 
in 45% yield after chromatography on silica gel (Scheme 2.7). While a dibenzylation 
side product similar to compound 5 was observed in the 1H NMR spectrum of the 
crude reaction mixture, it did not cause the same problems for the purification of 12. 
 
 
 
 
 
 
 
 
 
 
3 11  12 45% 
Scheme 2.7. Synthesis of aryl substituted 2-pyrone 12.  
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2-Pyridones 
2-Pyridone compounds are potential bioisosteres of 2-pyrone compounds, and have 
also been demonstrated to possess impressive biological activity.9-10 4-Hydroxy-1,6-
dimethylpyridin-2(1H)-one (13) and 1-benzyl-4-hydroxy-6-methylpyridin-2(1H)-one 
(14) were synthesised from 4-hydroxy-6-methyl-2-pyrone (3) in refluxing water 
(Scheme 2.8), and isolated in 50% and 51% yield respectively. Characterisation data 
corresponded to that reported in the literature.11-12  
 
 
 
 
3  13, 50% 
 
 
 
 
3  14, 51% 
Scheme 2.8. Synthesis of substituted 2-pyridones 13-14. 
Once synthesised, the substituted 2-pyridone compounds were benzylated using the 
reported procedure.13 The complete separation of mono- and di-benzylated 
compounds was achieved using column chromatography on silica gel with 
EtOAc/hexanes as the eluent. Both the bromo- and iodo- analogues were prepared 
(Scheme 2.9) to examine if the halide had an effect on the final direct arylation of the 
substituted 2-pyridone compounds.  
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13-14 X = I (2), Br  15-18 
  
  
15, 70% from 13 
 
16, 29% from 13 17, 53% from 14 18, 55% from 14 
Scheme 2.9. Synthesis of 4-benzyloxy 2-pyridones 15-18. 
2-Coumarins 
2-Coumarin compounds are structurally related to the 2-pyrone compounds, and 
have also been demonstrated to possess interesting bioactivity.14 4-Hydroxy-
2-coumarin (19) is commercially available and was benzylated using the procedure 
shown in Scheme 2.10.  
 
 
 
 
 
 
 
19 
 
2  20, 45% 
Scheme 2.10. Benzylation of 4-hydroxy-2-coumarin (19). 
6-Ethyl-4-hydroxy-2-coumarin (21), 6-methyl-4-hydroxy-2-coumarin (22) and 
6-methoxy-4-hydroxy-2-coumarin (23) were synthesised using a one-pot procedure 
reported by Gao et al.15 Starting from the corresponding phenol and Meldrum’s acid, 
the target coumarins were isolated in good yields after recrystallisation of the crude 
product from EtOH (Scheme 2.11).  
Chapter 2  Results and Discussion 
49 
 
 
 
  
   21-23 
   
21, 76% 22, 71% 23, 31% 
Scheme 2.11. Synthesis of substituted 4-hydroxy-2-coumarins 21-23. 
For 2-coumarins bearing electron-withdrawing groups, an alternative synthesis was 
required.16-17 5-Fluoro-2-hydroxyacetophenone was reacted with diethyl carbonate 
in the presence of NaH to give 6-fluoro-4-hydroxy-2-coumarin (24) in 26% yield after 
recrystallisation from EtOH (Scheme 2.12).  
 
  
 
   24, 26% 
Scheme 2.12. Synthesis of 6-fluoro-4-hydroxy-2-coumarin (24).  
6-Nitro-4-hydroxy-2-coumarin (25) was synthesised by nitration of 4-hydroxy-
2-coumarin (19) (Scheme 2.13).18 The 1H NMR spectrum of the crude reaction 
mixture showed residual starting material 19 and the selectively 6-nitrated product 
25, which was isolated, albeit in a poor yield of 26%, after recrystallisation from EtOH.  
 
 
 
19  25, 26% 
Scheme 2.13. Nitration of 4-hydroxy-2-coumarin (19).  
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The 4-hydroxy-2-coumarins 21-25 were then benzylated using 2-iodobenzylbromide 
(2) and purified by column chromatography on silica gel using DCM:MeOH as eluent 
to give 26-30 in moderate yields (Scheme 2.14).  
 
 
 
 
 
 
21-25 2  26-30 
   
26, 42% from 21 27, 42% from 22 28, 20% from 23 
  
29, 52% from 24 30, 50% from 25 
Scheme 2.14. Benzylation of substituted 4-hydroxy-2-coumarins 21-25. 
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2.2.2. Optimisation of reaction conditions for C–3 arylation 
With the desired substrates in hand, the development of reaction conditions to effect 
the direct arylation via C–H activation began. It was anticipated that both C–3 and C–
5 cyclisation could occur (Scheme 2.15).  
 
 
 
  
  31 32 
Scheme 2.15. Direct arylation of 4-benzyloxy 2-pyrones with two potential C–H 
activation sites. 
The Pd-catalysed cyclisation of 2-pyrones to form five-membered rings has been 
reported by Fairlamb.3 However, the reported conditions gave poor conversion to 
six-membered rings in our hands (Table 2.1, entry 1). Previously reported cyclisations 
by Majumdar1-2 and the McGlacken group to give six-membered rings,7 using so-
called Jeffery’s conditions,19 required the use of stoichiometric or 
superstoichiometric amounts of TBAB and thus suffer from poor atom and cost 
economy, and falter from an environmental viewpoint. 
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Table 2.1. Optimisation of direct arylation conditions. 
   
4  31 
Entry Additive Catalyst Ligand Base 
 
Solvent Time 
(h) 
Yield 
(%)a 
1 – Pd2(dba)3 PPh3 Na2CO3 NMP 2 11 
2 PivOH Pd2(dba)3 PPh3 Na2CO3 NMP 2 (77) 
3 TFA Pd2(dba)3 PPh3 Na2CO3 NMP 18 7 
4 Butyric acid Pd2(dba)3 PPh3 Na2CO3 NMP 18 6 
5 Acetic acid Pd2(dba)3 PPh3 Na2CO3 NMP 18 5 
6 Isobutyric acid Pd2(dba)3 PPh3 Na2CO3 NMP 18 13 
7 Citric acid Pd2(dba)3 PPh3 Na2CO3 NMP 18 9 
8 Ph2CHCO2H Pd2(dba)3 PPh3 Na2CO3 NMP 18 13 
9 1-adamantoic 
acid 
Pd2(dba)3 PPh3 Na2CO3 NMP 2 (62) 
10 PivOH Pd(OAc)2 PPh3 Na2CO3 NMP 2 64 (54) 
11 PivOH Pd(dba)2 PPh3 Na2CO3 NMP 2 51 
12 PivOH Pd(PPh3)4 PPh3 Na2CO3 NMP 2 66 
13 PivOH Pd2(dba)3 DavePhos Na2CO3 NMP 2 48 
14 PivOH Pd2(dba)3 cataCXium®A Na2CO3 NMP 2 52 
15 PivOH Pd2(dba)3 PCy3.HBF4 Na2CO3 NMP 2 60 
16 PivOH Pd2(dba)3 PPh3 K2CO3 NMP 2 42 (38) 
17 PivOH Pd2(dba)3 PPh3 NaOAc NMP 2 70 
18 PivOH Pd2(dba)3 PPh3 Na2CO3 DMA 2 56 (30) 
19 PivOH Pd2(dba)3 PPh3 Na2CO3 Toluene 2 7 
aYields determined from the 1H NMR spectrum of the crude reaction mixture with 
1,3,5-trimethoxybenzene as the internal standard for quantification. Isolated yields 
in parentheses. 
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The addition of an acidic co-catalyst, pivalic acid (PivOH), greatly enhanced the 
efficiency of the reaction, and the desired product 31 was obtained in 77% isolated 
yield (Table 2.1, entry 2). Fagnou demonstrated that PivOH is a promoter of the CMD 
reaction pathway for C–H activation,20 which had previously been described by 
Echavarren21-22 and Davies/Macgregor.23-24 Interestingly, Fairlamb reported that the 
addition of PivOH to their system for the direct arylation of 4-phenoxy-2-pyrones to 
give five-membered rings led to a reduction in yield from 79% to 45%.3 This is an 
indication that a different mechanism could be at play in the 4-benzyloxy system 
compared to Fairlamb’s 4-phenoxy system. Mechanistic insights into the 4-benzyloxy 
system will be further discussed in Chapter 4. 
An extensive screen of other acidic co-catalysts was then undertaken (Table 2.1, 
entries 3-9). Acids with a pKa similar to that of PivOH (Table 2.1, entry 2) such as 
acetic acid (Table 2.1, entry 5) and isobutyric acid (Table 2.1, entry 6) resulted in 
incomplete consumption of the starting material. Of the eight acids tested, PivOH 
(Table 2.1, entry 2) and 1-adamantoic acid (Table 2.1, entry 9) gave complete 
consumption of starting material, and in only 2 h. Given the higher yield with PivOH 
compared to 1-adamantoic acid, this additive was used in the optimisation of the 
other components of the reaction (Table 2.1, entries 10-19). Of the palladium 
catalysts screened, only Pd(OAc)2 (Table 2.1, entry 10) and Pd2(dba)3 (Table 2.1, 
entry 2) facilitated complete consumption of starting material. Other phosphine 
ligands, such as DavePhos (Table 2.1, entry 13), cataCXium®A (Table 2.1, entry 14) 
and PCy3.HBF4 (Table 2.1, entry 15) did not perform as well as PPh3 (Table 2.1, entry 
2). Carbonate bases are typically used in direct arylation reactions involving PivOH as 
a co-catalyst.24 K2CO3 (Table 2.1, entry 16) gave a reduced yield compared to Na2CO3. 
It is possible that the stronger base caused degradation of the 2-pyrone motif. NaOAc 
gave a moderate yield (Table 2.1, entry 17), and Na2CO3 remained the preferred base 
in this system. The reaction proceeded to completion in DMA, but with a reduced 
yield (Table 2.1, entry 18). Polar aprotic solvents are generally the solvents of choice 
for direct arylation reactions involving palladium catalysts, so it is unsurprising that 
toluene gave a very poor yield of 7% (Table 2.1, entry 19). NMP was favoured as the 
reaction solvent as it gave the best yield (Table 2.1, entry 2).  
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It was found by another member of the McGlacken group25 that reducing the 
palladium loading to 2 mol% with a concomitant reduction of PPh3 to 4 mol% resulted 
in no reduction in yield.26 McGlacken and co-workers have previously shown that 
lower catalytic loadings of palladium can have a positive outcome on reaction 
efficiency.7 The optimal conditions for direct arylation to give product 31 involved 
Pd2(dba)3 (2 mol%), PPh3 (4 mol%), PivOH (30 mol%) and Na2CO3 (3 equiv.) in NMP at 
130 °C for 2 h. 
The C–3 arylated product 31 was strongly favoured in all cases shown in Table 2.1. 
The C–5 arylated product 32 was observed in the 1H NMR spectrum of the crude 
reaction mixture for reactions involving 6-methyl-2-pyrones and the related product 
was observed for 6-methyl-2-pyridones. However, complete regioselectivity was 
observed with other C–6-substituted 2-pyrones, as in Scheme 2.16. Complete 
consumption of starting material 4 was achieved at the lower temperature of 100 °C 
in 5 h, with all other parameters the same as the optimal conditions. However, an 
erosion of yield and regioselectivity was observed. There was a 78:22 ratio of 31:32 
determined from the 1H NMR spectrum of the crude reaction mixture, and product 
31 was isolated in 46% yield.  
2.2.3. Demonstration of substrate scope for C–3 arylation 
With the optimised conditions in hand, the broader applicability of the system was 
tested using the previously synthesised library of compounds. 
It is generally accepted that oxidative addition occurs faster into C–I bonds compared 
to C–Br bonds.27 Interestingly, using the aryl bromide 9 in the conditions optimised 
for an aryl iodide did not seem to have an appreciable effect on yield or reaction 
time. The product 33 was isolated in 61% yield after chromatography on silica gel. In 
this case, complete regioselectivity was observed for C–3 arylation, presumably due 
to the steric influence of the phenyl group making the C–5 site disfavoured (Scheme 
2.16). 
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9  33, 61% 
Scheme 2.16. Direct arylation of 6-phenyl-2-pyrone 9.  
To determine the effect of placing an electron-withdrawing group para to the site of 
oxidative addition, 2-pyrone 12 was subjected to the reaction conditions (Scheme 
2.17). 
    
12  34, 65% 35, 15% 
Scheme 2.17. Direct arylation of a 2-pyrone 12 with substituted aryl group.  
The presence of the p-fluoro group had a significant effect on the reaction, and the 
C–5 arylated product 35 was formed as a side-product in isolable quantities for the 
first time using these conditions. Previously, only trace quantities of the C–5 arylated 
product could be observed in the 1H NMR spectrum of the crude reaction mixture 
from 4 using the PivOH conditions. The reason for the decline in regioselectivity is 
attributed to an increase in reactivity, especially considering the poor yield using an 
electron-rich p-methoxy substrate.26 Electron-poor aryl halides oxidatively add to 
Pd(0) more readily than the corresponding electron-rich aryl halides.28 This could 
lead to the oxidative addition product of electron-rich aryl halides persisting for 
longer, and ultimately, lead to degradation of the oxidative addition product. 
The substituted 2-pyridones 15-18 were subjected to the optimised direct arylation 
conditions (Scheme 2.18). Complete consumption of starting material took longer 
(6 h) for the 2-pyridone substrates compared to the 2-pyrone (2 h). The use of an 
iodide instead of a bromide is necessary to achieve good yields for these substrates. 
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This may be due, in part, to faster oxidative addition of the Pd(0) species into the C–
I bond versus the C–Br bond.27 It was anticipated that the nitrogen of the 2-pyridone, 
particularly the 2-pyridone bearing a free N–H bond,25-26 could ligate to Pd and hinder 
the reaction, but pleasingly, these substrates were well tolerated. 
  
 
 
 
 
15 X = Br 
16 X = I 
 36 
26% from 15 
74% from 16 
 
 
 
 
 
 
17 X = Br 
18 X = I 
 37 
42% from 17 
77% from 18 
Scheme 2.18. Direct arylation of 2-pyridones 15-18. 
2-Coumarin substrates were also subjected to the direct arylation conditions 
(Scheme 2.19). Using 4-((2-iodobenzyl)oxy)-2-coumarin (20) facilitated smooth 
coupling and the reaction furnished 38 in 61% yield. A short substrate scope involving 
substitution of the 2-coumarin aryl ring was investigated and good yields were 
observed for electron-rich 2-coumarins affording 39-41. These yields were broadly in 
line with those observed for the 2-pyrone and 2-pyridone substrates, showing that 
the additional aromaticity conferred by the aryl ring of the 2-coumarin did not have 
a perceptible effect on the outcome of the reaction. A slight reduction in yield was 
observed for electron-poor 2-coumarins with the 6-fluoro 42 and 6-nitro 43 products 
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formed in 43% and 58% yields respectively. These electronic effects will be further 
discussed in Chapter 4. 
  
 
 
 
20, 26-30  38-43 
   
38, 61% from 20 39, 71% from 26 40, 71% from 27 
   
41, 82% from 28 42, 43% from 29 43, 58% from 30 
Scheme 2.19. Direct arylation of 2-coumarins 20, 26-30. 
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 Direct arylation at C–5  
As previously discussed, the 2-pyrone framework bears two potential sites for C–H 
activation. The C–3 site has shown preferential reactivity towards C–H activation 
compared to the C–5 site. However, previous work by McGlacken and co-workers 
demonstrated that when the C–3 site is blocked, C–5 arylation occurs in excellent 
yields (Scheme 2.20).7 
 
 
 
 
44  45, 98% 
 
 
 
 
46  32, 69% 
Scheme 2.20. Blocking groups for C–5 arylation.  
The Fairlamb group29 installed a methyl group in the 3-position to give substrate 44. 
The direct arylation reaction proceeded to give 45 in an excellent yield of 98%. 
However, the methyl group is not a useful blocking group as it cannot be easily 
removed or further functionalised. It was reasoned that using a bromide blocking 
group at C–3 could allow the direct arylation to proceed. Additionally, retention of 
the C–Br bond would provide a synthetic handle for further cross-coupling, provided 
oxidative addition was preferred at the aryl iodide and no complications were 
encountered due to the C–Br bond at C–3. Direct arylation of 46 was accomplished 
within the McGlacken group, however, product hydrodebromination also occurred 
to give 32.7 All attempts by other members of the McGlacken group to expand the 
substrate scope of this direct arylation/hydrodebromination reaction to 2-pyridones 
were unsuccessful.25 While selective C–5 cyclisation was achieved using methyl and 
bromide blocking groups, gaining access to 5-cyclised compounds bearing a halogen 
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at C–3 would require the re-installation of a halide, which would be neither atom- 
nor step-economic. 
2.3.1. Synthesis of substrates  
2-Pyrones 
Cyclisation at the C–5 position of 2-pyrones gives access to an untapped heterocyclic 
framework, opening up new opportunities for the synthesis of valuable analogues 
not currently accessible by traditional synthetic methodologies (Figure 2.1). 
 
Figure 2.1. Untapped biological potential of C–5 cyclised 2-pyrones. 
We sought to develop a Pd-catalysed direct arylation protocol which would: 
1. Give direct arylation at C–5. 
2. Be more generally applicable. 
3. Allow further decoration of the 2-pyrone motif at C–3. 
As Lautens observed,30 there is a notable absence of polyhalogenated substrates in 
Pd-catalysed cross-coupling, which is probably due to selectivity issues. This potential 
pitfall was offset by the potential for follow-on coupling using a (hetero)aryl chloride, 
the benefits of which have been well documented by Buchwald,31-34 Hartwig35-37 and 
Fu.38-42 Fu stated that “aryl chlorides are both more readily available and less 
expensive than aryl bromides and aryl iodides”.38 “From a practical point of view, the 
use of aryl chlorides is highly desirable… However, they are much more difficult to 
activate than aryl iodides and bromides” according to Jin.43 
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It was therefore decided to install a 3–Cl blocking group, giving substrate 47, which 
should be stable towards the oxidative conditions of the direct arylation reaction, yet 
reactive enough to allow further decoration of the 2-pyrone framework using 
cross-coupling methods applicable to aryl chlorides. Chlorination of 2-pyrone 4 was 
achieved with NCS in the presence of TFA to give 47 in 65% yield (Scheme 2.21). 
 
 
 
4  47, 65% 
Scheme 2.21. Chlorination of 4. 
Successful product formation was determined by NMR spectroscopy, with the 
disappearance of the C–3 proton at 5.50 ppm, and the downfield shift of the C–5 
proton in the 1H NMR spectrum due to the deshielding effect of the inductively 
electron-withdrawing chloride. In the 13C NMR spectrum, the disappearance of a CH 
peak at 88.8 ppm and the appearance of a quaternary carbon peak at 100.5 ppm 
confirmed that chlorination had occurred. The C–5(H) peak shifted upfield from 
100.3 ppm to 96.1 ppm. Selective chlorination at the C–3 position was achieved, and 
no C–5 chlorinated product was observed. 
To investigate the scope of the reaction, further substrates related to 4 were 
prepared in a similar fashion, using substituted 2-iodobenzylbromides (Scheme 
2.22). The desired mono-benzylated products were purified from the crude reaction 
mixture by column chromatography on silica gel. This was relatively trouble-free in 
the case of 48 and 50, however only a 4% isolated yield of 49 was achieved due to 
problems with co-elution of a dibenzylated side-product similar to that described in 
Section 2.2.1. 
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3   48-50 
 
 
 
 
 
 
48, 38% 49, 4% 50, 40% 
Scheme 2.22. Synthesis of substituted aryl substrates 48-50.  
The pure benzylated 2-pyrones 48 and 50 were then chlorinated using NCS in the 
presence of TFA (Scheme 2.23) to give the desired substrates 51 and 53. The crude 
reaction mixture containing 49 was also subjected to these chlorination conditions. 
In the latter case, the difference in polarity between the chlorinated product 52 and 
the dibenzylated side-product was sufficient to allow the isolation of 52 in approx. 
24% yield (based on impure starting material).  
   
48-50  51-53 
   
51, 75% 52, ~24% 53, 29% 
Scheme 2.23. Chlorination of substrates 48-50. 
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4-Hydroxy-6-(4-methoxy)phenyl-2-pyrone (57) was prepared by a method developed 
by Katritzky et al.,44 as shown in Scheme 2.24. 
 
54, 47% 
 
 
55, 74% 
 
 
56, 6% 
 
  
57, 59% 
Scheme 2.24. Synthesis of 4-hydroxy-6-(4-methoxy)phenyl-2-pyrone (57). 
The N-acylbenzotriazole 55 was prepared in 74% yield by treating 
p-methoxyphenylcarboxylic acid with 1-(methylsulfonyl)-1H-1,2,3-benzotriazole (54) 
in the presence of Et3N under reflux overnight. Treatment of 2,2,6-trimethyl-4H-1,3-
dioxin-4-one with LDA and subsequent reaction with N-acylbenzotriazole 55, initially 
at −78 °C and warming to ambient temperature overnight, yielded 56 in a very poor 
6% yield. Finally, a solution of 56 was heated in toluene for 1.5 h at 127 °C, resulting 
in the formation of the 4-hydroxy-2-pyrone 57 in 59% isolated yield after column 
chromatography on silica gel. 
4-Hydroxy-6-(4-methoxy)phenyl-2-pyrone (57) was benzylated with dihalide 2 and 
the mono- and di-benzylation products were easily separated by column 
chromatography on silica gel to give 58 in 42% yield (Scheme 2.25). 
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57 2  58, 42% 
Scheme 2.25. Benzylation of 4-hydroxy-6-(4-methoxy)phenyl-2-pyrone (57). 
The benzylated 2-pyrone 58 was chlorinated with NCS in the presence of TFA to give 
the target substrate in 49% yield after chromatography on silica gel (Scheme 2.26).  
 
 
 
58  59, 49% 
Scheme 2.26. Chlorination of 2-pyrone 58. 
2-Pyridones 
We were interested to see if the direct arylation conditions would also be suitable 
for the C–5 arylation of 2-pyridones, which has not been previously reported, and 
which was unsuccessful using the previous direct arylation/hydrodebromination 
conditions which had been successful with 2-pyrone substrate 46.7 To this end, some 
2-pyridone substrates were prepared. 
The synthesis of N-methyl-4-hydroxy-2-pyridone substrate 16 was previously 
described in Section 2.2.1. The N-phenyl-4-hydroxy-2-pyridone substrate was 
prepared in a similar fashion. Thus, N-phenyl-4-hydroxy-2-pyridone 60 was 
synthesised from 4-hydroxy-6-methyl-2-pyrone 3, using aniline as the amine source, 
in 23% yield (Scheme 2.27). 
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3  60, 23% 
Scheme 2.27. Synthesis of N-phenyl-4-hydroxy-2-pyridone 60. 
Once synthesised, 60 was benzylated using the reported procedure,13 giving 61 in 
78% yield after column chromatography on silica gel (Scheme 2.28). 
 
 
 
 
 
 
 
 
 
 
60 2  61, 78% 
Scheme 2.28. Benzylation of N-phenyl-4-hydroxy-2-pyridone 60. 
The benzylated 2-pyridones 16 and 61 were chlorinated with NCS in the presence of 
TFA to give the target compounds in 50% and 15% yields respectively after 
purification (Scheme 2.29).  
 
 
 
16  62, 50% 
 
 
 
61  63, 15% 
Scheme 2.29. Chlorination of N-substituted 2-pyridones. 
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2.3.2. Optimisation of reaction conditions for C–5 arylation 
Initial investigation of the direct arylation of substrate 47 was performed by another 
member of the McGlacken group,45 and it was determined that the catalytic system 
shown in Scheme 2.30 allowed C–5 arylation with retention of the 3–Cl bond to give 
64 in very good yield. 
 
 
 
 
47  64, 85% 
Scheme 2.30. Direct arylation conditions discovered by the McGlacken group.45  
Further investigation of these conditions (Table 2.2) showed that no improvement 
over the conditions shown in Scheme 2.30 could be achieved. Attempts to scale up 
the synthesis of 64 to >100 mg with 2 mol% Pd(OAc)2 gave disappointing results. 
Large amounts of residual starting material and so-called “Pd black” was observed in 
the reaction mixture. Tetraalkylammonium halides such as TBAB have been shown 
to stabilise colloidal Pd clusters.46 Such colloidal clusters serve as a reservoir for 
catalytically active Pd nanoparticle (NP) species.47 It is possible that the presented 
reaction is mediated by Pd NPs. It has been reported that low, “homeopathic” Pd 
concentrations were required to prevent agglomeration of colloidal clusters, and 
thus inhibit the formation of insoluble Pd(0) black.48 However, in our case, reducing 
the Pd loading from 2 mol% to 0.5 mol% (Table 2.2, entry 2) inhibited conversion. 
Thus, the presented catalytic system is a delicate balance between the minimum 
quantity of Pd required to efficiently catalyse the reaction, and the maximum 
quantity of Pd which can be employed before aggregation.   
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Table 2.2. Investigation of C–5 direct arylation conditions. 
 
 
 
 
47  64 
Entry Pd(OAc)2 
mol% 
Additive 
(equiv.) 
Base Solvent T  
(°C) 
Time 
(h) 
Yield or 
Conversion (%) 
1 2 TBAB 
(1.0) 
KOAc THF 76 18 85a 
2 0.5 TBAB 
(1.0) 
KOAc THF 76 16 16b 
3 5 SPhos  
(0.15) 
KOAc Toluene 127 23 9b 
4 2 TBAB  
(1.2) 
KOAc 1,4-Dioxane 100 21 43c 
aIsolated yield. bConversion calculated from ratio of starting material 47 to product 64 in 1H 
NMR spectrum of the crude reaction mixture. cYield determined from the 1H NMR spectrum 
of the crude reaction mixture using 1,3,5-trimethoxybenzene as the internal standard for 
quantification. 
The direct arylation at C–5 to give 64 was confirmed using NMR spectroscopy. In the 
1H NMR spectrum of 64, the C–5 proton at 6.06 ppm observed in 47 was not present. 
In the 13C spectrum, the CH peak at 96.1 ppm had disappeared, and a new quaternary 
carbon peak was observed at 107.8 ppm (Figure 2.2). 
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Figure 2.2. Comparison of 13C NMR spectra of 47 and 64.  
47 
C–3–Cl 
C–I 
C–5(H) 
64 
C–5 C–3–Cl 
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An impurity peak was observed at 5.13 ppm in the 1H NMR spectra of the crude 
reaction mixtures in all reactions shown in Table 2.2. However, the amount of this 
impurity greatly increased when the reaction was performed in 1,4-dioxane (Table 
2.2, entry 4). The impurity was isolated after column chromatography on silica gel. 
With the aid of 1H and 13C NMR spectroscopy and mass spectrometry data in 
consultation with the literature,49 the impurity was determined to be 2-iodobenzyl 
acetate 65. 
 
65 
Figure 2.3. Impurity isolated from reaction mixture. 
This impurity is most likely formed from attack of the acetate anion at the benzylic 
carbon of 47. The acetate would be stabilised by the more polar 1,4-dioxane which 
explains the increased levels of this impurity in this solvent (65:35, 64:65)  compared 
to THF (91:9, 64:65). The formation of 65 or related impurities could be prevented by 
use of a less nucleophilic base. However, since the levels of impurity formation were 
low in the optimised conditions (Table 2.2, entry 1) and the yield was excellent at 
85%, it was determined to proceed with KOAc as the base. Our optimised conditions 
were therefore 2 mol% Pd(OAc)2, 1.0 equiv. TBAB, 2.5 equiv. KOAc in THF at 76 °C for 
18 h. We next sought to test the tolerance of the methodology to changes in 
substrate, and a short scope was investigated. 
2.3.3. Demonstration of substrate scope for C–5 arylation 
The synthesis of the target substrates is described in Section 2.3.1. Due to the small 
scale (approx. 0.1 mmol), the physical amount of Pd(OAc)2 required for a 2 mol% 
loading was too small (<0.5 mg) to be consistently measured out. Thus, to ensure 
reproducibility, the catalytic loading was increased to 5 mol% Pd(OAc)2 for the scope 
investigation, and 1.2 equiv. TBAB was used.  
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51-53, 59, 62-63  69-71 
   
66, 43% 67, 53%  68, 63% 
 
  
69, 0% 70, 55% 71, 60% 
Scheme 2.31. Substrate scope for C–5 arylation conditions. 
Pleasingly, a number of substrates were well tolerated under the reaction conditions 
(Scheme 2.31). Substituents para to the oxidative addition site worked well, with a 
p-fluoro substituent giving product 66 in 43% yield, a p-methyl substituent giving 
product 67 in 53% yield, and a p-methoxy substituent giving product 68 in 63% yield.  
Importantly, and in contrast to previous studies,7 the 2-pyridone substrates 62 and 
63 also coupled well, giving the desired products 70 and 71 in moderate yields. 
However, employing a bulky substituent in the 6-position (59) failed to give any 
product 69, presumably due to unfavourable steric interactions at palladium during 
the catalytic cycle, or at carbon in the product. 
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 Investigation of novel linkers for direct arylation at C–3  
With the success in constructing new ring systems on the 2-pyrone framework, we 
were interested in testing if our methodology could be expanded to include different 
heteroatom linkers, for example, to form benzothiophenylpyrones 72 or 
benzoaminophenylpyrones 73 (Figure 2.4).  
  
72 73 
Figure 2.4. Benzothiophenylpyrones and benzoaminophenylpyrones. 
A previous publication from the Fairlamb group on the formation of five-membered 
rings has shown that when the character of the intramolecular linker is changed, it 
can completely shut down the catalytic system.50 We decided to prepare a variety of 
intramolecular linkers to test if the same effect would be observed in our systems for 
the formation of new six-membered rings. 
Thus, a 2-pyrone possessing an ester linkage was synthesised in 81% yield from 
2-pyrone 3 via a Steglich esterification (Scheme 2.32).51 The Steglich esterification 
involves a N,N′-dicyclohexylcarbodiimide (DCC)-activated esterification of carboxylic 
acids with alcohols or thiols. A catalytic quantity of 4-dimethylaminopyridine (DMAP) 
suppresses the formation of N-acylurea side-products.  
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3  74, 81% 
 
Scheme 2.32. Steglich esterification to 74.  
This substrate was subjected to four different direct arylation conditions which have 
been developed in the McGlacken group (Table 2.3). In all cases, only ester hydrolysis 
of the starting material was detected to give 3 and 2-iodobenzoic acid. 
Table 2.3. Attempted direct arylation of 74. 
 
 
 
 
74  75 
Entry Conditions Result 
126 Pd2(dba)3, PPh3, PivOH, Na2CO3, NMP, 129 oC, 3 h Degradation of 74 
2 Pd2(dba)3, PPh3, Na2CO3, NMP, 129 oC, 2 h Degradation of 74 
3 Pd(OAc)2, PPh3, Na2CO3, NMP, 129 oC, 2 h Degradation of 74 
47 Pd(OAc)2, TBAB, KOAc, Toluene, 127 oC, 2 h Complex Mixture 
Although the direct arylation was unsuccessful, we were able to access 75, albeit in 
a poor yield of 26%, by oxidation of 31 using pyridinium chlorochromate (PCC) 
(Scheme 2.33). 
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31  75, 26% 
Scheme 2.33. Oxidation of 2-pyrone 31 with PCC. 
Next, we sought to test an amino linker because nitrogen-containing heterocycles 
are ubiquitous in biologically active compounds, and the ability to form N-containing 
heterocycles by direct arylation would be a highly useful transformation. The 
synthesis of the substrate involved reduction of the cyano group of 76 to a primary 
amine 77 using BH3.THF in 29% yield. The amine 77 was subsequently reacted with 
4-bromo-2-pyrone to give the desired substrate 78 in 85% yield (Scheme 2.34). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
 
 
 
76  77, 29%  78, 85% 
Scheme 2.34. Synthesis of substrate 78. 
A variety of direct arylation conditions that had been developed in the group were 
again applied to 78, however, none gave very encouraging results (Table 2.4). Only a 
trace of 79 could be detected in the 1H NMR spectrum of the crude reaction mixture 
(Table 2.4, entry 3). However, it was not possible to isolate the compound from the 
reaction mixture. The poor reactivity of 78 may be due, at least in part, to ligand 
effects of the free N–H to Pd. This likely shuts down the catalytic cycle by competing 
with the C–I bond for Pd. Due to the poor results, this line of investigation was not 
pursued further. 
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Table 2.4. Attempted direct arylation of 78. 
 
 
 
 
 
78  79 
Entry Conditions Result 
126 Pd2(dba)3, PPh3, PivOH, Na2CO3, NMP, 129 oC, 24 h Degradation of 78 
2 Pd2(dba)3, PPh3, Na2CO3, NMP, 129 oC, 24 h Unreacted 78 
37 Pd(OAc)2, TBAB, KOAc, Toluene, 127 oC, 24 h 
Trace of 79 and 
unreacted 78 
Finally, we sought to test a thio-linker, which was synthesised according to Scheme 
2.35. A 4-tosyloxy 2-pyrone 80 was synthesised from 4-hydroxy 2-pyrone 3 and 
p-tosylchloride in 84% yield. Dihalide 2 was reacted with thiourea to give an 
intermediate isothiourea which was hydrolysed with aqueous NaOH to give 
2-iodobenzylthiol (81) in 64% yield. Reaction of 81 with 4-tosyloxy 2-pyrone 80 gave 
substrate 82 in 50% yield. 
  
 
3   
 
 
 
 
 
 
 
 
 
 
 
80, 84% 
 
 
 
2  81, 64%  82, 50% 
Scheme 2.35. Synthesis of thio-linker 82.  
Substrate 82 was subjected to a number of direct arylation conditions previously 
developed in the McGlacken group (Table 2.5). In some cases (Table 2.5, entry 1 and 
Table 2.5, entry 2), only degradation of the substrate 82 was observed. However, 
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using so-called Jeffery’s conditions (Table 2.5, entry 3), it was possible to isolate 83 
in 21% yield. In the latter case, unreacted starting material 82 was also observed in 
the 1H NMR spectrum of the crude reaction mixture. 
Table 2.5. Direct arylation of 82. 
 
 
 
 
 
82  83 
Entry Conditions Result 
   126 Pd2(dba)3, PPh3, PivOH, Na2CO3, NMP, 129 oC, 4 h Degradation of 82 
2 Pd2(dba)3, PPh3, Na2CO3, NMP, 129 oC, 24 h Degradation of 82 
37 Pd(OAc)2, TBAB, KOAc, Toluene, 127 oC, 16 h 
21% isolated yield of 83 and 
unreacted 82 
Again, the ligand effect of the sulfur towards Pd is likely to be the reason for the poor 
success of this reaction. The action of sulfur as a Pd catalyst poison is well 
documented in the literature.52-53 
In summary, changes to the linker shut down the catalytic systems for direct arylation 
which have been developed by the McGlacken group. In the case of the ester linker, 
only ester hydrolysis of the starting material was observed. While traces of the 
desired products were observed in the reactions of the amino- and thio-linkers, the 
results were not deemed to be positive enough to continue with this line of 
investigation.  
 Intermolecular direct arylation 
Having successfully developed a number of protocols to effect the intramolecular 
direct arylation of 2-pyrones and related heterocycles, we turned our attention 
towards intermolecular direct arylation. For this section, we focused on the 
intermolecular direct arylation of 2-coumarins, since they are more robust than the 
corresponding 2-pyrones. 
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The intermolecular C–3 direct arylation of 4-hydroxy-2-pyridones has been described 
by Zografos (Scheme 2.36).54 
 
 
 
 
84 (3 equiv.)  85, 89% 
Scheme 2.36. Zografos’ intermolecular direct arylation of 4-hydroxy-2-pyridone 84. 
We were curious as to whether similar conditions would faciliate the intermolecular 
direct arylation of 4-hydroxy-2-coumarin (19). Applying the conditions reported by 
Zografos54 resulted in degradation of the 2-coumarin starting material while the 
PhB(OH)2 remained unreacted (Scheme 2.37). 
 
 
 
19 (3 equiv.)  
Scheme 2.37. Application of Zografos’ conditions to 4-hydroxy-2-coumarin 19. 
Rather than varying the reaction conditions, it was decided to initially investigate if 
2-coumarin 19 was a competent starting material for this transformation, i.e. if it 
could participate in oxidative addition by Pd. Zografos had reported that a palladated 
intermediate derived from 2-pyridone 84 was observed by 1H NMR analysis.54 
Therefore, the ability of 19 to undergo oxidative addition by Pd(OAc)2 was tested by 
mixing a stoichiometric amount of palladium and 19 in DMSO-d6 in an NMR tube 
(Scheme 2.38). A reduction in the integral of the C–3 proton at 5.60 ppm relative to 
the aromatic protons would have been considered evidence that oxidative addition 
had occurred. The 1H NMR spectrum of the 2-coumarin/Pd(OAc)2 mixture showed 
peaks corresponding to both 19 and dicoumarin 86. Evidence for the presence of 
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dicoumarin 86 was also observed in the nominal mass spectrum of the reaction 
mixture after it had been filtered through Celite®.  
 
 
  
19  86 
Scheme 2.38. Oxidative addition of palladium into C–3–H bond of 19. 
Zografos observed that dipyridone formation was pH-dependent.54-55 Therefore, the 
procedure illustrated in Scheme 2.38 was repeated and compared under acidic and 
basic conditions (Table 2.6). In the presence of K2CO3, only dicoumarin 86 was 
observed with no trace of starting material 19. The use of formic acid completely 
suppressed dicoumarin formation. However, it also appeared to suppress oxidative 
addition.  
Table 2.6. Effect of acidic and basic conditions on dicoumarin 86 formation. 
 
 
 
 
19  86 
Additive Conversion to dicoumarin 86 
– Trace (ca. 5%) 
HCOOH 0% 
K2CO3 100% 
In any case, a variety of reaction conditions related to those shown in Scheme 2.38 
were tested, but none gave any evidence of C–3 arylation. However, it was observed 
that using a catalytic rather than stoichiometric quantity of copper oxidant, gave 
reactions with fewer degradation products. This led us to suspect that perhaps 
copper was degrading the 2-coumarin framework. To confirm that copper was the 
reason for the degradation, the experiment shown in Scheme 2.39 was performed. 
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The starting material was heavily degraded and it was concluded that copper salts 
were not suitable oxidants for this 2-coumarin substrate. 
 
 
 
19  
Scheme 2.39. Effect of copper salts on 2-coumarin 19. 
Finally, a similar reaction using Ag2O as the oxidant was tried (Scheme 2.40). 
Unfortunately, only the starting 2-coumarin and boronic acid were observed in the 
1H NMR spectrum of the crude reaction mixture, but no degradation of the 
2-coumarin was observed. 
 
 
 
19 (3 equiv.)  
Scheme 2.40. Attempted intermolecular direct arylation of 19 with silver oxidant. 
Further development of this reaction is required, potentially involving an oxidant 
screen under neutral conditions. 
 Conclusions and Future Work 
The regioselective intramolecular cyclisation of the privileged 2-pyrone, 2-pyridone 
and 2-coumarin motifs under direct arylation conditions has been developed. For 
intramolecular cyclisation at C–3, a broad substrate scope and good to excellent 
yields were achieved. Further insight into the mechanism of this reaction will be 
discussed in Chapter 4. For the intramolecular cyclisation at C–5, a methodology 
which allows the preparation of some previously inaccessible 2-pyrones and 
2-pyridones was developed. The reactions proceed via direct arylation with retention 
of a C–Cl bond. Substituents para to the site of oxidative addition were well tolerated 
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by the reaction conditions. The further cross-coupling of the retained C–Cl bond will 
be discussed in Chapter 3. Attempts to vary the linker were relatively unsuccessful. 
The reported conditions for the intermolecular direct arylation of 4-hydroxy-
2-pyridones do not facilitate the same transformation in 4-hydroxy-2-coumarins. 
Homocoupling of the 2-coumarin 19 to give dicoumarin 86 occurs under basic 
conditions, and copper salts cause degradation of the 2-coumarin motif. 
Future work in this area will likely examine the application of direct arylation 
conditions, particularly intermolecular direct arylation and cross-dehydrogenative 
coupling, to the synthesis of natural products and other biologically active 
compounds. To date, C–H activation is rarely employed in total synthesis or fine 
chemical manufacture, particularly as an end-game strategy. This may be due to the 
harsh conditions typically required. It is hoped that by describing C–H activation as it 
has been applied to several classes of biologically interesting but chemically sensitive 
motifs: the 2-pyrones, 2-pyridones and 2-coumarins, efforts will be focused towards 
milder conditions for C–H activation and cross-dehydrogenative coupling. In general, 
it is anticipated that future development of C–H activation methodology will focus 
on using Earth-abundant metal catalysts such as iron, manganese and cobalt, rather 
than precious metal catalysts including palladium and rhodium. 
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Dripping water hollows out stone, not through force but through persistence. 
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Chapt er 3  Suzuki -Miya ura cr oss -coupling of 2-pyr one s and related heterocycl es  
 Introduction 
The formation of aryl-heteroaryl (Ar-HetAr) bonds is an important transformation in 
organic synthesis1 due to the abundance of the Ar-HetAr moiety in natural products 
and pharmaceuticals.2 One of the most widely employed methods for the formation 
of Ar-HetAr bonds is the Suzuki-Miyaura reaction,3-5 which involves the 
cross-coupling of an organohalide and an organoboron species6 in the presence of 
palladium, usually utilising phosphine ligands, and a suitable base. The reaction was 
first published by Akira Suzuki in 1979,7 and he shared the 2010 Nobel Prize in 
Chemistry with Richard F. Heck and Ei-ichi Negishi.8 The mechanism of the 
Suzuki-Miyaura has been proposed as follows (Scheme 3.1): oxidative addition of the 
organohalide to the catalytically active Pd(0) species initiates the catalytic cycle. A 
hydroxide or alkoxide base then replaces the halide on the Pd complex. 
Transmetallation of the organoboron species with the Pd complex gives a Pd(II) 
intermediate bearing the two organic coupling partners. Subsequent reductive 
elimination results in C–C bond formation with the Pd(0) species available to re-enter 
the catalytic cycle.  
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Scheme 3.1. General mechanism of the Suzuki-Miyaura cross-coupling reaction. 
The base has recently been discovered to fulfil several key, yet antagonistic, roles in 
the Suzuki-Miyaura reaction.9 Two are positive and facilitate the progression of the 
reaction: Formation of trans-[PdR1L2(OH)] that reacts with R2B(OH)2 in the (usually) 
rate-determining transmetallation step, and facilitation of the reductive elimination 
of Pd(0) from trans-[PdR1R2L2]. Two pathways can inhibit the reaction: Formation of 
unreactive anionic borates, and complexation of the OH group of [PdR1L2(OH)], in this 
case by the counterion of the base (e.g. Na+, K+, Cs+). It was also found that 
optimisation of the base is less crucial when oxidative addition is the 
rate-determining step, e.g. when aryl chlorides are used as the organohalide coupling 
partner.9 Iodide and bromide are largely preferred as the organohalide partner due 
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to their reactivity, however, organochlorides are more attractive substrates from a 
cost and availability viewpoint.10 
The advantages offered by the Suzuki-Miyaura reaction over other methods of C–C 
bond formation include mild reaction conditions, good accessibility and stability of 
organoboron reagents, a high tolerance towards a variety of functional groups 
(especially sterically demanding substrates) and a low toxicity profile of both the 
starting materials and side products.11 An engaging review of the field of 
cross-coupling chemistry in 201212 highlights the developments from the original 
discoveries to the prominent position of the Suzuki-Miyaura reaction in modern 
synthetic chemistry. 
 Cross-coupling of direct arylation product 64  
In Section 2.3, the development of a direct arylation methodology which facilitated 
retention of a C–Cl bond to give the cyclised 3-chloro 2-pyrone 64 was described. In 
this section, the development of conditions to facilitate the further cross-coupling at 
this position will be discussed. 
3.2.1. Optimisation of cross-coupling conditions 
The objective of this work was to demonstrate that although the C–Cl bond at C–3 
was stable enough to withstand the conditions of the direct arylation reaction, it 
remained reactive enough to participate in further reactions. Initially, a variety of 
cross-coupling conditions which had been reported for the functionalisation of aryl 
chlorides were tested (Table 3.1).  
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Table 3.1. Exploration of cross-coupling conditions. 
   
64   
 Partner 
(equiv.) 
Pd  
(mol%) 
Ligand 
(mol%) 
Base 
(equiv.) 
Solvent T 
(°C) 
t  
(h) 
Result 
1 
 
(1.2) 
Pd(OAc)2 
(5) 
PCy3.HBF4 
(15) 
K2CO3 
(3.0) 
Xylenes 130 15 
36 
134 
unreacted 64 
degradation 
degradation 
2 
 
(1.0) 
Pd2(dba)3 
(1.5) 
PtBu3.HBF4 
(6) 
K2CO3 
(1.1) 
1,4-
dioxane 
120 15 
36 
134 
unreacted 64 
degradation 
degradation 
3 nBu3SnPh 
(1.05) 
Pd2(dba)3 
(1.5) 
PtBu3.HBF4 
(6) 
CsF 
(2.2) 
1,4-
dioxane 
120 15 
36 
134 
unreacted 64 
unreacted 64 
64 (26%a) 
aYield determined from the 1H NMR spectrum of the crude reaction mixture using 
1,3,5-trimethoxybenzene as the internal standard for quantification. 
Heck-type conditions (Table 3.1, entry 113 and Table 3.1, entry 214) gave degradation 
of the starting material and no product was detected by 1H NMR spectroscopy. Stille 
conditions (Table 3.1, entry 3)15-16 also gave degradation of the starting material. A 
26% recovery of the unreacted starting material 64 was measured from the 1H NMR 
spectrum of the crude reaction mixture after 5 days under the Stille conditions, (using 
1,3,5-trimethoxybenzene as the internal standard for quantification) and no product 
was observed. 
Therefore, it was decided to focus on the Suzuki-Miyaura cross-coupling reaction. 
Despite the development of modern methods such as direct arylation,17 the 
Suzuki-Miyaura reaction remains the most common palladium-catalysed 
transformation for large-scale synthesis of drug candidates.18 It was expected that 
the plethora of conditions reported for the Suzuki-Miyaura cross-coupling of aryl 
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chlorides could be harnessed, and it was with these conditions that the optimisation 
study (Table 3.2) began. 
Table 3.2. Optimisation of Suzuki-Miyaura cross-coupling conditions. 
 
 
 
64  87 
 Pd Ligand Base Solvent T (°C) Conv. (%)a 
1b Pd2(dba)3 P(tBu)3.HBF4 KF THF 60 0 
2c Pd(OAc)2 DavePhos CsF Dioxane 110 0 
3 Pd(OAc)2 SPhosd K2CO3 Toluene 110 60 
4 Pd(OAc)2 SPhosd KOAc Toluene 110 70 
5 Pd(OAc)2 SPhos KOAc 2-MeTHF 90 69 
6 Pd(OAc)2 SPhos KOAc Dioxane 110 44 
7 Pd2(dba)3 SPhos KOAc THF 76 6 
8 Pd(OAc)2 RuPhos KOAc THF 76 64 
9 Pd(OAc)2 XPhos KOAc THF 76 29 
10 Pd(OAc)2 SPhos KOAc THF 76 93 (92) 
 
 
 
SPhos RuPhos XPhos 
aConversion from starting material to product was calculated from 1H NMR spectra of crude 
reaction mixture. Isolated yields in parenthesis. bPd2(dba)3 (1.5 mol%), P(tBu)3.HBF4 
(3.6 mol%) and KF (3.3 equiv.). cPd(OAc)2 (2 mol%), DavePhos (3 mol%) and CsF (3.0 equiv.). 
d10 mol%. 
Disappointingly, conditions such as those reported by Fu (Table 3.2, entry 1)19 and 
Buchwald (Table 3.2, entry 2)20 for the cross-coupling of aryl chlorides failed to give 
the desired product.  
Crucially, upon consideration of the 13C NMR spectrum of 64, it became apparent 
that the C–3–Cl bond (13C at δ = 100.8 ppm) did not necessarily possess the 
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characteristics of an aryl chloride bond (expect 13C at δ ~ 130 ppm). Therefore, the 
conditions reported by Hultin for the Suzuki-Miyaura cross-coupling of an α-chloro-
α,β-unsaturated ester were tested (Table 3.2, entry 3).21 Pleasingly, similar 
conditions gave 60% conversion to the desired product 87. Using KOAc as base (Table 
3.2, entry 4), gave a slightly increased conversion (to 70%). Using 2-MeTHF (Table 
3.2, entry 5) and 1,4-dioxane (Table 3.2, entry 6) as solvents, did not help to promote 
the reaction. Changing to a Pd(0) source in THF, surprisingly, led to poor catalytic 
turnover of 6% (Table 3.2, entry 7). Bulky, electron-rich ligands are reported to be 
efficient for the coupling of aryl chlorides due to their proclivity to donate electron 
density to the intermediate Pd(0) complex to facilitate oxidative addition.22 SPhos 
has the capacity to stabilise a monoligated Pd(0) centre by interaction between Pd 
and the ipso-carbon of the lower ring, and also to stabilise a Pd(II) center by 
coordination of the alkoxy group to Pd. This combination results in highly reactive 
catalysts that are also rather stable.23 RuPhos (Table 3.2, entry 8) possesses similar 
structural features to SPhos but was not as effective for this transformation. It would 
seem that increasing the steric bulk using XPhos (Table 3.2, entry 9) has a detrimental 
effect on conversion. Finally, the optimal conditions were found using Pd(OAc)2 and 
SPhos with KOAc in refluxing THF (Table 3.2, entry 10). These conditions gave 93% 
conversion and an excellent isolated yield of 92%. 
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3.2.2. Substrate effects on Suzuki-Miyaura cross-coupling 
To test the effect of varying the electronics of the phenylboronic acid, two other 
phenylboronic acids were tested (Scheme 3.2).  
 
   
64  88, 57% 
   
64  89, 28% conversion 
Scheme 3.2. Substrate scope for the Suzuki-Miyaura coupling reaction.  
An electron-poor p-trifluoromethylphenylboronic acid was first employed in the 
reaction. This provided the expected product 88 in 57% isolated yield. However, 
electron-rich p-methoxyphenylboronic acid gave only 28% conversion to 89. This 
indicates that electron-rich boronic acids may not be well tolerated by these 
reactions conditions. 
3.2.3. Conclusions 
A synthetic methodology was developed allowing access to previously inaccessible 
‘cyclised-at-C5’ 2-pyrones and 2-pyridones (Section 2.3). Further elaboration at C–3 
was enabled utilising the retained C–Cl bond in a Suzuki-Miyaura cross-coupling. This 
shows that while the C–Cl bond at the C–3 of the 2-pyrone framework is stable 
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enough to withstand the conditions of a direct arylation reaction, it remains reactive 
enough to participate in Suzuki-Miyaura cross-coupling. This methodology allows the 
synthesis of highly decorated 2-pyrone compounds. 
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 A greener approach to chlorination and Suzuki-Miyaura 
cross-coupling 
In modern synthetic chemistry, it is important achieve a successful chemical reaction 
in an efficient and sustainable way. In particular, top pharmaceutical companies are 
seeking reactions which are executed in non-chlorinated solvents.24-25 More 
generally applicable, environmentally friendly cross-coupling conditions were sought 
to allow the application of these principles to the Suzuki-Miyaura cross-coupling of 
2-coumarins. As previously discussed in Chapter 1, 2-coumarins display a remarkable 
biological profile including anti-cancer, anti-microbial, anti-inflammatory, anti-
thrombotic and anti-psychotic effects.26-27  
Previous work on Suzuki-Miyaura reactions at the C–3 position of 4-alkoxy-
2-coumarins has involved bromides.28 Suzuki-Miyaura reactions involving a chloride 
at the C–3 position of 2-coumarins have been reported for 4-hydro-29 and 
4-alkyl-2-coumarins,30 however, we have observed that the electronic changes 
caused by introducing 4-alkoxy groups can cause these reported conditions to fail. 
For example, the conditions described by Degorce et al.30 required the use of a 
bromide to achieve good yields when 4-alkoxy-2-coumarins were used. Application 
of the dioxane/water conditions described by Degorce et al.30 for a 3-chloro-4-alkyl-
2-coumarin gave a 43% yield of product 115, compared to 88% under our conditions. 
These yields were determined from the 1H NMR spectrum of the crude reaction 
mixture, using 1,3,5-trimethoxybenzene as the internal standard for quantification. 
3.3.1. Synthesis of starting materials 
It was decided to use 4-methoxy derivatives of 2-pyrone, 2-pyridone, 2-coumarin and 
2-quinolone as model substrates for the Suzuki-Miyaura cross-coupling because they 
are readily accessible. Additionally, 4-alkoxy derivatives of 2-pyrones, in particular, 
have been shown to possess a variety of biological effects.31 The 4-methoxy 
substrates were prepared by reaction of the 4-hydroxy derivative with 
trimethylphosphate in the presence of K2CO3 (Scheme 3.3). Trimethylphosphate is a 
mild methylating agent with a low acute toxicity (LD50 rats 2 g/kg32).33 4-Hydroxy-6-
methyl-2-pyrone (3) and 4-hydroxy-2-coumarin (19) were commercially available. 
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4-Hydroxy-1,6-dimethyl-2-pyridone (13) was prepared as described in Section 2.2.1. 
4-Hydroxy-1-ethyl-2-quinolone (93) was obtained from another member of the 
McGlacken group.34 
   
3  90, 46% 
   
19  91, 86% 
   
13  92, 58% 
   
93  94, 66% 
Scheme 3.3. Methylation of 4-hydroxy starting materials. 
The methylation of 4-hydroxy-2-pyrone 3 went to completion in 3 h, and the 
4-methoxy product 90 was isolated in 46% yield after recrystallisation from EtOH. 
The characteristic methoxy 3H singlet at 3.80 ppm in the 1H NMR spectrum, and at 
Chapter 3  Results and Discussion 
92 
 
55.8 ppm in the 13C NMR spectrum indicated the success of the transformation. 
Similarly, 4-hydroxy-2-coumarin (19) was methylated to give product 91 in 86% yield 
after just 1 h. The methylated 2-pyridone 92 and 2-quinolone 94 were prepared in 
58% and 66% isolated yields respectively. 
To examine the effect of different 4-alkoxy groups on the Suzuki-Miyaura reaction 
(see Section 3.3.2 and Section 3.3.3), a variety of alkylated 2-pyrones and 
2-coumarins were synthesised. 
4-Mesyloxy-2-pyrone 95 was synthesised as shown in Scheme 3.4. 4-Hydroxy-
6-methyl-2-pyrone (3) was deprotonated by K2CO3 at ambient temperature. Mesyl 
chloride was then added, and the reaction mixture was stirred at ambient 
temperature for 2 h. The crude product was purified by recrystallisation from EtOH 
to give 95 in 81% yield.  
   
3  95, 81% 
Scheme 3.4. Mesylation of 4-hydroxy-2-pyrone 3. 
4-Tosyloxy-2-pyrone 80 was synthesised as shown in Scheme 3.5. 4-Hydroxy-
6-methyl-2-pyrone (3) was deprotonated by Et3N at ambient temperature. p-Tosyl 
chloride was then added, and the reaction mixture was stirred at ambient 
temperature for 0.5 h. The crude product was purified by recrystallisation from a 
mixture of DCM/hexanes to give 80 in 84% yield. 
   
3  80, 84% 
Scheme 3.5. Tosylation of 4-hydroxy-2-pyrone 3. 
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4-Phenoxy-2-coumarin (97) was synthesised as shown in Scheme 3.6. 4-Hydroxy-
2-coumarin 19 was brominated by TBAB in the presence of P2O5 to give 4-bromo-
2-coumarin 96 in 71% yield, which was then coupled with phenol in the presence of 
K2CO3 to give the product 97 in 87% yield. 
     
19  96, 71%  97, 87% 
Scheme 3.6. Synthesis of 4-phenoxy-2-coumarin 97. 
4-Hydroxy-2-coumarin (19) was deprotonated with K2CO3 and treated with benzyl 
bromide to give 4-benzyloxy-2-coumarin (98) in 19% yield after column 
chromatography on silica gel (Scheme 3.7). Difficulties were encountered in the 
purification of the product due to the presence of a dibenzylated side-product 99, in 
a similar manner to that discussed in Section 2.2.1. 
    
19  
98, 19% 99 
Scheme 3.7. Benzylation of 4-hydroxy-2-coumarin 19. 
A 2-coumarin substrate bearing a silyl ether protecting group was also synthesised 
(Scheme 3.8). 4-Hydroxy-2-coumarin (19) reacted with t-butyldiphenylsilyl chloride 
(TBDPSCl) in the presence of Et3N. The crude reaction mixture was subjected to 
column chromatography on silica gel using 10:90 EtOAc:hexanes as the eluent. The 
product was further purified by recrystallisation from EtOH to give 100 in 54% yield. 
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19  100, 54% 
Scheme 3.8. Silyl ether protection of 4-hydroxy-2-coumarin 19.  
The next step towards preparing the desired substrates required selective 
chlorination of the C–3 position of the 4-methoxy substrates. 2-Pyridone 92 was 
chlorinated using N-chlorosuccinimide (NCS) in the presence of trifluoroacetic acid 
(TFA) (Scheme 3.9).  
    
92  101, 30% 102 
Scheme 3.9. Chlorination of 2-pyridone 92.  
Using these conditions, mono-chlorination of 2-pyridone 92 was the major product. 
However, 3,5-dichlorination was also observed to give 102. A nominal mass spectrum 
of the crude reaction mixture showed molecular ions corresponding to both mono- 
and di-chlorination. The formation of 102 could not be prevented, as it was present 
as a side-product even when there was residual starting material still present, as can 
be seen in the 1H NMR spectrum of the crude reaction mixture (Figure 3.1). The crude 
reaction mixture containing both the mono- and di-chlorinated products was 
subjected to column chromatography on silica gel using DCM as the eluent. The 
fractions containing the mono-chlorinated product were concentrated under 
reduced pressure and recrystallised from EtOH to give 101 in 30% yield. A pure 
sample of the di-chlorinated product could not be obtained. However, an impure 
sample was isolated which allowed the identification of the important 1H NMR 
signals. 
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Figure 3.1. 1H NMR spectrum of the crude reaction mixture for the chlorination of 
2-pyridone 92. 
2-Quinolone 94 was also chlorinated using NCS in the presence of TFA to give 103 in 
68% yield after column chromatography on silica gel (Scheme 3.10). 
   
94  103, 68% 
Scheme 3.10. Chlorination of 2-quinolone 94. 
3.3.2. Chlorination with trichloroisocyanuric acid 
While NCS is the reagent of choice in many cases for introducing chloride to 
heteroaromatic compounds, trichloroisocyanuric acid (TCCA) is more 
atom-economic, more soluble, less toxic and cheaper.35 2-Coumarin 91 was 
chlorinated by reaction with TCCA in refluxing EtOAc for 1 h to give the product 104 
(Scheme 3.11).  
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91  104, 58% 
Scheme 3.11. Chlorination of 4-methoxy-2-coumarin 91 with TCCA. 
While TCCA is soluble in the reaction mixture, the by-product cyanuric acid is largely 
insoluble. Thus the products can be purified via a simple filtration, followed by 
recrystallisation of the concentrated filtrate from EtOH. The appearance of cyanuric 
acid in the reaction mixture is a useful indicator that the reaction is progressing, as 
the mixture goes from a clear solution to a cloudy suspension when cyanuric acid 
forms. 
Compound 104 is known to have formed when the 1H signal at 5.70 ppm 
corresponding to the C–3 proton of 91 is no longer present in the 1H NMR spectrum 
of the crude reaction mixture. Also, the appearance of a quaternary carbon signal at 
106.0 ppm in the 13C NMR spectrum is attributed to the C–3 position of 104. The mass 
spectrum shows that the molecular ions of 211 (35Cl) and 213 (37Cl) g mol−1 are 
present in a 3:1 ratio, which is indicative of the presence of a chlorine atom in the 
molecule. 
The use of TCCA to chlorinate 2-coumarins represents a significant improvement in 
efficiency over the previously reported conditions.36 For example, 2-coumarin 105 
was previously synthesised in 67% isolated yield after 72 h at 55 °C using a 
combination of NCS and TFA.36 In this case, using TCCA, 105 can be produced in 64% 
isolated yield after 1 h at 85 °C in EtOAc (Scheme 3.12). Benzylated 2-coumarin 98 
was also successfully chlorinated to give 106 in 1 h in 67% isolated yield (Scheme 
3.12). 
Chapter 3  Results and Discussion 
97 
 
 
 
 
 
 
97  105, 64% 
   
98  106, 67% 
Scheme 3.12. Chlorination of 2-coumarins with TCCA. 
This procedure can be extended to the related 2-pyrone framework (Scheme 3.13). 
2-Pyrones are a less robust substrate than the corresponding 2-coumarins, which 
may explain the lower yields. It is pleasing, however, that chlorination proceeds 
cleanly, even in the presence of mesyl (95) and tosyl (80) groups in the starting 
materials. 
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     107-110 
    
107, 57% 
4 h 
108, 31% 
24 h 
109, 27% 
6 h 
110, 40% 
24 h 
Scheme 3.13. Chlorination of 2-pyrones. 
Attempts to use the TCCA conditions to chlorinate 2-pyridone 92 and 2-quinolone 94 
led to inseparable mixtures of products, even at lower temperatures. Hence, the 
NCS/TFA conditions (Scheme 3.9 and Scheme 3.10) were used to access substrates 
101 and 103. 
3.3.3. Suzuki-Miyaura cross-coupling of 3-chloro-2-coumarins 
With the desired 3-chloro-2-coumarin 104 in hand, reaction conditions were sought 
which would allow the Suzuki-Miyaura reaction to occur at this challenging site. Using 
SPhos as a ligand had previously been successful for the Suzuki-Miyaura coupling of 
3-chloro-2-pyrones (Section 3.2.1), so this formed the basis of the decision to use 
SPhos as the ligand for the cross-coupling reaction of 3-chloro-2-coumarins (Table 
3.3).  
The Innovative Medicines Initiative (IMI)-CHEM21 public-private partnership is a 
European consortium which comprises of pharmaceutical companies, universities 
and small to medium enterprises which promotes sustainable biological and 
chemical methodologies. A solvent selection guide published by this consortium was 
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used to limit our solvent choices to greener options during the development of 
reaction conditions.25  
Table 3.3. Optimisation of Suzuki-Miyaura reaction conditions. 
   
104  111 
Entry Pd 
(5 mol%) 
Ligand 
(15 mol%) 
Base 
(2.2 equiv.) 
Solvent T 
(°C) 
Conv. 
(%) 
Yielda 
(%) 
1 Pd(OAc)2 SPhos Na2CO3 EtOH 90 100 22b 
2 Pd(OAc)2 SPhos Na2CO3 2-MeTHF 90 63 54 
3 Pd(OAc)2 SPhos Na2CO3 iPrOAc 100 97 80 
4 Pd2(dba)3 SPhos Na2CO3 iPrOAc 100 90 70 
5 Pd(OAc)2 RuPhos Na2CO3 iPrOAc 100 100 80 
6 Pd(OAc)2 PPh3 Na2CO3 iPrOAc 100 14 12 
7 Pd(OAc)2 SPhos KOAc iPrOAc 100 36 29 
8 Pd(OAc)2 SPhos K2CO3 iPrOAc 100 100 84 (82) 
a Yields were determined using 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as the 
internal standard for quantification. Isolated yields in parenthesis. bA 45% yield (by internal 
standard) of dechlorinated side-product 91 was also identified in the 1H NMR spectrum of 
the crude reaction mixture.  
The use of EtOH as solvent (Table 3.3, entry 1) allowed the full consumption of 
starting material 104, with a 22% yield of desired product 111 along with a 45% yield 
of dechlorinated side-product 91. Switching to an aprotic polar solvent, 2-
methyltetrahydrofuran (2-MeTHF) gave a 54% yield of the desired product without 
significant dechlorination (Table 3.3, entry 2). The optimal solvent was determined 
to be isopropyl acetate (iPrOAc) which gave 111 in 80% yield (Table 3.3, entry 3). 
Changing to a palladium(0) source reduced the yield (Table 1, entry 4), while 
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changing to the RuPhos ligand (Table 3.3, entry 5) offered no advantages over SPhos, 
and PPh3 (Table 3.3, entry 6) gave a poor 12% yield. Employing KOAc as base 
hindered the reaction (Table 3.3, entry 7). The best conditions for the transformation 
were found when K2CO3 was used as the base, which gave 100% conversion to the 
desired product 111 in 82% isolated yield (Table 3.3, entry 8). 
To further demonstrate the utility and practicality of these conditions, the 
Suzuki-Miyaura cross-coupling of 104 with phenylboronic acid was performed on a 
gram-scale, giving 111 in an isolated yield of 84% (1.0 g) without chromatography. 
This constitutes a successful 20-fold scale-up from the demonstrated reaction 
conditions, and no loss of yield is observed (Scheme 3.14). 
   
104  111, 84% (1.0 g) 
Scheme 3.14. Scale-up of optimised Suzuki-Miyaura conditions.  
With the optimised conditions in hand, we sought to demonstrate the variety of 
substituted phenylboronic acids which were tolerated by our reaction conditions. A 
range of para-substituted phenylboronic acids were tested (Scheme 3.15), and no 
significant electronic effects were observed. p-Methoxyphenylboronic acid gave 113 
in 79% yield, while p-(trifluoromethyl)phenylboronic acid gave 114 in 76% yield. 
Sensitive functional groups such as aldehydes and esters also survived the coupling 
conditions, and products 117 and 118 were isolated in 48% and 91% yield 
respectively. 4-Styrylboronic acid coupled to give 121 in 77% isolated yield, with the 
alkenyl functionality remaining untouched, demonstrating some chemoselectivity 
over the potentially competitive Heck reaction. Substituents which could potentially 
ligate to Pd and inhibit the reaction were also well-tolerated, giving products such as 
nitrile 120 (Scheme 3.15), primary amine 122 and the nitro 124 (Scheme 3.16) in 
good yields. 
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104  112-121  
 
 
 
 
 
 
112, 89% 113, 79% 114, 76% 
 
 
  
115, 72% 116, 77% 117, 48% 
  
 
 
118, 91% 119, 76% 120, 84% 
   
 121, 77%  
Scheme 3.15. Variety of para-substituted phenylboronic acids tolerated under 
Suzuki-Miyaura reaction conditions. 
meta-Substituted phenylboronic acids gave higher yields than the corresponding 
para-substituted phenylboronic acids (Scheme 3.16), e.g. m-methoxyphenylboronic 
acid gave 125 in 91% yield. A somewhat sterically hindered ortho-substituted 
phenylboronic acid also coupled to give 126 in 56% yield.  
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104  122-126 
  
122, 79% 123, 87% 
   
124, 82% 125, 91% 126, 56% 
Scheme 3.16. Variety of meta and ortho-substituted phenylboronic acids tolerated 
under Suzuki-Miyaura reaction conditions. 
The presence of other halides, such as with p-bromo- or p-chlorophenylboronic acids, 
resulted in multiple side reactions, potentially including polymerisation to give 
inseparable mixtures of products. An alkenyl boronic acid, (4-methylstyryl)boronic 
acid, failed to participate in the Suzuki-Miyaura coupling, as did the alkyl boronic 
acids, isobutylboronic acid and n-propylboronic acid. 
Having achieved success with a wide range of substituted phenylboronic acids, we 
turned our attention towards more challenging heteroaryl boronic acids (Scheme 
3.17). 
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104  127-132 
   
127, 68% 128, 64% 129, 84% 
   
130, 93% 131, 75% 132, 99% 
Scheme 3.17. Variety of heteroaryl boronic acids tolerated under the reaction 
conditions. 
In Buchwald and co-workers systematic study on the powerful reactivity of SPhos, 
2-furanyl boronic acid failed to react efficiently with unactivated aryl chlorides.37 
Pleasingly, under our conditions 2- and 3-furanylboronic acids coupled successfully 
to give 127 and 128 in 68% and 64% yield respectively. The 3-thiopheneboronic acid 
gave 130 in 93% isolated yield. 2-Benzothiophene 131, dibenzofuran 129 and 
dibenzothiophene 132 groups were introduced at the 3-position using the standard 
conditions to give the Suzuki-Miyaura products in good to excellent yields. The 
highest yield for this study was obtained for product 132 in 99% yield. A 
2-thiopheneboronic acid and a 2-benzofuran boronic acid failed to participate in 
Suzuki-Miyaura coupling with 104. This is somewhat surprising given the success of 
the 2-furanyl and 2-benzothiophene boronic acids. However, 2-heterocyclic boronic 
acids are known to decompose in air via protodeboronation, oxidation, and/or 
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polymerisation.38 Such pathways are thought to be accelerated in the presence of 
heat, base, and/or a Pd catalyst, causing the in situ decomposition of unstable 
boronic acids to compete with their cross-coupling.38 In couplings with slower 
reacting halides, such as unactivated aryl chlorides, the latter challenge is 
exacerbated. This could explain the failure of the aforementioned boronic acids to 
couple under the presented conditions. Pyridylboronic acids or esters were also not 
tolerated, which is likely to be caused by interaction of Pd with the strongly 
coordinating lone pair of electrons on the pyridyl nitrogen. 
Additionally, a Boc-protected indole boronic acid successfully underwent the 
Suzuki-Miyaura cross-coupling (Scheme 3.18).  
    
104 (1.5 equiv.)  133 55% 
Scheme 3.18. Successful Suzuki-Miyaura cross-coupling with an indole boronic acid. 
The Boc group was cleaved in situ, likely by one of the acid sources in the reaction, 
to give 133 as the main product of the reaction in 55% isolated yield. 
3.3.4. Suzuki-Miyaura cross-coupling of related 3-chloro heterocycles 
Given the diverse range of both aryl and heteroaryl boronic acids which are tolerated 
by these reaction conditions, we questioned whether the conditions might also be 
general for the structurally-related 3-chloro-2-pyrone, -pyridone and -quinolone. 
These heterocycles, while structurally-related, are chemically diverse. The nitrogen 
of the 2-quinolone could potentially ligate to Pd, inhibiting the reaction, while 
2-pyrones and 2-pyridones are suspected to be less aromatic in character than the 
corresponding 2-coumarins and 2-quinolones. 2-Pyrones in particular have been 
demonstrated to have a rich variety of chemical properties and can behave like 
aromatics,39 dienes40-41 and enones.42 Moreover, the framework can ring-open under 
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certain cross-coupling conditions.43 Thus, 2-pyrones in particular, present significant 
chemoselectivity challenges. 
An optimisation study was conducted to investigate whether the conditions which 
gave successful Suzuki-Miyaura coupling of 2-coumarin 104 would also be applicable 
to 2-pyrone 107 (Table 3.4).  
Table 3.4. Suzuki-Miyaura coupling of 2-pyrone 107. 
 
 
 
107  134 
Entry Pd 
(5 mol%) 
Ligand 
(15 mol%) 
Base 
(2.2 equiv.) 
Solvent T 
(°C) 
Conv. 
(%)a 
1 Pd(OAc)2 SPhos KOAc THF 76 9 
2 Pd(OAc)2 SPhos KOAc 2-MeTHF 90 3 
3 Pd(OAc)2 SPhos KOAc EtOAc 85 5 
4 Pd(OAc)2 SPhos KOAc MEK 90 2 
5 Pd(OAc)2 SPhos KOAc EtOH 90 11 
6 Pd(OAc)2 SPhos KOAc iPrOH 90 4 
7 Pd(OAc)2 SPhos KOAc nBuOAc 100 41 
8 Pd(OAc)2 SPhos KOAc iPrOAc 100 45 
9 Pd(OAc)2 SPhos Na2CO3 iPrOAc 100 95 
10b Pd(OAc)2 SPhos Na2CO3 iPrOAc 100 76 
11 Pd(OAc)2 SPhos Na2CO3 iPrOAc 70 33 
12 Pd(OAc)2 SPhos Na2CO3 iPrOAc 50 5 
13 Pd(OAc)2 SPhos Na2CO3 iPrOAc 25 0 
14 Pd(CH3CN)2Cl2 SPhos Na2CO3 iPrOAc 100 59 
15 Pd(NH3)4SO4 SPhos Na2CO3 iPrOAc 100 2 
16 Pd2(dba)3 SPhos Na2CO3 iPrOAc 100 22 
17 Pd(OPiv)2 SPhos Na2CO3 iPrOAc 100 7 
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18 Pd(OAc)2 RuPhos Na2CO3 iPrOAc 100 78 
19 Pd(OAc)2 MePhos Na2CO3 iPrOAc 100 14 
20 Pd(OAc)2 DavePhos Na2CO3 iPrOAc 100 24 
21 Pd(OAc)2 XPhos Na2CO3 iPrOAc 100 21 
22 Pd(OAc)2 P(tBu)3 Na2CO3 iPrOAc 100 0 
23 Pd(OAc)2 PCy3 Na2CO3 iPrOAc 100 9 
24 Pd(OAc)2 PPh3 Na2CO3 iPrOAc 100 0 
25 Pd(OAc)2 SPhos K2CO3 iPrOAc 100 96 
(75) 
aConversion calculated as the ratio of starting material to product in the 1H NMR spectrum 
of the crude reaction mixture. Isolated yields in parenthesis. b2 mol% Pd(OAc)2 and 6 mol% 
SPhos were used. 
The first set of conditions tested were those that had proven successful for the 
Suzuki-Miyaura coupling of 2-pyrone 64 (Table 3.4, entry 1). Solvent selection was 
again limited by a solvent selection guide.25 Of the solvents tested (Table 3.4, entry 
2-8), iPrOAc (Table 3.4, entry 8) gave the best result and was carried forward. 
Switching to a carbonate base (Table 3.4, entry 9) greatly improved the conversion 
to the desired product 134. Reduced Pd loading (Table 3.4, entry 10) and lower 
temperatures (Table 3.4, entry 11-13) were not conducive to successful coupling. A 
range of alternative Pd sources were tested (Table 3.4, entry 14-17), but none gave 
better results than Pd(OAc)2. RuPhos performed similarly well in the presence of 
Na2CO3 (Table 3.4, entry 18), but all other phosphine ligands screened were less 
successful than SPhos (Table 3.4, entry 19-24). Finally, a stronger carbonate base, 
K2CO3 (Table 3.4, entry 25), was employed in the reaction, which gave an excellent 
conversion of 96%, and 75% isolated yield of 134. This shows that the optimal 
conditions for reaction with 2-coumarin 104 (Table 3.3, Entry 8) also gave the best 
result for 2-pyrone 107 (Table 3.4, entry 25). 
2-Pyridone 101 and 2-quinolone 103 were also coupled in excellent yields, and 135 
and 136 were isolated in 96% and 89% yields respectively (Scheme 3.19). As far as 
we are aware, this is the first time that Suzuki-Miyaura conditions optimised for one 
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of these heterocyclic substrates has been demonstrated to be general across 2-
coumarins, 2-pyrones, 2-pyridones and 2-quinolones. 
 
 
 
101  135 96% 
 
 
 
103  136, 89% 
Scheme 3.19. Suzuki-Miyaura cross-coupling of 2-pyridone 101 and 2-quinolone 103. 
Next, we tested the effect of varying the 4-alkoxy group. The 4-phenoxy group can 
prove more sterically demanding than the 4-methoxy group, and yet it did not hinder 
the progress of the reaction (Scheme 3.20).  
 
 
 
105  137, 85% 
 
 
 
109  138, 76% 
Scheme 3.20. Variation of the 4-OR group in the Suzuki-Miyaura cross-coupling. 
Compounds 105 and 109 were coupled with phenylboronic acid to give 137 and 138 
in 85% and 76% yields respectively. It is particularly interesting that no products as a 
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result of an intramolecular direct arylation process36 were observed in the 1H NMR 
spectrum of the crude reaction mixture.  
Unfortunately, attempts to couple 108 and 110 with phenylboronic acid gave 
mixtures of mono- and di-arylated products, along with other unidentified 
compounds (Scheme 3.21).  
 
 
 
 
inseparable mixture 
108   
 
 
 
110  139 major product 
Scheme 3.21. Attempted Suzuki-Miyaura coupling in the presence of other leaving 
groups.  
Interestingly, the reaction of substrate 110 gave the 3-phenyl-4-tosyloxy-2-pyrone 
139 as the major product, with both the 3-chloro-4-phenyl-2-pyrone and the 
3,4-diarylated product also observed. This result may warrant further development. 
Compound 139 could not be isolated, but a molecular ion corresponding to its 
molecular weight was observed in the nominal mass spectrum, and the 1H NMR 
spectrum of the crude reaction mixture provided evidence for its formation.  
3.3.5. Access to 3-aryl-4-hydroxy-2-coumarins 
In addition to the important biological activity of 4-alkoxy-2-coumarins and related 
heterocycles,31 many important coumarins contain a 4-hydroxy-2-coumarin motif, 
e.g. the anti-coagulant warfarin 140 (Figure 3.2).  
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140 
Figure 3.2. Warfarin. 
We sought to gain access to 3-aryl-4-hydroxy coumarins via hydroxy protection, 
chlorination, Suzuki-Miyaura coupling and deprotection. However, several common 
hydroxyl protecting groups, when present on our substrates, either completely 
inhibited the desired chlorination, or the subsequent Suzuki-Miyaura coupling. For 
example, a silyl ether (TBDPS) protecting group present in compound 100 did not 
tolerate the chlorination conditions, and only a 12% yield of the desired product was 
isolated, which was not synthetically useful (Scheme 3.22).  
   
100  141, 12% 
Scheme 3.22. Attempt to chlorinate 2-coumarin protected with silyl ether. 
Furthermore, a benzyl ether protecting group did not allow the Suzuki-Miyaura 
reaction to progress. Only starting material 106 was identified in the 1H NMR 
spectrum of the crude reaction mixture (Scheme 3.23). 
   
106  142 
Scheme 3.23. Attempted Suzuki-Miyaura cross-coupling of benzylated 2-coumarin. 
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Attempts to cleave the methyl ether of compound 111 with BBr3 were unsuccessful. 
Based on a procedure by Wiegrebe,44 coumarin 111 was treated with BBr3 in DCM 
(Scheme 3.24). Some conversion to product 143 was observed, however, all attempts 
to drive the reaction to completion were unsuccessful. Using BBr3.SMe2 was also 
unsuccessful. 
 
 
 
111  143 
Scheme 3.24. Attempt to demethylate 111 with BBr3. 
Pleasingly however, a remarkably facile method to cleave the methyl ether of 
compound 111 at 25 °C was identified (Scheme 3.25).  
   
111  143, 51% 
Scheme 3.25. Demethylation of Suzuki-Miyaura product to give 4-hydroxy-3-aryl-
2-coumarin. 
Arylated 2-coumarin 111 was converted to the hydroxyl compound 143 in 51% yield 
using TMSI45-46 (formed in situ from TMSCl and NaI47), followed by an acidic workup. 
The differing mechanisms of these two sets of conditions provide a rationale for why 
TMSI deprotection succeeded where BBr3 deprotection failed. 
Scheme 3.26 shows the mechanism for demethylation by BBr3, which involves the 
generation of a cation on the oxygen of the methoxy group. This is disfavoured on 
the 2-coumarin substrate 111 due to resonance localisation of electrons away from 
the oxygen of the methoxy group and onto the oxygen of the carbonyl. This has a 
destabilising effect on the positive charge on the methoxy oxygen which is required 
for the reaction to proceed. 
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Scheme 3.26. Potential mechanism of BBr3 demethylation. 
On the other hand, demethylation with TMSI is postulated to occur via a mechanism 
catalysed by the iodide ion, which is present in excess due to NaI (Scheme 3.27).47 
The protection of the carbonyl as a TMS ether changes the electronics of the 
molecule, such that there is now an inductive electron-donating effect rather than a 
resonance electron-withdrawing effect towards the methoxy group. This in turn 
facilitates the reaction of the methyl group with iodide and MeI is lost. The loss of 
MeI causes the appearance of an orange colour on the glass of the reaction vessel, 
which serves as a way to confirm that the reaction is progressing. Aqueous workup 
with 1M HCl cleaves the TMS ether to give the desired product 143. 
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Scheme 3.27. Potential mechanism of TMSI deprotection. 
It is noteworthy that previously reported routes to compound such as 143 require 
cyclisation of the appropriate diester,48 reactions of diaryliodonium salts,49 both of 
which limit diversification, or hazardous diazo compounds.50 
3.3.6. Conclusions 
The Suzuki-Miyaura cross-coupling of 4-alkoxy-3-chloro-2-coumarins in iPrOAc, an 
environmentally benign solvent, has been developed. Chlorination of the 2-coumarin 
and 2-pyrone framework is achieved through reaction with TCCA, a cheap and 
environmentally-friendly chlorinating agent. The presented Suzuki-Miyaura reaction 
conditions are tolerant of a diverse range of aryl and heteroaryl boronic acids. 
Conditions can be applied to the 2-pyrone, 2-pyridone and 2-quinolone frameworks 
with equal success. A practically useful demethylation of the Suzuki-Miyaura 
products allows access to 3-aryl-4-hydroxy-2-coumarins. This deprotection 
procedure allows the methoxy group, which is easily installed, to act as a protecting 
group. This proved preferrable to more traditional protecting groups, such as silyl 
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ethers and benzyl groups, which proved difficult to prepare. Finally, the 
Suzuki-Miyaura reaction was successfully scaled up to gram quantities. 
 Conclusions and Future Work 
Two sets of conditions for the Suzuki-Miyaura cross-coupling of 3-chloro-2-pyrones 
and related heterocycles have been developed. The use of chlorides for 
cross-coupling is preferable to other halides (iodides and bromides) because 
chlorides are cheaper and more readily available. A novel method for introducing 
chlorides into 2-pyrone and 2-coumarin compounds was achieved using TCCA, which 
is cheaper and more environmentally friendly than NCS. Top pharmaceutical 
companies are seeking reactions which are executed in non-chlorinated solvents, and 
the development of Suzuki-Miyaura conditions which can be performed in an 
environmentally benign solvent such as iPrOAc was achieved in this project.  
Future work with these conditions could potentially involve their application to the 
synthesis of biologically active 2-pyrone, 2-coumarin, 2-pyridone or 2-quinolone 
targets. The availability of a facile deprotection method, via demethylation of the 
Suzuki-Miyaura products, could also prove useful in this regard. 
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Chapt er 4  Mechanisti c insights i nto the direct arylati on of 2 coumarins a nd re lated heterocycle s  
 Introduction 
In parallel to the synthetic aspects of this project, mechanistic investigations were 
also performed to develop our understanding of the mechanisms through which 
2-coumarins and related heterocycles undergo C–H activation and direct arylation 
reactions. Insights into the mechanisms of C−H activation reactions are vital to allow 
extrapolation to untested systems and to inform future development and 
optimisation of reaction conditions. 
For Section 4.3 and Section 4.4 of this chapter, the synthetic studies (i.e. optimisation 
of conditions, demonstration of substrate scope, etc.) were performed by other 
members of the McGlacken group, while the mechanistic aspects were studied by 
the Candidate.  
It was necessary to develop a range of protocols to introduce deuterium into the 
target substrates as part of this work. The experiments which were performed as part 
of these mechanistic investigations are described. The results are presented and their 
interpretations are discussed. 
A brief introduction to some of the key concepts, such as kinetic isotope effects and 
deuterium exchange experiments, will be given prior to the discussion of results. 
4.1.1. Kinetic isotope effects 
In the study of C–H activation reactions, one of the most important experiments 
utilised are kinetic isotope effect studies.1-2 
Certain isotopes may differ in their chemical reactivity, because some chemical 
properties depend on atomic mass. However, this difference is particularly significant 
for hydrogen because moving from 1H to 2H (deuterium, D) is, in effect, a doubling of 
mass. The difference is not as significant, for example, between 12C and 13C in 
chemical reactions, because 13C is only 8% heavier than 12C. In the context of this 
work, a kinetic isotope effect (KIE) is the change in the rate of reaction observed 
when a hydrogen (1H) atom is replaced by a deuterium (D) atom in the same reaction, 
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and can be defined as shown in Equation 4.1, where kH is the rate of reaction with a 
1H atom in the molecule and kD is the rate with a D atom in the molecule.2 
KIE =
𝑘H
𝑘D
 
Equation 4.1. Kinetic isotope effect. 
Energy is required to raise the vibrational state of the bond to the point where it 
dissociates. The relationship between energy (E) and frequency (ν) is given by 
Planck’s Law, E=hν, where h is Planck’s constant. The frequency of a stretching 
vibration is modelled by Hooke’s Law for the stretching of a spring with a mass 
attached at both ends. Equation 4.2 gives the vibrational frequency of a spring with 
two masses (m1 and m2) at the ends. This equation gives the frequency, ν, for a 
harmonic oscillator. The force constant (k) for the spring reflects the strength of the 
bond.  
𝜈 =  
1
2π
√
𝑘
𝑚r
 where 𝑚r =  
𝑚1𝑚2
𝑚1 + 𝑚2
 
Equation 4.2. Stretching frequency of a bond. 
The frequency, ν, is directly proportional to the square root of the force constant for 
the bond, and inversely proportional to the square root of the reduced mass. The 
reduced mass for a bond between a relatively heavy atom such as C, N or O with a 
light atom such as H is significantly affected when the H atom is changed to D. The 
minimum vibrational frequency that a bond can have is called the zero point energy 
(ZPE). As shown in Equation 4.2, the vibrational frequency, and thus the ZPE, depends 
on the mass (m1 and m2) of the atoms attached to the bond. The stretching frequency 
of a bond with deuterium is reduced due to the heavier mass, and hence the ZPE for 
the bond is lower also. Since the ZPE for a C–D bond is less than the ZPE for a C–H 
bond, the C–D bond requires more energy to be broken, i.e. C–D bonds are marginally 
stronger than C–H bonds. KIEs arise because reactions in which C–H bonds break 
proceed faster than reactions where C–D bonds break, provided that the bond to H 
(or D) is involved in the rate-determining step (RDS) of the reaction. 
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If kH=kD (i.e. kH/kD is 1), one could conclude that the bond where the isotopic 
substitution occurred is not changing during the RDS. However, it may also just be 
that the isotope effect is too small to be measured accurately. When the ratio of 
kH/kD is different from 1, more reliable conclusions can be drawn. A normal isotope 
effect is when kH/kD is greater than 1. When kH/kD is less than 1, it is called an inverse 
isotope effect. A primary isotope effects means that the isotope effect can be 
attributed to a bond-breaking event at the substituted bond. When the effect arises 
from isotopic substitution remote from the bonds undergoing reaction, it is referred 
to as a secondary isotope effect.1 Primary isotope effects are of greater magnitude 
than secondary isotope effects. In essence, the observation of a KIE >1 indicates that 
C–H/C–D bond cleavage is involved in the RDS of the reaction.  
The IUPAC Gold Book recommends that the expressions rate-controlling, rate-
limiting and rate-determining be regarded as synonymous, and defines “the RDS in a 
reaction occurring by a composite reaction sequence is an elementary reaction the 
rate constant for which exerts a strong effect – stronger than that of any other rate 
constant – on the overall rate”.3 Another important definition to consider is the 
product-determining step: “the step of a stepwise reaction in which the product 
distribution is determined. The product-determining step may be identical to, or occur 
later than, the rate-controlling step on the reaction coordinate”.3 It is an irreversible 
step that controls which of two (or more) possible products are formed in a reaction 
with multiple competing pathways. Although the product-determining step can also 
be the RDS, the product-determining step does not need to be the RDS.4 
Catalytic reaction pathways are often distinct from the corresponding uncatalysed 
reaction pathways for the same transformation, involving multiple steps and the 
formation of catalytic intermediates which lower the activation energy of the 
reaction. Under steady-state conditions, all steps of a catalytic reaction proceed at 
the same rate by adjustment of the concentrations of the intermediates to offset the 
differences in the rate constants for each step. Technically, catalytic reactions do not 
have a “rate-determining step”; rather, the catalytic turnover frequency is controlled 
by the step with the lowest effective rate constant. This step is called the “turnover-
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limiting step”.5 For this chapter, the term “rate-determining step” will be used 
synonymously with “turnover-limiting step”. 
There are several types of experiments when can be used to determine a KIE, and 
each of them can provide different information about the reaction mechanism. The 
interpretation of KIEs is discussed in an excellent essay by Hartwig,4 so only a brief 
summary will be outlined here. The choice of KIE measurement technique and the 
interpretation of KIE data must be done carefully to avoid conclusions which are 
unsupported by the available data. 
In the first type of KIE experiment, using aryl C–H and C–D bonds as representative 
examples, two separate rate constants are measured (by NMR spectroscopy, GC, IR 
spectroscopy, etc.) for two reactions that are conducted in separate flasks, one with 
a substrate containing a C–H bond and one with a substrate containing an analogous 
C–D bond. The relative ratio of these independently determined reaction rate 
constants then gives the reported KIE value (Scheme 4.1). The accuracy of the KIE 
determined by this experiment is limited to the accuracy with which the individual 
rate constants can be measured. Measurement of the rate constant for a catalytic 
reaction can be hampered by the presence of induction periods and catalyst 
decomposition. However, this method of KIE measurement is generally the only one 
that provides conclusive information on whether the C–H bond cleavage occurs 
during the turnover-limiting step of a catalytic reaction. 
 
Scheme 4.1. KIE determined from two parallel reactions. 
The second type of experiment involves an intermolecular competition between two 
different substrates in the same reaction flask. Rather than being determined by 
comparing two reaction rate constants (i.e. kH/kD) measured separately, the KIE is 
calculated from the relative amount of products formed by the functionalisation of a 
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C–H versus a C–D bond (i.e. PH/PD) (Scheme 4.2). This method requires just one 
measurement because both substrates are present in the same flask. This also 
ensures that the C–H and C–D bond functionalisations both occur under exactly the 
same conditions, without inadvertent variation. The ratio of reactants and products 
can be measured with much greater precision than individual rate constants. 
However, this experiment does not provide the same information on whether C–H 
bond cleavage occurs during the RDS of a reaction that the first type of experiment 
does. The absence of an isotope effect would show that C–H bond cleavage does not 
occur during the RDS, but the observation of a primary isotope effect does not 
provide evidence that C–H bond cleavage occurs during the RDS, only the experiment 
shown in Scheme 4.1 can show that. 
 
Scheme 4.2. KIE determined from an intermolecular competition. 
The third type of experiment is conceptually similar to the second but involves an 
intramolecular competition between functionalisation of a C–H bond and a C–D bond 
in a single substrate. As is the case in Scheme 4.2, the KIE is calculated from the 
relative amount of products formed from the functionalisation of a C–H versus a C–
D bond (PH/PD).  
 
Scheme 4.3. KIE determined from an intramolecular competition. 
The lack of a KIE from this experiment rules out the potential that C–H bond cleavage 
occurs during the RDS. Therefore, this experiment can provide a simple means to 
show that C–H bond cleavage is not rate-determining, but the observation of a KIE 
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from this experiment does not indicate that C–H bond cleavage must occur during 
the RDS of a reaction. For example, a false positive KIE could be observed if the RDS 
of a reaction does not involve the substrate that ultimately undergoes C–H bond 
cleavage.  
The competition experiments shown in Scheme 4.2 and Scheme 4.3 measure a 
difference in product distribution that results from a difference in the rate of an 
irreversible C–H bond-cleavage step, and so these experiments could give rise to a 
product ratio reflecting a positive KIE, even though the C–H bond cleavage does not 
occur during the RDS of the overall process. In other words, a positive KIE determined 
by competition experiments could indicate that the C–H bond cleavage occurs in a 
step that is product-determining, but not rate-determining. 
4.1.2. Hydrogen-deuterium exchange 
Hydrogen-deuterium exchange (H–D exchange) is a chemical reaction in which a 
covalently bonded hydrogen atom is replaced by a deuterium atom, or vice versa. 
This can be applied most easily to exchangeable protons and deuterons. Exchange 
between XH (where X = O, N or S) protons is extremely fast, and in a deuterated 
solvent such as D2O, these exchangeable protons are easily replaced by D. The use of 
acid, base or metal catalysts, coupled with conditions of increased temperature and 
pressure, can facilitate the exchange of non-exchangeable hydrogen atoms, provided 
that the substrate is robust to the conditions applied. 
For the study of reaction mechanisms, H–D exchange can be used to identify the 
source of protons and the reversibility of proton abstraction. For example, if a 
deuterated analogue of the reaction solvent is used with non-deuterated starting 
materials, and deuterium is subsequently identified in the starting material and/or 
product, it may be said that the solvent was the source of the deuterium. Similarly, if 
a D-labelled starting material is used and the amount of deuterium incorporation is 
found to be decreased after subjecting it to the reaction conditions, it is inferred that 
the abstraction of the proton/deuteron at that position is reversible in the reaction. 
However, this does not necessarily mean that the productive mechanism involves 
this reversible step, i.e. the reversible step could occur as a non-productive, off-cycle 
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pathway. The inverse experiment is also possible, where a non-deuterated starting 
material is used and the amount of deuterium incorporation is found to be increased 
after a period of time. A deuterium source is required for this type of experiment.  
Deuterium can be observed by NMR spectroscopy. It is an isotope with a spin = 1, 
unlike 1H which has a spin = ½. Coupling of deuterium to 13C forms 1:1:1 triplets with 
a coupling constant of 20-25 Hz, which is a useful way to confirm the presence of 
deuterium in an isolated compound. 2H NMR has a chemical shift range similar to 
proton NMR, but peaks show poor resolution. 2H NMR may be used to observe the 
effectiveness of deuterium incorporation, or deuteration, because a deuterated 
compound will show a peak in a 2H NMR spectrum but not in a 1H NMR spectrum. 
For experimental ease, the absence of a previously observed signal by 1H NMR 
spectroscopy is often used as evidence of deuterium incorporation, and this is the 
case for all experiments described in this chapter. The extent of deuterium 
incorporation can also be quantified in this manner. Take, for example, the case of a 
signal in the 1H NMR spectrum that integrates to 1.00 H (relative to other known non-
deuterated peaks in the spectrum) in an unlabelled substrate; if the same signal 
integrates to 0.01 H in a D-labelled substrate, the labelled substrate is said to have 
99% deuterium incorporation at that position. The presence of deuterium can also 
be observed by MS, as D is 1 amu heavier than 1H.  
 Direct arylation via single C–H activation at C–3 
The first mechanism which will be investigated in this chapter is the direct arylation 
of 4-benzyloxy-2-coumarin 20 to give the cyclised 2-coumarin 38 (Scheme 4.4). The 
development of these reaction conditions was discussed in Section 2.2. 
   
20  38, 61% 
Scheme 4.4. Direct arylation of 4-benzyloxy-2-coumarin 20. 
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Firstly, the understanding of the C–H activation of 2-pyrones and related 
heterocycles at the time of this work will be outlined.  
In a report by Fairlamb on direct arylation of 2-pyrone, a number of informative 
mechanistic experiments were performed.6 In this report, a mechanism involving 
neutral palladium intermediates was proposed and two possible mechanistic 
pathways were entertained: a Concerted Metallation-Deprotonation 
(CMD)/Ambiphilic Metal-Ligand Assistance (AMLA)7 mechanism and a Heck-type 
mechanism.2 Initially, both mechanisms were considered for the direct arylation of 
4-benzyloxy-2-coumarin 20. 
Fairlamb proposed that if a “neutral pathway”8 Heck-like mechanism was operative 
then the mechanism could proceed as outlined in Scheme 4.5. However, there was 
an apparent problem in the β-hydride elimination step (III to B). Since there are no 
neighbouring syn-β-hydrogens, the anti-stereochemical relationship of the 
“Pd(II)(X)PPh3” group and the C–3 proton is a problem for the β-hydride elimination 
(III to B). However, it is possible that isomerisation from III to IV via a π-allyl species 
allows syn-elimination to ultimately occur (IV to B). 
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Scheme 4.5. Heck-like mechanism for 2-pyrone arylation proposed by Fairlamb.6 
The second mechanism proposed involved CMD and is outlined in Scheme 4.6.6 
Following the oxidative addition of the Pd(0) species into the C–I bond, the resulting 
Pd(II) complex I was anticipated to undergo ligand exchange whereby one of the 
phosphine ligands was displaced by a carbonate base, forming intermediate V. While 
it is possible that Cs2CO3 deprotonates the C–3 proton of A intermolecularly, Fairlamb 
proposed an iodide/carbonate metathesis to V followed by an intramolecular base-
assisted CMD process to give intermediate VII. Reductive elimination serves to 
restore the catalyst and expel the arylated product B. 
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Scheme 4.6. Possible CMD mechanism for 2-pyrone arylation.6 
This is, of course, not an exhaustive outline of the potential mechanisms at play.6 An 
SEAr mechanism could also be possible.9-10 
Pivalic acid (PivOH) has been demonstrated to be a promoter of the CMD reaction 
pathway for C–H activation by Echavarren11-12 and Fagnou.13 The pivalate anion is 
believed to act as a catalytic proton shuttle from the aryl to the stoichiometric 
carbonate base. As discussed in Section 2.2.2, without this additive, very little 
conversion of starting material to product was obtained.7 The optimal quantity of 
PivOH for most published procedures is 30 mol%.14 Much debate surrounds the 
existence and engagement of a CMD mechanism in direct arylation reactions. One 
key paper on the analysis of this mechanism from the Fagnou group in 200815 has 
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been cited over 470 times. Fagnou’s report demonstrated that the CMD pathway not 
only predicts the reactivity and regioselectivity observed with some simple and 
electron-deﬁcient arenes, but is also applicable to a diverse set of arenes spanning 
the entire spectrum of known direct arylation coupling partners, including those that 
have been previously proposed to react via SEAr. Another interesting publication by 
Fagnou investigated the mechanism of C(sp3)–H bond cleavage in Pd(0)-catalysed 
intramolecular arylation of alkanes adjacent to amides and sulphonamides.14 This 
report offered fascinating experimental support for the CMD transition state using 
stoichiometric studies, KIE experiments and DFT calculations. Further information 
was also provided on an important, additional role of pivalate as a promoter of 
phosphine dissociation from the Pd(II) intermediate, enabling the CMD transition 
state. 
4.2.1. Investigation of the oxidative addition intermediate 
For the investigation into the direct arylation of 4-benzyloxy-2-coumarin 20 to give 
the cyclised 2-coumarin 38 (Scheme 4.4), the first experiments were conducted to 
deduce if oxidative addition to the aryl halide was the preliminary step in the reaction 
mechanism. This could be evidence for either a Heck-type or CMD-type mechanism 
as described in Section 4.2. The isolation and characterisation of the oxidative 
addition product formed during these reactions was investigated. It was previously 
demonstrated by McGlacken and co-workers that reaction of Pd2(dba)3 with PPh3 
gave Pd(0)(η2-dba)(PPh3)2 (144), and that 8 equivalents of PPh3 was necessary to 
displace the dba ligand and to stabilise the oxidative addition product.16 
As shown in Scheme 4.7, 1 equivalent of Pd2(dba)3 was reacted with 8 equivalents of 
PPh3 in THF at room temperature, followed by the addition of 2 equivalents of 
coumarin 20. Oxidative addition product [Pd{(C7H6O-2-(C9H5O2))}I(PPh3)2] (145) was 
isolated from this reaction as a grey solid in 90% yield. Intermediate 145 was then 
characterised by NMR spectroscopy. A single peak was observed in the 31P NMR 
spectrum (22.8 ppm), characteristic of Pd(II) coordination. 
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20 (2 equiv.) 
 
 
 
 
 144  145, 90% 
Scheme 4.7. Isolation of oxidative addition intermediate 145. 
The nature of [Pd{(C7H6O-2-(C9H5O2))}I(PPh3)2] (145) as a catalytically relevant 
intermediate was then established. It was with this aim that 4-((2-iodobenzyl)oxy)-
2-coumarin (20) was subjected to the optimised reaction conditions, replacing 
Pd2(dba)3 (2 mol%) and PPh3 (4 mol%) with [Pd{(C7H6O-2-(C9H5O2))}I(PPh3)2] (145) 
(2 mol%). The cyclised product 38 was obtained in 55% yield, comparable to 61% 
under the standard reaction conditions. This indicates that 145 is likely to be an 
intermediate in the direct arylation reaction (Scheme 4.8).14 
 
 
 
 
 
145 (2 mol%) 
 
 
 
 
 
 
20  38, 55% 
Scheme 4.8. Cyclisation reaction using oxidative addition intermediate 145 in place 
of Pd2(dba)3/PPh3. 
The reaction shown in Scheme 4.8 was also performed in the absence of PivOH, 
resulting in a 3% yield of arylation product 38. This provides further evidence that 
PivOH is a necessary co-catalyst in this system. It could also be interpreted as 
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evidence that these arylation reactions proceed via CMD, based on the work by the 
Fagnou group which demonstrates the importance of PivOH as a promoter of 
phosphine dissociation from the Pd(II) intermediate, enabling the CMD transition 
state,14 and as a catalytic proton shuttle13 in the CMD mechanism. The need for both 
pivalate and carbonate anions in CMD systems has been rationalised by the 
requirement for a soluble basic species responsible for deprotonation of the aryl 
(pivalate) and an insoluble proton sink responsible for the sequestration of H+ and 
pivalate regeneration (carbonate).13-14  
Since intermediate 145 was isolated from a reaction using THF as the solvent, it was 
important to investigate if this same intermediate could form in the more polar NMP, 
which is the optimal reaction solvent. Again, 1 equivalent of Pd2(dba)3 was reacted 
with 8 equivalents of PPh3 at room temperature, but this time in NMP, followed by 
the addition of 2 equivalents of coumarin 20. [Pd{(C7H6O-2-(C9H5O2))}I(PPh3)2] (145) 
was identified by 1H and 31P NMR spectroscopy after the reaction mixture had been 
stirred at 70 °C for 1 h (Scheme 4.9).  
 
 
 
 
 
 
20 (2 equiv.) 
 
 
 
 
 144  145 
Scheme 4.9. Identification of oxidative addition intermediate 145 in NMP. 
Na2CO3 (10 equiv.) and PivOH (3 equiv.) were then added to the reaction mixture and 
the reaction stirred at 130 °C for a further 3 h, after which the cyclised product 38 
was determined to have formed in 47% yield; this is comparable to results (61% yield) 
after standard catalytic conditions are applied. The stoichiometric amounts of base 
and PivOH were found to be necessary by Fagnou in a similar experiment, in order to 
mimic the ratios of pivalate and carbonate to palladium.14 
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Taken together, these experiments demonstrate that oxidative addition of a Pd(0) 
catalytic species into the C–I bond of the 4-benzyloxy group to give intermediate 145 
is a step in the mechanism of the direct arylation of substrate 20 to give product 38. 
4.2.2. Investigation of the C–H activation at C–3 
The C–H activation event at the C–3 position of the 2-coumarin substrate 20 was the 
next mechanistic step to be investigated. Deuterium exchange and KIE experiments 
were performed in the investigation of this step. 
C–H activation as the first step 
The possibility that the initial step in the mechanism could involve a reversible C–H 
activation was examined. This is well-known for rhodium-based catalysts,17 but in 
cases involving palladium, usually a Pd(II)/Pd(IV) mechanism is invoked. Given the 
apparent acidity of the C–3–H bond,6 the potential for an initial reversible C–H bond 
activation was considered. This was assessed using three tests with deuterated 
pivalic acid (PivOD). PivOD was prepared by heating PivOH at 55 °C in D2O overnight. 
As outlined in Section 4.1.2, exchange between XH (where X = O, N or S) protons is 
extremely fast, and in a deuterated solvent such as D2O, these exchangeable protons 
are immediately replaced by D. 
To confirm the presence of deuterium in PivOD, an exchange experiment was 
performed with propiophenone (146). The α-protons of propiophenone are 
exchangeable due to keto-enol tautomerism. After heating for 21 h, the CH2 quartet 
at 3.00 ppm appeared as multiplet integrating as 1H relative to the aromatic protons, 
indicating that deuterium had been incorporated at the α-position to give compound 
147 (Figure 4.1).  
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146  147 
 
Figure 4.1. Confirmation of deuterium incorporation in PivOD. 
To investigate the possibility of reversible C–H activation, the H–D exchange 
experiments (Scheme 4.10) consisted of: 
1. Exposing the coumarin starting material 20 to the optimised reaction 
conditions in the presence of PivOD and halting the reaction before 
completion. 
2. Using an unhalogenated variant 98 under the standard conditions with PivOD. 
3. Using an unhalogenated variant 98 with PivOD but with a stoichiometric 
amount of the palladium and phosphine sources.  
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Scheme 4.10. Investigatation of reversible C–H activation. 
All three tests failed to give any deuterium incorporation. For substrate 20, 
deuterium incorporation would have shown that reversible pivalate-assisted C–H 
activation occurred after oxidative addition into the C–I bond. For tests involving the 
unhalogenated variant 98, any deuterium incorporation would have shown that 
reversible pivalate-assisted C–H activation occurred before oxidative addition into 
the C–I bond. These results allowed the elimination of pivalate-assisted reversible C–
H activation as a potential first mechanistic step. 
Electronic effects of 2-coumarin ring substitution 
As described in Section 2.2.3, it was found that good yields of 71-82% were observed 
for electron-rich 2-coumarins. A slight reduction in yield was noted for electron-poor 
2-coumarins. For example, the 6-fluoro 42 and 6-nitro 43 products formed in 43% 
and 58% yields respectively. Fagnou reported that there is an important C–H bond 
acidity parameter in regioselectivity and reactivity; results which were incompatible 
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with SEAr and radical processes, but correlated well with a proton-transfer 
pathway.13 Computational studies revealed the key C–H functionalisation step occurs 
via a CMD process, the accessibility of which depends directly on the acidity of the 
C–H bond being cleaved.18 
Thus, the effect of C–H acidity on the direct arylation of 2-coumarins was investigated 
by conducting competition reactions. Substitution of the 6-position of the 2-
coumarin ring was expected to affect the acidity C–3–H bond due to resonance 
delocalisation of electrons. 
However, in a one-pot competition experiment between the unsubstituted 2-
coumarin 20 and the less acidic 6-methoxy 2-coumarin 28 (Scheme 4.11), both 
substrates appeared to react at a similar rate.  
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28 
 
 
 
41, 24% 
 
 
20  38, 25% 
Scheme 4.11. Competition experiment between 6-methoxy 28 and 6-hydro 20 2-
coumarins. Yields were determined from the 1H NMR spectrum of the crude reaction 
mixture using 1,3,5-trimethoxybenzene as the internal standard for quantification. 
The reaction time during the substrate scope was 3 h, but for the competition 
experiments, the reactions were stopped early. Both product 38 and product 41 were 
present in ~25% yield after 20 min, as determined from the 1H NMR spectrum of the 
crude reaction mixture. 
A second one-pot competition experiment between the unsubstituted 2-coumarin 
20 and the more acidic 6-fluoro 2-coumarin 29 was then conducted (Scheme 4.12).  
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29 
 
 
 
42, 25% 
 
 
20  38, 19% 
Scheme 4.12. Competition experiment between 6-fluoro 29 and 6-hydro 20 2-
coumarins. Yields were determined from the 1H NMR spectrum of the crude reaction 
mixture using 1,3,5-trimethoxybenzene as the internal standard for quantification. 
The more acidic substrate 29 reacts at a slightly faster rate and product 42 was 
present in 25% yield after 20 min, while product 38 was present in 19% yield 
according to the 1H NMR spectrum of the crude reaction mixture. 
Finally the rate of reaction of a 2-coumarin bearing a strongly electron-withdrawing 
6-nitro group 30 and the rate of reaction of a 2-coumarin bearing a 6-methoxy group 
28 were compared via a one-pot competition experiment. Product 43 is formed in 
24% yield in just 15 min, while substrate 28, which presumably has a less acidic C–H 
bond, gives product 41 in only 8% yield under the same conditions. 
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28 
 
 
 
41, 8% 
 
 
30  43, 24% 
Scheme 4.13. Competition experiment between 6-methoxy 28 and 6-nitro 30 2-
coumarins. Yields were determined from the 1H NMR spectrum of the crude reaction 
mixture using 1,3,5-trimethoxybenzene as the internal standard for quantification. 
The presence of the electron-withdrawing groups at the 6-position should make the 
C–3–H bond more acidic. This in turn makes substrates bearing electron-withdrawing 
groups more reactive towards the CMD pathway for direct arylation, which could 
explain why greater yields were observed for substrate 30 compared to substrate 28 
bearing an electron-donating methoxy group. This is in line with Fagnou’s 
observations regarding the importance of C–H bond acidity in the CMD pathway.13, 
18 However, this is in contradiction with the observed yields for these compounds in 
the substrate scope (Scheme 2.19). In the substrate scope, compound 41 was 
isolated in 82% yield after the 3 h reaction time, while product 43 was isolated in 58% 
yield. The same reaction time was applied to every substrate, so it is possible that 
the products bearing EWGs formed faster than the compounds bearing EDGs, and 
then degraded over the prolonged reaction time. 
In hindsight, it may have been more useful to locate the substituents at the 7-position 
as this would have maximised the resonance delocalisation towards the C–3–H bond. 
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Investigation of the kinetic isotope effect 
The theory behind KIEs, as well as common experiments to determine KIEs, is 
discussed in Section 4.1.1. To examine the KIE at the C–3 position, it was necessary 
to synthesise a deuterated variant of 2-coumarin 20, which required extensive 
optimisation.  
Initially, it was attempted to access deuterated 2-coumarin 148 via H–D exchange of 
2-coumarin 20 using D2O under a range of conditions (Table 4.1).  
Table 4.1. Initial investigation of deuteration conditions. 
 
 
 
 
 
20  148 
Entry 
 
Reagents 
 
T  
(°C) 
t  
(h) 
C–3 Deuteration 
(%) 
1 D2O, dried acetone 79 16 0 
2 AcOD, D2O 79 48 0 
3 Na2CO3, D2O, acetone-d6 79 96 degradation 
It was found that neutral (Table 4.1, entry 1) and acidic conditions (Table 4.1, entry 
2) did not facilitate H–D exchange of the C–3 proton of 20. Basic conditions over an 
extended time frame degraded the starting material (Table 4.1, entry 3). 
It was then decided to attempt to deuterate the parent 4-hydroxy-2-coumarin (19), 
and benzylate the deuterated compound 149. To introduce deuterium to 4-hydroxy-
2-coumarin (19), a variety of conditions were tested (Table 4.2).  
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Table 4.2. Deuteration of 4-hydroxy-2-coumarin (19). 
 
 
 
 
19  149 
Entry Reagents T 
(°C) 
Time C–3 Deuteration 
(%) 
1 AcOD, D2O 79 48 h 0 
2 K2CO3, D2O, dried THF 79 4 h 6 
3 DCl, D2O 100 96 h 30 
4 D2O, dried acetone 25 1 h 21 
5 D2O, dried acetone 79 18 h 44 
6 D2O, acetone-d6 79 2 x 48 h 54 
7 D2O, acetone-d6 79 4 days 79 
8 D2O, acetone-d6 79 7 days 87 
Acidic (Table 4.2, entries 1 & 3) and basic (Table 4.2, entry 2) conditions gave poor 
deuterium incorporation, while neutral conditions required long reaction times for 
any considerable incorporation to occur (Table 4.2, entries 4-8). Deuterium 
incorporation in the isolated product also tended to decrease over time, even if the 
flask was filled with nitrogen and stored in the freezer. This can be explained by keto-
enol tautomerism, making the C–3 proton of 149 highly labile. 
In an attempt to reduce the reaction time, microwave conditions were applied. After 
2 h at 140 °C with 300 W of power, 90% deuterium incorporation was achieved 
(Scheme 4.14). 
 
 
  
19  149 (90% D) 
Scheme 4.14. Deuteration of 4-hydroxy-2-coumarin (19) under microwave 
conditions. 
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The sample of product 149 with the highest deuterium incorporation was benzylated 
(Scheme 4.15). The level of deuterium incorporation was retained during the 
benzylation reaction, and the deuterium incorporation did not decrease over time in 
the benzylated compound 148.  
 
  
 
149 (90% D) 2  148 (90% D) 
Scheme 4.15. Benzylation of deuterated 2-coumarin 149. 
To maximise the deuterium incorporation in the target substrate 148, a one-pot 
deuteration/benzylation procedure under microwave conditions was developed 
(Scheme 4.16).  
 
 
 
 
  
 
2 
 
 
19  149  148, 43%  
(98% D) 
Scheme 4.16. One pot deuteration/benzylation procedure. 
4-Hydroxy-2-coumarin (19) was dissolved in a mixture of D2O and acetone-d6 and 
stirred in a microwave reactor at 140 °C for 1.5 h. The microwave vial was removed 
from the reactor, and 2-iodobenzyl bromide (2) and K2CO3 were added to the 
reaction mixture. The vial was placed back in the reactor where the mixture was 
stirred at 100 °C for 0.5 h. Thus, after a total of 2 h reaction time, the reaction mixture 
was worked up and columned, to give product 148 with 98% deuterium 
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incorporation at C–3. A sample of the substrate could be stored at ambient 
temperature with no loss of deuterium incorporation, for at least one month.  
The KIE at C–3 was determined by the initial rates method (Figure 4.2).19 The rate of 
reaction for the non-deuterated substrate 20 and the deuterated substrate 148 for 
the formation of product 38 was determined by setting up six pairs of parallel 
reactions. The pairs of reactions were stopped at the indicated time points, and the 
yield of each reaction was determined by 1H NMR using 1,3,5-trimethoxybenzene as 
the internal standard for quantification. The experiment involving 12 reactions was 
performed in duplicate. The yields of product 38 at each time point were averaged, 
and the averaged yields were plotted against time to give Figure 4.2. This type of 
experiment allows one to conclude whether the C–H activation is the rate-
determining step, as discussed previously.4  
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20 148  38 
 
KIE =  
𝑘H
𝑘D
=  
m1
m2
=  
2.18
0.9429
= 2.3 
Figure 4.2. Determination of kinetic isotope effect. 
Using this method, the KIE was determined to be 2.3. This is a significant positive KIE 
and therefore it is concluded that C–H activation is the rate-determining step of the 
mechanism. The observation of a significant positive KIE from this experiment is 
incompatible with both Heck-type and SEAr mechanisms. 
4.2.3. Conclusions 
Based on these results, it is envisioned that a CMD mechanism is at play in this system 
(Scheme 4.17). Following the oxidative addition of the Pd(0) species into the C–I 
bond, the resulting Pd(II) complex 145 is anticipated to undergo ligand exchange 
whereby one of the phosphine ligands is displaced by a pivalate base, forming 
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intermediate I. This process has been shown to be promoted by PivOH.14 While it is 
possible that Na2CO3 deprotonates the C–3 proton of 20 intermolecularly, instead an 
iodide/pivalate metathesis to I followed by an intramolecular base-assisted CMD 
process to give intermediate II is proposed, based on the work by Fagnou,7, 13 
Echavarren11 and Davies/Macgregor.20-21 The pivalate anion is believed to act as a 
catalytic proton shuttle from the aryl to the stoichiometric carbonate base (proton 
sink).13 Reductive elimination from III serves to restore the catalyst and expel the 
arylated product 38. 
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Scheme 4.17. Proposed CMD mechanism for direct arylation of 2-coumarin 
substrates. 
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 Direct arylation via single C–H activation of an aryl C–H bond 
The intramolecular direct arylation of 2-pyrones to form five-membered6, 22-23 and 
six-membered16, 24-26 rings has been well-studied by the McGlacken group and others. 
In these examples, the coupling was realised between a C–H bond on the 2-pyrone 
and a C–X bond on the aryl ring. Such coupling reactions presumably proceed via 
well-known oxidative addition of Pd to the aryl halide, followed by C–H activation of 
the 2-pyrone. The C–3 proton of 2-pyrones has been shown to be acidic,6 making 
base-assisted proton abstraction a facile process. However, this approach has its 
limitations. 2-Pyrones have two potential sites for C–H activation (C–3 versus C–5), 
and thus complete regioselectivity is not guaranteed when the C–X bond is situated 
on the aryl ring. Also, halogenated phenoxy and benzyloxy coupling partners can be 
expensive to access, while the corresponding di- and tri-substituted phenols and 
benzyl alcohols are considerably cheaper. Poor yields when using electron-poor aryl 
halide coupling partners has proved a limitation of previous studies.6 All of these 
issues can be overcome by taking a more challenging approach to the direct arylation 
reaction: Using a halogenated 2-pyrone and activating the C–H bond of the phenoxy-
based coupling partner. Coupling involving an iodide on the 2-coumarin framework 
is known.27-28 
Within the McGlacken group, conditions were developed which facilitated the 
intramolecular direct arylation of 3-bromo-4-phenoxy-2-pyrones (Scheme 4.18).29-30 
Yields were moderate to excellent (40-93%), and electron-withdrawing substituents 
on the phenoxy ring were tolerated.  
 
 
 
Scheme 4.18. Direct arylation of 3-bromo-4-phenoxy-2-pyrones. 
Work on this section of the project involved the synthesis of a deuterated analogue 
of the 3-bromo-4-phenoxy-2-pyrone substrate, and subsequent determination of the 
KIE. The experiments, results and interpretations will be discussed. 
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4.3.1. Investigation of the kinetic isotope effect of the aryl C–H bond 
To examine the KIE, it was decided that an intramolecular competition experiment 
(Section 4.1.1, Scheme 4.3) would be performed because it is easy to conduct and 
gives an accurate result. The absence of a kinetic isotope effect would show that C–
H activation is not involved in the rate-determining step.4 However this type of 
experiment does not allow the confirmation of C–H activation as the rate-
determining step.  
Following the literature procedure,31 2-bromophenol was treated with 2 equivalents 
of nBuLi at 0 °C for 3 h to generate a lithiated dianion, which when quenched with 
D2O gave 2-deuteriophenol 150 in 62% yield after column chromatography, with 80% 
incorporation of deuterium at the indicated position (Scheme 4.19).  
   
  150, 62% (80% D) 
 
Scheme 4.19. Synthesis of 2-deuteriophenol 150. 
2-Deuteriophenol was subsequently reacted with 4-bromo-2-pyrone 6 overnight 
under basic conditions to give 151 in 88% yield with the retention of deuterium 
(Scheme 4.20). No purification was required. Compound 151 was then brominated 
with Br2 and purified by recrystallisation to give the target substrate 152 in 74% yield, 
again with 80% deuterium at the indicated position.  
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150 (80% D)  151, 88% (80% D)  152, 74% (80% D) 
Scheme 4.20. Synthesis of substrate 152 for kinetic isotope effect study. 
Despite several attempts, the amount of deuterium incorporation could not be 
improved above 80%. However, the 20% non-deuterated starting material was taken 
into account in the calculation of the KIE by subtracting 0.20 from each integral of 
1.00. 
3-Bromo-6-methyl-4-(phenoxy-2-d)-2-pyrone (152) was reacted under the standard 
catalytic conditions30 in an intramolecular competition KIE experiment (see Section 
4.1.1).  
It should be noted that no evidence of scrambling was observed under the standard 
reaction conditions. Scrambling is defined as a process whereby hydrogen atoms 
undergo intramolecular migration.32 However, throughout this chapter, scrambling 
is used to describe H–D exchange, which may be intra- or intermolecular. Often, the 
net effect of scrambling is that the level of deuteration in a compound is altered by 
the reaction conditions. 
The product of the reaction was purified by column chromatography and analysed 
by 1H NMR spectroscopy. Each 1H NMR signal arising from compound 153 was 
unambiguously assigned using 1D and 2D NMR spectroscopy. The integrals of the 
indicated protons were used to determine the KIE (Figure 4.3).  
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152 (80% D) 
 
 153 
 
KIE =
kH
kD
=
quantity of deuterated product
quantity of non deuterated product
=
(1 − 0.20) − (0.38 − 0.20)
(0.38 − 0.20)
=
(0.80 − 0.18)
0.18
=
0.62
0.18
= 3.4 
Figure 4.3. 1H NMR spectrum and calculation for determination of KIE with substrate 
152.  
This experiment was performed in duplicate. The first experiment (Figure 4.3) gave 
a KIE of 3.4, and the duplicate gave a KIE of 3.2. The average KIE was therefore 3.3. 
The observation of a KIE of 3.3 represents a kinetically significant C–H activation 
event (although not necessarily a rate-determining C–H activation step as discussed 
previously). This magnitude of KIE is typical of a CMD/AMLA mechanism, as reported 
in the literature.7, 33 A CMD mechanism is proposed for this reaction (Scheme 4.21), 
where an initial oxidative addition into the C–3–Br bond is followed by ligand 
H 
H/D 
H 
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exchange to form the key CMD transition state. An irreversible deprotonation 
followed by reductive elimination gives the product and regenerates the catalyst. 
 
Scheme 4.21. Proposed mechanism for the intramolecular direct arylation of 3-
bromo-4-phenoxy-2-pyrone. 
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 Direct arylation via double C–H activation 
Direct arylation which avoids one of the pre-activating groups by coupling a C–H and 
C–X bond is certainly progressive.34-35 However, the idealised approach would involve 
the coupling of two C–H bonds.36-37 When two unactivated species are coupled, it is 
often referred to as cross-dehydrogenative coupling (CDC).36, 38-40 In particular, 
efforts have been focused on direct oxidative coupling between two aromatic C−H 
bonds.41 This type of cross-coupling reaction is on the ‘wanted list’ of top 
pharmaceutical companies as a greener route to biaryls.42 However, such processes 
are thermodynamically disfavoured (for example, the homocoupling of benzene to 
give biphenyl and dihydrogen is thermodynamically disfavoured by 13.8 kJ mol−1),43 
and given that several sites are usually available for C–H activation in even the 
simplest organic molecules, regioselective oxidative coupling of this type is a 
daunting challenge.  
Within the McGlacken group, conditions were developed which allowed the 
formation of tricyclic pyrones and coumarins by the coupling of phenoxy-substituted 
substrates via CDC (Scheme 4.22).29, 44  
 
 
 
 
 
 
97  154 
Scheme 4.22. Double C–H activation of 2-coumarin 97. 
Work on this section of the project involved the synthesis of a range of 2-coumarin 
substrates, including deuterated substrates, and subsequent investigation of both C–
H activation events. These investigations involved reversibility studies and the 
determination of KIEs. Density Functional Theory (DFT) calculations were performed 
by our collaborator Prof. Zhenyang Lin at the Hong Kong University of Science and 
Technology. The experiments, results and interpretations will be discussed. 
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4.4.1. Synthesis of 2-coumarin substrates  
To allow the mechanistic investigations to be performed, a range of 2-coumarin 
substrates were synthesised. The preparation of 4-phenoxy-2-coumarin (97) is 
described in Section 3.3.1. A deuterated analogue of 97, 3-deuterio-4-phenoxy-
2-coumarin (156) was synthesised from 4-hydroxy-2-coumarin (19) (Scheme 4.23). 
4-Hydroxy-2-coumarin (19) was treated with phenyliodo(III)diacetate (PIDA) in the 
presence of Na2CO3 to give a zwitterion, which, at 165 °C in DMF, underwent thermal 
rearrangement via a spiro-Meisenheimer complex to give 3-iodo-4-phenoxy-2-
coumarin (155). 3-Iodo-4-phenoxy-2-coumarin (155) was purified by recrystallisation 
from MeOH and isolated in 38% yield over the two steps. Reductive deiodination in 
the presence of zinc and monodeuterioacetic acid gave 3-deuterio-4-phenoxy-2-
coumarin (156) in 86% yield with 97% deuterium incorporation at the indicated 
position. The deuterium incorporation was measured using 1H NMR spectroscopy, 
with a 0.03H integral at 5.41 ppm in the 1H NMR spectrum confirming the quantity 
of deuterium present, and a triplet at 93.3 ppm in the 13C NMR spectrum affirming 
the presence of deuterium. 
 
 
 
 
 
 
 
 
19  155, 38%  156, 86%  
(97% D) 
Scheme 4.23. Synthesis of 3-deuterio-4-phenoxy-2-coumarin (156). 
4-(Phenoxy-d5)-2-coumarin (157) was synthesised from the reaction of 4-bromo-
2-coumarin (96) and phenol-d6 under basic conditions in acetone at 65 °C overnight 
(Scheme 4.23). After aqueous workup and washing with 10% aqueous NaOH, 
4-(phenoxy-d5)-2-coumarin (157) was isolated as a light brown solid in 86% yield. 
Deuterium incorporation was >99%. 
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96  157, 86% 
Scheme 4.24. Synthesis of 4-(phenoxy-d5)-2-coumarin (157). 
Two 2-coumarin substrates with substituted aryl backbones were required for the 
mechanistic studies which will be described later. To this end, the required 
4-hydroxy-2-coumarins were synthesised. 4-Hydroxy-5-methoxy-2-coumarin (159) 
was synthesised from 2'-hydroxy-6'-methoxyacetophenone and diethyl carbonate in 
the presence of sodium hydride.45-46 Purification by recrystallisation from EtOH gave 
4-hydroxy-5-methoxy-2-coumarin (159) in 24% yield. 
 
 
 
 
 
 
158, 74%   159, 24% 
Scheme 4.25. Synthesis of 4-hydroxy-5-methoxy-2-coumarin (159). 
4-Hydroxy-5,7-dimethyl-2-coumarin (160) was synthesised from 3,5-dimethylphenol 
and Meldrum’s acid.47 The ester which formed was cyclised in the presence of Eaton’s 
reagent to give 4-hydroxy-5,7-dimethyl-2-coumarin (160) in 78% yield after 
recrystallisation. 
 
 
  
   160, 78% 
Scheme 4.26. Synthesis of 4-hydroxy-5,7-dimethyl-2-coumarin (160). 
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As before, the 4-hydroxy-2-coumarins were brominated with TBAB to give the 4-
bromo-2-coumarins 161 and 163 in 31% and 33% yields respectively, which were in 
turn reacted with phenol under basic conditions to give the 4-phenoxy-2-coumarins 
162 and 164, in 13% and 17% yields respectively (Scheme 4.27). 
     
159  161, 31%  162, 13% 
     
160  163, 33%  164, 17% 
Scheme 4.27. Synthesis of aryl substituted 4-phenoxy-2-coumarins 162 and 164. 
The corresponding penta-deuterated analogues were synthesised by reaction of the 
4-bromo-2-coumarins with phenol-d6, to give 4-(phenoxy-d5)-5-methoxy-2-coumarin 
(165) in 28% yield and 4-(phenoxy-d5)-5,7-dimethyl-2-coumarin (166) in 17% yield 
(Scheme 4.28). The yields for reactions at the 4-position when the 5-position is 
substituted are considerably lower than for the unsubstituted 2-coumarins. This is 
could be due to sterics or the effect of having electron-donating groups close to a 
reaction site which is required to be electrophilic. 
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161  165, 28% 
 
 
 
  
163  
166, 17% 
Scheme 4.28. Synthesis of aryl substituted 4-(phenoxy-d5)-2-coumarins 165 and 166. 
4.4.2. C–H Activation at C–3 of the 2-coumarin 
For the investigation of the mechanism of the double C–H activation of substrate 97 
to give cyclised product 154, the C–H activation at C–3 of the 2-coumarin was 
examined in the first instance. 
During the reaction, both the starting material 156 and the product 154 were 
carefully monitored by 1H NMR spectroscopy. For starting material 156, it was 
observed that the value of the integral for the C–3 proton at 5.41 ppm was increasing 
over time under the reaction conditions, corresponding to a decrease in deuterium 
incorporation at this position (Figure 4.4). After just 5 min of reaction time, the 
starting material was isolated and deuterium incorporation at this position had 
decreased from 97% to 89%. The reaction was then performed in the absence of 
palladium. In this experiment, the deuterium incorporation at C–3 was not affected 
by the reaction conditions. This is consistent with a reversible palladation of C–3 as 
part of the reaction mechanism. 
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Figure 4.4. Reversible palladation at C–3 of 2-coumarin 156.  
The inverse reaction was performed using substrate 97 in monodeuterated pivalic 
acid (PivOD) (Figure 4.5). The peaks corresponding to Ha of product 154 and H of the 
starting material 97 overlap at 8.03 ppm. Since Hb integrates as 0.10 H, it can be 
inferred that Ha comprises 0.10 H of the 1.00 H integral at 8.03 ppm. Therefore, the 
integral for H of 97/156 works out to 0.90 H. If only the non-deuterated starting 
material 97 were present, then the integral for the singlet at 5.41 ppm would also be 
0.90 H. However, since it integrates to 0.77 H, it can be said that the 3-deuterio-
2-coumarin 156 is present. This showed deuterium incorporation exclusively at the 
C–3 position, confirming a reversible C–H activation event.  
Internal standard 
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Figure 4.5. Reaction with PivOD. 
Next, the rate of formation of product 154 from non-deuterated substrate 97 and 
deuterated substrate 156 in parallel reactions was compared (Figure 4.6).19, 48 This 
method of KIE determination allows one to conclude whether the cleavage of a C–H 
bond is involved in the rate-determining step of a reaction.4 The reaction was 
performed at 120 °C rather than the optimised 140 °C so that the reaction would 
progress slightly slower, to conveniently facilitate reaction monitoring. Interestingly, 
an induction period can be observed in the first 15 min of the reaction, which could 
be a key pre-catalyst to catalyst step, such as ligand dissociation/association to form 
the active Pd(II) species. The rate of product formation was observed to be very 
similar for the two substrates (Figure 4.6).  
  
Hb 
0.10 H 
 
H + Ha 
1.00 H = 0.90 H + 0.10 H 
C–3–H + C–3–D 
0.77 H 
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97 156  154 
 
Figure 4.6. Reaction profile for the formation of product 154 from 97 and 156. 
The induction period is excluded from the calculation of the slope as it is the same 
for both substrates. The initial rates method was used to determine the KIE (Figure 
4.7).19 
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KIE =  
kH
kD
=  
m1
m2
=  
1.266
1.167
= 1.08 
Figure 4.7. The initial rates method for KIE determination. 
A KIE of ~1 indicates that the rate-determining step of the reaction does not involve 
cleavage of the C–H bond at the C–3 position of 2-coumarin 97.4 
4.4.3. C–H Activation of the aryl ring 
In our investigation of the mechanism of the double C–H activation of substrate 97 
to give product 154, the C–H activation of the aryl ring was next to be examined.  
Initially, determination the KIE using the initial rates method was desired, similar to 
the technique used for the C–3 position. To this end, compound 157 was subjected 
to the reaction conditions to determine the effect of penta-deuteration on the rate 
of reaction (Figure 4.8).  
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157  154-d4 
 
Figure 4.8. Scrambling of deuterium in the reaction of substrate 157. 
Surprisingly, unexpected peaks were observed in the 1H NMR spectrum of the crude 
reaction mixture. The peaks persisted after silica gel chromatography of product 
154-d4. It became clear that these peaks were the result of deuterium being 
exchanged for hydrogen, or scrambling, in the product. The extent of hydrogen 
incorporation at D–5 was found to be 33%, which indicates that the ortho position is 
most amenable to C–H activation. A total of 14% hydrogen incorporation was 
attributed to D–6 and D–7, as indicated in Figure 4.8. The 12% hydrogen 
incorporation at the D–8 position is believed to be caused by directed (C=O) C–H 
activation after the product is formed. 
H8 H1 
 
H5 
 
H3 
H4 
H7 H6 
H2 
Chapter 4  Results and Discussion 
159 
 
Scrambling appears early in the course of the reaction. However, even after the 
starting material is fully consumed, 154 itself can undergo further scrambling under 
these reaction conditions. This was confirmed by performing the same reaction with 
substrate 157 again, but leaving it on for 16 h. Analysis by 1H NMR spectroscopy 
showed that the level of hydrogen incorporation at positions D–5 to D–8 was 
increased compared to the level of hydrogen incorporation after 2 h.  
This scrambling presented other problems. Since there are no integrals unique to 
cyclised product 154-d4 which allow for delineation from the starting material 157 
and baseline-to-baseline integration, the system is unsuitable for use in determining 
the KIE using parallel reactions with 1H NMR spectroscopy as the method of 
measurement. A clear integral that is unique to each of the starting materials and 
products (deuterated and non-deuterated) is required for this technique. To 
circumvent this issue, 5-methoxy-2-coumarin 162 and its deuterated analogue 165 
were utilised. When subjected to the reaction conditions, these substrates give 
product 167 and its deuterated analogue. Since the 5-methoxy group is unlikely to 
participate in a C–H activation process, the 1H NMR signals corresponding to this 
group allowed the progress of the reaction to be monitored using 1H NMR 
spectroscopy. The 3H integral corresponding to the 5-methoxy peak shifts downfield 
significantly for the product compared to the starting material (3.93 ppm for starting 
material 162 and at 4.11 ppm for product 167). As before, the induction period is 
excluded from the calculation of the slope as it is the same for both substrates. The 
experiment was performed by comparing the conversion of substrate 162 and 165 
to product 167 (and its deuterated analogue) in parallel reactions. The initial rates 
method was used to determine the KIE (Figure 4.9).19  
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KIE =  
𝑘H
𝑘D
=  
m1
m2
=  
0.7198
0.261
= 2.76 
Figure 4.9. The initial rates method for KIE determination. 
The KIE was determined to be 2.76 from this method. This method of calculation is 
accurate because the 5-OMe group is not affected by scrambling, and so the value of 
that integral is reliable. The determination of a positive KIE by this method confirms 
that C–H bond cleavage on the aryl ring is involved in the rate-determining step of 
this reaction mechanism.4 
To confirm the KIE, the same experiment was performed with the 5,7-dimethyl-
2-coumarin substrate 164 and the corresponding penta-deuterated substrate 166 
(Figure 4.10). 
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KIE =  
𝑘H
𝑘D
=  
m1
m2
=  
0.3444
0.106
= 3.25 
Figure 4.10. The initial rates method for KIE determination. 
The KIE was determined to be 3.25 from this experiment, which is in good agreement 
with the KIE of 2.76 determined using the 5-OMe substrates, giving a positive KIE of 
approximately 3.  
It was necessary to use conversion values for the KIE experiments shown in Figure 
4.9 and Figure 4.10, rather than yields determined by quantitative 1H NMR 
spectroscopy, due to low yields in the synthesis of substrates. To ensure that this was 
a robust method, the KIE determination shown in Figure 4.7 was calculated using 
conversion values rather than yield, and the KIE result was similar. 
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The determination of a positive KIE (approx. 3) by both of initial rate experiments is 
good evidence that C–H bond cleavage on the aryl ring is involved in the rate-
determining step of this reaction mechanism.4 
4.4.4. Monitoring of double C–H activation by NMR 
It was then planned to monitor the progress of the double C–H activation by NMR 
spectroscopy with the assistance of the UCC NMR spectroscopist, Dr. Lorraine M. 
Bateman. The probe on the 500 MHz spectrometer in the School of Chemistry can be 
heated to and held at a maximum temperature of 80 °C. It was planned to perform 
the reaction in an NMR tube in the spectrometer, and monitor the reaction by 
recording multiple spectra over several hours. 
To this end, a series of control experiments were undertaken to determine if this was 
a viable method of investigation. 
First, it was examined whether the reaction could be run at lower temperatures than 
those reported in our methodology paper (Table 4.3).44 
Table 4.3. Investigation of effect of lower temperature on double C–H activation 
reaction. 
   
97  154 
Reaction Temperature (°C) Conversion (%) 
40 0 
60 4 
80 65 
These results revealed that the reaction would not progress at temperatures below 
60 °C, and that the reaction proceeds much slower at 80 °C than at 140 °C (as 
expected). However, it was hoped that the slower reaction would facilitate the NMR 
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monitoring study, and possibly allow the observation of reaction intermediates, such 
as those involving C–Pd bonds.  
Next, the effect of excluding the base was investigated (Scheme 4.29). 
   
97  154, 63% 
Scheme 4.29. Effect of excluding base from the reaction mixture. Yield determined 
from the 1H NMR spectrum of the crude reaction mixture using 1,3,5-
trimethoxybenzene as the internal standard for quantification. 
Surprisingly, the reaction proceeded to 100% conversion in the absence of NaOtBu, 
and a 63% yield was determined from the 1H NMR spectrum of the crude reaction 
mixture using 1,3,5-trimethoxybenzene as the internal standard for quantification. 
No other species except for product 154 was identified in the 1H NMR spectrum of 
the crude reaction mixture. For comparison, a yield of 92% was found in the presence 
of NaOtBu.44 Fagnou and co-workers also observed that the addition of 
substoichiometric amounts of base resulted in enhanced yields.49 It may be that 
NaOtBu has a role in the activation of the catalyst, as was recently reported by 
Docherty et al. for the activation of earth-abundant metals.50 Alternatively, NaOtBu 
may act as a proton shuttle, as previously discussed.7  
Thirdly, the effect of excluding Ag2O from the reaction mixture was studied (Scheme 
4.30). It was found that the reaction proceeds to 26% conversion, which is 2–3 
turnovers of the catalyst. This shows that at least some of the catalyst is oxidised 
back to Pd(II), possibly by air or some other internal oxidant. This could prove useful 
in further development of this reaction, as the use of stoichiometric silver salts to 
oxidise the catalyst is not cost-effective. 
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97  154  
26% conversion 
Scheme 4.30. Effect of excluding oxidant from the reaction mixture. 
The results from the control experiments informed our decision to conduct an initial 
reaction in an NMR tube at 80 °C with a stoichiometric quantity of palladium, without 
NaOtBu or Ag2O. Stoichiometric palladium was used for two reasons. Firstly, it would 
maximise the possibility of observing some palladated intermediate of the catalytic 
cycle, and secondly, it would allow the reaction to proceed to completion without 
the silver salt. The NMR tube selected for this study was used with a coaxial insert. 
The coaxial insert contained DMSO-d6. The use of a deuterated solvent such as 
DMSO-d6 allows the spectrometer to establish a lock signal. This mitigates against 
the possibility of field drift over the time course of the experiments. The 1H NMR 
signals arising from PivOH appear as a 9H singlet at 1.11 ppm, and a 1H singlet at 
11.84 ppm. These signals are far from the area of interest (4.5–9.5 ppm) in the 1H 
NMR spectrum. 
The reagents were added into an NMR tube as per Scheme 4.31, and a coaxial insert 
containing DMSO-d6 was placed in the NMR tube also. A series of spectra were 
obtained.  
   
97  154  
0% conversion 
Scheme 4.31. Monitoring of double C–H activation reaction at 80 °C in 500 MHz 
spectrometer. 
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Unfortunately, the reaction did not progress even after a prolonged period of time. 
This was likely due to the consistency of the reaction mixture. The paste-like material 
was not sufficiently agitated by the spinning of the sample in the spectrometer. 
Finally, it was decided to conduct the reaction under the same conditions (Scheme 
4.31), but in a reaction tube with stirring at 120 °C. Samples were removed at various 
time points, cooled to 80 °C and the spectra of those samples at were recorded at 
80 °C in the 500 MHz spectrometer using the coaxial insert containing DMSO-d6. 
While the reaction did progress in this case, only starting material 97 and product 
154 were observed in the recorded spectra. Disappointingly, no new peaks which 
could correspond to a palladated intermediate were identified. 
4.4.5. Mechanistic Proposals 
Initial proposal 
An initial mechanistic proposal was made in our methodology paper (Scheme 4.32).44 
This was based on the data available at the time of publication, i.e. H/D exchange at 
C–3–H which demonstrates reversible, palladium-mediated C–H bond cleavage 
(Figure 4.4 and Figure 4.5), and a non-significant KIE of 1.08 for the cleavage of the 
C–3–H bond (Figure 4.7). These experiments did not allow unambiguous 
determination of the mechanism of this reaction and shed little light on the 
mechanism of C–H activation of the aryl ring. However, an SEAr mechanism (Scheme 
4.32) was suspected at that stage. The absence of any scrambling on the aryl ring of 
starting material 157 suggested non-reversibility of that C–H cleavage step. An SEAr 
step would account for this observation.  
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Scheme 4.32. Initial mechanistic proposal.  
In our methodology paper, a reversible palladation of the C–3–H bond was proposed 
as the first step, giving I. This was supported by the observation that in the reaction 
of 4-phenoxy-2-coumarin (97) in PivOD, only deuterium incorporation at C–3 was 
observed in the starting material (Figure 4.5). Additionally, the level of deuterium 
incorporation at C–3 of 3-deuterio-4-phenoxy-2-coumarin (156) decreased under the 
reaction conditions (Figure 4.4). These two experiments indicated that activation of 
the C–3–H bond could be the first C–H activation event, and that it was likely to be 
reversible. A non-significant KIE of 1.08 (Figure 4.7) showed that C–3–H bond 
activation was not involved in the rate-determining step. 
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An SEAr-type step was envisaged next to give intermediate II. SEAr-type mechanisms 
have been proposed by Tunge and Foresee for the hydroarylation of alkenes and 
alkynes,51 and by Shi and Buchwald for the synthesis of substituted 3,3-difluoro-
2-oxindoles via intramolecular C–H difluoroalkylation.52 Such SEAr-type mechanisms 
include an electrophilic palladation of the aryl ring, i.e. the electrophilic palladium 
catalyst activates the unsaturated system towards nucleophilic attack by the arene 
to form a Wheland intermediate (II). The final steps were proposed to involve 
irreversible deprotonation (to give III) and reductive elimination to afford the 
product (154).44 However, a CMD mechanism7, 11-12, 33 for activation of both C–H 
bonds was also considered possible.  
Revised proposal 
The subsequent observation of a primary positive KIE of 3 (Figure 4.9 and Figure 4.10) 
showed that our mechanistic proposal in the methodology paper was correct for step 
1 (C–H activation at C–3), but incorrect for step 2 (C–H activation of the aryl ring). In 
an SEAr-type mechanism, the palladation is the rate-determining step, but the C–H 
bond cleavage to restore aromaticity is fast. Since a positive KIE was observed for the 
cleavage of the aryl C–H bond, a Wheland intermediate (Scheme 4.32, II) cannot be 
evoked, and therefore the mechanism of aryl C–H bond activation cannot involve 
SEAr-type steps. 
With this additional information, the experimental data gathered to date shows that: 
1. The C–3–H bond cleavage is palladium-mediated, reversible and not involved 
in the rate-determining step.  
2. The aryl C–H bond cleavage is involved in the rate-determining step. 
At this stage, we engaged with a collaborator, Prof. Zhenyang Lin of the Hong Kong 
University of Science and Technology, to carry out DFT(ωB97X-D) calculations to gain 
further mechanistic insights. The pathway for the CDC of 4-phenoxy-2-coumarin 97 
was calculated (Figure 4.11).   
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Figure 4.11. DFT calculations for the direct arylation of 97 to 154 via double C–H 
activation. Pathway shows that CMD of C–3–H bond happens first.  
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The first step of the reaction pathway was calculated to be a κ2-κ1 displacement of 
an acetate ligand (TS0, G‡ = 8.7 kcal mol−1) to give a π-complex IM1, which 
progresses through the CMD transition state (TS1, G‡ = 10.2 kcal mol−1) to give IM2. 
The abstraction of the proton at C–3 could be reversible due to the similarity of the 
free energies of the starting material (G = 0.0 kcal mol−1), IM1 (G = −0.2 kcal mol−1) 
and IM2 (G = −1.4 kcal mol−1). This correlates well with the experimentally observed 
ease of deuterium abstraction (Figure 4.4) and incorporation (Figure 4.5). 
Additionally, the initial activation of the C–3–H bond of the 2-coumarin is not 
turnover-limiting, which is consistent with the observed KIE of 1.08 for the isotopic 
substitution of this bond (Figure 4.7). 
From IM2, a π-complex (IM3) is formed via TSIM2-3. IM3 could then interconvert to 
IM3-2 (G‡ = −8.5 kcal mol−1). IM3-2 (G = −7.4 kcal mol−1) contains a stronger 
hydrogen bond and is calculated to be more stable than IM3 (G = 1.1 kcal mol−1). 
The summit of the potential energy surface, i.e. the turnover-limiting step, for the 
pathway is the activation of the aryl C–H bond via TS2 (G‡ = 19.6 kcal mol−1) to IM4. 
This is consistent with the experimentally observed KIE of approx. 3 for the cleavage 
of the aryl C–H bond. 
IM4 is calculated to isomerise to the lower energy IM5 through the formation of a 
hydrogen bond between the two acetate ligands. Reductive elimination of Pd(HOAc)2 
from IM5 to give product 154 proceeds through TS3 (G‡ = 14.3 kcal mol−1). The 
reductive elimination is relatively facile, and product 154 (G = −15.6 kcal mol−1) is 
lower in energy than IM5 (G = −8.2 kcal mol−1). This indicates that the activation of 
the aryl C–H is irreversible. 
The protons on the acetic acid ligands of Pd(HOAc)2 could transfer to a Brønsted base 
such as tert-butoxide (tBuO−) or pivalate (PivO−). One or more silver species could act 
as an insoluble proton sink, similar to the proposed role of the carbonate bases 
discussed in Section 4.2 and Section 4.3. Finally, Pd(0) is likely oxidised to Pd(II) by 
Ag2O.  
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The true nature of the active catalytic and deprotonating species are not fully 
understood. It is difficult to study the role of Ag2O and related species in a meaningful 
way using DFT calculations as there are no reasonable structural models for Ag2O at 
this time. However, it would be reasonable to postulate that a number of equilibria, 
such as those shown in Scheme 4.33,53 could exist in the reaction mixture. The 
presence of numerous basic species could offer an explanation for why the starting 
material 97 was fully consumed and a 63% yield of product 154 was measured in the 
absence of NaOtBu (Scheme 4.29). 
 
Scheme 4.33. Some potential species in the reaction mixture which were not 
modelled. 
In conclusion, the catalytic reaction detailed in Scheme 4.34 is considered most likely. 
It comprises of an initial reversible CMD of the C–3–H bond of 2-coumarin followed 
by irreversible, turnover-limiting CMD of the aryl C–H bond. Reductive elimination of 
Pd(0) gives the product, and deprotonation and oxidation of the Pd(0) back to the 
active catalyst Pd(II) likely completes the catalytic cycle. The experimental evidence 
is consistent with the DFT calculations. C–H activation at the C–3 position of the 2-
coumarin substrate (97 to IM2) was calculated to be reversible because the barrier 
for the reverse reaction was lower than the barrier for the forward reaction to IM4. 
This is supported by the observation of Pd-mediated H–D exchange at that position. 
A KIE of 1.08 was observed for the cleavage of the C–3–H bond, showing that this 
was not the RDS of the reaction. The DFT calculations also show that this is not the 
RDS. Instead, cleavage of the aryl C–H bond was calculated to be the highest energy 
transition state of the reaction coordinate diagram (TS2), which is consistent with the 
experimentally observed isotope effect of 3. Further study will be required to fully 
elucidate the roles of NaOtBu, Ag2O, PivOH and related species in this reaction. 
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Scheme 4.34. Revised mechanistic proposal. 
Computational Methods 
Calculations were performed by the Lin group at the Hong Kong University of Science 
and Technology. All calculations were performed using Gaussian 09 D.01 program.54 
The geometries were fully optimised at solvent phase with SMD solvation model55 
(propanoic acid was chosen as solvent because its structure is similar to pivalic acid 
and the dielectric constants are similar) using M. Head-Gordon’s long-range 
corrected (LC) hybrid density functional ωB97X-D56 which has been reported to take 
noncovalent interactions into consideration and worked well for similar systems.21, 
57-58 The effective core potentials (ECPs) of Hay and Wadt with a double-ζ valence 
basis set (LanL2DZ)59 were used to describe Pd atom. Polarisation functions were 
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added for Pd (ζf=1.472).60 The 6-31G(d,p) Pople basis set were used for all other 
atoms. Frequency calculations were carried out to confirm the characteristics of all 
of the optimised structures as minima or transition states. Calculations of intrinsic 
reaction coordinates (IRC)61 were also performed to confirm that transition states 
connect two relevant minima. In order to obtain more accurate free energy in 
solution, further single point calculations were carried out at basis set II level 
(LanL2DZ(f) for Pd and 6-311++G(d,p) for all other atoms) and solvation effect of 
propanoic acid was simulated by the SMD continuum solvent model. All natural bond 
orbital (NBO) analysis were performed using the NBO 3.0 package.54 
 Conclusions and Future Work 
Mechanistic investigations facilitated our understanding of the mechanisms through 
which 2-coumarins and related heterocycles undergo C–H activation, and 
subsequently, direct arylation reactions. The majority of the investigations 
undertaken involved H–D exchange and KIE experiments (both intra- and 
intermolecular competition experiments). For the three different sets of reaction 
conditions studied, a concerted metallation-deprotonation was determined to be the 
most likely mechanism for the C–H activation of these substrates.  
The development of a range of protocols to introduce deuterium into the substrates 
was a necessary, and initially underestimated, challenge of this work. 
The understanding of reaction mechanisms is crucial to their future development. 
For future work on C–H activation reactions, it is proposed that mechanistic 
investigations should be undertaken shortly after the identification of successful 
reaction conditions. This could potentially facilitate reaction development and 
optimisation, prior to the demonstration of the substrate scope. 
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Conclusions and Future Work 
Conclusions 
The arylation of 2-pyrones and related heterocycles has been accomplished through 
the development of several novel methodologies for the functionalisation of these 
frameworks. Some of the main results include: 
 Regioselective intramolecular cyclisation of the privileged 2-pyrone, 2-
pyridone and 2-coumarin motifs under direct arylation conditions was 
developed. 
 For the intramolecular cyclisation at C–3 a broad substrate scope and good to 
excellent yields were observed. 
 The intramolecular cyclisation at C–5 allows the preparation of some 
previously inaccessible 2-pyrones and 2-pyridones. The reaction proceeds 
with retention of a C–Cl bond.  
 Further elaboration at C–3 of ‘cyclised at C–5’ 2-pyrones was enabled utilising 
the retained C–Cl bond in a Suzuki-Miyaura cross-coupling, demonstrating 
that the C–Cl bond at the C–3 of the 2-pyrone framework is stable enough to 
withstand the conditions of a direct arylation reaction, but remains reactive 
enough to participate in Suzuki-Miyaura cross-coupling. This allowed the 
synthesis of highly decorated 2-pyrone compounds. 
 Chlorination of the 2-coumarin and 2-pyrone framework with TCCA, a cheap 
and environmentally-friendly chlorinating agent, was accomplished. 
 A diverse range of aryl and heteroaryl boronic acids, and 2-pyrone, 2-
pyridone, 2-coumarin and 2-quinolone frameworks are tolerated by the 
developed Suzuki-Miyaura conditions in iPrOAc, an environmentally benign 
solvent. 
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 A practically useful demethylation of the Suzuki-Miyaura products allows 
access to 3-aryl-4-hydroxy-2-coumarins. This was preferrable to more 
traditional protecting groups, such as silyl ethers and benzyl groups, which 
proved difficult to prepare. 
 Mechanistic investigations involved H–D exchange and KIE experiments (both 
intra- and intermolecular competition experiments). 
 The development of a range of protocols to introduce deuterium into the 
substrates was a necessary, and initially underestimated, challenge of this 
work. 
 Based upon these results from different sets of reaction conditions, it was 
proposed that C–H activation of these substrates occurs via concerted-
metallation deprotonation. 
Future Work 
Future work following on from this project will likely involve extension of direct 
arylation conditions, particularly further development of intermolecular direct 
arylation and cross-dehydrogenative coupling, to the synthesis of natural products 
and other biologically active compounds. It is anticipated that extension of 
mechanistic investigations from the 2-coumarin substrates to more generic biaryls 
will be pursued. 
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There are some things you can’t share without ending up liking each other, and 
knocking out a twelve-foot mountain troll is one of them. 
J. K. Rowling 
Harry Potter and the Philosopher’s Stone; 1997 
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Chapt er 5  Experimental  
 General Procedures 
Solvents and reagents were used as obtained from commercial sources and without 
purification unless otherwise stated, with the exception of THF, which was freshly 
distilled from sodium/benzophenone under nitrogen. 
Wet flash column chromatography was carried out using Kieselgel silica gel 60, 
0.040-0.063 μm (Merck). TLC was carried out on pre-coated silica gel plates 
(Merck 60 PF254). Visualisation was achieved by UV light. 
Microwave reactions were performed in a CEM Discover S-Class Synthesiser with the 
temperature monitored by infrared temperature control. 
Melting points were obtained on a uni-melt Thomas Hoover Capillary melting point 
apparatus. 
IR spectra were recorded on Perkin-Elmer FT-IR Paragon 1000 spectrophotometer. 
Liquid samples were examined as thin films interspersed on NaCl plates. Solid 
samples were either dispersed in KBr and recorded as pressed discs, or dissolved in 
dichloromethane, dispersed as thin films on NaCl plates and the dichloromethane 
allowed to evaporate before measurement of sample.  
NMR spectra were run in CDCl3 using TMS as the internal standard at 25 °C unless 
otherwise specified. 1H NMR (600 MHz) spectra, 1H NMR (500 MHz) spectra, 1H NMR 
(400 MHz) spectra and 1H NMR (300 MHz) spectra were recorded on Bruker Avance 
600, Bruker Avance 500, Bruker Avance 400 and Bruker Avance 300 NMR 
spectrometers respectively. 13C (150 MHz) spectra, 13C (126 MHz) spectra, 13C 
(100 MHz) spectra and 13C (75 MHz) spectra were recorded on Bruker Avance 600, 
Bruker Avance 500, Bruker Avance 400 and Bruker Avance 300 NMR spectrometers 
respectively in proton decoupled mode. 19F NMR (282 MHz) spectra were recorded 
on a Bruker Avance 300 NMR spectrometer in proton decoupled mode. 31P NMR 
(121 MHz) spectra were recorded on a Bruker Avance 300 NMR spectrometer in 
proton decoupled mode. All spectra were recorded at University College Cork. 
Chemical shifts are expressed as parts per million (ppm), relative to TMS 
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(δH = 0 ppm), the deuterated NMR solvent, usually CDCl3 (δC = 77.0 ppm), H3PO4 
(δP = 0 ppm) or C6F6 (δF = −162.2 ppm). Coupling constants (J) are expressed in hertz 
(Hz). Splitting patterns in 1H NMR spectra are designated as s (singlet), bs 
(broad singlet), d (doublet), dd (doublet of doublets), ddd (doublet of doublet 
of doublets), t (triplet), q (quartet) and m (multiplet). For 13C NMR spectra, the 
number of attached protons for each signal was determined using the DEPT pulse 
sequence run in the DEPT-90 and DEPT-135 modes. COSY, HSQC and HMBC 
experiments were routinely performed to aid the NMR assignment of novel chemical 
structures. 
LRMS were recorded on a Waters Quattro Micro triple quadrupole instrument in ESI 
mode using 50% acetonitrile-water containing 0.1% formic acid as eluent; samples 
were made up in acetonitrile or methanol. HRMS were recorded on a Waters LCT 
Premier Tof LC-MS instrument in ESI mode using 50% acetonitrile-water containing 
0.1% formic acid as eluent; samples were made up in acetonitrile or methanol. 
The Microanalysis Laboratory, National University of Ireland, Cork, performed 
elemental analysis using a Perkin-Elmer 240 and Exeter Analytical CE440 elemental 
analysers. 
5.1.1. Analysis of known and novel compounds 
1H NMR spectra, 13C NMR spectra, LRMS and melting point (if solid) analyses were 
recorded for all previously prepared compounds. For novel compounds, in addition 
to the previously mentioned analysis, 19F NMR (where applicable), 31P NMR 
(where applicable), IR, HRMS and elemental analysis (if possible) were also obtained. 
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  Synthesis of starting materials  
1-(Bromomethyl)-2-iodobenzene (2)1  
Method 1:1 PBr3 (0.2 mL, 2.55 mmol, 0.6 equiv.) was added to a 
solution of 2-iodobenzyl alcohol 1 (1.0 g, 4.27 mmol, 1.0 equiv.) in 
distilled THF (5 mL) at 0 °C under nitrogen atmosphere. After 30 min, 
the reaction was allowed to warm to ambient temperature and the mixture was 
concentrated under reduced pressure. This crude product was recrystallised from 
EtOH to give the pure product 2 (0.95 g, 75%) as an off-white solid. 
Method 2: To a round-bottomed flask were added 2-iodobenzyl alcohol 1 (4.00 g, 
17.09 mmol, 1.0 equiv.), tetrabutylammonium bromide (TBAB) (6.39 g, 19.83 mmol, 
1.16 equiv.) and P2O5 (5.82 g, 41.0 mmol, 2.4 equiv.). Toluene (70 mL) was added and 
the reaction mixture was heated to 94 °C and stirred at this temperature for 1.5 h. 
The reaction mixture was cooled to ambient temperature. The upper organic layer 
was separated from the residual mass. The residual mass was washed with toluene 
(2 × 20 mL). The combined organic layers were washed with saturated aqueous 
NaHCO3 (1 × 30 mL) and brine (1 × 40 mL). The organic extracts were dried, filtered 
and concentrated under reduced pressure to yield 2 as an off-white solid (4.1 g, 81%); 
m.p. 54–57 °C (lit.1 56–58 °C); 1H NMR (300 MHz, CDCl3) δ 7.85 (dd, J = 7.9, 1.2, 1H, 
C(2)H), 7.47 (dd, J = 7.7, 1.7, 1H, C(5)H), 7.33 (td, J = 7.6, 1.2, 1H, C(4)H), 6.97 (td, J = 
7.6, 1.6, 1H, C(3)H), 4.59 (s, 2H, C(7)H2); 13C NMR (75 MHz, CDCl3) δ 140.2 (qC-6), 
140.1 (C(2)H), 130.5 (C(5)H), 130.1 (C(3)H), 128.9 (C(4)H), 100.0 (qC-1), 38.7 (C(7)H2); 
m/z (ES+): 296 ((M+H)+ 6%). 
Spectral characteristics were consistent with previously reported data.1 
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4-((2-Iodobenzyl)oxy)-6-methyl-2H-pyran-2-one (4)2 
To a 3-necked round-bottomed flask were added 4-hydroxy-
6-methyl-2H-pyran-2-one 3 (0.89 g, 7.02 mmol, 1.0 equiv.), 
2-iodobenzyl bromide 2 (2.52 g, 8.42 mmol, 1.2 equiv.), 
potassium carbonate (2.91 g, 21.05 mmol, 3.0 equiv.) and 
acetone (30 mL). The resulting reaction mixture was then 
stirred in an oil bath at 79 °C for 4 h. The reaction mixture was allowed to cool to 
ambient temperature and filtered. The solid residue was washed with acetone 
(2 × 20 mL). The acetone portions were combined and concentrated under reduced 
pressure. The residual mass was dissolved in EtOAc (15 mL) and water (1 × 15 mL). 
The layers were separated and the aqueous layer was washed with EtOAc (3 × 10 mL). 
The combined organic extracts were dried over MgSO4 and concentrated under 
reduced pressure. The resulting crude product was purified by recrystallisation from 
EtOH to yield 4 as a white, crystalline solid (0.882 g, 37%); m.p. 105–106 °C (lit.2 101–
103 °C); 1H NMR (300 MHz, CDCl3) δ 7.89 (d, J = 7.8, 1H, C(11)H), 7.40 – 7.38 (m, 2H, 
C(12)H & C(14)H), 7.10 – 7.05 (m, 1H, C(13)H), 5.87 (dd, J = 2.0, 0.9, 1H, C(5)H), 5.51 
(d, J = 2.2, 1H, C(3)H), 5.01 (s, 2H, C(8)H2), 2.23 (s, 3H, C(7)H3), 13C NMR 
(75 MHz,  CDCl3) δ 169.9 (qC-2), 164.7 (qC-6), 162.4 (qC-4), 139.7 (C(11)H), 136.8 (qC-
9), 130.3 (C(12)H), 129.0 (C(14)H), 128.6 (C(13)H), 100.3 (C(5)H), 97.8 (qC-10), 88.8 
(C(3)H), 74.4 (C(8)H2), 19.9 (C(7)H3); m/z (ES+): 343 ((M+H)+ 100%). 
Spectral characteristics were consistent with previously reported data.2 
4-Bromo-6-methyl-2H-pyran-2-one (6)3  
To a 2-necked round-bottomed flask were added 4-hydroxy-6-methyl-
2H-pyran-2-one 3 (2.0 g, 15.86 mmol, 1.0 equiv.), 
tetrabutylammonium bromide (TBAB) (5.9 g, 18.40 mmol, 1.16 
equiv.), phosphorus pentoxide (5.4 g, 38.10 mmol, 2.4 equiv.) and toluene (50 mL) 
according to the literature procedure.4 The resulting reaction mixture was then 
stirred at 100 °C for 1.5 h. The reaction mixture was allowed to cool to ambient 
temperature. The clear upper layer was separated from the residual mass. The lower 
layer was rinsed with toluene (2 × 20 mL). The combined organic extracts were 
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washed with saturated aqueous NaHCO3 (1 × 30 mL) and brine (1 × 40 mL), dried over 
MgSO4 and concentrated under reduced pressure to yield 6 as an orange solid 
(1.357 g, 45%) which did not require further purification; m.p. 72–73 °C (lit.3 73–74 
°C); 1H NMR (300 MHz, CDCl3) δ 6.46 (s, 1H, C(3)H), 6.21 (s, 1H, C(5)H), 2.26 (s, 3H, 
C(7)H3); 13C NMR (75 MHz, CDCl3) δ 162.1 (qC-2), 160.7 (qC-6), 141.2 (qC-4), 114.7 
(C(5)H), 108.5 (C(3)H), 19.8 (C(7)H3); m/z (ES+): 79Br 189 ((M+H)+ 28%), 81Br 191 
((M+H)+ 26%). 
Spectral characteristics were consistent with previously reported data.3 
4-Hydroxy-6-phenyl-2H-pyran-2-one (8)2  
A solution of 2,2-dimethyl-6-(2-oxo-2-phenylethyl)-4H-1,3-
dioxin-4-one 7 (0.25 g, 1.015 mmol, 1.0 equiv.) in toluene (10 
mL) was added to a 25 mL round-bottomed flask fitted with stir 
bar. The solution was heated to 110 °C and stirred at this 
temperature for 30 min. The reaction mixture was allowed to cool to ambient 
temperature, and then concentrated under reduced pressure. The resulting crude 
product was purified by column chromatography (acetone:DCM 50:50) to yield 8 as 
a pale yellow solid (0.125 g, 65%); m.p. 235–237 °C (lit.5 250–251 °C); 1H NMR 
(300MHz, DMSO-d6) δ 8.04 – 7.75 (m, 2H, 2 × ArCH), 7.53 (dd, J = 6.7, 3.6, 3H, 3 × 
ArCH), 6.75 (d, J = 2.0, 1H, C(5)H), 5.40 (d, J = 2.0, 1H, C(3)H); 13C NMR (75 MHz, 
DMSO-d6) δ 171.1 (qC-4), 163.5 (qC-2), 160.5 (qC-6), 131.5 (qC-7), 131.4 (C(10)H), 
129.5 (C(9)H & C(11)H), 125.9 (C(8)H & C(12)H), 98.9 (C(5)H), 90.1 (C(3)H); m/z (ES+): 
189 ((M+H)+ 50%). 
Spectral characteristics were consistent with the previously reported data.2 
4-((2-Bromobenzyl)oxy)-6-phenyl-2H-pyran-2-one (9)2 
Compound 9 was prepared via the procedure described 
for compound 4 using 4-hydroxy-6-phenyl-2H-pyran-2-
one 8 (70 mg, 0.345 mmol, 1.0 equiv.) and 2-
bromobenzyl bromide (112 mg, 0.414 mmol, 1.2 equiv.). 
The residue was purified by column chromatography 
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(MeOH:DCM 0.5:99.5) to yield 9 as a yellow solid (0.0792 g, 64%); m.p. 133–134 °C 
(lit.2 134 °C); 1H NMR (300 MHz, CDCl3) δ 7.87 – 7.78 (m, 2H, 2 × ArCH), 7.63 (dd, J = 
4.0, 1.2, 1H, ArCH), 7.51 – 7.42 (m, 4H, 4 × ArCH), 7.38 (td, J = 7.5, 1.2, 1H, ArCH), 7.26 
(td, J = 7.5, 1.7, 1H, ArCH), 6.53 (d, J = 2.1, 1H, C(5)H), 5.65 (d, J = 2.1, 1H, C(3)H), 5.17 
(s, 2H, C(8)H2); m/z (ES+): 79Br 357 ((M+H)+ 98%), 81Br 359 ((M+H)+ 100%). 
Spectral characteristics were consistent with previously reported data.2 
1-Bromo-2-(bromomethyl)-4-fluorobenzene (11)6  
PBr3 (0.9 mL, 9.75 mmol, 2.8 equiv.) was added to a solution of (2-
bromo-5-fluorophenyl)methanol 10 (1.00 g, 4.88 mmol, 1.0 equiv.) 
in DCM (40 mL) at ambient temperature and the mixture was 
stirred overnight. The mixture was then cooled to 0 °C and neutralised with saturated 
aqueous NaHCO3 (20 mL). The organic component was extracted with DCM (2 × 15 
mL). The combined organic layers were washed with brine (30 mL), dried over MgSO4 
and concentrated under reduced pressure. The residue was purified by column 
chromatography (EtOAc:hexanes 30:70) to give 11 as a clear oil (0.465 g, 36%); 1H 
NMR (300 MHz, CDCl3) δ 7.53 (dd, J = 8.8, 5.3, 1H, C(2)H), 7.20 (dd, J = 8.8, 3.0, 1H, 
C(5)H), 6.92 (td, J = 8.3, 3.0, 1H, C(3)H), 4.55 (s, 2H, C(7)H2); 13C NMR (75 MHz, CDCl3) 
δ 161.9 (d, J = 248, qC-4), 138.8 (d, J = 8, qC-6), 134.6 (d, J = 8, C(2)H), 118.5 (d, J = 4, 
qC-1), 118.2 (d, J = 24, C(3)H), 117.4 (d, J = 23, C(5)H), 32.5 (d, J = 2, C(7)H2). 
Spectral characteristics were consistent with previously reported data.6 
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4-((2-Bromo-5-fluorobenzyl)oxy)-6-methyl-2H-pyran-2-one (12)7  
Compound 12 was prepared via the procedure described for 
compound 4 using 4-hydroxy-6-methyl-2H-pyran-2-one 3 
(0.18 g, 1.43 mmol, 1.0 equiv.) and 1-bromo-2-(bromomethyl)-
4-fluorobenzene 11 (0.46 g, 1.72 mmol, 1.2 equiv.). The 
residue was purified by column chromatography (MeOH:DCM 
0.5:99.5) to yield 12 as a white solid (0.209 g, 45%); m.p. 100–102°C (lit.7 111–113 
°C); 1H NMR (300 MHz, CDCl3) δ 7.61 – 7.52 (m, 1H, C(11)H), 7.17 (dd, J = 9.2, 3.0, 1H, 
C(12)H), 6.97 (td, J = 8.4, 3.0, 1H, C(14)H), 5.91 (s, 1H, C(5)H), 5.49 (d, J = 2.2, 1H, 
C(3)H), 5.05 (s, 2H, C(8)H2), 2.25 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 169.6 
(qC-4), 164.6 (qC-2), 162.7 (qC-6), 162.3 (d, J = 248, qC-13), 136.0 (d, J = 8, qC-9), 
134.2 (d, J = 8, C(11)H), 117.1 (d, J = 23, C(12)H), 116.1 (d, J = 3, qC-10), 115.9 (d, J = 
25, C(14)H), 100.2 (C(5)H), 88.8 (C(3)H), 69.3 (d, J = 1, C(8)H2), 19.9 (C(7)H3); m/z (ES-
): 311 ((M-H)– 33%). 
Spectral characteristics were consistent with previously reported data.7 
4-Hydroxy-1,6-dimethylpyridin-2(1H)-one (13)8 
To a 250 mL round-bottomed flask were added 4-hydroxy-6-methyl-
2-pyrone 3 (1.5 g, 11.89 mmol, 1.0 equiv.), methylamine (1.0 mL, 40% 
in H2O, 1.0 equiv.) and deionised water (40 mL). The reaction mixture 
was stirred for 6 h at 100 °C. The reaction mixture was then cooled to 
ambient temperature and 13 was isolated by suction filtration as a fine, off-white 
powder (0.83 g, 50%); m.p. 206–211 °C (lit.8 235–236); 1H NMR (300 MHz, DMSO-d6) 
δ 10.34 (br s, 1H, O–H), 5.76 (dd, J = 2.7, 0.9, 1H, C(5)H), 5.50 (d, J = 2.7, 1H, (C(3)H), 
3.30 (s, 3H, C(8)H3), 2.27 (s, 3H, C(7)H3); 13C NMR (75 MHz, DMSO-d6) δ 165.9 (qC-2), 
164.4 (qC-4), 148.3 (qC-6), 100.0 (C(5)H), 96.0 (C(3)H), 30.1 (C(8)H3), 20.8 (C(7)H3);  
m/z (ES+): 140 ((M+H)+ 100%). 
Spectral characteristic were consistent with previously reported data.8 
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1-Benzyl-4-hydroxy-6-methylpyridin-2(1H)-one (14)9 
Compound 14 was prepared via the procedure described for 
compound 13 using 4-hydroxy-6-methyl-2H-pyran-2-one 3 (1.5 g, 
11.89 mmol, 1.0 equiv.) and benzylamine (1.3 mL, 11.89 mmol, 1.0 
equiv.) to yield 14 as an off-white to grey powder (1.3043 g, 51%) 
after trituration in EtOH; m.p. 201–207 °C (lit.9 205–208 °C); 1H 
NMR (300 MHz, DMSO-d6) δ 10.51 (br s, 1H, O–H), 7.40 – 7.20 (m, 3H, C(11)H, C(12)H 
& C(13)H), 7.14 – 7.02 (m, 2H, C(10)H & C(14)H), 5.81 (dd, J = 2.7, 0.8, 1H, C(5)H), 
5.61 (d, J = 2.6, 1H, C(3)H), 5.20 (s, 2H, C(8)H2), 2.17 (s, 3H, C(7)H3); 13C NMR (75 MHz, 
DMSO-d6) δ 166.4 (qC-2), 164.5 (qC-4), 148.1 (qC-9), 138.2 (qC-6), 129.0 (C(11)H & 
C(13)H), 127.6 (C(12)H), 127.3 (C(10)H and C(14)H), 100.9 (C(5)H), 96.3 (C(3)H), 45.7 
(C(9)H2), 20.4 (C(7)H3); m/z (ES-): 214 ((M-H)- 42%). 
Spectral characteristics were consistent with previously reported data.9 
4-((2-Bromobenzyl)oxy)-1,6-dimethylpyridin-2(1H)-one (15)10 
A Schlenk tube was heated under vacuum and refilled with N2 
three times. 4-Hydroxy-1,6-dimethylpyridin-2(1H)-one 13 
(200 mg, 1.44 mmol, 1.0 equiv.), 2-bromobenzylbromide (402 
mg, 1.61 mmol, 1.12 equiv.) and K2CO3 (596 mg, 4.31 mmol, 
3.0 equiv.) were added. The Schlenk was then evacuated and 
refilled with N2 twice. DMF (6 mL) was added to give a cloudy grey suspension. The 
reaction was stirred overnight under inert atmosphere at ambient temperature. 
After 18 h, the reaction mixture was diluted with EtOAc (10 mL) and H2O (10 mL). The 
organic layer was separated and the aqueous layer washed with EtOAc (2 × 10 mL). 
The combined organic layers were washed with brine (1 × 20 mL), dried over MgSO4 
and concentrated under reduced pressure. The residue was purified by 
recrystallisation from DCM/hexanes to give an off-white solid 15 (0.309 g, 70%); m.p. 
131–134 °C (lit.10 134–135 °C); 1H NMR (300 MHz, CDCl3) δ: 7.58 (dd, J = 7.9, 1.2, 1H, 
C(11)H), 7.44 (dd, J = 7.6, 1.7, 1H, C(14)H), 7.33 (td, J = 7.5, 1.2, 1H, C(13)H), 7.20 (td, 
J = 7.8, 1.8, 1H, C(12)H), 5.92 (d, J = 2.8, 1H, C(5)H), 5.88 (dd, J = 2.9, 0.8, 1H, C(3)H), 
5.05 (s, 2H, C(8)H2), 3.46 (s, 3H, C(15)H3), 2.31 (s, 3H, C(7)H3); 13C NMR (75 MHz, 
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CDCl3) δ 165.9 (qC-4), 165.3 (qC-2), 146.4 (qC-6), 134.9 (qC-9), 132.8 (C(14)H), 129.6 
(C(12)H), 128.9 (C(11)H), 127.6 (C(13)H), 122.6 (qC-10), 100.8 (C(5)H), 95.8 (C(3)H), 
69.2 (C(8)H2), 30.6 (C(15)H3), 20.9 (C(7)H3); m/z (ES+): 310 (81Br (M+H)+ 52%). 
Spectral characteristics were consistent with previously reported data.10 
4-((2-Iodobenzyl)oxy)-1,6-dimethylpyridin-2(1H)-one (16) 
Method 1: Compound 16 was prepared via the procedure 
described for compound 15 using 4-hydroxy-1,6-
dimethylpyridin-2(1H)-one 13 (150 mg, 1.08 mmol, 1.0 equiv.), 
2-iodobenzylbromide 2 (358 mg, 1.21 mmol, 1.12 equiv.) and 
Na2CO3 (447 mg, 4.22 mmol, 3.9 equiv.). The residue was 
purified by column chromatography (EtOAc:hexanes 50:50) to give 16 as an off-white 
solid (0.112 g, 29%).  
Method 2: Compound 16 was prepared via the procedure described for compound 4 
using 4-hydroxy-1,6-dimethylpyridin-2(1H)-one 13 (0.5 g, 3.59 mmol, 1.0 equiv.) and 
2-iodobenzylbromide 2 (1.3 g, 4.31 mmol, 1.2 equiv.). The residue was purified by 
column chromatography (EtOAc:hexanes 80:20) to give 16 as a white solid (0.634 g, 
50%); m.p. 134–136 °C; IR νmax (KBr) 1644 (amide C=O stretch), 1591 (aromatic C–C 
stretch), 1356 (ether C–O stretch), 1200 (amide C–N stretch); 1H NMR (300 MHz, 
CDCl3) δ 7.86 (d, J = 7.9, 1H, C(11)H), 7.44 – 7.31 (m, 2H, C(13)H & C(14)H), 7.03 (td, 
J = 7.5, 1.8, 1H, C(12)H), 5.93 (d, J = 2.6, 1H, C(3)H), 5.88 (d, J = 2.4, 1H, C(5)H), 4.96 
(s, 2H, C(8)H2), 3.47 (s, 3H, C(15)H3), 2.31 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 
165.9 (qC-4), 165.3 (qC-2), 146.4 (qC-6), 139.5 (C(14)H), 137.8 (qC-9), 129.8 (C(12)H), 
128.7 (C(11)H), 128.4 (C(13)H), 100.8 (C(5)H), 97.5 (qC-10), 95.9 (C(3)H), 73.7 
(C(8)H2), 30.6 (C(15)H3), 20.9 (C(7)H3); m/z (ES+): 356 ((M+H)+ 18%); HRMS (ESI-TOF) 
m/z: [M+H]+ Calcd for C14H15INO2 356.0147; Found 356.0144. 
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1-Benzyl-4-((2-bromobenzyl)oxy)-6-methylpyridin-2(1H)-one (17)2  
Compound 17 was prepared via the procedure described 
for compound 15 using 1-benzyl-4-hydroxy-6-
methylpyridin-2(1H)-one 14 (300 mg, 1.39 mmol, 1.0 
equiv.) and 2-bromobenzylbromide 2 (390 mg, 1.56 mmol, 
1.12 equiv.). The residue was purified by column 
chromatography (EtOAc:hexanes 50:50) to give an off-
white solid 17 (0.282 g, 53%); m.p. 115–118 °C (lit.2 116–117 °C ); 1H NMR (300 MHz, 
CDCl3) δ 7.59 (dd, J = 7.9, 1.2, 1H, C(11)H), 7.47 (dd, J = 7.8, 1.6, 1H, C(14)H), 7.39 – 
7.11 (m, 7H, 7 × ArCH), 6.20 (d, J = 2.7, 1H, C(3)H), 5.95 (dd, J = 3.0, 0.7, 1H, C(5)H), 
5.30 (s, 2H, C(8)H2), 5.10 (s, 2H, C(15)H2), 2.25 (s, 3H, C(7)H3); 13C NMR (75 MHz, 
CDCl3) δ 166.5 (qC-4), 165.2 (qC-2), 147.0 (qC-6), 136.4 (qC-9), 134.7 (qC-16), 132.9 
(C(14)H), 129.9 (C(12)H), 129.3 (C(11)H), 128.8 (C(18)H & C(20)H), 127.7 (C(13)H), 
127.4 (C(17)H & C(21)H), 126.4 (C(19)H), 122.9 (qC-10), 102.2 (C(5)H), 95.9 (C(3)H), 
69.7 (C(8)H2), 46.9 (C(15)H2), 20.5 (C(7)H3); m/z (ES+): 385 (79Br (M+H)+ 86%). 
1-Benzyl-4-((2-iodobenzyl)oxy)-6-methylpyridin-2(1H)-one (18) 
Compound 18 was prepared via the procedure described 
for compound 16 using 1-benzyl-4-hydroxy-6-
methylpyridin-2(1H)-one 14 (200 mg, 0.93 mmol, 1.0 
equiv.) and 2-iodobenzylbromide 2 (309 mg, 1.04 mmol, 
1.12 equiv.). The residue was purified by column 
chromatography (EtOAc:hexanes 50:50) to give an off-
white solid 18 (0.221 g, 55%); m.p. 129–134 °C; IR νmax (KBr) 1653 (amide C=O 
stretch), 1591 (aromatic C–C stretch), 1242 (amide C–N stretch); 1H NMR (300 MHz, 
CDCl3) δ 7.87 (dd, J = 7.9, 0.7, 1H, C(11)H), 7.47 – 7.10 (m, 7H, 7 × ArCH), 7.04 (td, 1H, 
J = 7.6, 1.8, C(12)H), 6.01 (d, J = 2.7, 1H, C(5)H), 5.88 (d, J = 2.3, 1H, C(3)H), 5.29 (s, 
2H, C(8)H2), 5.00 (s, 2H, C(15)H2), 2.23 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 
166.2 (qC-4), 165.3 (qC-2), 146.7 (qC-6), 139.5 (C(14)H), 137.8 (qC-9), 136.8 (qC-16), 
129.9 (C(12)H), 128.8 (C(18)H, C(19)H & C(20)H), 128.4 (C(11)H), 127.3 (C(13)H), 
126.4 (C(17)H & C(21)H), 101.4 (C(5)H), 97.5 (qC-10), 96.1 (C(3)H), 73.8 (C(8)H2), 46.6 
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(C(15)H2), 20.6 (C(7)H3); m/z (ES+): 432 ((M+H)+ 28%); HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C20H19INO2 432.0460; Found 432.0444. 
4-((2-Iodobenzyl)oxy)-2H-chromen-2-one (20) 
Compound 20 was prepared via the procedure described for 
compound 4 using 4-hydroxy-2H-chromen-2-one 19 (1.00 g, 
6.17 mmol, 1.0 equiv.) and 2-iodobenzyl bromide 2 (2.20 g, 
7.40 mmol, 1.2 equiv.). The residue was purified by column 
chromatography (DCM) to give 20 as a white solid (1.0521 g, 45%); m.p. 159–162 °C; 
IR νmax (KBr) 1717 (ester C=O stretch), 1624 (alkene C=C stretch), 1566 (aromatic C–
C stretch), 1250 (ester C–O stretch), 1189 (ether C–O stretch), 935 (alkene C–H bend), 
750 (C–I stretch); 1H NMR (300 MHz, CDCl3) δ 7.93 (dd, J = 7.9, 1.1, 1H, C(14)H), 7.89 
(dd, J = 7.9, 1.6, 1H, C(17)H), 7.61 – 7.53 (m, 1H, C(16)H), 7.52 – 7.39 (m, 2H, C(6)H & 
C(8)H), 7.37 – 7.28 (m, 2H, C(7)H & C(9)H), 7.11 (td, J = 7.5, 1.9, 1H, C(15)H), 5.81 (s, 
1H, C(3)H), 5.21 (s, 2H, C(8)H2); 13C NMR (75 MHz, CDCl3) δ 165.1 (qC-4), 162.7 (qC-
2), 153.4 (qC-10), 139.8 (C(14)H), 136.7 (qC-12), 132.5 (C(15)H), 130.5 (C(17)H), 129.1 
(C(8)H), 128.6 (C(16)H), 124.0 (C(7)H), 123.2 (C(6)H), 116.9 (C(9)H), 115.6 (qC-5), 97.9 
(qC-13), 91.6 (C(3)H), 74.8 (C(11)H2); m/z (ES-): 377 ((M-H)- 8%); HRMS (ESI-TOF) m/z: 
[M + H]+ Calcd for C16H12O3I 378.9831; Found 378.9850. 
6-Ethyl-4-hydroxy-2H-chromen-2-one (21)11 
Following the literature procedure,12 a mixture of 
4-ethylphenol (1.00 g, 8.02 mmol, 1.0 equiv.) and 
Meldrum’s acid (1.18 g, 8.02 mmol, 1.0 equiv.) was stirred 
at 100 °C for 3 h. The small remaining amount of acetone 
was removed by vacuum. Eaton’s reagent (24.1 mL, 127 mmol, 16 equiv.) was added 
to the mixture and was stirred at 70 °C for 4 h. Water (25 mL) was then added to this 
mixture while stirring vigorously. The precipitate was filtered by suction, washed with 
water and dried. This solid was then purified by recrystallisation from EtOH to give 
21 as a brown crystalline solid (1.1612 g, 76%); m.p. 217–219 °C (lit.11 216–218 °C); 
1H NMR (300 MHz, DMSO-d6) δ 12.44 (br s, 1H, O–H), 7.63 (d, J = 2.1, C(6)H), 7.48 
(dd, J = 8.5, 2.2, C(8)H), 7.28 (d, J = 8.4, 1H, C(9)H), 5.58 (s, 1H, C(3)H), 2.68 (q, J = 7.5, 
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2H, C(11)H2), 1.20 (t, J = 7.6, 3H, C(12)H3); 13C NMR (75 MHz, DMSO-d6) δ 166.1 (qC-4), 
162.5 (qC-2), 152.3 (qC-10), 139.9 (qC-7), 132.9 (C(8)H), 122.0 (C(6)H), 116.7 (C(9)H), 
116.0 (qC-5), 91.4 (C(3)H), 27.9 (C(11)H2), 16.0 (C(12)H3); m/z (ES+): 191 ((M+H)+ 
90%). 
4-Hydroxy-6-methyl-2H-chromen-2-one (22)12 
Compound 22 was prepared via the procedure described for 
compound 21 using 4-methylphenol (1.00 g, 9.25 mmol, 
1.0 equiv.) to yield 22 as a brown crystalline solid (1.1636 g, 
71%); m.p. 246–252 °C (lit.12 261.0–261.2 °C); 1H NMR (300 MHz, 
DMSO-d6) δ 12.50 (br s, 1H, O–H), 7.62 (s, 1H, C(6)H), 7.46 (dd, J = 8.4, 2.1, 1H, C(8)H), 
7.27 (d, J = 8.4, 1H, C(9)H), 5.57 (s, 1H, C(3)H), 2.38 (s, 3H, C(11)H3); 13C NMR (75 MHz, 
DMSO-d6) δ 166.1 (qC-4), 162.5 (qC-2), 152.1 (qC-10), 133.9 (qC-7), 133.6 (C(8)H), 
123.2 (C(6)H), 116.6 (C(9)H), 116.0 (qC-5), 91.4 (C(3)H), 20.8 (C(11)H3); m/z (ES+): 
177.3 ((M+H)+ 100%). 
Spectral characteristics were consistent with previously reported data.12 
4-Hydroxy-6-methoxy-2H-chromen-2-one (23)12 
Compound 23 was prepared via the procedure described for 
compound 21 using 4-methyloxyphenol (0.67 g, 5.40 mmol, 
1.0 equiv.) to yield 23 as a brown crystalline solid (0.32 g, 
31%); m.p. >250 °C (lit.12 254.4–254.7 °C); 1H NMR (300 MHz, 
DMSO-d6) δ 12.51 (br s, 1H, O–H), 7.36 – 7.29 (m, 1H, C(9)H), 7.27 – 7.20 (m, 2H, 
C(6)H & C(8)H), 5.60 (s, 1H, C(3)H), 3.82 (s, 3H, C(11)H3); 13C NMR (75 MHz, DMSO-d6) 
δ 165.8 (qC-4), 162.5 (qC-2), 155.8 (qC-7), 148.3 (qC-10), 120.9 (C(9)H), 118.1 (C(8)H), 
116.7 (qC-5), 105.5 (C(6)H), 91.7 (C(3)H), 56.1 (C(11)H3); m/z (ES+): 193 ((M+H)+ 
100%). 
Spectral characteristics were consistent with previously reported data.13 
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6-Fluoro-4-hydroxy-2H-chromen-2-one (24)14  
A 50 mL 2-neck round-bottomed flask was heated under vacuum 
and refilled with N2 three times. NaH (2.4 g, 55% in oil, 
54.5 mmol, 8.4 equiv.) was added. The flask was evacuated and 
refilled with N2 three times. The flask was cooled to 0 °C, then diethyl carbonate 
(2 mL) was added and the suspension stirred. A solution of 5-fluoro-2-hydroxy-
acetophenone (1.0 g, 6.49 mmol, 1.0 equiv.) in diethyl carbonate (2 mL) was added 
to the NaH suspension over 10 min at 0 °C. The resulting mixture was allowed to 
warm to ambient temperature, 20 mL toluene was added. The mixture heated to 
110 °C and stirred overnight. The mixture was cooled and filtered to obtain a yellow 
solid. The solid was added to ice-cold H2O (20 mL) in a 250 mL beaker and stirred with 
a spatula until hydrogen gas evolution ceased. The cloudy yellow solution was 
acidified using 2 M aqueous HCl (approx. 25 mL) until precipitation appeared to 
cease. The precipitate was isolated by filtration, dissolved in EtOAc and the organic 
layer concentrated under reduced pressure to afford an off-white solid 24 (0.2995 g, 
26%); m.p. 243–245 °C (lit.13 240–241 °C); IR νmax (film) 1699 (ester C=O stretch), 1618 
(C=C stretch), 1573 (aromatic C–C stretch), 1224 (C–O stretch), 812 (C–F stretch); 1H 
NMR (300 MHz, DMSO-d6) δ 7.59 – 7.38 (m, 3H, 3 × ArCH), 5.56 (s, 1H, C(3)H); 13C 
NMR (75 MHz, DMSO-d6) δ 167.0 (qC-4), 162.7 (qC-2), 158.3 (d, J = 240, qC-7), 150.4 
(d, J = 2, qC-10), 120.0 (d, J = 25, C(8)H), 118.8 (d, J = 8, qC-5 & C(9)H), 109.3 (d, J = 
25, C(6)H), 91.12 (C(3)H); 19F NMR (282 MHz, DMSO-d6) δ: -118 (s, C(7)F); m/z (ES-): 
179 ((M−H)− 100%). 
Spectral characteristics were consistent with previously reported data.14 
4-Hydroxy-6-nitro-2H-chromen-2-one (25)15 
Modifying a literature procedure,15 a 100 mL round-bottomed 
flask fitted with stir bar was placed in an ice bath. 96% 
aqueous H2SO4 (20 mL) was added and stirred for 5 min until 
cool, then 65% aqueous HNO3 (0.43 mL, 1.0 equiv.) was added 
and the mixture was stirred for 5 min. 4-Hydroxycoumarin 19 (1.0 g, 1.0 equiv.) was 
slowly added to the stirring solution to ensure dissolution. The reaction was 
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maintained at 0 °C for 1 h. The mixture was then poured onto ice water (100 mL) and 
stirred. A yellow precipitate formed, which was isolated by suction filtration. The 
crude product was purified by recrystallisation from EtOH to give 25 as a pale yellow 
solid (0.329 g, 26%); m.p. >250 °C (lit.15 253–254 °C); 1H NMR (400 MHz, DMSO-d6) δ 
8.56 (1H, d, J = 2.8, C(6)H), 8.46 (dd, J = 9.2, 2.8, 1H, C(8)H), 7.62 (d, J = 9.2, 1H, C(9)H), 
5.72 (s, 1H, C(3)H); 13C NMR (100 MHz, DMSO-d6) δ 164.5 (qC-4), 160.8 (qC-2), 157.1 
(qC-10), 143.2 (qC-7), 127.3 (C(8)H), 119.1 (C(6)H), 118.1 (C(9)H), 116.4 (qC-5), 92.0 
(C(3)H); m/z (ES+): 208 ((M+H)+ 6%) 163 ((M-NO2)+ 100%). 
Spectral characteristics were consistent with previously reported data.15 
6-Ethyl-4-((2-iodobenzyl)oxy)-2H-chromen-2-one (26) 
Compound 26 was prepared via the procedure 
described for compound 4 using 6-ethyl-4-hydroxy-
2H-chromen-2-one 21 (0.5 g, 2.63 mmol, 1.0 equiv.) 
and 2-iodobenzyl bromide 2 (0.94 g, 3.15 mmol, 
1.2 equiv.). The residue was purified by column 
chromatography (DCM) to give 26 as a pale yellow solid (0.450 g, 42%); m.p. 156–
161 °C; IR νmax (KBr) 1716 (ester C=O stretch), 1632 (alkene C=C stretch), 1578 
(aromatic C–C stretch), 1366 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 7.92 (d, J = 
8.3, 1H, C(14)H), 7.67 (d, J = 2.0, 1H, C(6)H), 7.54 – 7.35 (m, 3H, C(8)H, C(9)H, C(16)H), 
7.30 – 7.21 (m, 1H, C(17)H), 7.11 (td, J = 7.6, 1.7, 1H, C(15)H), 5.77 (s, 1H, C(3)H), 5.19 
(s, 2H, C(11)H2), 2.71 (q, J = 7.5, 2H, C(18)H2), 1.26 (t, J = 7.6, 3H, C(19)H3); 13C NMR 
(75 MHz, CDCl3) δ 165.1 (qC-4), 162.9 (qC-2), 151.7 (qC-10), 140.2 (qC-12), 139.8 
(C(14)H), 136.8 (qC-7), 132.4 (C(15)H), 130.5 (C(17)H), 129.1 (C(8)H), 128.6 (C(16)H), 
121.7 (C(6)H), 116.7 (C(9)H), 115.3 (qC-5), 97.9 (qC-13), 91.5 (C(3)H), 74.8 (C(11)H2), 
28.4 (C(18)H2), 15.8 (C(19)H3); m/z (ES+): 407 ((M+H)+ 18%); HRMS (ESI-TOF) m/z: 
[M+H]+ Calcd for C18H16O3I 407.0144; Found 407.0146; Anal. Calcd for C18H15O3I: C, 
53.22; H, 3.72. Found: C, 53.11; H, 3.69. 
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4-((2-Iodobenzyl)oxy)-6-methyl-2H-chromen-2-one (27)7 
Compound 27 was prepared via the procedure described 
for compound 4 using 4-hydroxy-6-methyl-2H-chromen-
2-one 22 (0.50 g, 2.84 mmol, 1.0 equiv.) and 2-iodobenzyl 
bromide 2 (1.01 g, 3.41 mmol, 1.2 equiv.). The residue was 
purified by column chromatography (DCM) to give 27 as a pale yellow solid (0.467 g, 
42%); m.p. 171–173 °C (lit.7 168–169 °C); 1H NMR (300 MHz, CDCl3) δ 7.92 (d, J = 7.9, 
1H, C(14)H), 7.64 (d, J = 1.4, 1H, C(6)H), 7.54 – 7.32 (m, 3H, C(8)H, C(9)H, C(16)H), 
7.25 – 7.18 (m, 1H, C(17)H), 7.11 (td, J = 7.6, 1.8, 1H, C(15)H), 5.77 (s, 1H, C(3)H), 5.18 
(s, 2H, C(11)H2), 2.41 (s, 3H, C(18)H3); 13C NMR (75 MHz, CDCl3) δ 165.1 (qC-4), 162.9 
(qC-2), 151.6 (qC-10), 139.8 (C(14)H), 136.8 (qC-12), 133.8 (qC-7), 133.6 (C(8)H), 
130.5 (C(15)H), 129.1 (C(17)H), 128.7 (C(16)H), 122.8 (C(6)H), 116.6 (C(9)H), 115.2 
(qC-5), 97.9 (qC-13), 91.5 (C(3)H), 74.8 (C(11)H2), 20.9 (C(18)H3); m/z (ES+): 393 
((M+H)+ 34%). 
Spectral characteristics were consistent with previously reported data.7 
4-((2-Iodobenzyl)oxy)-6-methoxy-2H-chromen-2-one (28)7 
A solution of 4-hydroxy-6-methoxy-2H-chromen-2-one 
23 (100 mg, 0.52 mmol, 1.0 equiv.), 2-iodobenzyl 
bromide 2 (309 mg, 1.04 mmol, 2.0 equiv.) and CsF (158 
mg, 1.04 mmol, 2.0 equiv.) in DMF (3 mL) was stirred at 
ambient temperature for 24 h.16 H2O (10 mL) was added. The mixture was extracted 
with EtOAc (3 × 10 mL). The combined organic extracts were washed with H2O (2 × 
10 mL), dried over MgSO4 and concentrated under reduced pressure. The residue 
was purified by column chromatography (MeOH:DCM 1:99) to give 28 as a white solid 
(0.0424 g, 20%); m.p. 149–151 °C (lit.7 132–133 °C); 1H NMR (300 MHz, CDCl3) δ 7.93 
(dd, J = 7.9, 0.9, 1H, ArCH), 7.51 – 7.37 (m, 2H, 2 × ArCH), 7.34 – 7.27 (m, 1H, ArCH), 
7.26 (d, J = 0.6, 1H, ArCH), 7.18 – 7.07 (m, 2H, 2 × ArCH), 5.79 (s, 1H, C(3)H), 5.21 (s, 
2H, C(11)H2), 3.85 (s, 3H, C(18)H3); 13C NMR (75 MHz, CDCl3) δ 164.8 (qC-4), 162.9 
(qC-2), 155.9 (qC-7), 147.9 (qC-10), 139.9 (C(14)H), 136.7 (qC-12), 130.5 (C(15)H), 
129.2 (C(17)H), 128.6 (C(16)H), 120.2 (C(9)H), 117.9 (C(8)H), 115.9 (qC-5), 105.5 
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(C(6)H), 97.9 (qC-13), 91.9 (C(3)H), 74.8 (C(11)H2), 55.9 (C(18)H3); m/z (ES+): 409 
((M+H)+ 100%). 
Spectral characteristics were consistent with previously reported data.7 
6-Fluoro-4-(2-iodo(benzyloxy))-2H-chromen-2-one (29) 
Compound 29 was prepared via the procedure described 
for compound 4 using 6-fluoro-4-hydroxy-2H-chromen-2-
one 24 (0.25 g, 1.388 mmol, 1.0 equiv.) and 2-iodobenzyl 
bromide 2 (0.50 g, 1.665 mmol, 1.2 equiv.). The residue 
was purified by column chromatography (MeOH:DCM 
0.5:99.5) to give 29 as a white solid (0.283 g, 52%); m.p. 157–159 °C; IR νmax (film) 
1720 (C=O stretch), 1576 (C=C stretch), 1179 (C–O stretch), 826 (C–F stretch), 749 (C–
I stretch); 1H NMR (300 MHz, CDCl3) δ 7.99 – 7.88 (m, 1H, C(14)H), 7.54 (dd, J = 8.3, 
2.5, 1H, C(6)H), 7.39 – 7.51 (m, 2H, C(8)H & C(9)H), 7.36 – 7.23 (m, 2H, C(16)H & 
C(17)H), 7.17 – 7.08 (m, 1H, C(15)H), 5.85 (s, 1H, C(3)H), 5.20 (s, 2H, C(11)H2); 13C 
NMR (75 MHz, CDCl3) δ 164.2 (d, J = 3, qC-4), 162.4 (qC-2), 158.7 (d, J = 244, qC-7), 
149.5 (d, J = 2, qC-10), 139.9 (C(14)H), 136.4 (qC-12), 130.7 (C(15)H), 129.3 (C(17)H), 
128.7 (C(16)H), 120.1 (d, J = 25, C(8)H), 118.5 (d, J = 8, C(9)H), 116.5 (d, J = 9, qC-5), 
109.1 (d, J = 25, C(6)H), 98.1 (qC-13), 92.3 (C(3)H), 75.0 (C(11)2); 19F NMR (282 MHz, 
CDCl3) δ -117 (s, C(7)F); m/z (ES+): 397 ([M+H]+ 54%); HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C16H11O3FI 396.9737; Found 396.9733. 
4-((2-Iodobenzyl)oxy)-6-nitro-2H-chromen-2-one (30) 
Compound 30 was prepared via the procedure 
described for compound 28 using 4-hydroxy-6-nitro-2H-
chromen-2-one 25 (100 mg, 0.48 mmol, 1.0 equiv.) and 
2-iodobenzyl bromide 2 (287 mg, 0.97 mmol, 2.0 
equiv.).  The residue was purified by column chromatography (DCM) to give 30 as a 
white solid (0.102 g, 50%); m.p. 182–184 °C; IR νmax (film) 1728 (C=O stretch), 1626 
(C=C stretch), 1531 (N–O asymmetric stretch), 1338 (N–O symmetric stretch); 1H 
NMR (400 MHz, CDCl3) δ 8.75 (1H, d, J = 2.7, C(6)H), 8.43 (dd, J = 9.1, 2.7, 1H, C(8)H), 
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7.96 (d, J = 8.0, 1H, C(14)H), 7.53 – 7.42 (m, 3H, C(9)H, C(16)H & C(17)H), 7.20 – 7.13 
(m, 1H, C(15)H), 5.91 (s, 1H, C(3)H), 5.27 (s, 2H, C(11)H2); 13C NMR (100 MHz, CDCl3) 
δ 163.7 (qC-4), 160.9 (qC-2), 156.8 (qC-10), 144.0 (qC-7), 140.1 (C(14)H), 135.9 (qC-
12), 131.0 (C(15)H), 129.5 (C(17)H), 128.9 (C(16)H), 127.3 (C(8)H), 119.9 (C(6)H), 
118.1 (C(9)H), 116.1 (qC-5), 98.3 (qC-13), 92.9 (C(3)H), 75.5 (C(11)H2); m/z (ES+): 424 
((M+H)+ 98%); Anal. Calcd for C16H10O5IN: C, 45.41; H, 2.38; N, 3.31. Found: C, 45.76; 
H, 2.64; N, 2.89. 
3-Chloro-4-((2-iodobenzyl)oxy)-6-methyl-2H-pyran-2-one (47) 
To a stirring solution of 4-((2-iodobenzyl)oxy)-6-methyl-2H-
pyran-2-one 4 (0.54 g, 1.578 mmol, 1.0 equiv.) in CHCl3 (8 mL) 
in a 25 mL round-bottomed flask were added N-
chlorosuccinimide (NCS) (0.25 g, 1.894 mmol, 1.2 equiv.) and 
trifluoroacetic acid (TFA) (0.15 mL, 1.894 mmol, 1.2 equiv.). The 
flask was covered in aluminium foil and placed in an oil bath preheated to 55 °C. The 
resulting reaction mixture was then stirred at 55 °C for 18 h. The reaction mixture 
was allowed to cool to ambient temperature. The mixture was diluted with CHCl3 (10 
mL) and washed with saturated aqueous NaHCO3 (1 × 15 mL) and H2O (2 × 15 mL). 
The organic layer was dried over MgSO4 and concentrated under reduced pressure. 
The resulting crude product was purified by column chromatography (DCM) to yield 
47 as a white solid (0.387 g, 65%); m.p. 183–185 °C; IR νmax (film) 1725 (C=O stretch), 
1639 (alkene C=C stretch), 1542 (aromatic C-C stretch), 1322 (C-O stretch), 758 (C–X 
stretch); 1H NMR (300 MHz, CDCl3) δ 7.89 (dd, J = 8.0, 1.0, 1H, ArCH), 7.53 – 7.38 (m, 
2H, 2 × ArCH), 7.09 (td, J = 7.5, 1.9, 1H, ArCH), 6.06 (d, J =0.8, 1H, C(5)H), 5.21 (s, 2H, 
C(8)H2), 2.29 (d, J = 0.8, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 164.0 (qC-4), 161.8 
(qC-2), 160.8 (qC-6), 139.5 (ArCH), 136.7 (qC-9), 130.3 (ArCH), 128.9 (ArCH), 128.4 
(ArCH), 100.5 (qC-3), 96.4 (qC-10), 96.1 (C(5)H), 75.3 (C(8)H2), 20.3 (C(7)H3); m/z 
(ES+): 377 ((M+H)+ 20%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H11O3ICl 376.9441; 
Found 376.9446. 
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4-((2-Iodo-5-methylbenzyl)oxy)-6-methyl-2H-pyran-2-one (48) 
Compound 48 was prepared via the procedure described for 
compound 4 using 4-hydroxy-6-methyl-2H-pyran-2-one 3 
(220 mg, 1.742 mmol, 1.0 equiv.) and 2-iodo-
5-methylbenzylbromide (650 mg, 2.090 mmol, 1.2 equiv.). The 
residue was purified by column chromatography (MeOH:DCM 0.5:99.5) to yield 48 
as a white solid (0.236 g, 38%); m.p. 125–127 °C; IR νmax (film) 1719 (ester C=O 
stretch), 1649 (alkene C=C stretch), 1566 (aromatic C-C stretch), 1245 (ester C-O 
stretch), 1013 (ether C-O stretch), 806 (alkene C-H bend); 1H NMR (300 MHz, CDCl3) 
δ 7.73 (d, J = 8.0, 1H, C(11)H), 7.20 (d, J = 1.6, 1H, C(14)H), 6.89 (dd, J = 8.0, 1.7, 1H, 
C(12)H), 5.88 (dd, J = 2.1, 0.9, 1H, C(5)H), 5.50 (d, J = 2.1, 1H, C(3)H), 4.96 (s, 2H, 
C(8)H2), 2.32 (s, 3H, C(15)H3), 2.22 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 170.0 
(qC-4), 164.8 (qC-2), 162.4 (qC-6), 139.4 (C(11)H), 138.7 (qC-9), 136.4 (qC-13), 131.3 
(C(14)H), 130.0 (C(12)H), 100.4 (C(5)H), 93.7 (qC-10), 88.7 (C(3)H), 74.4 (C(8)H2), 21.0 
(C(15)H3), 19.9 (C(7)H3); m/z (ES+): 357 ((M+H)+ 40%); HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C14H14IO3 356.9988; Found 356.9987. 
4-((2-Iodo-5-methoxybenzyl)oxy)-6-methyl-2H-pyran-2-one (49) 
Compound 49 was prepared via the procedure described for 
compound 4 using 4-hydroxy-6-methyl-2H-pyran-2-one 3 
(138 mg, 1.096 mmol, 1.0 equiv.) and 2-iodo-
5-methoxybenzylbromide (430 mg, 1.315 mmol, 1.2 equiv.). 
The residue was purified by column chromatography (MeOH:DCM 0.5:99.5) to yield 
49 as a yellow solid (0.015 g, 4%), with the remainder (0.197 g) isolated as an 
inseparable mixture which was used without further purification in the next step; 
m.p. 100–104 °C; IR νmax (film) 1727 (ester C=O stretch), 1651 (alkene C=C stretch), 
1566 (aromatic C-C stretch), 1244 (ester C-O stretch), 1000 (ether C-O stretch), 811 
(alkene C-H bend); 1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.7, 1H, C(11)H), 6.96 (d, J 
= 3.0, 1H, C(14)H), 6.66 (dd, J = 8.7, 3.0, 1H, C(12)H), 5.88 (dd, J = 2.1, 0.9, 1H, C(5)H), 
5.49 (d, J = 2.1, 1H, C(3)H), 4.96 (s, 2H, C(8)H2), 3.80 (s, 3H, C(15)H3), 2.23 (s, 3H, 
C(7)H3); 13C NMR (75 MHz, CDCl3) δ 169.9 (qC-4), 164.7 (qC-2), 162.4 (qC-6), 160.2 
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(qC-13), 140.1 (C(11)H), 137.7 (qC-9), 115.8 (C(12)H), 115.3 (C(14)H), 100.3 (C(5)H), 
88.9 (C(3)H), 85.6 (qC-10), 74.2 (C(8)H2), 55.5 (C(15)H3), 19.9 (C(7)H3); HRMS (ESI-
TOF) m/z: [M+H]+ Calcd for C14H14IO4 372.9937; Found 372.9949. 
4-((5-Fluoro-2-iodobenzyl)oxy)-6-methyl-2H-pyran-2-one (50) 
Compound 50 was prepared via the procedure described for 
compound 4 using 4-hydroxy-6-methyl-2H-pyran-2-one 3 
(125 mg, 0.992 mmol, 1.0 equiv.) and 5-fluoro-
2-iodobenzylbromide (375 mg, 1.191 mmol, 1.2 equiv.). The 
residue was purified by column chromatography (DCM) to yield 50 as a pale yellow 
solid (0.143 g, 40%); m.p. 123–126 °C; IR νmax (film) 1714 (ester C=O stretch), 1650 
(alkene C=C stretch), 1569 (aromatic C-C stretch), 1239 (ester C-O stretch), 1020 
(ether C-O stretch), 666 (alkene C-H bend); 1H NMR (300 MHz, CDCl3) δ 7.81 (dd, J = 
8.7, 5.5, 1H, C(11)H), 7.15 (dd, J = 9.3, 3.0, 1H, C(14)H), 6.84 (td, J = 8.4, 3.0, 1H, 
C(12)H), 5.90 (dd, J = 2.1, 0.9, 1H, C(5)H), 5.48 (d, J = 2.2, 1H, C(3)H), 4.96 (s, 2H, 
C(8)H2), 2.24 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 169.6 (qC-4), 164.6 (qC-2), 
163.2 (d, J = 249, qC-13), 162.7 (qC-6), 140.7 (d, J = 8, C(11)H), 139.0 (d, J = 7, qC-9), 
117.5 (d, J = 22, C(12)H), 115.9 (d, J = 24, C(14)H), 100.2 (C(5)H), 89.4 (d, J = 3, qC-10), 
88.9 (C(3)H), 73.7 (d, J = 1, C(8)H2), 19.9 (C(7)H3); 19F NMR (282 MHz, CDCl3) δ -113 (s, 
C(13)F); m/z (ES+) 361 ((M+H)+ 6%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H11IFO3 
360.9737; Found 360.9741. 
3-Chloro-4-((2-iodo-5-methylbenzyl)oxy)-6-methyl-2H-pyran-2-one (51)  
Compound 51 was prepared via the procedure described for 
compound 47 using 4-((2-iodo-5-methylbenzyl)oxy)-6-methyl-
2H-pyran-2-one 48 (200.0 mg, 0.562 mmol, 1.0 equiv.). The 
residue was purified by column chromatography (MeOH:DCM 
0.5:99.5) to yield 51 as a white solid (0.164 g, 75%); m.p. 204–
206 °C; IR νmax (film) 1722 (ester C=O stretch), 1638 (alkene C=C stretch), 1544 
(aromatic C-C stretch), 1319 (ester C-O stretch), 1239 (ester C-O stretch), 1075 (ether 
C-O stretch), 743 (C-Cl stretch); 1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.0, 1H, 
C(11)H), 7.28 (d, J = 1.3, 1H, C(14)H), 6.91 (dd, J = 8.0, 1.7, 1H, C(12)H), 6.06 (s, 1H, 
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C(5)H), 5.17 (s, 2H, C(8)H2), 2.34 (s, 3H, C(15)H3), 2.29 (s, 3H, C(7)H3); 13C NMR (75 
MHz, CDCl3) δ 164.0 (qC-4), 161.8 (qC-2), 160.8 (qC-6), 139.2 (C(11)H), 139.1 (qC-9), 
136.4 (qC-13), 131.3 (C(14)H), 129.3 (C(12)H), 100.5 (qC-3), 96.2 (C(5)H), 92.4 (qC-10) 
75.3 (C(8)H2), 21.1 (C(15)H3), 20.3 (C(7)H3); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C14H13IClO3 390.9598; Found 390.9601. 
3-Chloro-4-((2-iodo-5-methoxybenzyl)oxy)-6-methyl-2H-pyran-2-one (52)  
Compound 52 was prepared via the procedure described for 
compound 47 using an impure sample of 4-((2-iodo-5-
methoxybenzyl)oxy)-6-methyl-2H-pyran-2-one 49 (0.2 g, 0.537 
mmol, 1.0 equiv.), except that the mixture was stirred at 55 °C 
for 24 h. The residue was purified by column chromatography 
(MeOH:DCM 0.5:99.5) to yield 52 as a white solid (0.052 g, ~24% based on impure 
starting material); m.p. 180–184 °C; IR νmax (film) 1719 (ester C=O stretch), 1637 
(alkene C=C stretch), 1545 (aromatic C-C stretch), 1318 (ester C-O stretch), 1232 
(ester C-O stretch), 1053 (ether C-O stretch), 874 (C-Cl stretch); 1H NMR (300 MHz, 
CDCl3) δ 7.71 (d, J = 8.7, 1H, C(11)H), 7.08 (d, J = 3.0, 1H, C(14)H), 6.67 (dd, J = 8.7, 
3.0, 1H, C(12)H), 6.07 (d, J = 0.6, 1H, C(5)H), 5.16 (s, 2H, C(8)H2), 3.80 (s, 3H, C(15)H3), 
2.29 (d, J = 0.6, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 163.9 (qC-4), 161.9 (qC-2), 
160.8 (qC-6), 160.4 (qC-13), 139.9 (C(11)H), 137.7 (qC-9), 116.4 (C(14)H), 114.2 
(C(12)H), 100.6 (qC-3), 96.1 (C(5)H), 84.1 (qC-10), 75.1 (C(8)H2), 55.5 (C(15)H3), 20.3 
(C(7)H3); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H13IClO4 406.9547; Found 
406.9550. 
3-Chloro-4-((5-fluoro-2-iodobenzyl)oxy)-6-methyl-2H-pyran-2-one (53)  
Compound 53 was prepared via the procedure described for 
compound 47 using 4-((5-fluoro-2-iodobenzyl)oxy)-6-methyl-
2H-pyran-2-one 50 (115 mg, 0.319 mmol, 1.0 equiv.), except 
that the mixture was stirred at 55 °C for 60 h. The residue was 
purified by column chromatography (MeOH:DCM 0.5:99.5) to 
yield 53 as a white solid (0.036 g, 29%); m.p. 221–223 °C; IR νmax (film) 1719 (ester 
C=O stretch), 1639 (alkene C=C stretch), 1544 (aromatic C-C stretch), 1321 (ester C-
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O stretch), 1235 (ester C-O stretch), 1074 (ether C-O stretch), 868 (C-Cl stretch); 1H 
NMR (300 MHz, CDCl3) δ 7.82 (dd, J = 8.7, 5.4, 1H, C(11)H), 7.37 – 7.15 (m, 1H, 
C(14)H), 6.86 (td, J = 8.4, 3.0, 1H, C(12)H), 6.05 (d, J = 0.6, 1H, C(5)H), 5.14 (s, 2H, 
C(8)H2), 2.31 (d, J = 0.7, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 163.5 (qC-4), 163.4 
(d, J = 249, qC-13), 161.7 (qC-2), 160.6 (qC-6), 140.6 (d, J = 8, C(11)H), 139.0 (d, J = 8, 
qC-9), 117.6 (d, J = 22, C(14)H), 115.8 (d, J = 24, C(12)H), 100.8 (qC-3), 95.9 (C(5)H), 
88.3 (d, J = 3, qC-10), 74.6 (d, J = 1, C(8)H2), 20.3 (C(7)H3); 19F NMR (282 MHz, CDCl3) 
δ -112 (s, C(13)F); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H10ClFIO3 394.9347; 
Found 394.9360. 
1-(Methylsulfonyl)-1H-benzo[d][1,2,3]triazole (54)17 
A 500 mL 3-neck round-bottomed flask was evacuated and refilled 
with N2 three times. Benzotriazole (5 g, 42 mmol, 1 equiv.), toluene 
(100 mL) and anhydrous pyridine (5.4 mL, 67 mmol, 1.6 equiv.) were 
added to the flask. The stirring, clear solution was cooled to 0 °C. A 
solution of mesyl chloride (3.9 mL, 50 mmol, 1.2 equiv.) in toluene (50 mL) was 
prepared and slowly added to the benzotriazole solution. The mixture was stirred at 
0 °C for 5 min, then the ice bath was removed and the mixture was left stirring at 
ambient temperature overnight. The mixture was diluted with H2O (100 mL) and the 
layers were separated. The organic components were extracted from the aqueous 
layer with EtOAc (2 × 50 mL). The combined organic layers were washed with H2O (1 
× 50 mL) and brine (1 × 50 mL), dried over MgSO4 and concentrated under reduced 
pressure. The crude product was recrystallised from toluene to yield 54 as pale 
yellow crystals (3.9251 g, 47%); m.p. 103–106 °C (lit.17 110–111.5 °C); 1H NMR (300 
MHz, CDCl3) δ 8.15 (d, J = 8.4, 1H, C(6)H), 8.01 (d, J = 8.4, 1H, C(3)H), 7.68 (t, J = 7.7, 
1H, C(4)H), 7.54 (t, J = 7.7, 1H, C(5)H), 3.52 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) 
δ 145.2 (qC-1), 131.7 (qC-2), 130.5 (C(4)H), 126.1 (C(5)H), 120.7 (C(6)H), 112.0 
(C(3)H), 42.9 (C(7)H3); m/z (ES+): 198 ((M+H)+ 14%). 
Spectral characteristics were consistent with previously reported data.18 
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(1H-Benzo[d][1,2,3]triazol-1-yl)(4-methoxyphenyl)methanone (55) 
A 50 mL round-bottomed flask was charged with 
1-(methylsulfonyl)-1H-benzo[d][1,2,3]triazole 54 
(1.9 g, 9.63 mmol, 1.0 equiv.), 4-methoxybenzoic acid 
(1.5 g, 9.63 mmol, 1.0 equiv.), Et3N (1.9 mL, 13.49 
mmol, 1.4 equiv.) and THF (25 mL). The flask was placed in an oil bath which was 
heated to 72 °C. The mixture was stirred at this temperature overnight. The mixture 
was cooled to ambient temperature and concentrated under reduced pressure. The 
residue was dissolved in CHCl3 (40 mL) and washed with H2O (2 × 20 mL). The organic 
layer was dried over MgSO4 and concentrated under reduced pressure. The residue 
was purified by column chromatography (EtOAc:hexanes 10:90) to yield 55 as a white 
solid (1.8 g, 74%); m.p. 101–104 °C; 1H NMR (300 MHz, CDCl3) δ 8.38 (d, J = 8.3, 1H, 
C(3)H), 8.34 – 8.25 (m, 2H, C(9)H & C(13)H), 8.17 (d, J = 8.3, 1H, C(6)H), 7.70 (ddd, J = 
8.2, 7.2, 1.0, 1H, C(4)H), 7.55 (ddd, J = 8.2, 7.2, 1.0, 1H, C(5)H), 7.16 – 6.90 (m, 2H, 
C(10)H & C(12)H), 3.94 (s, 3H, C(14)H3); 13C NMR (126 MHz, CDCl3) δ 165.7 (qC-11), 
162.2 (qC-7), 145.7 (qC-1), 134.4 (C(9)H & C(13)H), 132.6 (qC-2), 130.2 (C(4)H), 126.1 
(C(5)H), 123.5 (qC-8), 120.1 (C(6)H), 114.9 (C(3)H), 113.9 (C(10)H & C(12)H), 55.6 
(C(14)H3); m/z (ES+): 254 ((M+H)+ 14%). 
6-(2-(4-Methoxy)phenyl)-2-oxoethyl)-2,2-dimethyl-4H-1,3,-dioxin-4-one (56)19  
A 50 mL, 2-neck round-bottomed flask fitted with 
stir bar was heated under vacuum and refilled with 
N2 three times. The flask was allowed cool, then 
freshly distilled THF (5 mL) was added. The THF was 
cooled to -78 °C. LDA (8.0 mL, 1.0 M in THF/hexanes, 1.15 equiv.) was added. The 
solution was stirred at -78 °C for 15 min. A solution of 2,2,6-trimethyl-4H-1,3-dioxin-
4-one (1.0 mL, 7.90 mmol, 1.13 equiv.) in freshly distilled THF (5 mL) was added 
dropwise to the LDA solution over 30 min. The mixture was then stirred at -78 °C for 
4 h. A suspension of (1H-benzo[d][1,2,3]triazol-1-yl)(4-methoxyphenyl)methanone 
55 (1.8 g, 6.96 mmol, 1 equiv.) in freshly distilled THF (10 mL) was added to the 
reaction and the mixture was stirred for 30 min at -78 °C, then left to warm to 
Chapter 5  Experimental 
201 
 
ambient temperature overnight. The reaction was quenched with saturated aqueous 
NH4Cl (2 mL) and concentrated under reduced pressure. The residue was diluted with 
H2O (50 mL) and extracted with EtOAc (3 × 25 mL). The combined organic layers were 
washed with saturated aqueous Na2CO3 (30 mL), dried over MgSO4 and concentrated 
under reduced pressure. The residue was purified by column chromatography 
(EtOAc:hexanes 0:100 → 70:30) to give 56 as an oily yellow solid (0.169, 6%); m.p. 
57–59 °C (lit.19 82 °C); 1H NMR (300 MHz, CDCl3) δ 7.92 (d, J = 9.0, 2H, C(3)H & C(7)H), 
6.96 (d, J = 9.0, 2H, C(4)H & C(6)H), 5.42 (s, 1H, C(11)H), 3.88 (s, 3H, C(1)H3), 3.86 (s, 
2H, C(9)H), 1.70 (s, 6H, C(14)H3 & C(15)H3); 13C NMR (75 MHz, CDCl3) δ 191.5 (qC-8), 
165.7 (qC-12), 164.2 (qC-2), 161.0 (qC-10), 130.7 (C(4)H & C(6)H), 128.9 (qC-5), 114.1 
(C(3)H & C(7)H), 107.3 (qC-13), 96.8 (C(11)H), 55.6 (C(1)H3), 43.0 (C(9)H2), 25.0 
(C(14)H3 & C(15)H3); m/z (ES-): 275 ((M-H)- 70%). 
Spectral characteristics were consistent with previously reported data.19 
4-Hydroxy-6-(4-methoxyphenyl)-2H-pyran-2-one (57)7  
Compound 57 was prepared via the procedure described 
for compound 8 using 6-(2-(4-methoxy)phenyl)-
2-oxoethyl)-2,2-dimethyl-4H-1,3,-dioxin-4-one 56 (146 mg, 
0.532 mmol, 1.0 equiv.) as the starting material. The 
resulting crude product was purified by column chromatography (acetone:DCM 
30:70) to yield the pure product 57 as an off-white solid (0.068 g, 59%); m.p. 196–
199 °C (lit.7 193–195 °C);  1H NMR (300 MHz, acetone-d6) δ 7.89 – 7.81 (m, 2H, C(8)H 
& C(12)H), 7.12 – 7.03 (m, 2H, C(9)H & C(11)H), 6.58 (d, J = 2.1, 1H, C(5)H), 5.41 (d, J 
= 2.0, 1H, C(3)H), 3.90 (s, 3H, C(13)H3); 13C NMR (75 MHz, acetone-d6) δ 170.3 (qC-2), 
163.0 (qC-4), 162.0 (qC-7), 161.1 (qC-6), 127.3 (C(8)H & C(12)H), 124.0 (qC-10), 114.3 
(C(9)H & C(11)H), 96.0 (C(5)H), 89.1 (C(3)H), 55.0 (C(13)H3); m/z (ES+): 219 ((M+H)+ 
32%). 
Spectral characteristics were consistent with the previously reported data.7 
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4-((2-Iodobenzyl)oxy)-6-(4-methoxyphenyl)-2H-pyran-2-one (58) 
Compound 50 was prepared via the procedure 
described for compound 4 using 4-hydroxy-6-(4-
methoxyphenyl)-2H-pyran-2-one 57 (65 mg, 
0.298 mmol, 1.0 equiv.) and 2-iodobenzyl bromide 
2 (106 mg, 0.357 mmol, 1.2 equiv.). The residue was 
purified by column chromatography (MeOH:DCM 0.5:99.5) to yield 58 as an orange 
solid (0.054 g, 42%); m.p. 107–109 °C; IR νmax (film) 1720 (C=O stretch), 1634 (alkene 
C=C stretch), 1510 (aromatic C–C stretch), 1178 (C–O stretch), 752 (C–I stretch); 1H 
NMR (300 MHz, CDCl3) δ 7.89 (dd, J = 7.9, 1.0, 1H, ArCH), 7.84 – 7.72 (m, 2H, 2 × 
ArCH), 7.50 – 7.35 (m, 2H, 2 × ArCH), 7.14 – 7.03 (m, 1H, ArCH), 7.01 – 6.90 (m, 2H, 2 
× ArCH), 6.41 (d, J = 2.1, 1H, C(5)H), 5.58 (d, J = 2.1, 1H, C(3)H), 5.06 (s, 2H, C(8)H2), 
3.85 (s, 3H, C(20)H3); 13C NMR (75 MHz, CDCl3) δ 170.3 (qC-4), 164.2 (qC-2), 162.0 
(qC-17), 160.6 (qC-6), 139.7 (ArCH), 136.9 (qC-9), 130.4 (ArCH), 129.1 (ArCH), 128.6 
(ArCH), 127.4 (C(15)H & C(19)H), 123.6 (qC-7), 114.3 (C(16)H & C(18)H), 97.8 (qC-10), 
96.3 (C(5)H), 89.0 (C(3)H), 74.5 (C(8)H2), 55.5 (C(20)H3); m/z (ES-): 433 ((M−H)− 14%); 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C19H16O4I 435.0093; Found 435.0095. 
3-Chloro-4-((2-iodobenzyl)oxy)-6-(4-methoxyphenyl)-2H-pyran-2-one (59) 
Compound 59 was prepared via the procedure described 
for compound 47 using 4-((2-iodobenzyl)oxy)-6-(4-
methoxyphenyl)-2H-pyran-2-one 58 (150.0 mg, 0.345 
mmol, 1.0 equiv.), except that the mixture was stirred at 
55 °C for 60 h. The residue was purified by column 
chromatography (MeOH:DCM 0.5:99.5) to yield 59 as a yellow solid (0.080 g, 49%); 
m.p. 183–185 °C; IR νmax (film) 1713 (ester C=O stretch), 1625 (alkene C=C stretch), 
1507 (aromatic C-C stretch), 1265 (ester C-O stretch), 1180 (ether C-O stretch), 1107 
(alkene C-H bend), 738 (C-Cl stretch); 1H NMR (300 MHz, CDCl3) δ 7.90 (d, J = 7.9, 1H, 
C(11)H), 7.81 – 7.71 (m, 2H, C(15)H & C(20)H), 7.54 (d, J = 7.7, 1H, C(14)H), 7.44 (t, J 
= 7.5, 1H, C(13)H), 7.09 (t, J = 7.6, 1H, C(12)H), 6.96 (d, J = 8.9, 2H, C(16)H & C(19)H), 
6.53 (s, 1H, C(5)H), 5.33 (s, 2H, C(8)H2), 3.87 (d, J = 1.2, 3H, C(21)H3); 13C NMR (75 
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MHz, CDCl3) δ 164.3 (qC-4), 162.4 (qC-2), 160.3 (qC-17), 159.8 (qC-6), 139.5 (C(11)H), 
136.9 (qC-9), 130.4 (C(12)H), 129.0 (C(14)H), 128.6 (C(13)H), 127.7 (C(15)H & C(20)H), 
123.0 (qC-7), 114.5 (C(16)H & C(19)H), 100.7 (qC-3), 96.6 (qC-10), 91.8 (C(5)H), 75.3 
(C(8)H2), 55.5 (C(21)H3); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C19H15IClO3 468.9704; 
Found 468.9715. 
4-Hydroxy-6-methyl-1-phenylpyridin-2(1H)-one (60)20  
Compound 60 was prepared via the procedure described for 
compound 13 using 4-hydroxy-6-methyl-2H-pyran-2-one 3 (5.0 g, 
39.65 mmol, 1.0 equiv.) and aniline (3.6 mL, 39.65 mmol, 1.0 equiv.) 
to yield 60 as a pale yellow solid (1.8407 g, 23%) after trituration in 
EtOH; m.p. >250 °C (lit.20 277–278 °C); 1H NMR (300 MHz, DMSO-d6) 
δ 10.60 (br s, 1H, O–H), 7.64 – 7.33 (m, 3H, C(10)H, C(11)H & C(12)H), 7.32 – 7.04 (m, 
2H, C(9)H & C(13)H), 5.89 (d, J = 1.7, 1H, C(5)H), 5.56 (d, J = 2.4, 1H, C(3)H), 1.83 (s, 
3H, C(7)H3); 13C NMR (75 MHz, DMSO-d6) δ 166.9 (qC-4), 164.6 (qC-2), 147.4 (qC-6), 
139.3 (qC-8), 129.7 (C(10)H & C(12)H), 129.1 (C(9)H & C(13)H), 128.6 (C(11)H), 100.5 
(C(5)H), 96.6 (C(3)H), 21.5 (C(7)H3); m/z (ES+): 202 ((M+H)+ 100%). 
4-((2-Iodobenzyl)oxy)-6-methyl-1-phenylpyridin-2(1H)-one (61) 
Compound 61 was prepared via the procedure described for 
compound 15 using 4-hydroxy-6-methyl-1-phenylpyridin-
2(1H)-one 60 (0.50 g, 2.48 mmol, 1.0 equiv.) and 
2-iodobenzylbromide 2 (0.83 g, 2.78 mmol, 1.12 equiv.). The 
residue was purified by column chromatography 
(EtOAc:hexanes 70:30) to yield 61 as a yellow solid (0.805 g, 
78%); m.p. 120–124 °C; IR νmax (film) 1662 (amide C=O stretch), 1590 (alkene C=C 
stretch), 1558 (aromatic C–C stretch), 1241 (ether C–O stretch), 1118 (C–N stretch), 
1044 (alkene C–H bend); 1H NMR (300 MHz, CDCl3) δ 7.88 (dd, J = 7.9, 0.8, 1H, ArCH), 
7.59 – 7.32 (m, 5H, 5 × ArCH), 7.24 – 7.15 (m, 2H, 2 × ArCH), 7.05 (td, J = 7.7, 1.7, 1H, 
ArCH), 6.00 (d, J = 2.6, C(5)H), 5.96 (d, J = 1.9, C(3)H), 5.01 (s, 2H, C(8)H2), 1.92 (s, 3H, 
C(7)H3); 13C NMR (75 MHz, CDCl3) δ 166.6 (qC-4), 165.4 (qC-2), 146.4 (qC-6), 139.5 
(ArCH), 138.6 (qC-15), 137.8 (qC-9), 129.9 (ArCH), 129.7 (2 × ArCH), 128.8 (ArCH), 
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128.7 (ArCH), 128.5 (ArCH), 128.3 (2 × ArCH), 100.8 (C(5)H), 97.6 (qC-10), 96.4 (C(3)H), 
73.9 (C(8)H2), 21.5 (C(7)H3); m/z (ES+): 418 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: 
[M+H]+ Calcd for C19H17INO2 418.0304; Found 418.0307. 
3-Chloro-4-((2-iodobenzyl)oxy)-1,6-dimethylpyridin-2(1H)-one (62) 
Compound 62 was prepared via the procedure described for 
compound 47 using 4-((2-iodobenzyl)oxy)-1,6-
dimethylpyridin-2(1H)-one 16 (200 mg, 0.563 mmol, 
1.0 equiv.), except that the mixture was stirred at 55 °C for 24 
h. The residue was purified by recrystallisation from EtOH to 
yield 62 as a white solid (0.1092 g, 50 %); m.p. 170–171 °C; IR νmax (film) 1569 (C=O 
stretch), 1635 (alkene C=C stretch), 1600 (aromatic C–C stretch), 1019 (C–N stretch), 
735 (C–X stretch); 1H NMR (300 MHz, CDCl3) δ 7.86 (dd, J = 7.9, 1.1, 1H, C(11)H), 7.55 
(dt, J = 7.7, 0.7, 1H, C(14)H), 7.40 (td, J = 7.6, 1.2, 1H, C(13)H), 7.05 (td, J = 7.6, 1.8, 
1H, C(12)H), 5.95 (d, J = 0.6, 1H, C(5)H), 5.14 (s, 2H, C(8)H2), 3.56 (s, 3H, C(15)H3), 2.36 
(d, J = 0.6, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 160.9 (qC-4), 160.6 (qC-2), 145.2 
(qC-6), 139.2 (ArCH), 137.7 (qC-9), 129.9 (ArCH), 128.7 (ArCH), 128.3 (ArCH), 106.4 
(qC-3), 96.2 (qC-10), 95.9 (C(5)H), 74.4 (C(8)H2), 32.0 (C(15)H3), 21.4 (C(7)H3); m/z 
(ES−): 388 ((M−H)− 10%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H14NO2ICl 
389.9758; Found 389.9761. 
3-Chloro-4-((2-iodobenzyl)oxy)-6-methyl-1-phenylpyridin-2(1H)-one (63) 
Compound 63 was prepared via the procedure described for 
compound 47 using 4-((2-iodobenzyl)oxy)-6-methyl-
1-phenylpyridin-2(1H)-one 61 (0.69 g, 1.654 mmol, 1.0 equiv.), 
except that the mixture was stirred at 55 °C for 42 h. The 
residue was purified by column chromatography 
(EtOAc:hexanes 90:10) to give a yellow solid which was 
triturated in EtOH to yield 63 as a yellow solid (0.1152 g, 15%); m.p. 239–243 °C; IR 
νmax 1654 (amide C=O stretch), 1531 (aromatic C–C stretch), 1350 (ether C–O stretch, 
1222 (C–N stretch), 1052 (alkene C–H bend), 751 (C–Cl stretch); 1H NMR (300 MHz, 
CDCl3) δ 7.87 (dd, J = 7.9, 0.9, 1H, ArCH), 7.60 (d, J = 7.7, 1H, ArCH), 7.55 – 7.37 (m, 
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4H, 4 × ArCH), 7.22 – 7.13 (m, 2H, 2 × ArCH), 7.07 (td, J = 7.8, 1.6, 1H, ArCH), 6.05 (s, 
1H, C(5)H), 5.20 (s, 2H, C(8)H2), 1.98 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 161.2 
(qC-4), 161.0 (qC-2), 145.3 (qC-6), 139.3 (ArCH), 138.5 (qC-15), 137.7 (qC-9), 129.9 
(ArCH), 129.8 (2 × ArCH), 129.0 (ArCH), 128.8 (ArCH), 128.4 (ArCH), 127.9 (2 × ArCH), 
106.8 (qC-3), 96.2 (qC-10), 95.9 (C(5)H), 74.6 (C(8)H2), 22.0 (C(7)H3); m/z (ES+): 452 
(35Cl (M+H)+ 100%), 454 (37Cl (M+H)+ 38%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C19H16IClNO2 451.9914; Found 451.9918. 
6-Methyl-2-oxo-2H-pyran-4-yl 2-iodobenzoate (74) 
Using a procedure based on the Steglich esterification,21 a 
solution of 4-hydroxy-6-methyl-2H-pyran-2-one 3 (0.40 g, 3.17 
mmol, 2.0 equiv.), 2-iodobenzoic acid (0.49 g, 1.586 mmol, 1.0 
equiv.), N,N′-dicyclohexylcarbodiimide (DCC) (0.36 g, 1.744 
mmol, 1.1 equiv.) and 4-dimethylaminopyridine (DMAP) (9.7 
mg, 0.079 mmol, 5 mol%) in DCM (10 mL) was stirred at ambient temperature for 24 
h. The solids were then removed by gravity filtration through fluted filter paper. The 
solids were washed with DCM. The combined organic extracts were dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by 
column chromatography (EtOAc:hexanes 30:70) to give 74 as a cream solid (0.457 g, 
81%); m.p. 112–113 °C; IR νmax (film) 1736 (ester C=O stretch), 1638 (alkene C=C 
stretch), 1561 (aromatic C–C stretch), 1238 (ester C–O stretch), 1213 (ester C–O 
stretch), 1010 (ester C–O stretch), 729 (C–I stretch); 1H NMR (300 MHz, CDCl3) δ 8.09 
(d, J = 8.0, 1H, C(11)H), 7.97 (dd, J = 8.0, 1.5, 1H, C(14)H), 7.50 (t, J = 7.6, 1H, C(13)H), 
7.27 (td, J = 7.4, 1.4, 1H, C(12)H), 6.23 – 6.17 (m, 1H, C(5)H), 6.16 – 6.08 (m, 1H, 
C(3)H), 2.31 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 163.6 (qC-4 & qC-8), 163.1 
(qC-2), 162.3 (qC-6), 142.1 (C(11)H), 134.2 (C(12)H), 132.3 (qC-9), 132.0 (C(14)H), 
128.3 (C(13)H), 101.5 (C(5)H), 101.3 (C(3)H), 95.0 (qC-10), 20.2 (C(7)H3); m/z (ES+): 
357 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H10O4I 356.9624; Found 
356.9620. 
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(2-Iodophenyl)methanamine (77)22  
This compound was prepared according to the literature 
procedure.22 A 2-neck round-bottomed flask was heated under 
vacuum and refilled with N2 three times. 2-Iodobenzonitrile 76 
(1.15 g, 5.00 mmol, 1.0 equiv.) was added and the flask was evacuated and refilled 
with N2 three times. Freshly distilled THF (10 mL) was added via syringe. The stirring 
solution was cooled to 0 °C. A solution of BH3.THF (10 mL, 1.0 M, 2.0 equiv.) was 
added slowly over 10 min to the stirring solution. The reaction mixture was 
maintained at 0 °C for 5 min once the addition was complete. The ice bath was 
removed and the mixture was stirred at ambient temperature for 24 h under 
nitrogen. The reaction was again cooled to 0 °C and H2O (20 mL) was slowly added 
dropwise to quench the reaction. The mixture was transferred to a round-bottomed 
flask and the THF was removed under reduced pressure. 10% (w/v) aqueous NaOH 
(2 mL) was added to make the aqueous solution alkaline (~pH 10). The organic 
component was extracted with Et2O (3 × 15 mL). The combined organic layers were 
dried over MgSO4 and concentrated under reduced pressure. The crude product was 
purified by column chromatography (MeOH:DCM 5:95) to yield 77 as a clear oil 
(0.3413 g, 29%); 1H NMR (300 MHz, CDCl3) δ 7.81 (dd, J = 7.8, 1.0, 1H, C(2)H), 7.40 – 
7.28 (m, 2H, C(4)H & C(5)H), 6.99 – 6.88 (m, 1H, C(3)H), 3.85 (s, 2H, C(7)H2), 1.53 (br 
s, 2H, NH2); 13C NMR (75 MHz, CDCl3) δ 145.2 (qC-6), 139.5 (C(2)H), 128.6 (C(5)H), 
128.6 (C(3)H), 128.5 (C(4)H), 99.0 (qC-1), 51.4 (C(7)H2); m/z (ES+): 234 ((M+H)+ 100%). 
Spectral characteristics were consistent with previously reported data.22 
4-N-((2-Iodobenzyl)amino)-6-methyl-2H-pyran-2-one (78)  
Based on a literature procedure,23 a solution of 
2-iodobenzylamine 77 (260 mg, 1.12 mmol, 2.5 equiv.) in dried 
EtOH (2 mL) was added to a Schlenk tube containing 4-bromo-
6-methyl-2H-pyran-2-one 6 (84 mg, 0.45 mmol, 1.0 equiv.) and 
set stirring. The Schlenk tube was placed in an oil bath which was heated to 85 °C. 
The reaction was stirred at this temperature for 20 h, then cooled to ambient 
temperature and concentrated under reduced pressure. The residue was purified by 
Chapter 5  Experimental 
207 
 
column chromatography (acetone:hexanes 40:60 → 50:50) to give 78 as a yellow 
solid (0.15 g, 85%); m.p. 186–189 °C; IR νmax (film) 3248 (N–H stretch), 1678 (C=O 
stretch), 1551 (N–H bend); 1H NMR (300 MHz, DMSO-d6) δ 7.90 (dd, J = 7.8, 1.1, 1H, 
C(11)H), 7.72 (t, J = 5.3, 1H, N–H), 7.42 (td, J = 7.4, 1.1, 1H, C(13)H), 7.30 (dd, J = 7.8, 
1.4, 1H, C(14)H), 7.08 (td, J = 7.6, 1.8, 1H, C(12)H), 5.88 (s, 1H, C(5)H), 4.63 (s, 1H, 
C(3)H), 4.24 (d, J = 5.3, 2H, C(8)H2), 2.09 (s, 3H, C(7)H3); 13C NMR (75 MHz, DMSO-d6) 
δ 163.8 (qC-4), 160.7 (qC-2), 158.2 (qC-6), 139.8 (C(11)H), 139.5 (qC-9), 130.0 
(C(13)H), 129.3 (C(12)H), 129.0 (C(14)H), 99.8 (qC-10), 99.1 (C(5)H), 79.5 (C(3)H), 51.1 
(C(8)H2), 19.9 (C(7)H3); m/z (ES+): 342 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C13H13NO2I 341.9991; Found 341.9993. 
6-Methyl-4-(p-toluenesulfonyloxy)-2H-pyran-2-one (80)24 
A solution of 4-hydroxy-6-methyl-2H-pyran-2-one 3 (2.0 g, 
15.86 mmol, 1.0 equiv.), p-tosyl chloride (3.6 g, 19.03 mmol, 
1.2 equiv.) and Et3N (2.7 mL, 19.03 mmol, 1.2 equiv.) in DCM 
(60 mL) was stirred at ambient temperature for 30 min. The 
reaction mixture was concentrated under reduced pressure 
to give a cream solid, which was recrystallised from 
DCM/hexanes to give 80 as a cream solid (3.726 g, 84%); m.p. 103–104 °C (lit.24 100–
102 °C); 1H NMR (300 MHz, CDCl3) δ 7.86 – 7.66 (m, 2H, C(10)H & C(12)H), 7.44 – 7.35 
(m, 2H, C(9)H & C(13)H), 6.03 – 5.97 (m, 1H, C(5)H), 5.83 – 5.78 (m, 1H, C(3)H), 2.48 
(s, 3H, C(14)H3), 2.24 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 164.3 (qC-4), 162.8 
(qC-2), 162.0 (qC-6), 146.7 (qC-8), 131.7 (qC-11), 130.3 (C(10)H & C(12)H), 128.4 
(C(9)H & C(13)H), 100.7 (C(5)H), 100.7 (C(3)H), 21.8 (C(14)H3), 20.2 (C(7)H3); m/z 
(ES+): 281 ((M+H)+ 80%). 
Spectral characteristics were consistent with previously reported data.24 
(2-Iodophenyl)methanethiol (81)25  
Modifying a procedure described for benzenethiol,26 a mixture of 
2-iodobenzyl bromide 2 (0.54 g, 1.82 mmol, 1.0 equiv.), thiourea 
(0.18 g, 2.36 mmol, 1.3 equiv.) and H2O (5 mL) were placed in a 
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Schlenk tube and heated to 100 °C with vigorous stirring until the thiourea dissolved. 
The resulting clear solution was refluxed for 2 h. A solution of NaOH (0.23 g, 
5.75 mmol, 3.0 equiv.) in H2O (2 mL) was then added to the mixture, turning it cloudy. 
This mixture was refluxed for a further 2 h, then cooled to ambient temperature. The 
reaction mixture was extracted with Et2O (3 × 20 mL). The combined organic layers 
were washed with 1 M aqueous HCl (1 × 20 mL) and H2O (1 × 20 mL), dried over 
MgSO4 and concentrated under reduced pressure to give 81 as a clear yellow oil 
(0.292 g, 64%); 1H NMR (300 MHz, CDCl3) δ 7.82 (d, J = 7.8, 1H, C(2)H), 7.41 – 7.27 
(m, 2H, C(3)H & C(5)H), 6.92 (td, J = 7.6, 1.8, 1H, C(4)H), 3.81 (d, J = 8.1, 2H, C(7)H2), 
2.00 (t, J = 8.1, 1H, S–H); 13C NMR (75 MHz, CDCl3) δ 143.7 (qC-6), 139.8 (C(2)H), 129.2 
(C(5)H), 128.9 (C(3)H), 128.8 (C(4)H), 99.3 (qC-1), 34.6 (C(7)H2); m/z (ES+): 217 ((M-
SH)+ 4%). 
Spectral characteristics were consistent with previously reported data.25 
4-((2-Iodobenzyl)thio)-6-methyl-2H-pyran-2-one (82) 
Based on a literature procedure,27 a Schlenk tube was heated 
under vacuum and refilled with N2 three times. 
2-Iodobenzylthiol 81 (257 mg, 1.03 mmol, 1.10 equiv.) and 
methanol (5 mL) were added through a syringe and the 
solution was stirred. Small pieces of sodium metal (without 
oil washed off) (22 mg, 0.953 mmol, 1.02 equiv.) were added to the stirring solution. 
Once the sodium had dissolved to give a clear yellow solution, 4-tosyloxy-6-methyl-
2H-pyran-2-one 80 (262 mg, 0.935 mmol, 1.00 equiv.) was added under a positive 
pressure of N2 to give a cloudy suspension. The flask was lowered into an oil bath and 
heated to 70 °C with stirring. The pyrone dissolved giving a clear yellow solution. The 
reaction mixture was stirred at 70 °C for 4 h. The mixture was cooled to ambient 
temperature and H2O (10 mL) was added. The mixture was extracted with DCM 
(3 × 10 mL). The combined organic layers were dried over MgSO4 and concentrated 
under reduced pressure. The crude product was purified by column chromatography 
(EtOAc:hexanes 30:70) to give 82 as a yellow solid (0.166 g, 50%); m.p. 111–115 °C; 
IR νmax (film) 1712 (ester C=O stretch), 1634 (alkene C=C stretch), 1528 (aromatic C–
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C stretch), 1309 (ester C–O stretch); 1H NMR (300 MHz, CDCl3) δ 7.87 (dd, J = 8.0, 0.9, 
1H, C(11)H), 7.44 (dd, J = 7.7, 1.5, 1H, C(14)H), 7.34 (td, J = 7.5, 0.9, 1H, C(12)H), 7.01 
(td, J = 7.7, 1.6, 1H, C(13)H), 5.88 (s, 1H, C(5)H), 5.86 (s, 1H, C(3)H), 4.22 (s, 2H, C(8)H2), 
2.20 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 161.3 (qC-2), 160.2 (qC-6), 158.6 
(qC-4), 140.1 (C(11)H), 136.6 (qC-9), 130.0 (C(14)H), 129.8 (C(12)H), 128.9 (C(13)H), 
103.2 (C(5)H), 103.1 (C(3)H), 100.5 (qC-10), 40.9 (C(8)H2), 19.8 (C(7)H3); m/z (ES+): 
359 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H12O2IS 358.9603; 
Found 358.9601. 
4-Methoxy-6-methyl-2H-pyran-2-one (90)28 
Following the literature procedure,28 trimethylphosphate (9.8 mL, 
83.2 mmol, 2.1 equiv.) was added to a 100 mL round-bottomed flask 
containing 4-hydroxy-6-methyl-2H-pyran-2-one 3 (5.0 g, 39.6 mmol, 
1.0 equiv.) and K2CO3 (6.6 g, 47.5 mmol, 1.2 equiv.). The flask was 
placed in an oil bath preheated to 140 °C and stirred at this temperature for 3 h. 
While the mixture was warm, it was transferred to a separating funnel with H2O (50 
mL). Extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The residue was recrystallised 
from EtOH to give 90 as a yellow solid (2.5263 g, 46%); m.p. 85–87 °C (lit.28 85–87 °C); 
1H NMR (300 MHz, CDCl3) δ 5.79 (dd, J = 2.1, 0.9, 1H, C(5)H), 5.41 (d, J = 2.2, 1H, 
C(3)H), 3.80 (s, 3H, C(8)H3), 2.21 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 171.3 
(qC-4), 165.0 (qC-2), 162.1 (qC-6), 100.4 (C(5)H), 87.3 (C(3)H), 55.8 (C(8)H3), 19.8 
(C(7)H3); m/z (ES+): 141 ((M+H)+ 98%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C7H9O3 
141.0552; Found 141.0553. 
Spectral characteristics were consistent with previously reported data.28 
4-Methoxy-2H-chromen-2-one (91)29 
Compound 91 was prepared via the procedure described for 
compound 90 using 4-hydroxy-2H-chromen-2-one 19 (5.0 g, 
30.837 mmol, 1.0 equiv.), except that the mixture was stirred at 
140 °C for 1 h. The residue was recrystallised from EtOH to yield 91 
as an off-white solid (4.6932 g, 86%); m.p. 116–118 °C (lit.29 122–124 °C); 1H NMR 
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(300 MHz, CDCl3) δ 7.81 (dd, J = 7.9, 1.5, 1H, ArCH), 7.55 (ddd, J = 8.6, 7.4, 1.6, 1H, 
ArCH), 7.36 – 7.22 (m, 2H, 2 × ArCH), 5.70 (s, 1H, C(3)H), 4.00 (s, 3H, C(11)H3); 13C 
NMR (75 MHz, CDCl3) δ 166.5 (qC-4), 162.9 (qC-2), 153.3 (qC-10), 132.4 (ArCH), 123.9 
(ArCH), 123.0 (ArCH), 116.8 (ArCH), 115.6 (qC-5), 90.1 (C(3)H), 56.4 (C(11)H3); m/z 
(ES+): 177 ([M+H]+ 100%). 
Spectral characteristics were consistent with previously reported data.29 
4-Methoxy-1,6-dimethylpyridin-2(1H)-one (92)30  
Compound 92 was prepared via the procedure described for 
compound 90 using 4-hydroxy-1,6-dimethylpyridin-2(1H)-one 13 
(5.0 g, 35.931 mmol, 1.0 equiv.), except that the mixture was stirred 
at 140 °C for 18 h. The residue was recrystallised from DCM/hexanes 
to yield 92 as a yellow solid (3.1936 g, 58%); m.p. (EtOH) 56–58 °C (lit.30 (C6H6) 115–
116 °C); 1H NMR (300 MHz, CDCl3) δ 5.83 (d, J = 2.8, 1H, C(5)H), 5.79 – 5.74 (m, 1H, 
C(3)H), 3.74 (s, 3H, (C(8)H3), 3.46 (s, 3H, C(9)H3), 2.30 (s, 3H, C(7)H3); 13C NMR (75 
MHz, CDCl3) δ 167.2 (qC-4), 165.4 (qC-2), 146.0 (qC-6), 100.7 (C(5)H), 94.5 (C(3)H), 
55.2 (C(8)H3), 30.5 (C(9)H3), 20.9 (C(7)H3); m/z (ES+): 154 ([M+H]+ 100%). 
Spectral characteristics were consistent with previously reported data.30  
1-Ethyl-4-methoxyquinolin-2(1H)-one (94)  
Compound 94 was prepared via the procedure described for 
compound 90 using 1-ethyl-4-hydroxyquinolin-2(1H)-one 93 (0.5 g, 
2.64 mmol, 1.0 equiv.), except that the mixture was stirred at 140 
°C for 2 h. The residue was recrystallised from EtOH to yield 94 as 
an orange solid (0.3534 g, 66%); m.p. 60–63 °C; IR νmax (film) 2981 
(aromatic C–H stretch), 1634 (amide C=O stretch), 1575 (aromatic C=C stretch), 1324 
(ether C–O stretch), 1122 (amide C–N stretch); 1H NMR (400 MHz, CDCl3) δ 7.98 (dd, 
J = 8.0, 1.5, 1H, C(6)H), 7.58 (ddd, J = 9.6, 7.2, 1.6, 1H, C(8)H), 7.36 (d, J = 8.6, 1H, 
C(9)H), 7.21 (td, J = 7.6, 0.7, 1H, C(7)H), 6.03 (s, 1H, C(3)H), 4.33 (q, J = 7.1, 2H, 
C(12)H2), 3.94 (s, 3H, C(11)H3), 1.34 (t, J = 7.1, 3H, C(13)H3); 13C NMR (100 MHz, CDCl3) 
δ 163.4 (qC-4), 162.6 (qC-2), 138.7 (qC-10), 131.2 (ArCH), 123.6 (ArCH), 121.4 (ArCH), 
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116.7 (qC-5), 113.9 (ArCH), 96.5 (C(3)H), 55.8 (C(11)H3), 36.8 (C(12)H2), 12.9 
(C(13)H3); m/z (ES+): 204 ([M+H]+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C12H14O2N 204.1025; Found 204.1023. 
6-Methyl-2-oxo-2H-pyran-4-yl methanesulfonate (95)  
A stirring suspension of 4-hydroxy-2H-pyran-2-one 3 (2.0 g, 15.86 
mmol, 1.0 equiv.) and K2CO3 (2.6 g, 19.03 mmol, 1.2 equiv.) in acetone 
(50 mL) was stirred at ambient temperature for 10 min. Mesyl 
chloride (1.5 mL, 19.03 mmol, 1.2 equiv.) was added, and the mixture 
was stirred at ambient temperature for 2 h. The reaction mixture was concentrated 
under reduced pressure to give a yellow solid, which was recrystallised from EtOH to 
give 95 as an off-white solid (2.6189 g, 81%); m.p. 84–85 °C; IR νmax (film) 1720 (ester 
C=O stretch)), 1646 (alkene C=C stretch), 1571 (aromatic C–C stretch), 1372 (ester C–
O stretch), 1319 (ether C–O stretch); 1H NMR (300 MHz, CDCl3) δ 6.08 (s, 2H, C(3)H & 
C(5)H), 3.28 (s, 3H, C(8)H3), 2.30 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 164.7 
(qC-4), 162.7 (qC-2), 161.4 (qC-6), 100.2 (C(5)H), 100.2 (C(3)H), 39.0 (C(8)H3), 20.2 
(C(7)H3); m/z (ES+): 205 ((M+H)+ 30%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C7H9O5S 
205.0171; Found 205.0168. 
4-Bromo-2H-chromen-2-one (96)31 
To a 250 mL round-bottomed flask were added 4-hydroxy-2H-
chromen-2-one 19 (3.0 g, 18.50 mmol, 1.0 equiv.), TBAB (6.9 g, 
21.46 mmol, 1.16 equiv.), P2O5 (6.3 g, 44.40 mmol, 2.4 equiv.) and 
toluene (75 mL). The flask was fitted with a condenser and placed 
in an oil bath preheated to 100 °C. The reaction mixture was stirred at this 
temperature for 1.5 h, then cooled to ambient temperature. The organic layer was 
separated from the viscous inorganic layer. The inorganic layer was washed with 
toluene (2 × 20 mL). The combined organic layers were washed with saturated 
aqueous NaHCO3 (60 mL) and brine (80 mL), dried over MgSO4 and concentrated 
under reduced pressure to yield 96 as a yellow solid (2.946 g, 71%); m.p. 87–90 °C 
(lit.31 88–89 °C); 1H NMR (300 MHz, CDCl3) δ 7.85 (dd, J = 7.9, 1.5, 1H, ArCH), 7.74 – 
7.49 (m, 1H, ArCH), 7.44 – 7.29 (m, 2H, 2 × ArCH), 6.87 (s, 1H, C(3)H); 13C NMR (75 
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MHz, CDCl3) δ 158.7 (qC-2), 152.5 (qC-10), 141.4 (qC-4), 133.2 (ArCH), 128.0 (ArCH), 
124.9 (ArCH), 119.6 (ArCH), 119.0 (qC-5), 117.0 (C(3)H); m/z (ES+): 225 (79Br (M+H)+ 
60%), 227 (81Br (M+H)+ 56%). 
Spectral characteristics were consistent with previously reported data.31 
4-Phenoxy-2H-chromen-2-one (97)31  
To a 100 mL round-bottomed flask were added 4-bromo-2H-
chromen-2-one 96 (1.5 g, 6.67 mmol, 1.0 equiv.), phenol (0.7 
g, 7.33 mmol, 1.1 equiv.), K2CO3 (1.7 g, 12.00 mmol, 1.8 equiv.) 
and acetone (35 mL). The flask was fitted with a condenser and 
placed in an oil bath preheated to 65 °C. The reaction mixture 
was stirred at this temperature overnight, then cooled to ambient temperature. The 
mixture was diluted with H2O (20 mL) and extracted with EtOAc (3 × 15 mL). The 
combined organic layers were washed with 10% (w/v) aqueous NaOH (3 × 10 mL), 
dried over MgSO4 and concentrated under reduced pressure to yield 97 as a light 
brown solid (1.3812 g, 87%); m.p. 130–133 °C (lit.31 131–132 °C); 1H NMR (300 MHz, 
CDCl3) δ 8.03 (dd, J = 7.9, 1.2, 1H, C(6)H), 7.61 (ddd, J = 8.6, 7.3, 1.6, 1H, C(8)H), 7.54 
– 7.42 (m, 2H, C(13)H & C(15)H), 7.41 – 7.29 (m, 3H, C(7)H, C(9)H & C(14)H), 7.22 – 
7.12 (m, 2H, C(12)H & C(16)H), 5.41 (s, 1H, C(3)H); 13C NMR (75 MHz, CDCl3) δ 166.4 
(qC-4), 162.6 (qC-2), 153.7 (qC-10), 152.5 (qC-11), 132.8 (C(8)H), 130.4 ((C(13)H) & 
(C(15)H)), 126.8 (C(14)H), 124.1 (C(7)H), 123.1 (C(6)H), 121.3 ((C(12)H) & (C(16)H)), 
116.9 (C(9)H), 115.4 (qC-5), 93.6 (C(3)H); m/z (ES+): 239 ((M+H)+ 96%). 
Spectral characteristics were consistent with previously reported data.31 
4-(Benzyloxy)-2H-chromen-2-one (98)  
Compound 98 was prepared via the procedure described for 
compound 4 using 4-hydroxy-2H-chromen-2-one 19 (0.5 g, 
3.08 mmol, 1.0 equiv.) and benzyl bromide (0.4 mL, 3.70 
mmol, 1.2 equiv.). The residue was purified by column 
chromatography (DCM) to give a 98 as white solid (0.151 g, 19%); m.p. 164–167 °C; 
IR νmax (film) 1728 (ester C=O stretch), 1627 (alkene C=C stretch), 1372 (ester C–O 
Chapter 5  Experimental 
213 
 
stretch), 1251 (ether C–O stretch), 935 (alkene C–H bend), 742 (C–I stretch); 1H NMR 
(300 MHz, CDCl3) δ 7.86 (dd, J = 8.0, 1.4, 1H, ArCH), 7.62 – 7.50 (m, 1H, ArCH), 7.49 – 
7.21 (m, 7H, 7 × ArCH), 5.78 (s, 1H, C(3)H), 5.20 (s, 2H, C(11)H2); 13C NMR (75 MHz, 
CDCl3) δ 165.3 (qC-4), 162.8 (qC-2), 153.4 (qC-10), 134.4 (qC-12), 132.5 (C(8)H), 128.9 
(C(14)H & C(16)H), 128.9 (C(15)H), 127.8 (C(13)H & C(17)H), 123.9 (C(7)H), 123.2 
(C(6)H), 116.8 (C(9)H), 115.7 (qC-5), 91.2 (C(3)H), 71.2 (C(11)H2); m/z (ES+): 253 
([M+H]+ 94%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H13O3 253.0865, found 
253.0857. 
4-((tert-Butyldiphenylsilyl)oxy)-2H-chromen-2-one (100)  
A Schlenk tube was heated under vacuum and refilled with 
N2 three times, then allowed to cool to ambient 
temperature. Freshly distilled DCM (9 mL) and 
tert-butylchlorodiphenylsilane (TBDPSCl) (1.0 mL, 
3.70 mmol, 1.2 equiv.) were added to the Schlenk tube, and 
the stirring solution was cooled to 0 °C using an ice-water 
bath. Et3N (0.5 mL, 3.70 mmol, 1.2 equiv.), 4-hydroxy-2H-chromen-2-one 19 (0.5 g, 
3.08 mmol, 1.0 equiv.), then DMAP (38 mg, 0.31 mmol, 0.1 equiv.) were added to the 
stirring solution. The Schlenk was removed from the ice-water bath and the solution 
was stirred at ambient temperature overnight (20 h). The solution was diluted with 
DCM (10 mL) and washed with brine (15 mL). The organic layer was dried, filtered 
and concentrated under reduced pressure. The resulting crude product was purified 
by column chromatography (EtOAc:hexanes 10:90), and then recrystallised from 
EtOH to give a 100 as white solid (0.6697 g, 54%); m.p. 150–152 °C; IR νmax (film) 1726 
(ester C=O stretch), 1619 (alkene C=C stretch), 1387 (ester C–O stretch), 1238 (ether 
C–O stretch), 884 (alkene C–H bend); 1H NMR (300 MHz, CDCl3) δ 8.05 (dd, J = 7.9, 
1.6, 1H, ArCH), 7.77 – 7.67 (m, 4H, 4 × ArCH), 7.58 (ddd, J = 8.3, 7.4, 1.6, 1H, ArCH), 
7.53 – 7.28 (m, 8H, 8 × ArCH), 5.29 (s, 1H, C(3)H), 1.18 (s, 9H, C(24)H3, C(25)H3 & 
C(26)H3); 13C NMR (75 MHz, CDCl3) δ 163.4 (qC-4), 162.7 (qC-2), 153.9 (qC-10), 135.2 
(4 × ArCH), 132.4 (ArCH), 130.9 (2 × ArCH), 129.9 (qC-11 & qC-17), 128.4 (4 × ArCH), 
124.0 (ArCH), 123.3 (ArCH), 117.7 (qC-5), 116.9 (ArCH), 98.7 (C(3)H), 26.4 (C(24)H3, 
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C(25)H3 & C(26)H3), 19.7 (qC-23); m/z (ES+): 401 ([M+H]+ 100%); HRMS (ESI-TOF) m/z: 
[M+H]+ Calcd for C25H25O3Si 401.1573, found 401.1555. 
3-Chloro-4-methoxy-1,6-dimethylpyridin-2(1H)-one (101) 
Compound 101 was prepared via the procedure described for 
compound 47 using 4-methoxy-1,6-dimethylpyridin-2(1H)-one 92 
(1.2 g, 7.83 mmol, 1.0 equiv.), except that the mixture was stirred at 
55 °C for 19 h. The residue was subjected to column chromatography 
(DCM) and further purified by recrystallisation from EtOH to yield 101 
as a white solid (0.4452 g, 30%); m.p. 180–182 °C; IR νmax (film) 1647 (C=O stretch), 
1589 (alkene C=C stretch), 1535 (aromatic C–C stretch), 1083 (C–N stretch), 751 (C–
Cl stretch); 1H NMR (300 MHz, CDCl3) δ 5.97 (s, 1H, C(5)H), 3.92 (s, 3H, C(8)H3), 3.54 
(s, 3H, C(9)H3), 2.38 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 161.7 (qC-4), 160.7 
(qC-2), 145.3 (qC-6), 105.2 (qC-3), 94.7 (C(5)H), 56.4 (C(8)H3), 31.9 (C(9)H3), 21.4 
(C(7)H3); m/z (ES+): 188 (35Cl (M+H)+ 78%), 190 (37Cl (M+H)+ 26%); HRMS (ESI-TOF) 
m/z: [M+H]+ Calcd for C8H11NO2Cl 188.0478; Found 188.0480. 
3-Chloro-1-ethyl-4-methoxyquinolin-2(1H)-one (103)  
Compound 103 was prepared via the procedure described for 
compound 47 using 1-ethyl-4-methoxyquinolin-2(1H)-one 94 
(1.3 g, 6.40 mmol, 1.0 equiv.), except that the mixture was stirred 
at 55 °C for 19 h. The residue was purified by column 
chromatography (EtOAc:hexanes 50:50) to yield 103 as a yellow 
solid (1.033 g, 68%); m.p. 73–76 °C; IR νmax (film) 1652 (C=O stretch), 1615 (alkene 
C=C stretch), 1598 (aromatic C–C stretch), 1113 (C–N stretch), 755 (C–Cl stretch); 1H 
NMR (300 MHz, CDCl3) δ 7.92 (dd, J = 8.0, 1.4, 1H, C(6)H), 7.60 (ddd, J = 8.7, 7.2, 1.6, 
1H, C(8)H), 7.40 (d, J = 8.5, 1H, C(9)H), 7.33 – 7.22 (m, 1H, C(7)H), 4.40 (q, J = 7.1, 2H, 
C(12)H2), 4.12 (s, 3H, C(11)H3), 1.37 (t, J = 7.1, 3H, C(13)H3); 13C NMR (100 MHz, CDCl3) 
δ 159.7 (qC-4), 159.4 (qC-2), 137.1 (qC-10), 131.3 (C(8)H), 123.8 (C(7)H), 122.4 
(C(6)H), 117.8 (qC-5), 115.0 (qC-3), 114.2 (C(9)H), 61.1 (C(11)H3), 38.6 (C(12)H2), 12.7 
(C(13)H3); m/z (ES+): 238 (35Cl (M+H)+ 14%), 240(37Cl (M+H)+ 6%); HRMS (ESI-TOF) 
m/z: [M+H]+ Calcd for C12H13O2NCl 238.0635; Found 238.0632. 
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3-Chloro-4-methoxy-2H-chromen-2-one (104)32  
Compound 104 was prepared using the procedure described for 
compound 107 using 4-methoxy-2H-chromen-2-one 91 (2.0 g, 
11.35 mmol, 1.0 equiv.), except that the mixture was stirred at 85 
°C for 1 h. The residues were recrystallised from EtOH to yield 104 
as a cream solid (1.377 g, 58%); m.p. 84–85 °C (lit.33 87.9–88.6 °C); 1H NMR (300 MHz, 
CDCl3) δ 7.85 – 7.75 (m, 1H, C(6)H), 7.63 – 7.51 (m, 1H, C(8)H), 7.38 – 7.28 (m, 2H, 
C(7)H & C(9)H), 4.34 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 162.1 (qC-4), 159.6 
(qC-2), 151.2 (qC-10), 132.4 (ArCH), 124.6 (ArCH), 123.4 (ArCH), 117.2 (qC-5), 116.7 
(ArCH), 106.0 (qC-3), 61.6 (C(11)H3); m/z (ES+): 211 (35Cl (M+H)+ 100%), 213 (37Cl 
(M+H)+ 32%). 
Spectral characteristics were consistent with previously reported data.32 
3-Chloro-4-phenoxy-2H-chromen-2-one (105)31 
Compound 105 was prepared using the procedure described 
for compound 107 using 4-phenoxy-2H-chromen-2-one 97 
(1.0 g, 4.20 mmol, 1.0 equiv.), except that the mixture was 
stirred at 85 °C for 1 h. The residues were triturated in EtOH to 
yield 105 as a pale orange solid (0.727 g, 64%); m.p. 70–75 °C 
(lit.31 74–75 °C); 1H NMR (300 MHz, CDCl3) δ 7.71 – 7.53 (m, 2H, 2 × ArCH), 7.47 – 7.24 
(m, 4H, 4 × ArCH), 7.14 (t, J = 7.4, 1H, ArCH), 7.05 – 6.94 (m, 2H, 2 × ArCH); 13C NMR 
(75 MHz, CDCl3) δ 158.8 (qC-4), 158.4 (qC-2), 155.6 (qC-10), 151.7 (qC-11), 132.8 
(ArCH), 130.1 (2 × ArCH), 125.0 (ArCH), 124.1 (ArCH), 123.8 (ArCH), 117.0 (ArCH), 
116.7 (qC-5), 116.1 (2 × ArCH), 112.0 (qC-3); m/z (ES+): 273 (35Cl (M+H)+ 58%), 275 
(37Cl (M+H)+ 18%). 
Spectral characteristics were consistent with previously reported data.31 
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4-(Benzyloxy)-3-chloro-2H-chromen-2-one (106)34  
Compound 106 was prepared using the procedure described for 
compound 107 using 4-benzyloxy-2H-chromen-2-one 98 (0.19 g, 
0.737 mmol, 1.0 equiv.), except that the mixture was stirred at 85 
°C for 1 h. The residues were purified by column chromatography 
(DCM) to yield 106 as a white solid (0.142 g, 67%); m.p. 88–90 °C 
(lit.34 68 °C); 1H NMR (300 MHz, CDCl3) δ 7.75 – 7.66 (m, 1H, ArCH), 
7.54 (ddd, J = 8.4, 7.3, 1.6, 1H, ArCH), 7.50 – 7.35 (m, 5H, 5 × ArCH), 7.35 – 7.22 (m, 
2H, 2 × ArCH), 5.55 (s, 2H, C(11)H2); 13C NMR (75 MHz, CDCl3) δ 161.6 (qC-4), 159.4 
(qC-2), 151.3 (qC-10), 135.2 (qC-12), 132.5 (C(8)H), 129.1 (C(15)H), 128.9 (C(14)H & 
C(16)H), 128.4 (C(13)H & C(17)H), 124.7 (C(7)H), 123.7 (C(6)H), 117.6 (qC-5), 116.6 
(C(9)H), 107.3 (qC-3), 75.9 (C(11)H2); m/z (ES+): 287 (35Cl (M+H)+ 100%), 289 (37Cl 
(M+H)+ 34%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H12O3Cl 287.0475; Found 
287.0465. 
Spectral characteristics were consistent with previously reported data.34 
3-Chloro-4-methoxy-6-methyl-2H-pyran-2-one (107)  
To a 100 mL round-bottomed flask were added 4-methoxy-6-methyl-
2H-pyran-2-one 90 (2.17 g, 15.48 mmol, 1.0 equiv.) and 
trichloroisocyanuric acid (TCCA) (1.80 g, 7.74 mmol, 0.5 equiv.). EtOAc 
(50 mL) was slowly added to the mixture. The flask was placed in an oil 
bath, which was then heated to 85 °C. The mixture was stirred at this temperature 
for 4 h, then cooled to ambient temperature. The reaction mixture was filtered 
through fluted filter paper to remove the insoluble material, and the filtrate was 
concentrated under reduced pressure. The residues were recrystallised from EtOH 
to yield 107 as a yellow solid (1.5342 g, 57%); m.p. 140–142 °C (lit.35 147–148 °C); IR 
νmax (film) 1704 (ester C=O stretch), 1537 (alkene C=C stretch), 1322 (ester C–O 
stretch), 1233 (ether C–O stretch), 737 (C–Cl stretch); 1H NMR (300 MHz, CDCl3) δ 
6.14 (d, J = 0.6, 1H, C(5)H), 4.00 (s, 3H, C(8)H3), 2.31 (d, J = 0.7, 3H, C(7)H3); 13C NMR 
(75 MHz, CDCl3) δ 165.2 (qC-4), 161.9 (qC-2), 160.9 (qC-6), 99.3 (qC-3), 95.2 (C(5)H), 
57.3 (C(8)H3), 20.3 (C(7)H3); m/z (ES+): 175 (35Cl (M+H)+ 100%), 177 (37Cl (M+H)+ 40%); 
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HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C7H8ClO3 175.0162; Found 175.0154; Anal. 
Calc. for C7H7ClO3: C, 48.16; H, 4.04; Found: C, 48.27; H, 4.08. 
3-Chloro-6-methyl-2-oxo-2H-pyran-4-yl methanesulfonate (108)  
Compound 108 was prepared using the procedure described for 
compound 107 using 6-methyl-2-oxo-2H-pyran-4-yl 
methanesulfonate 95 (2.0 g, 9.79 mmol, 1.0 equiv.), except that the 
mixture was stirred at 85 °C for 24 h. The filtrate was concentrated 
under reduced pressure to give a viscous yellow oil, which was crystallised from EtOH 
to give 108 as an off-white solid (0.7359 g, 31%); m.p. 107–110 °C; IR νmax (film) 1738 
(ester C=O stretch), 1642 (alkene C=C stretch), 1556 (aromatic C–C stretch), 1376 
(ester C–O stretch), 1189 (ether C–O stretch), 790 (C–Cl stretch); 1H NMR (400 MHz, 
CDCl3) δ 6.37 (d, J = 0.7, 1H, C(5)H), 3.37 (d, J = 0.5, 1H, C(8)H3), 2.32 (d, J = 0.6, 1H, 
C(7)H3); 13C NMR (100 MHz, CDCl3) δ 161.4 (qC-4), 159.7 (qC-6), 156.2 (qC-2), 109.6 
(qC-3), 101.7 (C(5)H), 40.1 (C(8)H3), 20.0 (C(7)H3); m/z (ES+): 239 (35Cl (M+H)+ 50%), 
241 (37Cl (M+H)+ 26%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C7H8O5SCl 238.9781; 
Found 238.9787. 
3-Chloro-4-phenoxy-6-methyl-2H-pyran-2-one (109)  
Compound 109 was prepared using the procedure described for 
compound 107 using 4-phenoxy-6-methyl-2H-pyran-2-one (161 
mg, 0.80 mmol, 1.0 equiv.), except that the mixture was stirred at 
85 °C for 6 h. The residue was purified by column chromatography 
(EtOAc:hexanes 25:75) to yield 109 as a pale yellow solid (0.078 g, 
27%); m.p. 100–103 °C (lit.31 96–97 °C); 1H NMR (300 MHz, CDCl3) δ 7.52 – 7.41 (m, 
2H, C(10)H & C(12)H), 7.40 – 7.26 (m, 1H, C(11)H), 7.16 – 7.04 (m, 2H, C(9)H & 
C(13)H), 5.68 (s, 1H, C(5)H), 2.19 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 163.6 
(qC-4), 161.4 (qC-2), 160.9 (qC-8), 152.8 (qC-6), 130.4 (C(10)H & C(12)H), 126.5 
(C(11)H), 120.8 (C(9)H & C(13)H), 101.7 (qC-3), 97.6 (C(5)H), 20.1 (C(7)H3); HRMS (ESI-
TOF) m/z: [M+H]+ Calcd for C12H10ClO3 237.0318; Found 237.0312.  
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3-Chloro-6-methyl-2-oxo-2H-pyran-4-yl 4-methylbenzenesulfonate (110) 
Compound 110 was prepared using the procedure described 
for compound 107 using 6-methyl-2-oxo-2H-pyran-4-yl 4-
methylbenzenesulfonate 80 (1.5 g, 5.35 mmol, 1.0 equiv.), 
except that the mixture was stirred at 85 °C for 24 h. The 
residues were recrystallised from EtOH to yield 110 as a pale 
yellow solid (0.6730 g, 40%); m.p. 144–147 °C; IR νmax (film) 1741 (ester C=O stretch), 
1547 (alkene C=C stretch), 1386 (ester C–O stretch), 1195 (ether C–O stretch), 666 
(C–Cl stretch); 1H NMR (300 MHz, CDCl3) δ 7.86 (d, J = 8.4, 2H, C(9)H & C(13)H), 7.39 
(d, J = 8.1, 2H, C(10)H & C(12)H), 6.43 (d, J = 0.8, 1H, C(5)H), 2.48 (s, 3H, C(14)H3), 2.30 
(d, J = 0.7, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 161.0 (qC-4), 159.8 (qC-2), 156.5 
(qC-6), 147.0 (qC-8), 131.9 (qC-11), 130.3 (C(10)H & C(12)H), 128.5 (C(9)H & C(13)H), 
110.0 (qC-3), 101.6 (C(5)H), 21.9 (C(14)H3), 19.9 (C(7)H3); m/z (ES+): 315 (35Cl (M+H)+ 
100%), 317 (37Cl (M+H)+ 40%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H12ClSO5 
315.0094; Found 315.0086. 
4-((tert-Butyldiphenylsilyl)oxy)-3-chloro-2H-chromen-2-one (141)  
Compound 141 was prepared using the procedure described 
for compound 107 using 4-((tert-butyldiphenylsilyl)oxy)-2H-
chromen-2-one 100 (200 mg, 0.50 mmol, 1.0 equiv.), except 
that the mixture was stirred at 85 °C for 2 h. The residues 
were purified by column chromatography (DCM) to yield 141 
as a colourless oil (0.027 g, 12%); IR νmax (film) 1709 (C=O 
stretch), 1606 (alkene C=C stretch), 1555 (aromatic C–C stretch), 1365 (C–O stretch), 
700 (C–Cl stretch); 1H NMR (300 MHz, CDCl3) δ 7.85 – 7.69 (m, 5H, 5 × ArCH), 7.56 – 
7.30 (m, 8H, 8 × ArCH), 7.18 (ddd, J = 8.3, 7.3, 1.1, 1H, ArCH), 1.18 (s, 9H, C(24)H, 
C(25)H & C(26)H); 13C NMR (75 MHz, CDCl3) δ 159.5 (qC-4), 158.6 (qC-2), 151.3 (qC-
10), 134.8 (4 × ArCH), 132.1 (ArCH), 131.8 (2 × qC-Ar), 130.5 (2 × ArCH), 128.0 (4 × 
ArCH), 124.2 (ArCH), 124.0 (ArCH), 117.7 (qC-5), 116.9 (ArCH), 106.4 (qC-3), 26.6 
(C(24)H, C(25)H & C(26)H), 20.5 (qC-23); m/z (ES+): 435 (35Cl (M+H)+ 100%), 437 (37Cl 
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(M+H)+ 58%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C25H24O3SiCl 435.1183; Found 
435.1190. 
4-Hydroxy-3-phenyl-2H-chromen-2-one (143)36  
To an oven-dried reaction tube were added NaI (120 mg, 
0.792 mmol, 4.0 equiv.) and CH3CN (1 mL, stored over 4 Å 
molecular sieves before use), and the mixture was stirred at 
ambient temperature. To the stirring mixture was added 
TMSCl (0.05 mL, 0.396 mmol, 2.0 equiv.). The mixture was stirred at ambient 
temperature for 1 h. 4-Methoxy-3-phenyl-2H-chromen-2-one 111 (50 mg, 
0.198 mmol, 1.0 equiv.) was added to the stirring mixture. The mixture was stirred at 
25 °C overnight with the reaction tube open to the air, then poured into a beaker 
containing cold 1 M aqueous HCl (15 mL). The mixture was extracted with EtOAc 
(3 × 15 mL). The combined organic layers were washed with 5% aqueous sodium 
thiosulfate (25 mL), dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography (EtOAc:hexanes 20:80 → 50:50) to 
yield 143 as a pale pink solid (0.024 g, 51%); m.p. 232–233 °C (lit.37 232–233 °C); 1H 
NMR (300 MHz, DMSO-d6) δ 8.02 (dd, J = 7.9, 1.2, 1H, C(6)H), 7.72 – 7.61 (m, 1H, 
C(8)H), 7.49 – 7.31 (m, 7H, 7 × ArCH); 13C NMR (75 MHz, DMSO-d6) δ 162.4 (qC-4), 
160.7 (qC-2), 152.8 (qC-10), 132.8 (C(14)H), 132.5 (qC-11), 131.5 (C(12)H & C(16)H), 
128.5 (C(13)H & C(15)H), 127.9 (C(8)H), 124.4 C(7)H, 124.2 (C(6)H), 116.9 (qC-5), 
116.7 (C(9)H), 106.6 (qC-3); m/z (ES−): 237 ((M−H)− 100%). 
Spectral characteristics were consistent with previously reported data.36 
4-((2-Iodobenzyl)oxy)-2H-chromen-2-one-3-d (148) 
4-Hydroxy-2H-chromen-2-one 19 (200 mg, 1.233 mmol, 1.0 
equiv.), D2O (0.5 mL) and acetone-d6 (1 mL) were added to a 
2-5 mL Smith MW vial and the reaction mixture was irradiated 
(300 W) with stirring for 1.5 h at 140 °C. The reaction mixture 
was allowed cool to room temperature. 2-Iodobenzyl bromide 2 
(440 mg, 1.480 mmol, 1.2 equiv.) and K2CO3 (511 mg, 3.70 mmol, 
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3.0 equiv.) were added. The reaction mixture was irradiated (300 W) with stirring for 
30 min at 100 °C. The reaction mixture was allowed cool to room temperature. DCM 
(5 mL) and D2O (5 mL) were added. The layers were separated and the aqueous layer 
was washed with DCM (2 × 5 mL). The organic layer was dried over MgSO4 and 
concentrated under reduced pressure. The resiude was purified by column 
chromatography (DCM) to give 148 as a white solid (203 mg, 43%, 98% D); m.p. 159–
161 °C; IR νmax (film) 1708 (ester C=O stretch), 1605 (alkene C=C stretch), 1557 
(aromatic C–C stretch), 1348 (ester C–O stretch), 1158 (ether C–O stretch), 965 
(alkene C–D bend), 761 (C–I stretch); 1H NMR (300 MHz, CDCl3) δ 7.97 – 7.86 (m, 2H, 
C(14)H & C(16)H), 7.63 – 7.53 (m, 1H, C(17)H), 7.53 – 7.39 (m, 2H, C(6)H & C(8)H), 
7.38 – 7.28 (m, 2H, C(7)H & C(9)H), 7.12 (td, J = 7.6, 1.8, 1H, C(15)H), 5.81 (s, 0.02H, 
C(3)H), 5.20 (s, 2H, C(11)H2); 13C NMR (125 MHz, CDCl3) δ 165.0 (qC-4), 162.8 (qC-2), 
153.4 (qC-10), 139.8 (C(14)H), 136.7 (qC-12), 132.6 (C(15)H), 130.5 (C(17)H), 129.1 
(C(8)H), 128.6 (C(16)H), 124.0 (C(7)H), 123.2 (C(6)H), 116.9 (C(9)H), 115.6 (qC-5), 97.9 
(qC-13), 91.5 (t, J = 26, qC-3), 74.8 (C(11)H2); m/z (ES+): 380 ((M+H)+ 98%); HRMS (ESI-
TOF) m/z: [M+H]+ Calcd for C16H11DO3I 379.9894; Found 379.9909. 
2-Deuteriophenol (150)38 
A 2-neck, 100 mL round-bottomed flask was heated under vacuum and 
refilled with N2 three times. Freshly distilled THF (35 mL) was added, 
followed by 2-bromophenol (2.0 mL, 17.3 mmol, 1 equiv.). The solution 
was cooled to 0 °C with stirring. nBuLi (13.9 mL, 2.5 M in hexanes) was added steadily 
over 15 min. The reaction mixture was stirred at 0°C for 3 hours and quenched with 
D2O (4.0 mL, 221 mmol, 12.8 equiv.) over 10 min. The reaction was maintained at 
0 °C for a further 5 min, then stirred at ambient temperature for 1 h. The reaction 
mixture was then concentrated under reduced pressure. The residue was dissolved 
in Et2O (50 mL) and then washed with saturated aqueous NH4Cl (2 × 25 mL). The 
organic layer was dried over MgSO4 and concentrated under reduced pressure. The 
crude residue was purified by column chromatography (EtOAc:hexanes 5:95) to yield 
150 as a pale yellow oil (1.025 g, 62%, 80% D); 1H NMR (300 MHz, CDCl3) δ 7.31 – 7.16 
(m, 2H, C(3)H & C(5)H), 6.93 (td, J = 7.4, 1.0, 1H, C(4)H), 6.87 – 6.78 (m, 1.2H, C(2)H 
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& C(6)H); 13C NMR (75 MHz, CDCl3) δ 155.4 (qC-1), 129.7 (C(3)H & C(5)H), 120.8 
(C(4)H), 115.4 (qC-2 & C(6)H); m/z (ES-): 95 ((M-H)- 8%). 
Spectral characteristics were consistent with previously reported data.39 
4-(2-Deuteriophenoxy)-6-methyl-2H-pyran-2-one (151)  
Compound 151 was prepared via the procedure described for 
compound 97 using 4-bromo-6-methyl-2H-pyran-2-one 6 (1.48 g, 
7.80 mmol, 1.0 equiv.) and 2-deuteriophenol 150 (0.9 g, 9.36 
mmol, 1.2 equiv.) to yield 151 as a dark orange solid (1.403 g, 
88%, 80% D) which did not require further purification; m.p. 76–
81 °C; 1H NMR (300 MHz, CDCl3) 7.49 – 7.38 (m, 2H, C(10)H & C(12)H), 7.34 – 7.25 (m, 
1H, C(11)H), 7.11 – 7.03 (m, 1.2H, C(9)H & C(13)H), 6.00 – 5.95 (m, 1H, C(5)H), 5.20 
(d, J = 2.1, 1H, C(3)H), 2.26 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 170.8 (qC-4), 
164.7 (qC-2), 163.3 (qC-6), 152.3 (qC-8), 130.2 (C(10)H & C(12)H), 126.6 (C(11)H), 
121.1 (qC-9 & C(13)H), 100.0 (C(5)H), 91.0 (C(3)H), 20.1 (C(7)H3); m/z (ES+): 204 
((M+H)+ 32%). 
3-Bromo-4-(2-deuteriophenoxy)-6-methyl-2H-pyran-2-one (152)  
To a stirring solution of 4-(2-deuteriophenoxy)-6-methyl-2H-
pyran-2-one 151 (0.6 g, 2.95 mmol, 1.0 equiv.) in DCM (10 mL) 
was added Br2 (0.2 mL, 3.25 mmol, 1.1 equiv.). The round-
bottomed flask was wrapped in aluminium foil to exclude light. 
The reaction was stirred at ambient temperature for 3 h, then 
concentrated under reduced pressure. The crude residue was recrystallised from 
EtOH to yield 152 as a pale yellow solid (0.5209 g, 74%, 80% D); m.p. 118–120 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.58 – 7.39 (m, 2H, C(10)H & C(12)H), 7.39 – 7.28 (m, 1H, 
C(11)H), 7.10 (dd, J = 8.5, 1.0, 1.2H, C(9)H & C(13)H), 5.62 (d, J = 0.8, 1H, C(5)H), 2.16 
(d, J = 0.8, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 165.6 (qC-4), 162.3 (qC-2), 160.9 
(qC-6), 152.8 (qC-8), 130.3 (C(10)H & C(12)H), 126.6 (C(11)H), 120.6 (qC-9 & C(13)H), 
97.6 (C(5)H), 90.9 (qC-3), 20.1 (C(7)H3); m/z (ES+): 282  (79Br (M+H)+ 68%), 284 (81Br 
(M+H)+ 67%). 
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3-Iodo-4-phenoxy-2H-chromen-2-one (155)40  
A solution of Na2CO3 (1.1 g, 10.0 mmol, 1.0 equiv.) in H2O (100 
mL) was prepared in a 250 mL round-bottomed flask. 
Phenyliodo(III)diacetate (PIDA) (3.2 g, 10.0 mmol, 1.0 equiv.) 
was added and the mixture was stirred at ambient 
temperature for 30 min. In a 500 mL round-bottomed flask, 4-
hydroxy-2H-chromen-2-one 19 (1.6 g, 10.0 mmol, 1.0 equiv.) and Na2CO3 (1.1 g, 10.0 
mmol, 1.0 equiv.) in H2O (100 mL) were stirred to give a solution. The PIDA mixture 
was added to the coumarin solution. The reaction mixture was stirred at ambient 
temperature for 2 h. The solid was isolated by suction filtration, washed with H2O 
and triturated in MeOH to give 2-oxo-3-(phenyliodonio)-2H-chromen-4-olate41 as an 
off-white solid (2.1012 g, 58%). 
m.p. 147–152 °C (lit.41 136 °C); 1H NMR (300 MHz, DMSO-
d6) δ 7.95 – 7.82 (m, 3H, 3 × ArCH), 7.62 – 7.48 (m, 2H, 2 
× ArCH), 7.47 – 7.36 (m, 2H, 2 × ArCH), 7.33 – 7.19 (m, 2H, 
2 × ArCH); 13C NMR (75 MHz, DMSO-d6) δ 172.6 (qC-Ar), 
161.0 (qC-Ar), 153.9 (qC-Ar), 133.1 (2 × ArCH), 132.9 (ArCH), 131.1 (2 × ArCH), 130.7 
(ArCH), 125.7 (ArCH), 123.5 (ArCH), 119.9 (qC), 116.3 (ArCH), 115.0 (qC), 82.0 (qC-3); 
m/z (ES+) 365 ((M+H)+ 18%); Anal. Calc. for C15H9IO3: C, 49.48; H, 2.49; Found: C, 
49.06; H, 2.45. 
A solution of 2-oxo-3-(phenyliodonio)-2H-chromen-4-olate (1.9 g, 5.22 mmol, 1.0 
equiv.) in anhydrous DMF (20 mL) was prepared in a 50 mL round-bottomed flask. A 
condenser was fitted to the flask and the flask was placed in a sand bath preheated 
to 165 °C. The mixture was stirred at this temperature for 15 min, during which time 
the mixture changed from yellow to orange. The flask was cooled to ambient 
temperature. The mixture was concentrated under reduced pressure and the residue 
was transferred to a conical flask. H2O (40 mL) was added and a yellow precipitate 
formed. The precipitate was isolated by suction filtration and recrystallised from 
MeOH to give 155 as a yellow crystalline solid (1.2621 g, 66%); m.p. 134–136 °C (lit.41 
138–139 °C); 1H NMR (300 MHz, CDCl3) δ 7.66 – 7.50 (m, 2H, 2 × ArCH), 7.43 (dd, J = 
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8.3, 0.6, 1H, ArCH), 7.39 – 7.30 (m, 2H, 2 × ArCH), 7.25 – 7.08 (m, 2H, 2 × ArCH), 7.02 
– 6.88 (m, 2H, 2 × ArCH); 13C NMR (75 MHz, CDCl3) δ 165.0 (qC-4), 159.6 (qC-2), 155.5 
(qC-11), 153.4 (qC-10), 133.1 (C(8)H), 130.2 (C(13)H & C(15)H), 124.7 (C(7)H), 123.9 
(C(6)H), 123.8 (C(14)H), 116.9 (C(9)H), 116.3 (qC-5), 116.0 (C(12)H & C(16)H), 80.5 
(qC-3); m/z (ES+) 365 ((M+H)+ 100%); Anal. Calc. for C15H9IO3: C, 49.48; H, 2.49; 
Found: C, 49.44; H, 2.52. 
Spectral characteristics were consistent with previously reported data.40 
3-Deuterio-4-phenoxy-2H-chromen-2-one (156) 
A Schlenk tube was heated under vacuum and refilled with N2 
three times. 3-Iodo-4-phenoxy-2H-chromen-2-one 155 (1.20 
g, 3.30 mmol, 1.0 equiv.) and zinc dust (1.1 g, 20.60 mmol, 6.2 
equiv.) were added to the Schlenk tube. The Schlenk tube was 
evacuated and refilled with N2 three times. 
Monodeuterioacetic acid (AcOD) (10 mL) was added and the mixture was stirred at 
ambient temperature for 17 h. A saturated solution of K2CO3 in D2O (2 mL) was slowly 
added, evolving gas and forming a precipitate. The mixture was stirred at ambient 
temperature for 30 min. The mixture was diluted with DCM (25 mL), dissolving the 
precipitate, and the zinc metal was removed by gravity filtration. The layers in the 
filtrate were separated and the aqueous layer was washed with DCM (2 × 15 mL). 
The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. The crude yellow residue was purified by column chromatography 
(DCM) to yield 156 as a pale yellow solid (0.680 g, 86%, 97% D); m.p. 134–135 °C; IR 
νmax (film); 1726 (ester C=O stretch), 1619 (alkene C=C stretch), 1368 (ester C–O 
stretch), 1190 (ether C–O stretch), 752 (alkene C-H bend); 1H NMR (300 MHz, CDCl3) 
δ 8.03 (dd, J = 8.3, 1.5, 1H, C(9)H), 7.67 – 7.56 (m, 1H, C(7)H), 7.54 – 7.42 (m, 2H, 
C(13)H & C(15)H), 7.42 – 7.29 (m, 3H, C(6)H, C(8)H & C(14)H), 7.18 (dd, J = 7.5, 1.1, 
2H, C(12)H & C(16)H), 5.41 (s, 0.03H, C(3)H); 13C NMR (75 MHz, CDCl3) δ 166.3 (qC-
4), 162.5 (qC-2), 153.7 (qC-11), 152.5 (qC-10), 132.8 (C(7)H), 130.4 (C(13)H & C(15)H), 
126.8 (C(8)H), 124.1 (C(14)H), 123.1 (C(9)H), 121.3 (C(12)H & C(16)H), 116.8 (C(6)H), 
115.4 (qC-5), 93.3 (t, J = 25, qC-3); m/z (ES+): 240 ((M+H)+ 74%); HRMS (ESI-TOF) m/z: 
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[M+H]+ Calcd for C15H10DO3 240.0771; Found 240.0771; Anal. Calcd. for C15H9DO3: C, 
75.30; H, 4.63; Found: C, 75.10; H, 4.37. 
4-(Phenoxy-d5)-2H-chromen-2-one (157)  
Compound 157 was prepared via the procedure described 
for compound 97 using 4-bromo-2H-chromen-2-one 96 (1.0 
g, 4.44 mmol, 1.0 equiv.) and phenol-d6 (0.5 g, 4.89 mmol, 1.1 
equiv.) to yield 157 as a light brown solid (0.9282 g, 86%) 
which did not require further purification; m.p. 131–133 °C; 
IR νmax (film) 1725 (ester C=O stretch), 1625 (alkene C=C 
stretch), 1568 (aromatic C–C stretch), 1371 (ester C–O stretch), 1224 (ether C–O 
stretch), 790 (alkene C–H bend); 1H NMR (300 MHz, CDCl3) δ 8.04 (dd, J = 7.9, 1.2, 1H, 
C(9)H), 7.62 (ddd, J = 8.6, 7.3, 1.6, 1H, C(7)H), 7.42 – 7.29 (m, 2H, C(6)H & C(8)H), 5.42 
(s, 1H, C(3)H); 13C NMR (75 MHz, CDCl3) δ 166.4 (qC-4), 162.6 (qC-2), 153.7 (qC-11), 
152.4 (qC-10), 132.8 (C(7)H), 129.9 (t, J = 25, qC-13 & qC-15), 126.3 (t, J = 25, qC-14), 
124.1 (C(8)H), 123.1 (C(9)H), 120.9 (t, J = 25, qC-12 & qC-16), 116.9 (C(6)H), 115.5 (qC-
5), 93.6 (C(3)H); m/z (ES+): 244 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd 
for C15H6D5O3 244.1022; Found 244.1022. 
2'-Hydroxy-6'-methoxyacetophenone (158)42 
Following the literature procedure,42 2’,6’-dihydroxyacetophenone 
(5.0 g, 32.86 mmol, 1.0 equiv.), K2CO3 (4.5 g, 32.86 mmol, 1.0 equiv.) 
and acetone (100 mL) were added to a 250 mL round-bottomed flask 
and the mixture was set stirring at ambient temperature. Methyl 
iodide (2 mL, 32.86 mmol, 1.0 equiv.) was added and the mixture was heated to 79 °C 
using an oil bath. The reaction was stirred at this temperature for 24 h, then cooled 
to ambient temperature. The mixture was filtered through fluted filter paper and the 
filtrate was concentrated under reduced pressure. The residue was purified by 
column chromatography (EtOAc:hexanes 20:80) to yield 158 as a yellow solid 
(4.0666 g, 74%); m.p. 53–56 °C (lit.42 57–58 °C); 1H NMR (300 MHz, CDCl3) δ 13.24 (s, 
1H, O–H), 7.33 (t, J = 8.4, 1H, C(3)H), 6.55 (dd, J = 8.4, 0.9, 1H, C(2)H), 6.38 (d, J = 8.3, 
1H, C(4)H), 3.89 (s, 3H, C(9)H3), 2.66 (s, 3H, C(8)H3); 13C NMR (75 MHz, CDCl3) δ 205.2 
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(qC-7), 164.7 (qC-1), 161.5 (qC-5), 136.1 (C(3)H), 111.3 (qC-6), 110.7 (C(2)H), 101.1 
(C(4)H), 55.6 (C(8)H3), 33.7 (C(9)H3); m/z (ES+): 167 ((M+H)+ 100%). 
Spectral characteristics were consistent with previously reported data.42 
4-Hydroxy-5-methoxy-2H-chromen-2-one (159)43 
Modifying the literature procedures,44-45 a 100 mL, 2-neck 
round-bottomed flask was heated under vacuum and refilled with 
N2. 2'-Hydroxy-6'-methoxyacetophenone 158 (4.5 g, 27.08 mmol, 
1.0 equiv.) and toluene (30 mL) were added. A 500 mL, 3-neck 
round-bottomed flask was heated under vacuum and refilled with N2. NaH (11.8 g, 
55% dispersion in mineral oil, 10.0 equiv.) and toluene (60 mL) were added. The 
acetophenone solution was added dropwise to the stirring suspension of NaH over 
15 min. The mixture was stirred until hydrogen evolution ceased, about 10 min. A 
solution of diethyl carbonate (4.4 mL, 36.11 mmol, 1.5 equiv.) in toluene (10 mL) was 
added to the reaction mixture over 5 min. The reaction mixture was stirred at 
ambient temperature for 15 min., then heated to 110 °C using an oil bath. The 
reaction was stirred at this temperature for 21 h, then cooled to ambient 
temperature. The mixture was concentrated under reduced pressure to obtain a 
yellow solid which was slowly added to 100 mL of ice water. The mixture was acidified 
with aqueous HCl (36.5-38.5%) until no further precipitate was formed and the 
mixture was pH 2 as indicated by universal indicator paper. The precipitate was 
isolated by suction filtration, and washed with H2O. The resulting solid was 
recrystallised from EtOH to yield 159 as a cream solid (1.2265 g, 24%); m.p. 153–154 
°C (lit.46 152–153 °C); 1H NMR (300 MHz, DMSO-d6) δ 11.32 (br s, 1H, O–H), 7.55 (t, J 
= 8.4, 1H, C(8)H), 7.10 – 6.66 (m, 2H, C(7)H & C(9)H), 5.51 (s, 1H, C(3)H), 3.90 (s, 3H, 
C(11)H3); 13C NMR (75 MHz, DMSO-d6) δ 167.7 (qC-4), 161.9 (qC-2), 157.8 (qC-6), 
155.6 (qC-10), 133.5 (C(8)H), 109.7 (C(9)H), 107.2 (C(7)H), 105.5 (qC-5), 91.3 (C(3)H), 
57.0 (C(11)H3); m/z (ES+) 193 ((M+H)+ 100%). 
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4-Hydroxy-5,7-dimethyl-2H-chromen-2-one (160)47  
Compound 160 was prepared via the procedure described for 
compound 21 using 3,5-dimethylphenol (1.0 g, 8.19 mmol, 1.0 
equiv.) to yield 160 as a pale yellow solid (1.2183 g, 78%); m.p. 
>250 °C (lit.47 219–220 °C); IR νmax (film) 1644 (C=O stretch), 
1604 (alkene C=C stretch), 1550 (aromatic C–C stretch), 1345 (C–O stretch), 1271 (C–
O stretch); 1H NMR (300 MHz, DMSO-d6) δ 12.21 (s, 1H, O–H), 6.97 (d, J = 0.6, 1H, 
C(9)H), 6.89 (d, J = 0.7, 1H, C(7)H), 5.48 (s, 1H, C(3)H), 2.60 (s, 3H, C(12)H3), 2.31 (s, 
3H, C(11)H3); 13C NMR (75 MHz, DMSO-d6) δ 169.2 (qC-4), 162.1 (qC-2), 155.6 (qC-10), 
142.7 (qC-8), 137.1 (qC-6), 128.7 (C(7)H), 115.2 (C(9)H), 112.2 (qC-5), 90.8 (C(3)H), 
22.9 (C(12)H3), 21.2 (C(11)H3); m/z (ES+) 191 ((M+H)+ 6%). 
4-Bromo-5-methoxy-2H-chromen-2-one (161) 
Compound 161 was prepared via the procedure described for 
compound 6 using 4-hydroxy-5-methoxy-2H-chromen-2-one 159 
(0.77 g, 4.01 mmol, 1.0 equiv.) to yield 161 as a yellow solid 
(0.314 g, 31%) which did not require further purification; m.p. 
>250 °C; IR νmax (film) 1651 (ester C=O stretch), 1072 (ester C–O stretch), 981 (alkene 
C–H bend), 666 (C–Br stretch); 1H NMR (300 MHz, CDCl3) δ 7.47 (t, J = 8.4, 1H, C(8)H), 
6.92 (dd, J = 8.4, 0.8, 1H, C(7)H), 6.78 (d, J = 8.4, 1H, C(9)H), 6.74 (s, 1H, C(3)H), 3.93 
(s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 158.5 (qC-2), 157.0 (qC-6), 154.1 (qC-10), 
136.5 (qC-4), 133.1 (C(8)H), 120.1 (C(9)H), 109.6 (C(7)H), 108.6 (qC-5), 107.1 (C(3)H), 
56.0 (C(11)H3); m/z (ES+): 255 (79Br (M+H)+ 100%), 257 (81Br (M+H)+ 98%); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C10H8O3Br 254.9657; Found 254.9646. 
5-Methoxy-4-phenoxy-2H-chromen-2-one (162) 
Compound 162 was prepared via the procedure described for 
compound 97 using 4-bromo-5-methoxy-2H-chromen-2-one 
161 (0.15 g, 0.588 mmol, 1.0 equiv.) and phenol (0.06 g, 
0.647  mmol, 1.1 equiv.). The residue was purified by column 
chromatography (EtOAc:hexanes 70:30) to yield 162 as an 
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off-white solid (0.020 g, 13%); m.p. 213–215 °C; IR νmax (film) 1705 (ester C=O 
stretch), 1614 (aromatic C–C stretch), 1255 (ester C–O stretch), 1095 (ether C–O 
stretch); 1H NMR (300 MHz, CDCl3) δ 7.57 – 7.41 (m, 3H, 3 × ArCH), 7.36 – 7.27 (m, 
1H, ArCH), 7.22 – 7.09 (m, 2H, 2 × ArCH), 6.98 (dd, J = 8.4, 0.9, 1H, ArCH), 6.81 (d, J = 
8.4, 1H, ArCH), 5.33 (s, 1H, C(3)H), 3.93 (s, 3H, C(17)H3); 13C NMR (75 MHz, CDCl3) δ 
168.7 (qC-4), 162.5 (qC-2), 158.0 (qC-6), 155.7 (qC-11), 152.8 (qC-10), 132.8 (ArCH), 
130.4 (2 × ArCH), 126.4 (ArCH), 121.4 (2 × ArCH), 109.8 (ArCH), 106.7 (ArCH), 105.8 
(qC-5), 93.4 (C(3)H), 56.5 (C(17)H3); m/z (ES+): 269 ((M+H)+ 58%); HRMS (ESI-TOF) 
m/z: [M+H]+ Calcd for C16H13O4 269.0814; Found 269.0814. 
4-Bromo-5,7-dimethyl-2H-chromen-2-one (163)48 
Compound 163 was prepared via the procedure described for 
compound 6 using 4-hydroxy-5,7-dimethyl-2H-chromen-2-one 
160 (1.0 g, 5.26 mmol, 1.0 equiv.). The residue was 
recrystallised from EtOH to yield 163 as an orange solid (0.4373 
g, 33%); m.p. 160–163 °C (lit.48 125–127 °C); 1H NMR (300 MHz, CDCl3) δ 7.03 (s, 1H, 
C(9)H), 6.94 (s, 1H, C(7)H), 6.80 (s, 1H, C(3)H), 2.86 (s, 3H, C(12)H3), 2.39 (s, 3H, 
C(11)H3); 13C NMR (75 MHz, CDCl3) δ 158.6 (qC-2), 154.1 (qC-10), 143.4 (qC-8), 139.7 
(qC-6), 137.4 (qC-4), 130.4 (C(7)H), 120.4 (C(3)H), 116.3 (C(9)H), 114.8 (qC-5), 24.4 
(C(12)H3), 21.3 (C(11)H3); m/z (ES+): 252 (79Br (M+H)+ 42%), 254 (81Br (M+H)+ 38%). 
Spectral characteristics were consistent with previously reported data.48 
5,7-Dimethyl-4-phenoxy-2H-chromen-2-one (164) 
Compound 164 was prepared via the procedure described 
for compound 97 using 4-bromo-5,7-dimethyl-2H-chromen-
2-one 163 (200 mg, 0.79 mmol, 1.0 equiv.) and phenol (82 
mg, 0.87 mmol, 1.1 equiv.). The residue was purified by 
column chromatography (EtOAc:hexanes 10:90) to yield 164 
as a white solid (0.036 g, 17%); m.p. 130–133 °C; IR νmax (film) 1718 (ester C=O 
stretch), 1611 (aromatic C–C stretch), 1369 (ester C–O stretch), 1194 (ether C–O 
stretch); 1H NMR (400 MHz, CDCl3) δ 7.48 (t, J = 7.8, 2H, C(13)H & C(15)H), 7.33 (t, J = 
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7.4, 1H, C(14)H), 7.15 (d, J = 7.8, 2H, C(12)H & C(16)H), 7.03 (s, 1H, C(9)H), 6.94 (s, 1H, 
C(7)H), 5.33 (s, 1H, C(3)H), 2.76 (s, 3H, C(17)H3), 2.41 (s, 3H, C(18)H3); 13C NMR (100 
MHz, CDCl3) δ 169.4 (qC-4), 162.8 (qC-2), 155.3 (qC-10), 152.2 (qC-11), 143.1 (qC-8), 
136.7 (qC-6), 130.5 (C(13)H & C(15)H), 129.0 (C(7)H), 126.7 (C(14)H), 121.4 (C(12)H & 
C(16)H), 115.5 (C(9)H), 111.7 (qC-5), 93.0 (C(3)H), 23.3 (C(17)H3), 21.5 (C(18)H3); m/z 
(ES+): 267 ((M+H)+ 8%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H15O3 267.1021; 
Found 267.1034. 
5-Methoxy-4-(phenoxy-d5)-2H-chromen-2-one (165)  
Compound 165 was prepared via the procedure described for 
compound 97 using 4-bromo-5-methoxy-2H-chromen-2-one 
161 (390 mg, 1.529 mmol, 1.0 equiv.) and phenol-d6 (168 mg, 
1.682 mmol, 1.1 equiv.). The residues were purified by 
column chromatography (EtOAc:hexanes 20:80) to yield 165 
as a white solid (0.116 g, 28%); m.p. 212–217 °C; IR νmax (film) 
1704 (ester C=O stretch), 1612 (alkene C=C stretch), 1471 (aromatic C–C stretch), 
1255 (ester C–O stretch), 1189 (ether C–O stretch), 1094 (ether C–O stretch); 1H NMR 
(300 MHz, CDCl3) δ 7.49 (t, J = 8.4, 1H, C(8)H), 6.97 (dd, J = 8.4, 0.9, 1H, C(7)H), 6.80 
(d, J = 8.4, 1H, C(9)H), 5.33 (s, 1H, C(3)H), 3.92 (s, 3H, C(17)H3); 13C NMR (75 MHz, 
CDCl3) δ 168.6 (qC-4), 162.4 (qC-2), 158.0 (qC-6), 155.7 (qC-11), 152.8 (qC-10), 132.8 
(C(7)H), 129.8 (t, J = 25, qC-13 & qC-15), 125.9 (t, J = 24, qC-14), 120.9 (t, J = 25, qC-
12 & qC-16), 109.7 (C(9)H), 106.8 (C(8)H), 105.8 (qC-5), 93.5 (C(3)H), 56.5 (C(17)H3); 
m/z (ES+): 274 ((M+H)+ 70%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H8D5O4 
274.1128; Found 274.1118. 
5,7-Dimethyl-4-(phenoxy-d5)-2H-chromen-2-one (166)  
Compound 166 was prepared via the procedure described 
for compound 97 using 4-bromo-5,7-dimethyl-2H-
chromen-2-one 163 (190 mg, 0.75 mmol, 1.0 equiv.) and 
phenol-d6 (83 mg, 0.83 mmol, 1.1 equiv.). The residue was 
purified by column chromatography (EtOAc:hexanes 
10:90) to yield 166 as a white solid (0.036 g, 17%); m.p. 
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129–132 °C; IR νmax (film) 1715 (ester C=O stretch), 1613 (aromatic C–C stretch), 1366 
(ester C–O stretch), 1232 (ether C–O stretch); 1H NMR (400 MHz, CDCl3) δ 7.03 (s, 1H, 
C(9)H), 6.94 (s, 1H, C(7)H), 5.33 (s, 1H, C(3)H), 2.76 (s, 3H, C(17)H3), 2.41 (s, 3H, 
C(18)H3); 13C NMR (101 MHz, CDCl3) δ 169.4 (qC-4), 162.8 (qC-2), 155.3 (qC-10), 152.2 
(qC-11), 143.0 (qC-8), 136.7 (qC-6), 130.0 (t, J = 25, qC-13 & qC-15), 129.0 (C(7)H), 
126.2 (t, J = 24, qC-14), 121.0 (t, J = 25, qC-12 & qC-16), 115.5 (C(9)H), 111.7 (qC-5), 
93.0 (C(3)H), 23.3 (C(17)H3), 21.5 (C(18)H3); m/z (ES+): 272 ((M+H)+ 10%); HRMS (ESI-
TOF) m/z: [M+H]+ Calcd for C17H10D5O3 272.1335; Found 272.1336. 
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 Palladium-catalysed intramolecular direct arylation 
5.3.1.  Palladium/pivalic acid-mediated direct arylation 
General Procedure: A Schlenk tube was heated under vacuum and refilled with N2 
three times. Dry Na2CO3 (3.0 equiv.) was added to a Schlenk tube. The Schlenk was 
heated under vacuum and refilled with N2 twice. Pd2(dba)3 (2 mol%), PPh3 (4 mol%), 
PivOH (30 mol%) and substrate (1.0 equiv.) were added. The Schlenk was evacuated 
and refilled with N2 twice. Anhydrous NMP (3 mL) was added and the Schlenk tube 
was placed in an oil bath preheated to 130 °C. After 2-6 h, the mixture was allowed 
to cool to ambient temperature and diluted with water (10 mL) and EtOAc (10 mL). 
The organic layers were extracted with EtOAc (2 × 10 mL) and washed with 1 M 
aqueous HCl (1 × 20 mL), H2O (3 × 10 mL) and brine (1 × 20 mL). The combined organic 
extracts were dried, filtered and concentrated under reduced pressure. The residue 
was purified by column chromatography. 
3-Methylpyrano[4,3-c]isochromen-1(6H)-one (31)10 
4-((2-Iodobenzyl)oxy)-6-methyl-2H-pyran-2-one 4 (100 mg, 
0.292 mmol, 1.0 equiv.) was used as the substrate in the 
General Procedure, except that Pd2(dba)3 (5 mol%) and PPh3 
(10 mol%) were used, and stirred at 130 °C for 2 h. The residue 
was purified by column chromatography (EtOAc:hexanes 25:75) to afford 31 as a 
yellow solid (0.048 g, 77%); m.p. 141–144 °C (lit. 10 110-113 °C); 1H NMR (300 MHz, 
CDCl3) δ 8.46 (d, J = 7.9, 1H, C(13)H), 7.30 – 7.44 (m, 1H, C(11)H), 7.30 – 7.19 (m, 1H 
C(10)H), 7.08 – 6.98 (m, 1H, C(12)H), 5.90 (s, 1H, C(5)H), 5.23 (s, 2H, C(8)H2), 2.26 (s, 
3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 166.2 (qC-4), 162.5 (qC-2), 161.6 (qC-6), 128.9 
(C(11)H), 127.5 (C(12)H), 126.8 (qC-9), 126.5 (qC-14), 124.0 (C(13)H), 123.7 (C(10)H), 
100.2 (C(5)H), 99.8 (qC-3), 69.3 (C(8)H2), 20.1 (C(7)H3); m/z (ES+): 215 ((M+H)+ 44%). 
Spectal data were consistent with previously reported data.10 
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3-Phenylpyrano[4,3-c]isochromen-1(6H)-one (33)2 
4-((2-Bromobenzyl)oxy)-6-phenyl-2H-pyran-2-one 9 
(45 mg, 0.126 mmol, 1.0 equiv.) was used as the 
substrate in the General Procedure and stirred at 130 °C 
for 3 h. The residue was purified by column 
chromatography (DCM) to afford a yellow solid 33 
(0.0214 g, 61%); m.p. 124–130 °C (lit.2 137 °C); 1H NMR (300 MHz, CDCl3) δ 8.53 (dd, 
J = 7.9, 0.8, 1H, C(13)H), 7.92 – 7.82 (m, 2H, 2 × ArCH), 7.49 – 7.44 (m, 3H, 3 × ArCH), 
7.44 – 7.36 (m, 1H, ArCH), 7.28 (td, J = 7.5, 1.3, 1H, C(12)H), 7.08 (dd, J = 7.5, 0.8, 1H, 
C(10)H), 6.57 (s, 1H, C(5)H), 5.30 (s, 2H, C(8)H2); 13C NMR (75 MHz, CDCl3) δ 166.1 
(qC-4), 160.9 (qC-6), 160.1 (qC-2), 131.1 (ArCH), 130.0 (qC-14), 129.0 (3 × ArCH), 
127.8 (ArCH), 127.1 (qC-7), 126.5 (qC-9), 125.7 (2 × ArCH), 124.3 (ArCH), 123.8 (ArCH), 
101.1 (qC-3), 97.6 (C(5)H), 69.4 (C(8)H2); m/z (ES+): 277 ((M+H)+ 100%). 
Spectal data were consistent with previously reported data.2 
8-Fluoro-3-methylpyrano[4,3-c]isochromen-1(6H)-one (34)7 
4-((2-Bromo-5-fluorobenzyl)oxy)-6-methyl-2H-pyran-2-one 
12 (100 mg, 0.319 mmol, 1.0 equiv.) was used as the substrate 
in the General Procedure and stirred at 130 °C for 3 h. The 
residue was purified by column chromatography (DCM) to 
afford 34 as a yellow solid (0.048 g, 65%) and 35 as a yellow solid (0.011 g, 15%). 
1H NMR (300 MHz, CDCl3) δ 8.46 (dd, J = 8.9, 5.6, 1H, C(13)H), 7.03 (td, J = 8.8, 2.6, 
1H, C(12)H), 6.76 (dd, J = 8.4, 2.6, 1H, C(10)H), 5.91 (s, 1H, C(5)H), 5.20 (s, 2H, C(8)H2), 
2.26 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 165.6 (qC-4), 163.6 (qC-2), 161.6 (d, 
J = 156, qC-11), 160.4 (qC-6), 129.0 (d, J = 7, qC-9), 126.2 (d, J = 8, C(13)H), 122.5 
(qC-14), 115.5 (d, J = 21, C(12)H), 111.1 (d, J = 23, C(10)H), 100.1 (C(5)H), 99.4 (qC-3), 
68.8 (C(8)H2), 20.1 (C(7)H3).  
Spectal data were consistent with previously reported data.7 
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8-Fluoro-1-methylpyrano[4,3-c]isochromen-3(6H)-one (35)7 
1H NMR (300 MHz, CDCl3) δ 7.47 (dd, J = 8.7, 5.0, 1H, C(13)H), 
7.14 (td, J = 8.5, 2.7, 1H, C(12)H), 6.97 (dd, J = 8.2, 2.5, 1H, 
C(10)H), 5.78 (s, 1H, C(3)H), 5.03 (s, 2H, C(8)H2), 2.62 (s, 3H, 
C(7)H3); 13C NMR (126 MHz, CDCl3) δ 168.4 (qC-4), 163.3 
(qC-2), 161.7 (d, J = 250, qC-11), 159.2 (qC-6), 133.7 (d, J = 8, qC-9), 127.6 (d, J = 8, 
C(13)H), 122.3 (d, J = 3, qC-14), 115.9 (d, J = 22, C(12)H), 112.6 (d, J = 23, C(10)H), 
106.9 (qC-5), 93.7 (C(3)H), 68.9 (d, J = 2, C(8)H2), 20.5 (C(7)H3). 
Spectal data were consistent with previously reported data.7 
2,3-Dimethyl-2,6-dihydro-1H-isochromeno[4,3-c]pyridin-1-one (36)10 
4-((2-Iodobenzyl)oxy)-1,6-dimethylpyridin-2(1H)-one 16 
(62.5 mg, 0.176 mmol, 1.0 equiv.) was used as the substrate in 
the General Procedure, except that Pd2(dba)3 (5 mol%) and 
PPh3 (10 mol%) were used, and stirred at 130 °C for 6 h. The 
residue was purified by column chromatography (DCM) to afford 36 as a pale yellow 
solid (0.0295 g, 74%); m.p. 89–94 °C (lit.2 95–96 °C); 1H NMR (300 MHz, CDCl3) δ 8.79 
(d, J = 8.0, 1H, C(13)H), 7.35 (t, J = 8.0, 1H, C(11)H), 7.21 (t, J = 7.4, 1H, C(12)H), 7.05 
(d, J = 7.4, 1H, C(10)H), 5.88 (s, 1H, C(5)H), 5.10 (s, 2H, C(8)H2), 3.54 (s, 3H, C(15)H3), 
2.34 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 160.8 (qC-4), 160.3 (qC-2), 144.4 (qC-
6), 126.9 (qC-14), 126.6 (C(11)H), 126.2 (qC-9), 124.9 (C(12)H), 122.5 (C(13)H), 121.8 
(C(10)H), 103.6 (qC-3), 98.3 (C(5)H), 67.1 (C(8)H2), 29.1 (C(15)H3), 19.4 (C(7)H3); m/z 
(ES+): 228 ((M+H)+ 100%). 
Using 4-((2-bromobenzyl)oxy)-1,6-dimethylpyridin-2(1H)-one 15 (100 mg) as the 
substrate gave 36 (0.019 g, 26%). Spectral characteristics were consistent with 
previously reported data.2 
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2-Benzyl-3-methyl-2,6-dihydro-1H-isochromeno[4,3-c]pyridin-1-one (37)2 
1-Benzyl-4-((2-iodobenzyl)oxy)-6-methylpyridin-2(1H)-one 
18 (100 mg, 0.232 mmol, 1.0 equiv.) was used as the 
substrate in the General Procedure, except that Pd2(dba)3 
(5 mol%) and PPh3 (10 mol%) were used, and stirred at 
130 °C for 6 h. The residue was purified by column 
chromatography (EtOAc:hexanes 20:80) to afford 37 as a 
pale yellow solid (0.054 g, 77%); m.p. 125–130 °C (lit.2 126–127 °C); 1H NMR (300 
MHz, CDCl3) δ 8.83 (d, J = 7.9, 1H, C(13)H), 7.39 – 7.14 (m, 7H, C(12)H, C(11)H, C(17)H, 
C(18)H, C(19)H, C(20)H & C(21)H), 7.06 (d, J = 7.4, 1H, C(10)H), 5.89 (s, 1H, C(5)H), 
5.38 (s, 2H, C(15)H2), 5.14 (s, 2H, C(8)H2), 2.27 (s, 3H, C(7)H3); 13C NMR (75 MHz, 
CDCl3) δ 162.9 (qC-4), 162.2 (qC-2), 146.5 (qC-6), 136.9 (qC-16), 128.8 (C(18)H & 
C(20)H), 128.7 (qC-14), 128.6 (C(12)H), 128.0 (qC-9), 127.3 (C(11)H), 126.9 (C(19)H), 
126.4 (C(17)H & C(21)H), 124.5 (C(13)H), 123.7 (C(10)H), 105.8 (qC-3), 100.8 (C(5)H), 
69.0 (C(8)H2), 47.0 (C(15)H2), 20.9 (C(7)H3); m/z (ES+): 304.3 ((M+H)+ 100%). 
Using 1-benzyl-4-((2-bromobenzyl)oxy)-6-methylpyridin-2(1H)-one 17 (100 mg) as 
substrate gave 37 (0.033 g, 42%). Spectral characteristics were consistent with 
previously reported data.2 
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6H,11H-Isochromeno[4,3-c]chromen-11-one (38)49 
4-((2-Iodobenzyl)oxy)-2H-chromen-2-one 20 (50 mg, 
0.130 mmol, 1.0 equiv.) was used as the substrate in the 
General Procedure and stirred at 130 °C for 3 h. The residue 
was purified by column chromatography (DCM) to afford 38 
as a red-brown solid (0.020 g, 61%); m.p. 131–134 °C (lit.49 154 °C); 1H NMR (300 MHz, 
CDCl3) δ 8.56 (d, J = 7.8, 1H, C(16)H), 7.86 (dd, J = 8.0, 1.5, 1H, C(6)H), 7.59 – 7.52 (1H, 
m, C(8)H), 7.45 – 7.26 (m, 4H, C(7)H, C(13)H, C(14)H, C(15)H), 7.12 (d, J = 7.5, 1H, 
C(9)H), 5.40 (s, 2H, C(11)H2); 13C NMR (75 MHz, CDCl3) δ 161.2 (qC-4), 160.1 (qC-2), 
152.9 (qC-10), 132.5 (C(8)H), 129.0 (C(14)H), 128.2 (C(15)H), 127.4 (qC-17), 126.7 
(qC-12), 124.9 (C(16)H), 124.0 (C(7)H), 123.9 (C(13)H), 123.1 (C(6)H), 116.5 (C(9)H), 
115.2 (qC-5), 102.7 (qC-3), 69.8 (C(11)2); m/z (ES+): 251 ((M+H)+ 88%). 
Spectral characteristics were consistent with previously reported data.49  
3-Ethyl-6H,11H-isochromeno[4,3-c]chromen-11-one (39) 
6-Ethyl-4-((2-iodobenzyl)oxy)-2H-chromen-2-one 26 
(100 mg, 0.246 mmol, 1.0 equiv.) was used as the 
substrate in the General Procedure and stirred at 
130 °C for 3 h. The residue was purified by column 
chromatography (DCM) to afford 39 as an orange solid (0.049 g, 71%); m.p. 72–75 °C; 
IR νmax (KBr) 1710 (ester C=O stretch), 1621 (alkene C=C stretch), 1566 (C–O stretch); 
1H NMR (300 MHz, CDCl3) δ 8.54 (dd, J = 7.9, 0.7, 1H, C(16)H), 7.64 (d, J = 1.9, 1H, 
C(6)H), 7.44 – 7.18 (m, 4H, C(8)H, C(13)H, C(14)H, C(15)H), 7.14 – 7.06 (m, 1H, C(9)H), 
5.36 (s, 2H, C(11)H2), 2.70 (q, J = 7.6, 2H, C(18)H2), 1.27 (t, J = 7.6, 3H, C(19)H3); 13C 
NMR (75 MHz, CDCl3) δ 161.3 (qC-4), 160.3 (qC-2), 151.2 (qC-10), 140.2 (qC-7), 132.5 
(C(8)H), 129.0 (C(14)H), 128.1 (C(15)H), 127.4 (qC-17), 126.8 (qC-12), 124.9 (C(16)H), 
123.9 (C(13)H), 121.5 (C(6)H), 116.3 (C(9)H), 114.9 (qC-5), 102.4 (qC-3), 69.7 
(C(11)H2), 28.4 (C(18)H2), 15.6 (C(19)H3); m/z (ES+): 279 ((M+H)+ 2%); HRMS (ESI-TOF) 
m/z: [M+H]+ Calcd for C18H15O3 279.1021; Found 279.1019. 
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3-Methyl-6H,11H-isochromeno[4,3-c]chromen-11-one (40)50  
6-Methyl-4-((2-iodobenzyl)oxy)-2H-chromen-2-one 27 
(40 mg, 0.102 mmol, 1.0 equiv.) was used as the substrate 
in the General Procedure and stirred at 130 °C for 3 h. The 
residue was purified by column chromatography (DCM) to 
afford 40 as an off-white solid (0.226 g, 71%); m.p. 155–159 °C (lit.50 165 °C); 1H NMR 
(300 MHz, CDCl3) δ 8.55 (dd, J = 7.9, 0.8, 1H, C(16)H), 7.66 – 7.61 (m, 1H, C(6)H), 7.46 
– 7.16 (m, 4H, 4 × ArCH), 7.15 – 7.06 (m, 1H, C(9)H), 5.37 (s, 2H, C(11)H2), 2.41 (s, 3H, 
C(18)H3); 13C NMR (75 MHz, CDCl3) δ 161.2 (qC-4), 160.3 (qC-2), 151.1 (qC-10), 133.8 
(qC-7), 133.6 (C(8)H), 129.0 (C(14)H), 128.1 (C(15)H), 127.4 (qC-17), 126.8 (qC-12), 
124.9 (C(16)H), 123.9 (C(13)H), 122.7 (C(6)H), 116.3 (C(9)H), 114.8 (qC-5), 102.5 (qC-
3), 69.7 (C(11)H2), 20.9 (C(18)H3); m/z (ES+): 265 ((M+H)+ 28%). 
3-Methoxy-6H,11H-isochromeno[4,3-c]chromen-11-one (41)7  
4-((2-Iodobenzyl)oxy)-6-methoxy-2H-chromen-2-one 
28 (20 mg, 0.049 mmol, 1.0 equiv.) was used as the 
substrate in the General Procedure and stirred at 130 
°C for 3 h. The residue was purified by column 
chromatography (DCM) to afford 41 as a white solid (0.0113 g, 82%); m.p. 138–139 
°C (lit.7 178–179 °C); 1H NMR (300 MHz, CDCl3) δ 8.57 (dd, J = 8.0, 0.7, 1H, C(16)H), 
7.41 (td, J = 7.8, 1.3, 1H, C(15)H), 7.36 – 7.23 (m, 3H, C(9)H, C(13)H & C(14)H), 7.19 – 
7.09 (m, 2H, C(6)H & C(8)H), 5.40 (s, 2H, C(11)H), 3.87 (s, 3H, C(18)H); 13C NMR (75 
MHz, CDCl3) δ 160.9 (qC-4), 160.3 (qC-2), 156.0 (qC-7), 147.5 (qC-10), 129.1 (C(16)H), 
128.3 (C(14)H), 127.4 (qC-17), 126.8 (qC-12), 125.0 (C(15)H), 123.9 (C(9)H), 121.0 
(C(13)H), 117.7 (C(8)H), 115.5 (qC-5), 104.5 (C(6)H), 102.8 (qC-3), 69.8 (C(11)H2), 55.9 
(C(18)H3); m/z (ES+): 281 ((M+H)+ 100%). 
Spectral characteristics were consistent with previously reported data.7 
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3-Fluoro-6H,11H-isochromeno[4,3-c]chromen-11-one (42)  
6-Fluoro-4-((2-iodobenzyl)oxy)-2H-chromen-2-one 29 
(100 mg, 0.252 mmol, 1.0 equiv.) was used as the 
substrate in the General Procedure and stirred at 130 °C 
for 3 h. The residue was purified by column 
chromatography (DCM) to afford 42 as a yellow solid (0.029 g, 43%); m.p. 154–157 
°C; IR νmax (film) 1710 (C=O stretch), 1563 (C=C stretch), 1178 (C-O stretch); 1H NMR 
(300 MHz, CDCl3) δ 8.54 (dd, J = 7.9, 0.9, 1H, C(16)H), 7.51 (ddd, J = 8.3, 2.8, 0.6, 1H, 
C(13)H), 7.41 (td, J = 7.7, 1.5, 1H, C(15)H), 7.37 – 7.21 (m, 3H, C(6)H, C(9)H & C(14)H), 
7.17 – 7.09 (m, 1H, C(8)H), 5.41 (s, 2H, C(11)H2); 13C NMR (75 MHz, CDCl3) δ 160.2 (d, 
J = 3, qC-4), 159.8 (qC-2), 158.7 (d, J = 244, qC-7), 149.0 (d, J = 2, qC-10), 129.1 
(C(14)H), 128.6 (C(15)H), 127.4 (qC-17), 126.2 (qC-12), 125.0 (C(16)H), 124.0 (C(13)H), 
120.1 (d, J = 25, C(8)H), 118.2 (d, J = 8, C(9)H), 116.1 (d, J = 9, qC-5), 108.7 (d, J = 26, 
C(6)H), 103.3 (qC-3), 69.9 (C(11)H2); 19F NMR (282 MHz, CDCl3) δ -117 (s, C(7)F); m/z 
(ES+): 277 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H10O3F 269.0614; 
Found 269.0617; Anal. Calcd for C16H9FO3: C, 71.64; H, 3.38. Found: C, 71.49; H, 3.58. 
3-Nitro-6H,11H-isochromeno[4,3-c]chromen-11-one (43)  
4-((2-Iodobenzyl)oxy)-6-nitro-2H-chromen-2-one 30 
(40 mg, 0.095 mmol, 1.0 equiv.) was used as the 
substrate in the General Procedure and stirred at 130 °C 
for 3 h. The residue was purified by column 
chromatography (DCM) to afford 43 as a yellow solid (0.0161 g, 58%); m.p. 222–225 
°C; IR νmax (film) 1722 (C=O stretch), 1613 (C=C stretch), 1531 (N–O asymmetric 
stretch), 1347 (N–O symmetric stretch), 1334 (C–O stretch); 1H NMR (300 MHz, 
CDCl3) δ 8.77 (d, J = 2.6, 1H, C(6)H), 8.52 (dd, J = 7.6, 1.4, 1H, C(16)H), 8.41 (dd, J = 
9.1, 2.7, 1H, C(8)H), 7.50 – 7.33 (m, 3H, C(9)H, C(14)H & C(15)H), 7.20 – 7.13 (m, 1H, 
C(13)H), 5.50 (s, 2H, C(11)H2); 13C NMR (75 MHz, CDCl3) δ 159.5 (qC-4), 158.6 (qC-2), 
156.0 (qC-10), 144.0 (qC-7), 129.3 (C(9)H), 129.2 (C(15)H), 127.3 (qC-17), 127.0 
(C(8)H), 125.5 (qC-12), 125.1 (C(16)H), 124.2 (C(13)H), 119.7 (C(6)H), 117.7 (C(14)H), 
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115.7 (qC-5), 104.0 (qC-3), 70.1 (C(11)H2); Anal. Calcd for C16H9O5N: C, 65.09; H, 3.07; 
N, 4.74. Found: C, 64.35; H, 2.72; N, 4.76. 
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5.3.2. Palladium-mediated C–5 direct arylation 
General Procedure: A Schlenk tube was heated under vacuum and refilled with N2 
three times. KOAc (2.5 equiv.) was added. The Schlenk tube was heated under 
vacuum and refilled with N2 twice. Allowed Schlenk tube to cool to ambient 
temperature. Substrate (1.0 equiv.), Pd(OAc)2 (5 mol%) and TBAB (1.2 equiv.) were 
added. The Schlenk tube was evacuated and refilled with N2 three times. Freshly 
distilled THF (4 mL) was added via syringe. The Schlenk tube was placed in an oil bath 
preheated to 76 °C. The reaction mixture was stirred at this temperature for 18 h, 
then cooled to ambient temperature. The mixture was diluted with H2O (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with 
H2O (10 mL), dried over MgSO4 and concentrated under reduced pressure. The 
resulting crude product was purified by column chromatography (DCM). 
4-Chloro-1-methyl-3H,6H-pyrano[4,3-c]isochromen-3-one (64) 
3-Chloro-4-((2-iodobenzyl)oxy)-6-methyl-2H-pyran-2-one 47 
(50.0 mg, 0.133 mmol, 1.0 equiv.) was used as the substrate in 
the General Procedure, except that Pd(OAc)2 (2 mol%) and 
TBAB (1.0 equiv.) were used, to yield 64 as a white solid (0.028 
g, 85%); m.p. 155–158 °C; IR νmax (film) 1726 (ester C=O stretch), 1638 (alkene C=C 
stretch), 1544 (aromatic C–C stretch), 1185 (C–O stretch), 770 (C–Cl stretch); 1H NMR 
(300 MHz, CDCl3) δ 7.54 – 7.42 (m, 2H, C(12)H & C(13)H), 7.38 (td, J = 7.3, 1.7, 1H, 
C(11)H), 7.27 (d, J = 7.4, 1H, C(10)H), 5.19 (s, 2H, C(8)H2), 2.65 (s, 3H, C(7)H3); 13C NMR 
(75 MHz, CDCl3) δ 163.1 (qC-4), 159.9 (qC-2), 156.9 (qC-6), 131.0 (qC-14), 129.1 
(C(13)H), 128.2 (C(12)H), 125.7 (C(11)H), 125.6 (qC-9), 125.4 (C(10)H), 107.8 (qC-5), 
100.8 (qC-3), 70.2 (C(8)H2), 20.3 (C(7)H3); m/z (ES+): 249 (35Cl (M+H)+ 16%), 251 (37Cl 
(M+H)+ 6%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H10ClO3 249.0318; Found 
249.0318. 
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4-Chloro-8-fluoro-1-methyl-3H,6H-pyrano[4,3-c]isochromen-3-one (66) 
2-Pyrone 50 (28.0 mg, 0.071 mmol, 1.0 equiv.) was used as 
the substrate in the General Procedure to yield 66 as an off-
white solid (0.012 g, 43%); m.p. 147–151 °C; IR νmax (film) 1733 
(ester C=O stretch), 1635 (alkene C=C stretch), 1549 (aromatic 
C–C stretch), 1185 (ester C–O stretch), 1027 (ether C–O stretch), 834 (C–Cl stretch); 
1H NMR (300 MHz, CDCl3) δ 7.48 (dd, J = 8.8, 5.0, 1H, C(13)H), 7.17 (td, J = 8.6, 2.7, 
1H, C(12)H), 7.01 (dd, J = 8.0, 2.6, 1H, C(10)H), 5.17 (s, 2H, C(8)H2), 2.63 (s, 3H, C(7)H3); 
13C NMR (75 MHz, CDCl3) δ 162.6 (qC-4), 162.0 (d, J = 251, qC-11), 159.7 (qC-2), 156.5 
(d, J = 2, qC-6), 133.3 (d, J = 8, qC-9), 127.8 (d, J = 8, C(13)H), 121.8 (d, J = 3, qC-14), 
116.2 (d, J = 22, C(12)H), 112.7 (d, J = 23, C(10)H), 107.2 (qC-5), 101.2 (qC-3), 69.6 (d, 
J = 2, C(8)H2), 20.2 (C(7)H3); 19F NMR (282 MHz, CDCl3) δ -112 (s, C(11)F); HRMS (ESI-
TOF) m/z: [M+H]+ Calcd for C13H9ClFO3 267.0224; Found 267.0229. 
4-Chloro-1,8-dimethyl-3H,6H-pyrano[4,3-c]isochromen-3-one (67) 
2-Pyrone 48 (30.0 mg, 0.077 mmol, 1.0 equiv.) was used as 
the substrate in the General Procedure to yield 67 as a pale 
orange solid (0.016 g, 53%); m.p. 158–163 °C; IR νmax (film) 
1726 (ester C=O stretch), 1636 (alkene C=C stretch), 1548 
(aromatic C–C stretch), 1301 (ester C–O stretch), 1190 (ether C–O stretch), 825 (C–Cl 
stretch); 1H NMR (300 MHz, CDCl3) δ 7.38 (d, J = 8.1, 1H, C(13)H), 7.25 (d, J = 8.4, 1H, 
C(12)H), 7.08 (s, 1H, C(10)H), 5.16 (s, 2H, C(8)H2), 2.63 (s, 3H, C(7)H3), 2.40 (s, 3H, 
C(15)H3); 13C NMR (75 MHz, CDCl3) δ 163.1 (qC-4), 160.0 (qC-2), 156.2 (qC-6), 138.4 
(qC-14), 130.9 (qC-11), 129.8 (ArCH), 126.0 (ArCH), 125.6 (ArCH), 122.7 (qC-9), 107.8 
(qC-5), 100.8 (qC-3), 70.2 (C(8)H2), 21.2 (C(15)H3), 20.2 (C(7)H3); m/z (ES+): 263 (35Cl 
(M+H)+ 18%), 265 (37Cl (M+H)+ 6%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H12ClO3 
263.0475; Found 263.0471. 
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4-Chloro-8-methoxy-1-methyl-3H,6H-pyrano[4,3-c]isochromen-3-one (68) 
2-Pyrone 52 (30.0 mg, 0.074 mmol, 1.0 equiv.) was used 
as the substrate in the General Procedure. The resulting 
crude product was purified by column chromatography 
(MeOH:DCM 0.5:99.5) to give 68 as a pale orange solid 
(0.013 g, 63%); m.p. 193–197 °C; IR νmax (film) 1728 (ester C=O stretch), 1635 (alkene 
C=C stretch), 1544 (aromatic C–C stretch), 1140 (ester C–O stretch), 1052 (ether C–O 
stretch), 934 (C–Cl stretch); 1H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 8.7, 1H, C(13)H), 
6.98 (dd, J = 8.7, 2.7, 1H, C(12)H), 6.79 (d, J = 2.6, 1H, C(10)H), 5.16 (s, 2H, C(8)H2), 
3.86 (s, 3H, C(15)H3), 2.61 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 162.9 (qC-4), 
160.0 (qC-2), 159.4 (qC-11), 155.3 (qC-9), 132.6 (qC-6), 127.2 (C(13)H), 117.8 (qC-14), 
114.7 (C(10)H), 110.7 (C(12)H), 107.6 (qC-5), 100.9 (qC-3), 70.2 (C(8)H2), 55.5 
(C(15)H3), 20.2 (C(7)H3); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H12ClO4 279.0424; 
Found 279.0428. 
4-Chloro-1,2-dimethyl-2,6-dihydro-3H-isochromeno[4,3-c]pyridin-3-one (70) 
2-Pyridone 62 (30.0 mg, 0.077 mmol, 1.0 equiv.) was used as 
the substrate in the General Procedure, except that the 
mixture was stirred for 24 h. The residue was purified by 
column chromatography (DCM:MeOH 99.7:0.3) to yield 70 as a 
white solid (0.011 g, 55%); m.p. 218–220 °C; IR νmax (film) 1730 (amide C=O stretch), 
1651 (alkene C=C stretch), 1533 (aromatic C–C stretch), 1266 (ether C–O stretch), 
738 (C–Cl stretch); 1H NMR (300 MHz, CDCl3) δ 7.52 – 7.14 (m, 4H, 4 × ArCH), 5.06 (s, 
2H, C(8)H2), 3.70 (s, 3H, C(15)H3), 2.73 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 
160.2 (qC-4), 159.6 (qC-2), 141.9 (qC-Ar), 132.1 (qC-Ar), 128.5 (ArCH), 128.5 (qC-Ar), 
127.0 (ArCH), 126.3 (ArCH), 125.4 (ArCH), 107.9 (qC-5), 106.1 (qC-3), 70.0 (C(8)H2), 
32.6 (C(15)H3), 19.8 (C(7)H3); m/z (ES+): 262 (35Cl (M+H)+ 100%), 264 (37Cl (M+H)+ 
38%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H13NO2Cl 262.0635; Found 262.0639. 
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4-Chloro-1-methyl-2-phenyl-2,6-dihydro-3H-isochromeno[4,3-c]pyridin-3-one (71) 
2-Pyridone 63 (30.0 mg, 0.066 mmol, 1.0 equiv.) was used as 
the substrate in the General Procedure. The residue was 
purified by column chromatography (EtOAc:hexanes 70:30) to 
give 71 as a brown solid (0.018 g, 60%); m.p. >250 °C; IR νmax 
(film) 1655 (amide C=O stretch), 1528 (alkene C=C stretch), 
1349 (aromatic C–C stretch), 1206 (ester C–O stretch), 1041 
(ether C–O stretch), 700 (C–Cl stretch); 1H NMR (300 MHz, DMSO) δ 7.65 – 7.50 (m, 
4H, 4 × ArCH), 7.48 – 7.31 (m, 5H, 5 × ArCH), 5.23 (s, 2H, C(8)H2), 2.27 (s, 3H, C(7)H3); 
13C NMR (75 MHz, DMSO) δ 160.7 (qC-4), 159.6 (qC-2), 143.6 (qC-15), 139.3 (qC-14), 
132.5 (qC-6), 130.1 (2 × ArCH), 129.3 (ArCH), 128.9 (ArCH), 128.9 (2 × ArCH), 128.3 
(qC-9), 127.4 (ArCH), 126.8 (ArCH), 125.9 (ArCH), 107.1 (qC-5), 104.9 (qC-3), 69.9 
(C(8)H2), 21.4 (C(7)H3); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C19H15NO2Cl 324.0791; 
Found 324.0787. 
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5.3.3. Palladium/TBAB-mediated C–3 direct arylation 
3-Methyl-1H,6H-isothiochromeno[4,3-c]pyran-1-one (83)  
A Schlenk tube was heated under vacuum and refilled with N2 
three times. Dry KOAc (20.6 mg, 0.209 mmol, 2.5 equiv.) was 
added to a Schlenk tube. The Schlenk was heated under 
vacuum and refilled with N2 twice. Pd(OAc)2 (0.4 mg, 0.002 
mmol, 2 mol%), TBAB (27.0 mg, 0.084 mmol, 1.0 equiv.) and 4-((2-iodobenzyl)thio)-
6-methyl-2H-pyran-2-one 82 (30 mg, 0.084 mmol, 1.0 equiv.) were added. The 
Schlenk was evacuated and refilled with N2 twice. Toluene (2 mL, previously dried 
over 4Å molecular sieves) was added and the Schlenk was placed in an oil bath 
preheated to 127 °C. After 16 h, the mixture was allowed to cool to ambient 
temperature and diluted with water (10 mL) and EtOAc (10 mL). The organic 
components were extracted with EtOAc (2 × 10 mL) and washed with 1 M aqueous 
HCl (1 × 20 mL), H2O (3 × 10 mL) and brine (1 × 20 mL). The combined organic extracts 
were dried, filtered and concentrated under reduced pressure. The crude residue 
(mixture of starting material and product) was purified by column chromatography 
(DCM) to afford 83 as a yellow solid (0.0040 g, 21%); m.p. 158–162 °C; IR νmax (film) 
1705 (ester C=O stretch), 1635 (alkene C=C stretch), 1436 (aromatic C–C stretch), 
1325 (ester C– O stretch), 783 (C–I stretch); 1H NMR (300 MHz, CDCl3) δ 8.34 (dd, J = 
7.8, 1.3, 1H, C(13)H), 7.35 (td, J = 7.5, 1.6, 1H, C(12)H), 7.29 (td, J = 7.3, 1.5, 1H, 
C(10)H), 7.19 – 7.13 (m, 1H, C(11)H), 6.08 (d, J = 0.9, 1H, C(5)H), 3.85 (s, 2H, C(8)H2), 
2.26 (d, J = 0.8, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 159.6 (qC-4), 158.7 (qC-2), 
153.9 (qC-6), 130.4 (qC-9), 129.4 (qC-14), 128.5 (C(13)H), 128.0 (C(10)H), 126.7 
(C(12)H), 126.5 (C(11)H), 115.2 (qC-3), 105.3 (C(5)H), 31.3 (C(8)H2), 19.6 (C(7)H3); m/z 
(ES+): 231 ((M+H)+ 100%). HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C13H11O2S 231.0480; 
Found 231.0476. 
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5.3.4. Palladium-mediated double C–H activation 
General Procedure: To a reaction vial were added substrate (1.0 equiv.), Pd(OAc)2 (10 
mol%), NaOtBu (20 mol%), Ag2O (1.5 equiv.) and PivOH (0.5 M). The vial was capped 
and placed in a mantle preheated to 140 °C. The mixture was stirred at this 
temperature until the substrate was fully consumed, then cooled to ambient 
temperature. The mixture was diluted with DCM and filtered through a plug of celite. 
The organic layer was washed with 10% (w/v) aqueous NaOH, dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by column 
chromatography (DCM). 
6H-Benzofuro[3,2-c]chromen-6-one (154)31  
4-Phenoxy-2H-chromen-2-one 97 (60.0 mg, 0.252 mmol, 1.0 
equiv.) was used as a substrate in the General Procedure 
(stirred at 140 °C for 40 min) to yield 154 as a white solid 
(0.0253 g, 43%); m.p. 180–182 °C (lit.31 177–180 °C); 1H NMR 
(300 MHz, CDCl3) δ 8.17 – 8.05 (m, 1H, C(15)H), 7.99 (dd, J = 7.8, 1.5, 1H, C(6)H), 7.72 
– 7.57 (m, 2H, C(8)H & C(12)H), 7.51 – 7.33 (m, 4H, C(7)H, C(9)H, C(13)H & C(14)H); 
13C NMR (75 MHz, CDCl3) δ 159.9 (qC-4), 158.0 (qC-2), 155.5 (qC-11), 153.7 (qC-10), 
131.9 (C(8)H), 126.7 (C(13)H), 125.2 (C(14)H), 124.6 (C(7)H), 123.4 (qC-16), 121.8 
(C(6)H & C(15)H), 117.5 (C(9)H), 112.6 (qC-5), 111.7 (C(12)H), 105.8 (qC-3); m/z (ES+): 
237 ((M+H)+ 70%). 
Spectral characteristics were consistent with previously reported data.31 
1-Methoxy-6H-benzofuro[3,2-c]chromen-6-one (167) 
4-Phenoxy-5-methoxy-2H-chromen-2-one 162 (13 mg, 0.048 
mmol, 1.0 equiv.) was used as a substrate in the General 
Procedure (stirred at 140 °C for 18 h) to yield 167 as a white 
solid (0.006 g, 47%); m.p. 205–206 °C; IR νmax (film) 1742 
(ester C=O stretch), 1617 (alkene C=C stretch), 1596 (aromatic C–C stretch), 1286 (C–
O stretch), 1083 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 8.25 – 8.04 (m, 1H, 
C(15)H), 7.80 – 7.66 (m, 1H, C(12)H), 7.59 – 7.38 (m, 3H, C(8)H, C(13)H and C(14)H), 
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7.13 (d, J = 8.4 Hz, 1H, C(7)H), 6.88 (d, J = 8.4, 1H, C(9)H), 4.11 (s, 3H, C(17)H3); 13C 
NMR (75 MHz, CDCl3) δ 159.8 (qC-4), 158.2 (qC-2), 156.0 (qC-6), 155.6 (qC-11), 154.9 
(qC-10), 132.1 (C(8)H), 126.4 (C(13)H), 125.1 (C(14)H), 123.0 (qC-16), 121.5 (C(15)H), 
111.9 (C(12)H), 110.0 (C(7)H), 106.1 (C(9)H), 105.3 (qC-3), 103.8 (qC-5), 56.5 
(C(17)H3); m/z (ES+): 267 ((M+H)+ 10%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C16H11O4 267.0657; Found 267.0650. 
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 Suzuki-Miyaura cross-coupling of 4-chloro-1-methyl-3H,6H-
pyrano[4,3-c]isochromen-3-one 
General Procedure: A Schlenk tube was heated under vacuum and refilled with N2 
three times. KOAc (2.2 equiv.) was added. The Schlenk tube was heated under 
vacuum and refilled with N2 twice. 3-Chloro-4-((2-iodobenzyl)oxy)-6-methyl-2H-
pyran-2-one 64 (1.0 equiv.), boronic acid (1.5 equiv.), Pd(OAc)2 (5 mol%) and SPhos 
(15 mol%) were added. The Schlenk tube was evacuated and refilled with N2 three 
times. Freshly distilled THF (0.03 M) was added via syringe. The Schlenk tube was 
placed in an oil bath preheated to 76 °C. The reaction was stirred at this temperature 
for 18 h, then cooled to ambient temperature. The reaction mixture was diluted with 
H2O (15 mL) and extracted with EtOAc (3 × 15 mL). The combined organic layers were 
dried over MgSO4 and concentrated under reduced pressure. The residue was 
purified by column chromatography (DCM). 
1-Methyl-4-(p-tolyl)-3H,6H-pyrano[4,3-c]isochromen-3-one (87) 
p-Tolylboronic acid (24.6 mg, 0.181 mmol, 1.5 equiv.) 
was used in the General Procedure to yield 87 as an 
orange solid (0.0337 g, 92%); m.p. 159–164 °C; IR νmax 
1711 (ester C=O stretch), 1555 (aromatic C–C stretch), 
1161 (ether C–O stretch), 1013 (alkene C–H bend); 1H NMR (300 MHz, CDCl3) δ 7.53 
(d, J = 7.7, 1H, ArCH), 7.49 – 7.29 (m, 4H, 4 × ArCH), 7.22 (appd, J = 8.3, 3H, 3 × ArCH), 
5.00 (s, 2H, C(8)H2), 2.68 (s, 3H, C(21)H3), 2.37 (s, 3H, C(7)H3); 13C NMR (75 MHz, 
CDCl3) δ 163.5 (qC-4), 163.4 (qC-2), 157.7 (qC-6), 137.6 (qC-18), 131.7 (qC-14), 130.3 
(C(16)H & C(20)H), 128.8 (C(12)H), 128.7 (C(17)H & C(19)H), 128.0 (qC-15), 127.6 
(C(11)H), 126.8 (qC-9), 125.9 (C(13)H), 125.2 (C(10)H), 107.9 (qC-5), 107.1 (qC-3), 69.6 
(C(8)H2), 21.3 (C(21)H3), 20.3 (C(7)H3); m/z (ES+): 305 ((M+H)+ 100%); HRMS (ESI-TOF) 
m/z: [M+H]+ Calcd for C20H17O3 305.1178; Found 305.1174.   
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1-Methyl-4-(4-(trifluoromethyl)phenyl)-3H,6H-pyrano[4,3-c]isochromen-3-one 
(88) 
4-(Trifluoromethyl)phenylboronic acid (46.0 mg, 
0.242 mmol, 1.5 equiv.) was used in the General 
Procedure to yield 88 as a white solid (0.033 g, 57%); 
m.p. 188–191 °C; IR νmax (film) 1713 (ester C=O 
stretch), 1110 (ether C–O stretch), 845 (alkene C–H bend); 1H NMR (300 MHz, CDCl3) 
δ 7.65 (s, 4H, C(16)H, C(17)H, C(19)H & C(20)H), 7.54 (d, J = 7.6, 1H, C(13)H), 7.47 (td, 
J = 7.7, 1.2, 1H, C(12)H), 7.37 (td, J = 7.4, 1.2, 1H, C(11)H), 7.25 (d, J = 6.9, 1H, C(10)H), 
5.03 (s, 2H, C(8)H2), 2.70 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 164.3 (qC-4), 
162.8 (qC-2), 158.7 (qC-6), 134.9 (d, J = 1, qC-15), 131.4 (qC-14), 130.9 (C(16)H & 
C(20)H), 129.5 (q, J = 32, qC-18), 129.0 (C(12)H), 127.9 (C(11)H), 126.4 (qC-9), 125.9 
(C(13)H), 125.3 (C(10)H), 124.8 (q, J = 4, C(17)H & C(19)H), 124.2 (q, J = 272, qC-21), 
107.9 (qC-5), 105.7 (qC-3), 69.8 (C(8)H2), 20.4 (C(7)H3); 19F NMR (282 MHz, CDCl3) δ -
63 (s, C(21)F3); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C20H14F3O3 359.0895; Found 
359.0885. 
4-(4-Methoxyphenyl)-1-methyl-3H,6H-pyrano[4,3-c]isochromen-3-one (89) 
4-(Methoxy)phenylboronic acid (36.8 mg, 0.242 
mmol, 1.5 equiv.) was used in the General 
Procedure. The 1H NMR spectrum of the crude 
reaction mixture indicated 28% conversion from 
starting material 64 to product 89. The residue was purified by column 
chromatography (MeOH:DCM 1:99) to yield 89 as an impure mixture (contaminated 
with starting material 64), yellow solid (0.011 g, approx. 20%). The NMR signals 
belonging to the title compound could be assigned as follows: 1H NMR (300 MHz, 
CDCl3) δ 7.62 – 7.10 (m, 7H, 7 × ArCH), 6.95 (d, J = 8.8 Hz, 1H, ArCH), 5.00 (s, 2H, 
C(8)H2), 3.83 (s, 3H, C(21)H3), 2.67 (s, 3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 163.5 
(qC-4), 163.3 (qC-2), 159.0 (qC-18), 157.5 (qC-6), 131.7 (qC-14), 131.7 (C(16)H & 
C(20)H), 128.8 (C(12)H), 127.6 (C(11)H), 126.8 (qC-9), 125.9 (C(13)H), 125.2 (C(10)H), 
123.2 (qC-15), 113.5 (C(17)H & C(19)H, 108.0 (qC-5), 106.8 (qC-3), 69.6 (C(8)H2), 55.3 
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(C(21)H3), 20.3 (C(7)H3); m/z (ES+): 321 ((M+H)+ 78%); HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C20H17O4 321.1127; Found 321.1114. 
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 Suzuki-Miyaura cross-coupling of 3-chloro-4-methoxy-2H-
chromen-2-one and related heterocycles 
General Procedure: A Schlenk tube was heated under vacuum and refilled with N2 
three times. Substrate (1.0 equiv.), boronic acid (1.5 equiv.), Pd(OAc)2 (5 mol%), 
SPhos (15 mol%) and K2CO3 (2.2 equiv.) were added. The Schlenk tube was evacuated 
and refilled with N2 three times. Distilled iPrOAc (0.03 M) was added via syringe. The 
Schlenk tube was placed in an oil bath preheated to 100 °C. The reaction was stirred 
at this temperature for 16 h, then cooled to ambient temperature. The reaction 
mixture was diluted with H2O (10 mL) and extracted with EtOAc (3 × 10 mL). The 
combined organic layers were dried over MgSO4 and concentrated under reduced 
pressure. The residue was purified by column chromatography (DCM). 
4-Methoxy-3-phenyl-2H-chromen-2-one (111)7 
Method 1 (50 mg scale): 3-Chloro-4-methoxy-2H-chromen-
2-one 104 (50.0 mg, 0.237 mmol, 1.0 equiv.) and 
phenylboronic acid (43.3 mg, 0.356 mmol, 1.5 equiv.) were 
used in the General Procedure to yield 111 as a yellow solid 
(0.049 g, 82%); m.p. 111–114 °C (lit.7 117–119 °C); 1H NMR (300 MHz, CDCl3) δ 7.87 
(dd, J = 7.9, 1.3, 1H, ArCH), 7.60 – 7.51 (m, 1H, ArCH), 7.50 – 7.26 (m, 7H, 7 × ArCH), 
3.56 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.4 (qC-4), 162.9 (qC-2), 152.5 
(qC-10), 132.4 (qC-12), 132.0 (C(8)H), 131.0 (C(13)H & C(17)H), 128.4 (C(15)H), 128.3 
(C(14)H & C(16)H), 124.0 (C(7)H), 123.9 (C(6)H), 117.8 (qC-5), 116.5 (C(9)H), 111.1 
(qC-3), 61.3 (C(11)H3); m/z (ES+): 253 ((M+H)+ 12%). 
Method 2 (1.00 g scale): A 100 mL, 3-neck round-bottomed flask fitted with a 
condenser and a vacuum/N2 inlet was heated under vacuum and refilled with N2 
three times. Allowed apparatus to cool to ambient temperature. K2CO3 (1.44 g, 
10.446 mmol, 2.2 equiv.), Pd(OAc)2 (53 mg, 0.237 mmol, 5 mol%), SPhos (292 mg, 
0.712 mmol, 15 mol%), phenylboronic acid (0.87 g, 7.122 mmol, 1.5 equiv.) and 
3-chloro-4-methoxy-2H-chromen-2-one 104 (1.00 g, 4.478 mmol, 1.0 equiv.) were 
added under positive pressure of N2. Distilled iPrOAc (50 mL) was added via syringe 
through a rubber septum. The mantle containing the reaction apparatus was heated 
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to 100 °C. The reaction was stirred at this temperature for 16 h, then cooled to 
ambient temperature. The reaction mixture was poured onto a pad of celite and the 
solvent drawn through the celite by suction. The celite was rinsed with EtOAc (2 × 30 
mL). The combined organic layers were concentrated under reduced pressure. The 
residue was dissolved in EtOAc (30 mL) and washed with H2O (30 mL). The aqueous 
layer was extracted with EtOAc (30 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by 
recrystallisation from EtOH to give 111 as a yellow solid (1.0022 g, 84%) with identical 
1H and 13C NMR spectra to when the compound was prepared on a 50 mg scale. 
Spectral characteristics were consistent with previously reported data.7 
4-Methoxy-3-(4-methylphenyl)-2H-chromen-2-one (112) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and p-tolylboronic acid (48.4 mg, 
0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 112 as a white solid (0.056 g, 89%); 
m.p. 128–130 °C; IR νmax (film) 1702 (ester C=O stretch), 1608 (alkene C=C stretch), 
1571 (aromatic C–C stretch), 1345 (C–O stretch), 1106 (C–O stretch); 1H NMR (300 
MHz, CDCl3) δ 7.86 (dd, J = 7.9, 1.4, 1H, C(6)H), 7.54 (ddd, J = 8.4, 7.3, 1.6, 1H, C(8)H), 
7.40 – 7.20 (m, 6H, 6 × ArCH), 3.57 (s, 3H, C(11)H3), 2.40 (s, 3H, C(18)H3); 13C NMR (75 
MHz, CDCl3) δ 163.6 (qC-2), 162.7 (qC-4), 152.4 (qC-10), 138.3 (qC-15), 131.8 (C(8)H), 
130.8 (C(13)H & C(17)H), 129.3 (qC-12), 129.1 (C(14)H & C(16)H), 124.0 (C(7)H), 123.8 
(C(6)H), 117.8 (qC-5), 116.4 (C(9)H), 111.0 (qC-3), 61.2 (C(11)H3), 21.4 (C(18)H3); m/z 
(ES+): 267 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H15O3 267.1021; 
Found 267.1011.   
4-Methoxy-3-(4-methoxyphenyl)-2H-chromen-2-one (113) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 4-methoxyphenylboronic 
acid (54.1 mg, 0.356 mmol, 1.5 equiv.) were used in the 
General Procedure to yield 113 as a yellow solid 
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(0.053 g, 79%); m.p. 134–138 °C; IR νmax (film) 1710 (ester C=O stretch), 1606 (alkene 
C=C stretch), 1512 (aromatic C–C stretch), 1347 (C–O stretch), 1246 (C–O stretch), 
1109 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 7.86 (dd, J = 7.9, 1.4, 1H, C(6)H), 7.60 
– 7.47 (m, 1H, C(8)H), 7.45 – 7.36 (m, 2H, C(13)H & C(17)H), 7.36 – 7.24 (m, 2H, C(7)H 
& C(9)H), 7.06 – 6.90 (m, 2H, C(14)H & C(16)H), 3.85 (s, 3H, C(18)H3), 3.58 (s, 3H, 
C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.7 (qC-2), 162.7 (qC-4), 159.6 (qC-15), 152.4 
(qC-10), 132.1 (C(13)H & C(17)H), 131.8 (C(8)H), 124.3 (qC-12), 124.0 (C(7)H), 123.8 
(C(6)H), 117.9 (qC-5), 116.4 (C(9)H), 113.8 (C(14)H & C(16)H), 111.0 (qC-3), 61.1 
(C(11)H3), 55.3 (C(18)H3); m/z (ES+): 283 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C17H15O4 283.0970; Found 283.0970.   
4-Methoxy-3-(4-(trifluoromethyl)phenyl)-2H-chromen-2-one (114) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 
4-(trifluoromethyl)phenylboronic acid (67.6 mg, 
0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 114 as a yellow solid (0.058 g, 76%); m.p. 153–156 °C; IR νmax (film) 
1700 (ester C=O stretch), 1612 (alkene C=C stretch), 1567 (aromatic C–C stretch), 
1327 (C–O stretch), 1121 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 7.89 (dd, J = 8.0, 
1.5, 1H, C(6)H), 7.71 (d, J = 8.2, 2H, C(14)H & C(16)H), 7.67 – 7.53 (m, 3H, C(8)H, 
C(13)H & C(17)H), 7.41 – 7.28 (m, 2H, C(7)H & C(9)H), 3.59 (s, 3H, C(11)H3); 13C NMR 
(75 MHz, CDCl3) δ 163.7 (qC-4), 162.9 (qC-2), 152.6 (qC-10), 136.2 (qC-12), 132.5 
(C(8)H), 131.4 (C(13)H & C(17)H), 130.5 (q, J = 32, qC-15), 125.2 (q, J = 4, C(14)H & 
C(16)H), 124.3 (C(7)H), 124.0 (C(6)H), 124.0 (q, J = 272, qC-18), 117.4 (qC-5), 116.6 
(C(9)H), 110.2 (qC-3), 61.6 (C(11)H3); 19F NMR (282 MHz, CDCl3) δ -63 (s, C(18)F3); m/z 
(ES+): 321 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H12O3F3 
321.0739; Found 321.0735.  
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4-Methoxy-3-(4-fluorophenyl)-2H-chromen-2-one (115) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 4-fluorophenylboronic acid 
(49.8 mg, 0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 115 as a yellow solid (0.046 g, 72%); 
m.p. 135–137 °C; IR νmax (film) 1699 (ester C=O stretch), 1609 (alkene C=C stretch), 
1570 (aromatic C–C stretch), 1222 (C–O stretch), 1161 (C–O stretch); 1H NMR (300 
MHz, CDCl3) δ 7.87 (dd, J = 7.9, 1.6, 1H, C(6)H), 7.56 (ddd, J = 8.4, 7.3, 1.6, 1H, C(8)H), 
7.51 – 7.41 (m, 2H, C(13)H & C(17)H), 7.39 – 7.27 (m, 2H, C(7)H & C(9)H), 7.21 – 7.08 
(m, 2H, C(14)H & C(16)H), 3.58 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.3 
(qC-4), 163.2 (qC-2), 162.6 (d, J = 248, qC-15), 152.5 (qC-10), 132.8 (d, J = 8, C(13)H & 
C(17)H), 132.2 (C(8)H), 128.1 (d, J = 4, qC-12), 124.1 (C(7)H), 123.9 (C(6)H), 117.6 
(qC-5), 116.5 (C(9)H), 115.4 (d, J = 22, C(14)H & C(16)H), 110.4 (qC-3), 61.3 (C(11)H3); 
19F NMR (282 MHz, CDCl3) δ -113 (s, C(15)F); m/z (ES+): 271 ((M+H)+ 100%); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C16H12O3F 271.0770; Found 271.0770.   
4-Methoxy-3-(4-(trifluoromethoxy)phenyl)-2H-chromen-2-one (116) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 
mg, 0.237 mmol, 1.0 equiv.) and 4-
(trifluoromethoxy)phenylboronic acid (73.3 mg, 0.356 
mmol, 1.5 equiv.) were used in the General Procedure 
to yield 116 as a yellow solid (0.061 g, 77%); m.p. 145–146 °C; IR νmax (film) 1700 
(ester C=O stretch), 1616 (alkene C=C stretch), 1570 (aromatic C–C stretch), 1351 (C–
O stretch), 1258 (C–O stretch), 1211 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 7.88 
(dd, J = 7.9, 1.4, 1H, C(6)H), 7.62 – 7.48 (m, 3H, 3 × ArCH), 7.41 – 7.27 (m, 4H, 4 × 
ArCH), 3.59 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.5 (qC-4), 163.1 (qC-2), 
152.6 (qC-10), 149.1 (q, J = 2, qC-15), 132.5 (C(13)H & C(17)H), 132.3 (C(8)H), 130.9 
(qC-12), 124.2 (C(7)H), 123.9 (C(6)H), 120.6 (C(14)H & C(16)H), 120.5 (q, J = 258, qC-
18), 117.5 (qC-5), 116.6 (C(9)H), 110.2 (qC-3), 61.4 (C(11)H3); 19F NMR (282 MHz, 
CDCl3) δ -58 (s, C(18)F3); m/z (ES+): 337 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ 
C17H12O4F3 337.0688; Found 337.0671. 
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4-(4-Methoxy-2-oxo-2H-chromen-3-yl)benzaldehyde (117) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 4-formylphenylboronic acid 
(53.4 mg, 0.356 mmol, 1.5 equiv.) were used in the 
General Procedure. The residue was purified by column 
chromatography (MeOH:DCM 1:99) to yield 117 as a 
yellow solid (0.032 g, 48%); m.p. 154–155 °C; IR νmax (film) 2729 (aldehyde C–H 
stretch), 1701 (ester C=O stretch), 1607 (alkene C=C stretch), 1567 (aromatic C–C 
stretch), 1348 (C–O stretch), 1207 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 10.07 
(s, 1H, C(18)H), 8.02 – 7.93 (m, 2H, C(14)H & C(16)H), 7.89 (dd, J = 8.0, 1.3, 1H, C(6)H), 
7.74 – 7.65 (m, 2H, C(13)H & C(17)H), 7.64 – 7.53 (m, 1H, C(8)H), 7.42 – 7.28 (m, 2H, 
C(7)H & C(9)H), 3.60 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 191.7 (C(18)H), 163.8 
(qC-4), 162.7 (qC-2), 152.7 (qC-10), 138.9 (qC-12), 136.0 (qC-15), 132.6 (C(8)H), 131.8 
(C(13)H & C(17)H), 129.5 (C(14)H & C(16)H), 124.3 (C(7)H), 124.0 (C(6)H), 117.4 (qC-
5), 116.6 (C(9)H), 110.3 (qC-3), 61.7 (C(11)H3); m/z (ES+): 281 ((M+H)+ 100%); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C17H13O4 281.0814; Found 281.0815.   
Ethyl 4-(4-methoxy-2-oxo-2H-chromen-3-yl)benzoate (118) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 
(50.0 mg, 0.237 mmol, 1.0 equiv.) and 
4-ethoxycarbonylbenzeneboronic acid (69.1 mg, 
0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 118 as an off-white solid 
(0.070 g, 91%); m.p. 131–133 °C; IR νmax (film) 1715 (ester C=O stretch), 1610 (alkene 
C=C stretch), 1573 (aromatic C–C stretch), 1348 (C–O stretch), 1274 (C–O stretch); 1H 
NMR (300 MHz, CDCl3) δ 8.18 – 8.07 (m, 2H, C(14)H & C(16)H), 7.88 (dd, J = 8.0, 1.3, 
1H, C(6)H), 7.64 – 7.52 (m, 3H, C(8)H, C(13)H & C(17)H), 7.41 – 7.28 (m, 2H, C(7)H & 
C(9)H), 4.41 (q, J = 7.1, 2H, C(19)H2), 3.57 (s, 3H, C(11)H3), 1.41 (t, J = 7.1, 3H, C(20)H3); 
13C NMR (75 MHz, CDCl3) δ 166.2 (qC-18), 163.5 (qC-4), 162.9 (qC-2), 152.6 (qC-10), 
137.2 (qC-12), 132.4 (C(8)H), 131.1 (C(13)H & C(17)H), 130.4 (qC-15), 129.4 (C(14)H 
& C(16)H), 124.2 (C(7)H), 124.0 (C(6)H), 117.5 (qC-5), 116.6 (C(9)H), 110.4 (qC-3), 61.5 
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(C(11)H3), 61.1 (C(19)H2), 14.3 (C(20)H3); m/z (ES+): 325 ((M+H)+ 100%); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C19H17O5 325.1076; Found 325.1079.   
3-(4-Acetylphenyl)-4-methoxy-2H-chromen-2-one (119) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 4-acetylphenylboronic acid 
(58.4 mg, 0.356 mmol, 1.5 equiv.) were used in the 
General Procedure to yield 119 as a white solid 
(0.053 g, 76%); m.p. 183–187 °C; IR νmax (film) 1712 
(ester C=O stretch), 1682 (ketone C=O stretch), 1611 (alkene C=C stretch), 1571 
(aromatic C–C stretch), 1347 (C–O stretch), 1267 (C–O stretch); 1H NMR 
(300 MHz, CDCl3) δ 8.10 – 7.99 (m, 2H, C(14)H & C(16)H), 7.89 (dd, J = 7.9, 1.5, 1H, 
C(6)H), 7.65 – 7.52 (m, 3H, 3 × ArCH), 7.41 – 7.28 (m, 2H, 2 × ArCH), 3.59 (s, 3H, 
C(11)H3), 2.65 (s, 3H, C(19)H3); 13C NMR (75 MHz, CDCl3) δ 197.6 (qC-18), 163.6 (qC-4), 
162.9 (qC-2), 152.6 (qC-10), 137.5 (qC-12), 136.8 (qC-15), 132.5 (C(8)H), 131.3 (C(13)H 
& C(17)H), 128.2 (C(14)H & C(16)H), 124.2 (C(7)H), 124.0 (C(6)H), 117.5 (qC-5), 116.6 
(C(9)H), 110.3 (qC-3), 61.6 (C(11)H3), 26.7 (C(19)H3); m/z (ES+): 295 ((M+H)+ 100%); 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C18H15O4 295.0970; Found 295.0952. 
4-(4-Methoxy-2-oxo-2H-chromen-3-yl)benzonitrile (120) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 4-cyanophenylboronic acid 
(52.3 mg, 0.356 mmol, 1.5 equiv were used in the 
General Procedure to yield 120 as a white solid (0.055 g, 
84%); m.p. 199–202 °C; IR νmax (film) 2225 (C≡N stretch), 1699 (ester C=O stretch), 
1610 (alkene C=C stretch), 1454 (aromatic C–C stretch), 1351 (C–O stretch); 1H NMR 
(300 MHz, CDCl3) δ 7.89 (dd, J = 8.0, 1.3, 1H, C(6)H), 7.79 – 7.71 (m, 2H, C(14)H & 
C(16)H), 7.68 – 7.56 (m, 3H, C(8)H, C(13)H & C(17)H), 7.41 – 7.30 (m, 2H, C(7)H & 
C(9)H), 3.60 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 164.1 (qC-4), 162.5 (qC-2), 
152.7 (qC-10), 137.4 (qC-12), 132.8 (C(8)H), 132.0 (C(14)H & C(16)H), 131.8 (C(13)H 
& C(17)H), 124.4 (C(7)H), 124.1 (C(6)H)), 118.5 (qC-18), 117.2 (qC-5), 116.7 (C(9)H), 
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112.2 (qC-15), 110.0 (qC-3), 61.8 (C(11)H3); m/z (ES+): 278 ((M+H)+ 100%); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C17H12NO3 278.0817; Found 278.0808. 
4-Methoxy-3-(4-vinylphenyl)-2H-chromen-2-one (121) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and (4-vinylphenyl)boronic 
acid (52.7 mg, 0.356 mmol, 1.5 equiv.) were used in the 
General Procedure to yield 121 as an yellow solid 
(0.051 g, 77%); m.p. 102–104 °C; IR νmax (film) 1713 (ester C=O stretch), 1608 (alkene 
C=C stretch), 1571 (aromatic C–C stretch), 1346 (C–O stretch), 1328 (C–O stretch); 1H 
NMR (300 MHz, CDCl3) δ 7.92 – 7.82 (m, 1H, C(6)H), 7.60 – 7.41 (m, 5H, 5 × ArCH), 
7.39 – 7.26 (m, 2H, 2 × ArCH), 6.76 (dd, J = 17.6, 10.9, 1H, C(18)H), 5.81 (dd, J = 17.6, 
0.8, 1H, C(19)H2), 5.30 (dd, J = 10.9, 0.8, 1H, C(19)H2), 3.59 (s, 3H, C(11)H3); 13C NMR 
(75 MHz, CDCl3) δ 163.3 (qC-4), 163.0 (qC-2), 152.5 (qC-10), 137.7 (qC-12), 136.4 
(C(18)H), 132.0 (C(8)H), 131.7 (qC-15), 131.1 (C(13)H & C(17)H), 126.1 (C(14)H & 
C(16)H), 124.1 (C(7)H), 123.9 (C(6)H), 117.7 (qC-5), 116.5 (C(9)H), 114.6 (C(19)H2), 
110.9 (qC-3), 61.3 (C(11)H3); m/z (ES+): 279 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: 
[M+H]+ Calcd for C18H15O3 279.1021; Found 279.1025. 
3-(3-Aminophenyl)-4-methoxy-2H-chromen-2-one (122) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 3-aminophenylboronic acid 
monohydrate (55.2 mg, 0.356 mmol, 1.5 equiv.) were used 
in the General Procedure to yield 122 as an orange solid 
(0.050 g, 79%); m.p. 131–136 °C; IR νmax (film) 3367 (N–H 
stretch), 1712 (ester C=O stretch), 1645 (N–H bend), 1610 (alkene C=C stretch), 1570 
(aromatic C–C stretch), 1266 (C–O stretch), 738 (N–H wag); 1H NMR (300 MHz, CDCl3) 
δ 7.90 – 7.81 (m, 1H, C(6)H), 7.53 (ddd, J = 8.4, 7.3, 1.6, 1H, C(8)H), 7.38 – 7.14 (m, 
3H, C(7)H, C(9)H & C(16)H), 6.86 – 6.76 (m, 2H, C(13)H & C(17)H), 6.71 (ddd, J = 8.0, 
2.4, 1.0, 1H, C(15)H), 3.63 (s, 3H, C(11)H3), 3.53 (br s, 2H, NH2); 13C NMR (75 MHz, 
CDCl3) δ 163.5 (qC-4), 162.6 (qC-2), 152.4 (qC-10), 146.4 (qC-14), 133.3 (qC-12), 131.9 
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(C(8)H), 129.2 (C(7)H), 124.0 (C(16)H), 123.9 (C(6)H), 121.5 (C(17)H), 117.8 (qC-5), 
117.7 (C(15)H), 116.4 (C(9)H), 115.4 (C(13)H), 110.8 (qC-3), 61.1 (C(11)H3); m/z (ES+): 
268 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H14NO3 268.0974; 
Found 268.0961. 
4-Methoxy-3-(3-(trifluoromethyl)phenyl)-2H-chromen-2-one (123) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 
3-(trifluoromethyl)phenylboronic acid (67.6 mg, 0.356 
mmol, 1.5 equiv.) were used in the General Procedure to 
yield 123 as a yellow solid (0.066 g, 87%); m.p. 95–97 °C; 
IR νmax (film) 1716 (ester C=O stretch), 1610 (alkene C=C stretch), 1570 (aromatic C–
C stretch), 1330 (C–O stretch), 1125 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 7.93 
– 7.84 (m, 1H, C(6)H), 7.79 – 7.53 (m, 5H, 5 × ArCH), 7.40 – 7.28 (m, 2H, 2 × ArCH), 
3.57 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.7 (qC-4), 162.9 (qC-2), 152.6 
(qC-10), 134.4 (C(17)H), 133.2 (qC-12), 132.5 (C(8)H), 130.8 (q, J = 33, qC-14), 128.8 
(C(16)H), 127.8 (q, J = 4, C(15)H), 125.2 (q, J = 4, C(13)H), 124.3 (C(7)H), 124.0 (C(6)H), 
124.0 (q, J = 273, qC-18), 117.4 (qC-5), 116.6 (C(9)H), 110.1 (qC-3), 61.6 (C(11)H3); 19F 
NMR (282 MHz, CDCl3) δ -63 (s, C(18)F3); m/z (ES+): 321 ((M+H)+ 100%); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C17H12O3F3 321.0739; Found 321.0734.   
4-Methoxy-3-(3-nitrophenyl)-2H-chromen-2-one (124) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 3-nitrophenylboronic acid 
(59.4 mg, 0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 124 as a yellow solid (0.058 g, 82%); m.p. 
153–155 °C; IR νmax (film) 1714 (ester C=O stretch), 1611 
(alkene C=C stretch), 1570 (aromatic C–C stretch), 1528 (asymmetric N–O stretch), 
1349 (symmetric N–O stretch), 1298 (C–O stretch), 1106 (C–O stretch); 1H NMR (300 
MHz, CDCl3) δ 8.39 (t, J = 1.9, 1H, C(13)H), 8.26 (ddd, J = 8.3, 2.3, 1.1, 1H, C(15)H), 
7.95 – 7.82 (m, 2H, C(6)H & C(17)H), 7.69 – 7.57 (m, 2H, C(8)H & C(16)H), 7.42 – 7.31 
(m, 2H, C(7)H & C(9)H), 3.62 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 164.2 (qC-4), 
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162.7 (qC-2), 152.7 (qC-10), 148.2 (qC-14), 137.1 (C(17)H), 134.1 (qC-12), 132.8 
(C(16)H), 129.3 (C(8)H), 125.9 (C(13)H), 124.5 (C(7)H), 124.1 (C(6)H), 123.3 (C(15)H), 
117.2 (qC-5), 116.7 (C(9)H), 109.6 (qC-3), 61.9 (C(11)H3); m/z (ES+): 298 ((M+H)+ 
100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C16H12NO5 298.0715; Found 298.0720.   
4-Methoxy-3-(3-methoxyphenyl)-2H-chromen-2-one (125) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 3-methoxyphenylboronic acid 
(54.1 mg, 0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 125 as a yellow oil (0.061 g, 91%); IR νmax 
(film) 1715 (ester C=O stretch), 1611 (alkene C=C stretch), 
1572 (aromatic C–C stretch), 1347 (C–O stretch), 1214 (C–O stretch), 1106 (C–O 
stretch); 1H NMR (300 MHz, CDCl3) δ 7.87 (dd, J = 7.9, 1.4, 1H, C(6)H), 7.55 (ddd, J = 
8.6, 7.4, 1.6, 1H, C(8)H), 7.44 – 7.22 (m, 3H, 3 × ArCH), 7.10 – 6.87 (m, 3H, 3 × ArCH), 
3.83 (s, 3H, C(18)H3), 3.60 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.3 (qC-2), 
162.8 (qC-4), 159.4 (qC-14), 152.5 (qC-10), 133.7 (qC-12), 132.0 (C(8)H), 129.3 
(C(16)H), 124.0 (C(7)H), 123.9 (C(6)H), 123.5 (C(17)H), 117.7 (qC-5), 116.6 (C(15)H), 
116.4 (C(9)H), 114.1 (C(13)H), 110.7 (qC-3), 61.1 (C(11)H3), 55.3 (C(18)H3); m/z (ES+): 
283 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H15O4 283.0970; Found 
283.0961.   
4-Methoxy-3-(2-(trifluoromethyl)phenyl)-2H-chromen-2-one (126) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 
2-(trifluoromethyl)phenylboronic acid (67.6 mg, 0.356 
mmol, 1.5 equiv.) were used in the General Procedure to 
yield 126 as a yellow solid (0.042 g, 56%); IR νmax (film) 1716 (ester C=O stretch), 1613 
(alkene C=C stretch), 1573 (aromatic C–C stretch), 1350 (C–O stretch), 1315 (C–O 
stretch); 1H NMR (300 MHz, CDCl3) δ 7.89 (dd, J = 8.0, 1.3, 1H, C(13)H), 7.82 – 7.74 
(m, 1H, C(16)H), 7.68 – 7.45 (m, 4H, C(6)H, C(7)H, C(8)H & C(15)H), 7.41 – 7.27 (m, 
2H, C(9)H & C(14)H), 3.56 (s, 3H, C(11)H3); 13C NMR (151 MHz, CDCl3) δ 163.0 (qC-4), 
161.5 (qC-2), 152.6 (qC-10), 133.7 (C(8)H), 132.5 (q, J = 29, qC-12), 132.3 (C(7)H), 
Chapter 5  Experimental 
257 
 
131.7 (C(6)H), 130.7 (q, J = 30, qC-17), 129.2 (C(15)H), 126.6 (q, J = 5, C(16)H), 124.2 
(C(13)H), 124.1 (C(14)H), 123.9 (d, J = 274, qC-18), 116.9 (qC-5), 116.6 (C(9)H), 105.7 
(qC-3), 60.3 (C(11)H3); 19F NMR (282 MHz, CDCl3) δ -61 (s, C(18)F3); m/z (ES+): 321 
((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C17H12O3F3 321.0739; Found 
321.0726. 
3-(Furan-2-yl)-4-methoxy-2H-chromen-2-one (127) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 2-furanylboronic acid (39.8 mg, 
0.356 mmol, 1.5 equiv.) were used in the General Procedure 
to yield 127 as a yellow oil (0.039 g, 68%); IR νmax (film) 1723 
(ester C=O stretch), 1625 (C=C stretch), 1610 (C=C stretch), 1549 (aromatic C–C 
stretch), 1348 (C–O stretch), 1328 (C–O stretch), 1124 (C–O stretch); 1H NMR (300 
MHz, CDCl3) δ 7.88 (dd, 1H, J = 8.0, 1.4, C(6)H), 7.61 – 7.51 (m, 2H, C(8)H & C(15)H), 
7.37 – 7.27 (m, 2H, C(7)H & C(9)H), 6.82 (dd, J = 3.3, 0.8, 1H, C(13)H), 6.55 (dd, J = 3.3, 
1.9, 1H, C(14)H), 3.80 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.9 (qC-4), 161.9 
(qC-2), 152.4 (qC-10), 144.5 (qC-12), 142.9 (C(13)H), 132.5 (C(8)H), 124.2 (C(6)H), 
124.0 (C(7)H), 117.3 (qC-5), 116.6 (C(9)H), 113.9 (C(15)H), 111.6 (C(14)H), 101.4 
(qC-3), 60.5 (C(11)H3); m/z (ES+): 243 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ 
Calcd for C14H11O4 243.0657; Found 243.0652.   
3-(Furan-3-yl)-4-methoxy-2H-chromen-2-one (128) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 3-furanylboronic acid (39.8 mg, 
0.356 mmol, 1.5 equiv.) were used in the General 
Procedure. The residue was purified by column 
chromatography (EtOAc:hexanes 10:90) to yield 128 as a white solid (0.037 g, 64%); 
m.p. 97–99 °C; IR νmax (film) 1710 (ester C=O stretch), 1614 (C=C stretch), 1602 (C=C 
stretch), 1538 (aromatic C–C stretch), 1329 (C–O stretch), 1161 (C–O stretch); 1H 
NMR (300 MHz, CDCl3) δ 8.18 (d, J = 0.6, 1H, C(15)H), 7.80 (dd, J = 7.9, 1.4, 1H, C(6)H), 
7.63 – 7.45 (m, C(7)H & C(8)H), 7.42 – 7.28 (m, 2H, C(9)H & C(14)H), 7.10 – 6.92 (m, 
1H, C(13)H), 3.87 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 162.7 (qC-4), 162.1 
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(qC-2), 152.2 (qC-10), 144.3 (C(14)H), 142.5 (C(15)H), 131.7 (C(8)H), 124.3 (C(6)H), 
123.4 (C(7)H), 117.5 (qC-5), 116.6 (C(9)H), 115.8 (qC-12), 111.2 (C(13)H), 108.1 (qC-3), 
60.8 (C(11)H3); m/z (ES+): 243 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C14H11O4 243.0657; Found 243.0656.   
3-(Dibenzo[b,d]furan-4-yl)-4-methoxy-2H-chromen-2-one (129) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and dibenzofuran-4-boronic acid 
(75.5 mg, 0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 129 as a yellow solid (0.068 g, 84%); m.p. 
196–198 °C; IR νmax (film) 1714 (ester C=O stretch), 1645 
(C=C stretch), 1570 (aromatic C–C stretch), 1349 (C–O 
stretch); 1H NMR (300 MHz, CDCl3) δ 8.05 – 7.90 (m, 3H, 3 × ArCH), 7.64 – 7.49 (m, 
3H, 3 × ArCH), 7.49 – 7.29 (m, 5H, 5 × ArCH), 3.50 (s, 3H, C(11)H3); 13C NMR (75 MHz, 
CDCl3) δ 163.7 (qC-4), 162.8 (qC-2), 156.2 (qC-10), 154.7 (qC-Ar), 152.7 (qC-Ar), 132.3 
(ArCH), 130.0 (ArCH), 127.4 (ArCH), 124.5 (qC-Ar), 124.2 (qC-Ar), 124.1 (ArCH), 124.1 
(ArCH), 123.0 (ArCH), 122.8 (ArCH), 121.2 (ArCH), 120.8 (ArCH), 117.6 (qC-Ar), 117.3 
(qC-5), 116.6 (C(9)H), 112.0 (ArCH), 104.3 (qC-3), 60.6 (C(11)H3); m/z (ES+): 343 
((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C22H15O4 343.0970; Found 
343.0960. 
4-Methoxy-3-(thiophen-3-yl)-2H-chromen-2-one (130) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and 3-thiophenylboronic acid (45.6 
mg, 0.356 mmol, 1.5 equiv.) were used in the General 
Procedure to yield 130 as a yellow oil (0.057 g, 93%); IR νmax 
(film) 1717 (ester C=O stretch), 1610 (C=C stretch), 1573 (aromatic C–C stretch), 1341 
(C–O stretch), 1326 (C–O stretch), 756 (C–S stretch); 1H NMR (300 MHz, CDCl3) δ 7.85 
(dd, J = 7.9, 1.6, 1H, C(6)H), 7.68 – 7.63 (m, 1H, C(14)H), 7.54 (ddd, J = 8.7, 7.3, 1.6, 
1H, C(8)H), 7.43 – 7.27 (m, 4H, 4 × ArCH), 3.66 (s, 3H, C(11)H3); 13C NMR (75 MHz, 
CDCl3) δ 163.4 (qC-4), 162.8 (qC-2), 152.3 (qC-10), 132.0 (C(8)H), 131.2 (qC-12), 129.6 
(C(13)H), 126.9 (C(14)H), 124.9 (C(15)H), 124.2 (C(6)H), 123.8 (C(7)H), 117.7 (qC-5), 
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116.5 (C(9)H), 107.9 (qC-3), 60.8 (C(11)H3); m/z (ES+): 259 ((M+H)+ 100%); HRMS 
(ESI-TOF) m/z: [M+H]+ Calcd for C14H11O3S 259.0429; Found 259.0432.   
3-(Benzo[b]thiophen-2-yl)-4-methoxy-2H-chromen-2-one (131) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and benzo[b]thiophene-2-
boronic acid (63.4 mg, 0.356 mmol, 1.5 equiv.) were 
used in the General Procedure to yield 131 as a yellow 
solid (0.055 g, 75%); m.p. 132–136 °C; IR νmax (film) 1720 (ester C=O stretch), 1608 
(C=C stretch), 1554 (aromatic C–C stretch), 1351 (C–O stretch), 1328 (C–O stretch), 
749 (C–S stretch); 1H NMR (300 MHz, CDCl3) δ 7.95 (d, J = 0.6, 1H, C(13)H), 7.90 – 7.75 
(m, 3H, C(6)H, C(16)H & C(17)H), 7.57 (ddd, J = 8.4, 7.3, 1.6, 1H, C(8)H), 7.41 – 7.28 
(m, 4H, C(7)H, C(9)H, C(15)H & C(18)H), 3.90 (s, 3H, C(11)H3); 13C NMR (75 MHz, 
CDCl3) δ 163.8 (qC-4), 161.8 (qC-2), 152.4 (qC-10), 140.9 (qC-19), 139.1 (qC-14), 132.6 
(qC-12), 132.5 (ArCH), 127.6 (ArCH), 125.0 (ArCH), 124.4 (ArCH), 124.4 (ArCH), 124.1 
(ArCH), 124.0 (ArCH), 121.9 (ArCH), 117.2 (qC-5), 116.7 (C(9)H), 107.8 (qC-3), 61.3 
(C(11)H3); m/z (ES+): 309 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C18H13O3S 309.0585; Found 309.0590.   
3-(Dibenzo[b,d]thiophen-4-yl)-4-methoxy-2H-chromen-2-one (132) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and dibenzothiophene-4-boronic 
acid (81.2 mg, 0.356 mmol, 1.5 equiv.) were used in the 
General Procedure to yield 132 as a yellow solid (0.084 g, 
99%); m.p. 191–196 °C; IR νmax (film) 1714 (ester C=O 
stretch), 1611 (C=C stretch), 1566 (aromatic C–C stretch), 
1349 (C–O stretch), 754 (C–S stretch); 1H NMR (300 MHz, CDCl3) δ 8.27 – 8.12 (m, 2H, 
C(15)H & C(18)H), 7.94 (dd, J = 8.0, 1.5, 1H, ArCH), 7.86 – 7.75 (m, 1H, C(6)H), 7.65 – 
7.28 (m, 7H, 7 × ArCH), 3.50 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.2 (qC-4), 
162.5 (qC-2), 152.7 (qC-10), 141.7 (qC-23), 139.4 (qC-22), 135.8 (qC-Ar), 135.8 
(qC-Ar), 132.4 (ArCH), 129.8 (ArCH), 127.9 (qC-12), 127.0 (ArCH), 124.7 (ArCH), 124.6 
(ArCH), 124.2 (ArCH), 124.1 (ArCH), 122.9 (ArCH), 121.9 (ArCH), 121.8 (ArCH), 117.3 
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(qC-5), 116.6 (C(9)H), 107.1 (qC-3), 60.3 (C(11)H3); m/z (ES+): 359 ((M+H)+ 100%); 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C22H15O3S 359.0742; Found 359.0746. 
3-(1H-Indol-2-yl)-4-methoxy-2H-chromen-2-one (133) 
3-Chloro-4-methoxy-2H-chromen-2-one 104 (50.0 mg, 
0.237 mmol, 1.0 equiv.) and (1-(tert-butoxycarbonyl)-
1H-indol-2-yl)boronic acid (92.9 mg, 0.356 mmol, 1.5 
equiv.) were used in the General Procedure to yield 133 
as a yellow solid (0.038 g, 55%); m.p. 169–174 °C; IR νmax 
(film) 3403 (N–H stretch), 1645 (ester C=O stretch), 1454 (aromatic C–C stretch), 
1346 (C–O stretch), 1266 (C–N stretch), 1112 (C–O stretch); 1H NMR (300 MHz, CDCl3) 
δ 10.43 (br s, 1H, N–H), 7.89 – 7.81 (m, 1H, C(6)H), 7.67 (dd, J = 7.9, 0.9, 1H, C(18)H), 
7.60 – 7.52 (m, 1H, C(8)H), 7.45 (dd, J = 8.1, 0.9, 1H, C(15)H), 7.42 – 7.28 (m, 3H, 
C(7)H, C(9)H & C(13)H), 7.23 (ddd, J = 8.2, 7.0, 1.2, 1H, C(16)H), 7.13 (ddd, J = 8.0, 7.0, 
1.0, 1H, C(17)H), 3.98 (s, 3H, C(11)H3); 13C NMR (75 MHz, CDCl3) δ 163.4 (qC-4), 163.0 
(qC-2), 152.0 (qC-10), 135.6 (qC-19), 132.0 (C(8)H), 128.2 (qC-14), 128.1 (qC-12), 
124.7 (C(7)H), 123.7 (C(6)H), 123.1 (C(16)H), 120.8 (C(18)H), 120.1 (C(17)H), 117.6 
(qC-5), 116.7 (C(9)H), 111.4 (C(15)H), 108.1 (qC-3), 106.6 (C(13)H), 60.5 (C(11)H3); m/z 
(ES+): 292 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C18H14NO3 
292.0974; Found 292.0979. 
4-Methoxy-6-methyl-3-phenyl-2H-pyran-2-one (134)51 
3-Chloro-4-methoxy-6-methyl-2H-pyran-2-one 107 (30.0 mg, 
0.172 mmol, 1.0 equiv.) and phenylboronic acid (31.5 mg, 
0.258 mmol, 1.5 equiv.) were used in the General Procedure. 
The residue was purified by column chromatography 
(EtOAc:hexanes 50:50) to yield 134 as a yellow solid (0.028 g, 75%); m.p. 155–159 °C 
(lit.51 156-157 °C); 1H NMR (300 MHz, CDCl3) δ 7.46 – 7.33 (m, 4H, 4 × ArCH), 7.32 – 
7.24 (m, 1H, ArCH), 6.13 (d, J = 0.8, 1H, C(5)H), 3.82 (s, 3H, C(8)H3), 2.32 (d, J = 0.8, 
3H, C(7)H3); 13C NMR (75 MHz, CDCl3) δ 165.9 (qC-4), 164.3 (qC-6), 162.7 (qC-2), 131.4 
(qC-9), 130.5 (C(10)H & C(14)H), 127.9 (C(11)H & C(13)H), 127.4 (C(12)H), 105.3 
(C(5)H), 95.3 (qC-3), 56.5 (C(8)H3), 20.5 (C(7)H3); m/z (ES+): 217 ((M+H)+ 22%). 
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Spectral characteristics were consistent with previously reported data.51 
4-Methoxy-1,6-dimethyl-3-phenylpyridin-2(1H)-one (135)52 
3-Chloro-4-methoxy-1,6-dimethylpyridin-2(1H)-one 101 (44.5 
mg, 0.237 mmol, 1.0 equiv.) and phenylboronic acid (43.3 mg, 
0.356 mmol, 1.5 equiv.) were used in the General Procedure. 
The residue was purified by column chromatography 
(MeOH:DCM 0.5:99.5) to yield 135 as a yellow semi-solid (0.052 g, 96%); IR νmax (film) 
1634 (amide C=O stretch), 1558 (alkene C=C stretch), 1362 (C–O stretch), 1266 (C–N 
stretch); 1H NMR (300 MHz, CDCl3) δ 7.45 – 7.20 (m, 5H, 5 × ArCH), 6.02 (d, J = 0.5, 
1H, C(5)H), 3.75 (s, 3H, C(8)H3), 3.54 (s, 3H, C(18)H3), 2.40 (d, J = 0.6 Hz, 3H, C(7)H3); 
13C NMR (75 MHz, CDCl3) δ 163.7 (qC-4), 162.8 (qC-2), 146.1 (qC-6), 133.6 (qC-9), 
130.8 (C(10)H & C(14)H), 127.7 (C(11)H & C(13)H), 126.8 (C(12)H), 111.8 (qC-3), 95.3 
(C(5)H), 55.8 (C(8)H3), 31.4 (C(18)H3), 21.6 (C(7)H3); m/z (ES+): 230 ((M+H)+ 100%); 
HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C14H16NO2 230.1181; Found 230.1180. 
Spectral characteristics were consistent with previously reported data.52 
1-Ethyl-4-methoxy-3-phenylquinolin-2(1H)-one (136)  
3-Chloro-1-ethyl-4-methoxyquinolin-2(1H)-one 103 
(56.3 mg, 0.237 mmol, 1.0 equiv.) and phenylboronic acid 
(43.3 mg, 0.356 mmol, 1.5 equiv.) were used in the General 
Procedure. The residue was purified by column 
chromatography (EtOAc:hexanes 10:90) to yield 136 as a 
clear colourless oil (0.059 g, 89%); IR νmax (film) 1635 (amide C=O stretch), 1593 
(alkene C=C stretch), 1356 (C–O stretch), 1111 (C–N stretch); 1H NMR (400 MHz, 
CDCl3) δ 8.03 (dd, J = 8.0, 1.3, 1H, ArCH), 7.66 – 7.56 (m, 1H, ArCH), 7.55 – 7.48 (m, 
2H, 2 × ArCH), 7.48 – 7.31 (m, 4H, 4 × ArCH), 7.30 – 7.20 (m, 1H, 1 × ArCH), 4.39 (q, J 
= 7.1, 2H, C(18)H2), 3.50 (s, 3H, C(11)H3), 1.38 (t, J = 7.1, 3H, C(19)H3); 13C NMR 
(101 MHz, CDCl3) δ 162.9 (qC-4), 160.4 (qC-2), 138.4 (qC-10), 133.5 (qC-12), 130.9 
(ArCH), 130.9 (2 × ArCH), 128.1 (2 × ArCH), 127.7 (ArCH), 124.4 (ArCH), 121.7 (ArCH), 
119.3 (qC-5), 118.5 (qC-3), 113.8 (ArCH), 60.8 (C(11)H3), 37.8 (C(18)H2), 12.8 
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(C(19)H3); m/z (ES+): 280 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for 
C18H18NO2 280.1338; Found 280.1335.   
4-Phenoxy-3-phenyl-2H-chromen-2-one (137)  
3-Chloro-4-phenoxy-2H-chromen-2-one 105 (64.6 mg, 
0.237 mmol, 1.0 equiv.) and phenylboronic acid (43.3 mg, 
0.356 mmol, 1.5 equiv.) were used in the General 
Procedure. The residue was purified by column 
chromatography (EtOAc:hexanes 10:90) to yield 137 as a 
white solid (0.063 g, 85%); m.p. 191–194 °C; IR νmax (film) 1723 (ester C=O stretch), 
1625 (C=C stretch), 1483 (aromatic C–C stretch), 1350 (C–O stretch), 1207 (C–O 
stretch); 1H NMR (300 MHz, CDCl3) δ 7.63 (dd, J = 8.0, 1.5, 1H, ArCH), 7.56 (ddd, J = 
8.8, 7.3, 1.6, 1H, ArCH), 7.47 – 7.32 (m, 3H, 3 × ArCH), 7.31 – 7.10 (m, 6H, 6 × ArCH), 
7.00 – 6.90 (m, 1H, ArCH), 6.84 – 6.75 (m, 2H, 2 × ArCH); 13C NMR (75 MHz, CDCl3) δ 
162.4 (qC-2), 158.6 (qC-4), 156.5 (qC-11), 153.1 (qC-10), 132.3 (ArCH), 130.4 (qC-17), 
130.1 (2 × ArCH), 129.7 (2 × ArCH), 128.4 (ArCH), 128.0 (2 × ArCH), 124.4 (ArCH), 124.3 
(ArCH), 123.2 (ArCH), 118.3 (qC-5), 117.0 (qC-3), 116.8 (ArCH), 116.3 (2 × ArCH); m/z 
(ES+): 315 ((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C21H15O3 315.1021; 
Found 315.1013. 
6-Methyl-4-phenoxy-3-phenyl-2H-pyran-2-one (138)  
3-Chloro-6-methyl-4-phenoxy-2H-pyran-2-one 109 
(56.1 mg, 0.237 mmol, 1.0 equiv.) and phenylboronic acid 
(43.3 mg, 0.356 mmol, 1.5 equiv.) were used in the General 
Procedure. The residue was purified by column 
chromatography (EtOAc:hexanes 8:92) to yield 138 as an 
off-white solid (0.050 g, 76%); m.p. 129–133 °C; IR νmax (film) 1716 (ester C=O 
stretch), 1647 (C=C stretch), 1566 (C=C stretch), 1489 (aromatic C–C stretch), 1345 
(C–O stretch), 1220 (C–O stretch); 1H NMR (300 MHz, CDCl3) δ 7.59 – 7.50 (m, 2H, 2 
× ArCH), 7.44 – 7.33 (m, 4H, 4 × ArCH), 7.33 – 7.19 (m, 2H, 2 × ArCH), 7.07 – 6.98 (m, 
2H, 2 × ArCH), 5.72 (d, J = 0.8, 1H, C(5)H), 2.20 (d, J = 0.8, 3H, C(7)H3); 13C NMR 
(75 MHz, CDCl3) δ 164.2 (qC-6), 163.9 (qC-2), 162.1 (qC-4), 153.7 (qC-8), 130.8 
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(qC-14), 130.4 (2 × ArCH), 130.2 (2 × ArCH), 128.0 (2 × ArCH), 127.8 (ArCH), 125.6 
(ArCH), 120.5 (2 × ArCH), 108.7 (qC-3), 98.4 (C(5)H), 20.2 (C(7)H3); m/z (ES+): 279 
((M+H)+ 100%); HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C18H15O3 279.1021; Found 
279.1018. 
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 Oxidation of 3-methylpyrano[4,3-c]isochromen-1(6H)-one 
3-Methyl-1H,6H-pyrano[4,3-c]isochromene-1,6-dione (75)  
To a reaction vial with a stir bar was added pyridinium 
chlorochromate (PCC) (20.5 mg, 1.5 equiv.). 
3-Methylpyrano[4,3-c]isochromen-1(6H)-one 31 (13.6 mg, 1.0 
equiv.) was dissolved in 1 mL DCE and added to the vial. The vial 
was capped and placed in an oil bath preheated to 84 °C. The 
reaction mixture was refluxed for 4 h, cooled to ambient temperature and filtered 
through a plug of celite, then a plug of silica with the aid of DCM. The crude product 
was a yellow solid consisting of both starting material and product (1.8:1.0 SM:P). 
The crude product was dissolved in 1 mL DCE and added to a fresh reaction vial 
containing PCC (22.5 mg, 1.5 equiv.). The reaction mixture was stirred at 84 °C for 4 
days, then at ambient temperature for 3 days, and the reaction mixture was 
transferred onto a plug of silica and eluted with DCM to afford 75 as a tan solid 
(0.0041 g, 26%); 1H NMR (300 MHz, CDCl3) δ 9.02 (ddd, J = 8.3, 1.0, 0.5, 1H, C(10)H), 
8.33 (ddd, J = 7.9, 1.5, 0.5, 1H, C(13)H), 7.87 (ddd, J = 8.3, 7.3, 1.5, 1H, C(12)H), 7.59 
(ddd, J = 8.0, 7.4, 1.1, 1H C(11)H), 6.25 (d, J = 0.9, 1H, C(5)H), 2.39 (d, J = 0.8, 3H, 
C(7)H3); 13C NMR (75 MHz, CDCl3) δ 163.7 (qC-6), 162.2 (qC-8), 160.4 (qC-4), 159.5 
(qC-2), 136.0 (C(10)H), 133.1 (qC-14), 130.1 (C(13)H), 128.8 (C(12)H), 125.5 (C(11)H), 
119.7 (qC-9), 99.4 (C(5)H), 98.9 (qC-3), 20.3 (C(7)H3); m/z (ES-): 227 ((M−H)− 100%). 
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 Isolation of oxidative addition intermediate 145 
[Pd{(C7H6O-2-(C9H5O2))}I(PPh3)2] (145) 
A Schlenk tube was heated under vacuum and refilled 
with N2 three times. Pd2(dba)3 (42.4 mg, 0.046 mmol, 1.0 
equiv.) and PPh3 (97.0 mg, 0.370 mmol, 8.0 equiv.) were 
added. The Schlenk tube was evacuated and refilled with 
N2 three times. Freshly distilled THF (10 mL) was added 
giving a brown solution. The reaction was stirred at ambient temperature for 15 min, 
resulting in a dark green solution. 4-((2-Iodobenzyl)oxy)-2H-chromen-2-one 20 
(35.0 mg, 0.093 mmol, 2.0 equiv.) was added to the solution. The coumarin dissolved 
and the solution remained dark green. The Schlenk tube was placed in an oil bath 
preheated to 70 °C and stirred at this temperature for 1 h. The vessel was then cooled 
to ambient temperature and the reaction mixture concentrated under reduced 
pressure yielding a green residue. Et2O (5 mL) was used to dissolve the residue. The 
solution was stored at 5–8 °C overnight. The resulting grey precipitate was isolated 
by suction filtration and dried under vacuum to yield 145 as a grey powder (42.1 mg, 
90% yield); 1H NMR (300 MHz, CDCl3) δ 7.52 – 7.41 (m, 13H, 13 × ArCH), 7.35 – 7.14 
(m, 20H, 20 × ArCH), 7.08 – 7.00 (m, 1H, ArCH), 6.87 – 6.81 (m, 1H, ArCH), 6.64 – 6.57 
(m, 2H, C(16)H & C(17)H), 6.37 – 6.30 (m, 1H, C(15)H), 5.64 (s, 1H, C(3)H), 4.85 (s, 2H, 
C(11)H2); 13C NMR (75 MHz, CDCl3) δ 165.5 (qC-4), 162.9 (qC-2), 161.3 (t, J = 3, qC-
13), 153.3 (qC-10), 137.1 (t, J = 4, qC-Ar), 136.3 (t, J = 5, ArCH), 134.7 (t, J = 6, 12 × 
ArCH), 132.1 (ArCH), 131.6 (t, J = 24, 6 × qC-Ar), 130.0 (6 × ArCH), 128.7 (ArCH), 127.9 
(t, J = 5, 12 × ArCH), 127.4 (ArCH), 123.5 (ArCH), 123.2 (ArCH), 123.0 (ArCH), 116.6 
(ArCH), 115.7 (qC-5), 90.4 (C(3)H), 74.3 (C(11)H2); 31P{1H} NMR (121 MHz, CDCl3) δ: 
22.8 (s, P-18 & P-19). 
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 Procedures for mechanistic experiments 
5.8.1.  Use of oxidative addition product 145 as a catalyst  
 
 
 
 
 
145 (2 mol%) 
 
 
 
 
 
 
20  38 
This experiment was conducted as per the General Procedure in Section 5.3.1, except 
that [Pd{(C7H6O-2-(C9H5O2))}I(PPh3)2] 145 (2.7 mg, 0.003 mmol, 2 mol%) was used 
instead of Pd2(dba)3 and PPh3 with 4-((2-iodobenzyl)oxy)-2H-chromen-2-one 20 (50 
mg, 0.132 mmol, 1.0 equiv.) as the substrate. The yield of 38 was determined from 
the 1H NMR spectrum of the crude reaction mixture with 1,3,5-trimethoxybenzene 
as the internal standard for quantification. In the presence of PivOH, the yield of 38 
was determined to be 55%. In the absence of PivOH, the yield of 38 was determined 
to be 3%. 
  
Chapter 5  Experimental 
267 
 
5.8.2.  Investigation of the competence of oxidative addition product 
145 to form the product 38 without additional substrate 20 
  
 
 
145  38 
A Schlenk tube was heated under vacuum and refilled with N2 three times. Dry 
Na2CO3 (15.8 mg, 0.149 mmol, 10.0 equiv.) was added to a Schlenk tube. The Schlenk 
was then heated under vacuum and refilled with N2 twice. [Pd{(C7H6O-2-
(C9H5O2))}I(PPh3)2] 145 (15.0 mg, 0.0.015 mmol, 1.0 equiv.) and PivOH (4.6 mg, 0.045 
mmol, 3.0 equiv., if used) were then added. The Schlenk was then evacuated and 
refilled with N2 twice. Anhydrous NMP (1 mL) was added and the reaction mixture 
was placed in an oil bath preheated to 130 °C. After 3 hours, the mixture was allowed 
to cool to room temperature and diluted with water (10 mL) and EtOAc (10 mL). The 
organic layers were extracted with EtOAc (2 × 10 mL) and washed with 1 M aqueous 
HCl (1 × 20 mL), H2O (3 × 10 mL) and brine (1 × 20 mL). The combined organic extracts 
were dried, filtered and concentrated under reduced pressure. The yield of 38 was 
determined from the 1H NMR spectrum of the crude reaction mixture with 
1,3,5-trimethoxybenzene as the internal standard for quantification. In the presence 
of PivOH, the yield of 38 was determined to be 36%. In the absence of PivOH, the 
yield was determined to be 5%. 
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5.8.3.  Detection of oxidative addition product 145 in reaction solvent 
 
A Schlenk tube was heated under vacuum and refilled with N2 three times. Pd2(dba)3 
(48.4 mg, 0.053 mmol, 1.0 equiv.) and PPh3 (111.0 mg, 0.423 mmol, 8.0 equiv.) were 
then added. The Schlenk was then evacuated and refilled with N2 three times. 
Anhydrous NMP (2 mL) was added giving a dark green solution. The reaction was 
stirred at ambient temperature for 15 minutes. 4((2-Iodobenzyl)oxy)-2H-chromen-
2-one 20 (40 mg, 0.106 mmol, 1.0 equiv.) was added to the NMP solution. The 
coumarin dissolved and the solution remained dark green. The reaction mixture was 
heated to 70 °C and stirred at this temperature for 1 h. 0.1 mL of the reaction mixture 
was removed at this point and analysed using 1H and 31P{1H} NMR to confirm the 
presence of the oxidative addition intermediate 145. PivOH (16.2 mg, 0.159 mmol, 
3.0 equiv.) and Na2CO3 (56.1 mg, 0.529 mmol, 10.0 equiv.) were then added to the 
reaction mixture. The reaction was then heated to 130 °C and stirred at this 
temperature for a further 3 h. The mixture was then allowed to cool to ambient 
temperature and diluted with water (10 mL) and EtOAc (10 mL). The organic layers 
were extracted with EtOAc (2 × 10 mL) and washed with 1 M aqueous HCl (1 × 20 mL), 
H2O (3 × 10 mL) and brine (1 × 20 mL). The combined organic extracts were dried, 
filtered and concentrated under reduced pressure. The yield of 38 was determined 
to be 47% from the 1H NMR spectrum of the crude reaction mixture with 
1,3,5-trimethoxybenzene as the internal standard for quantification. 
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5.8.4.  Determination of kinetic isotope effect at C–3 for the formation 
of 6H,11H-isochromeno[4,3-c]chromen-11-one (38) 
Using a Carousel® parallel reactor, 12 reaction tubes were heated at 140 °C under 
vacuum for 30 min, then refilled with N2. The hot tubes were then evacuated and 
refilled with N2 twice more. Na2CO3 (79.0 mg, 0.750 mmol, 3.0 equiv.) was added to 
each tube. The hot tubes were evacuated and refilled with N2 twice. The heat was 
turned off and the tubes were allowed to cool to ambient temperature under N2. To 
each of the 12 tubes was added Pd2(dba)3 (4.6 mg, 0.005 mmol, 2 mol%), PPh3 (2.6 
mg, 0.010 mmol, 4 mol%) and PivOH (7.7 mg, 0.075 mmol, 30 mol%). To 6 of the 
tubes was added 4-((2-iodobenzyl)oxy)-2H-chromen-2-one 20 (95.0 mg, 0.250 mmol, 
1.0 equiv.), and to the other 6 tubes was added 4-((2-iodobenzyl)oxy)-2H-chromen-
2-one-3-d 148 (95.0 mg, 0.250 mmol, 1.0 equiv.). The 12 tubes were evacuated and 
refilled with N2 three times. The hot plate was set to heat to 130 °C while anhydrous 
NMP (2 mL) was added to each tube. Each tube was sealed off from the N2 inlet after 
NMP addition. When the addition of NMP to the final tube was complete, the hot 
plate had reached the desired temperature (t = 0). The reactions were quenched in 
pairs (one non-deuterated, one deuterated) by adding H2O (10 mL) at the following 
time points: 5 min, 10 min, 20 min, 45 min, 90 min, 180 min. The quenched reactions 
were removed from the Carousel® and cooled to ambient temperature. Each mixture 
was extracted with EtOAc (3 × 10 mL). The combined organic layers for each mixture 
were washed with 1 M aqueous HCl (1 × 20 mL), H2O (3 × 10 mL) and brine (1 × 20 
mL), dried over MgSO4 and concentrated under reduced pressure. 
Each crude reaction mixture was analysed by 1H NMR using 1,3,5-trimethoxybenzene 
as an internal standard for quantification. This set of reactions was performed twice 
and the data from the two runs were averaged. The yields of 6H,11H-benzofuro[4,3-
c]chromen-11-one 38 were plotted against reaction time to give the plot shown in 
Figure 4.2. 
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5.8.5. Determination of intramolecular kinetic isotope effect for 3-
bromo-2-pyrone direct arylation 
K2CO3 (0.15 g, 1.07 mmol) was added to a Schlenk tube. The Schlenk tube was then 
heated under vacuum using a heat gun and refilled with N2. This was repeated twice 
more and the Schlenk tube was allowed to cool. 3-Bromo-4-(2-deuterio)phenoxy-6-
methyl-2H-pyran-2-one 152 (0.10 g, 0.36 mmol), Pd(OAc)2 (0.004 g, 0.02 mmol) and 
PPh3 (0.014 g, 0.05 mmol) were then added. The reagents were then stirred under 
vacuum and the Schlenk tube was refilled with N2. This procedure was repeated twice 
more. Xylenes (1 mL/0.25 mmol) was then added. The reaction was heated to 130 °C 
and stirred for 15 hours. Upon cooling, the reaction was diluted with water (15 mL) 
and EtOAc (15mL). The mixture was extracted with EtOAc (2 × 15 mL). The organic 
layer was then dried over MgSO4, filtered and concentrated under reduced pressure. 
The residues were purified by column chromatography (EtOAc:hexanes 4:96). A 1H 
NMR spectrum of the isolated product was recorded. The ratio of non-deuterated to 
deuterated product was used to determine the KIE, as shown in Figure 4.3. 
5.8.6. Determination of kinetic isotope effect for C–3 position in 
double C–H activation  
Following the reported methodology,12 six identical reactions were set side-by-side. 
Each reaction tube was charged with 4-phenoxy-2H-chromen-2-one 97 (50 mg, 0.21 
mmol), Pd(OAc)2 (4.7 mg, 0.02 mmol), NaOtBu (4.0 mg, 0.04 mmol), Ag2O (73 mg, 
0.31 mmol) and PivOH (0.5 M). The reactions were stirred at 120 °C in air and stopped 
at 5, 10, 20, 40, 60 and 120 min, respectively. In a parallel experiment, six reactions 
were performed using 3-deuterio-4-phenoxy-2H-chromen-2-one 156 (50 mg, 0.21 
mmol) as a substrate under otherwise identical conditions. Each of the reactions was 
diluted with DCM and filtered through a pad of celite. The organic layers were 
washed with 10% (w/v) aqueous NaOH, dried over MgSO4 and concentrated under 
reduced pressure.  
The crude reaction mixture was analysed by 1H NMR using 1,3,5-trimethoxybenzene 
as an internal standard for quantification. This set of experiments was performed 
twice, and the data from the two runs were averaged. The yields of 6H-
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benzofuro[3,2-c]chromen-6-one 154 were plotted against reaction time to give the 
plot shown in Figure 4.7. 
5.8.7. Determination of kinetic isotope effect for aryl C–H position in 
double C–H activation 
Experiment 1 
A reaction tube was charged with 5-methoxy-4-phenoxy-2H-chromen-2-one 162 
(40 mg, 0.150 mmol), Pd(OAc)2 (3.4 mg, 0.0150 mmol), NaOtBu (2.9 mg, 
0.030 mmol), Ag2O (52.1 mg, 0.225 mmol) and PivOH (889 mg, 1 mL). The reaction 
mixture was stirred at 120 °C in air. In a parallel experiment, a reaction was 
performed using 5-methoxy-4-(phenoxy-d5)-2H-chromen-2-one 165 (41 mg, 
0.150 mmol) as a substrate under otherwise identical conditions. After 5, 10, 20 and 
40 mins, a sample was simultaneously removed from both reactions. The sample was 
diluted with DCM and filtered through a pad of celite. The organic layers were dried 
over MgSO4 and concentrated under reduced pressure.  
The crude reaction mixtures were analysed by 1H NMR. The % conversion from 
starting material to 1-methoxy-6H-benzofuro[3,2-c]chromen-6-one 167 for each 
sample was determined. This set of reactions was performed twice, and the data 
from the two runs were averaged. % Conversion was plotted against reaction time to 
give the plot shown in Figure 4.9. 
Experiment 2 
A reaction tube was charged with 5,7-dimethyl-4-phenoxy-2H-chromen-2-one 164 
(26.6 mg, 0.10 mmol), Pd(OAc)2 (2.2 mg, 0.01 mmol), NaOtBu (1.9 mg, 0.02 mmol), 
Ag2O (34.8 mg, 0.15 mmol) and PivOH (889 mg, 1 mL). The reaction was stirred at 
120 °C in air. In a parallel experiment, a reaction was performed using 5,7-dimethyl-
4-(phenoxy-d5)-2H-chromen-2-one 166 (27.1 mg, 0.10 mmol) as a substrate under 
otherwise identical conditions. After 5, 10, 20 and 40 mins, a sample was 
simultaneously removed from both reactions. The sample was diluted with DCM and 
filtered through a pad of celite. The organic layers were concentrated under reduced 
pressure.  
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The crude reaction mixtures were analysed by 1H NMR. The % conversion to 
1,3-dimethyl-6H-benzofuro[3,2-c]chromen-6-one 168 for each sample was plotted 
against reaction time to give the plot shown in Figure 4.10. 
5.8.8. Scrambling experiment 
A reaction tube was charged with 4-phenoxy(-d5)-2H-chromen-2-one 157 (50 mg, 
0.21 mmol), Pd(OAc)2 (4.7 mg, 0.02 mmol), NaOtBu (4.0 mg, 0.04 mmol), Ag2O 
(73 mg, 0.31 mmol) and PivOH (0.5 M). The reaction was stirred at 140 °C in air for 
2 h, then cooled to ambient temperature, diluted with DCM and filtered through a 
pad of celite. The organic layers were washed with 10% (w/v) aqueous NaOH, dried 
over MgSO4 and concentrated under reduced pressure. The residue was then flushed 
through silica gel using DCM as eluent to afford the product, which was purified by 
recrystallisation from DCM/hexanes and analysed by 1H NMR to give the spectrum 
shown in Figure 4.8. 
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Appendix II 
 
  
Other mechanisms for CDC of 4-phenoxy-2-
coumarins 
Several mechanistic modes of action were considered possible for the CDC of 4-
phenoxy-2-coumarins. The most likely mechanistic pathway is discussed in Section 
4.4.5. In addition to that pathway, other pathways were considered but discounted. 
It is these pathways which are discussed in this Appendix. 
The activation of the aryl C–H bond could occur before coumarin C–3–H activation, 
as in Scheme I. A CMD pathway1 and a carbopalladation pathway2 were both 
considered as possibilities for this sequence of activation.  
 
Scheme I. Mechanistic possibilities investigated for Pd-catalysed CDC of 4-phenoxy-
2-coumarin. 
The CMD pathway shown in Scheme I was calculated using DFT (Figure I).  
  
  
 
Figure I. DFT calculations for the direct arylation of 97 to 154 via double C–H 
activation. Pathway (a) shows that CMD of phenyl ring happens first.   
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This pathway was calculated to begin with an κ2-κ1 displacement of an acetate ligand 
(TS4, G‡ = 9.8 kcal mol−1) to give a π-complex IM6. The structure of this intermediate 
only shows small distortion, which cannot be regarded as Wheland intermediate, 
thus ruling out an SEAr mechanism.1, 3-4 IM6 is followed by a CMD5 transition state 
TS5 (G‡ = 6.2 kcal mol−1) which generates IM7. TS5 represents the summit of the 
potential energy surface for this pathway, which is consistent with the observed 
primary positive KIE of 3 for the cleavage of the aryl C–H bond. 
After interconversion from IM7 to the π-complex IM8, the acetate ligand could rotate 
to coordinate to the hydrogen of the other acetate acid ligand to generate IM3-2 (G 
= −12.8 kcal mol−1) via a stronger intramolecular hydrogen bond which confers 
additional stability.6 An acetate ligand abstracts the C–3 proton from the 2-coumarin 
(Figure I, blue hydrogen) via a second CMD transition state TS6 (G‡ = 22.6 kcal mol−1) 
to generate IM5. IM5 is also calculated to exist in the DFT calculation shown in Figure 
4.11. 
The palladation and C–H cleavage at the C–3 position is not calculated to be 
reversible in this pathway due to the energy barrier between intermediates IM8 and 
IM5. Additionally, the relatively facile reductive elimination (TS7, G‡ = 21.8 kcal 
mol−1) is likely irreversible. This conflicts with the experimental evidence which shows 
that palladium-mediated H/D exchange is reversible at the C–3 position (Figure 4.4 
and Figure 4.5). 
The reductive elimination (TS7, G‡ = 21.8 kcal mol−1) releases product 154 and the 
palladium complex Pd(0)(HOAc)2. The proton on the acetic acid ligand could transfer 
to a Brønsted base such as tert-butoxide (tBuO−) or pivalate (PivO−), while Pd(0) is 
likely oxidised to Pd(II) by Ag2O. It is difficult to study the oxidation step in a 
meaningful way as there are no reasonable structural models for Ag2O at this time. 
The summit of the potential energy surfaces for both DFT calculations can be 
compared. The summit of the potential energy surface for the pathway shown in 
Figure 4.11 is TS2 (G = 12.2 kcal mol−1) which is lower than the summit of the other 
pathway (Figure I, TS5, G = 14.4 kcal mol−1). The pathway in Figure 4.11 is therefore 
more favourable by 2.2 kcal mol (in the free energy barrier).  
  
In general, it would seem unlikely that this is the operative mechanism due to the 
conflicts between the experimental evidence and the computational data. 
Next, it was important to consider carbopalladation (Scheme I) as a possible 
mechanism for the CDC of 4-phenoxy-2-coumarins due to the similarities between 2-
coumarins and 4-chromones. A carbopalladation pathway has been reported for the 
arylation of 4-chromones by Choi et al. (Scheme II).2 The objective of their 
computational work was to explain the experimentally observed regioselectivity of 
4-chromone arylation, in favour of 2-arylation. 
 
Scheme II. Mechanism of chromone arylation proposed by Choi et al.2 
The C–H activation of benzene was computed to occur more quickly than the C–H 
activation at either the C–2 or C–3 position of chromone. Additionally, the resultant 
phenylpalladium species is more stable than the analogous intermediate at either 
  
position of chromone. Since arylpalladium species were known experimentally to add 
across the π-bonds of enones, a carbopalladation of the phenylpalladium 
intermediate across the isolated π-bond of chromone was investigated by Choi et al.2 
Two carbopalladation transition states were identified (one for the 2-arylated 
product (Scheme II) and one for the 3-arylated product) and it was confirmed that 
there was no feasible means of interconversion between the two adducts, meaning 
that carbopalladation was the regioselective step. The greater π-electron density at 
the C–3 position of chromone favours the delivery of the electrophilic Pd(OTFA) 
centre to this position, which leads to the C–2 delivery of the phenyl group in the 
carbopalladation step (Scheme II). The experimentally observed KIE of 2.90 for 
benzene-h6/d6 agrees with the computed turnover-limiting C–H cleavage of benzene. 
These carbopalladation transition states were found to lie much lower in energy 
(>7 kcal mol−1) than the structures obtained for a sequential CMD pathway, lending 
support for a carbopalladation pathway. The calculations showed that the steps 
following carbopalladation were relatively facile, rendering carbopalladation 
irreversible and therefore the regiodetermining step in chromone arylation.  
In our case, the electrophilic Pd species also prefers to approach the C–3 position due 
to the greater π-electron density, consistent with the calculations described by Choi 
et al.2 This electronic preference of Pd for the C–3 position restricts the ability of the 
aryl ring to approach the C–3 position to give the observed product 154. In order to 
achieve our observed product 154, Pd would need to approach either C–2 or C–4. 
Since the phenyl ring of the arylpalladium intermediate IM7 is connected to the 
2-coumarin through an oxygen atom, a conformation to fulfil a carbopalladation-type 
addition could not be found (Figure II). This is in contast to Choi et al.’s report which 
describes an intermolecular reaction.2 
  
 
Figure II. The optimised structure IM7. Some hydrogen atoms are omitted for clarity. 
Overall, this data seems to render a carbopalladation mechanism for the CDC of 
4-phenoxy-2-coumarin (97) unlikely. 
Having identified conflicts between the experimental observations and the 
computational data for both of the mechanistic modes shown in Scheme I, these 
mechanisms were considered unlikely. The available experimental and 
computational evidence at this time indicates that the mechanistic proposal shown 
in Scheme 4.34 (Section 4.4.5) is most likely to be operative. 
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